,Date,Title,Url
0,2018-01-01,포항대웅파크2차67가구추가대피,http://www.kukinews.com/news/article.html?no=513552
1,2018-01-01,포항시위험판정대웅파크2차67가구추가대피,http://www.newsis.com/view/?id=NISX20180101_0000191551&cID=10810&pID=10800
2,2018-01-01,포항시위험판정대웅파크2차67가구기쁨의교회로추가대피,http://news.heraldcorp.com/village/view.php?ud=201801011734205411578_10
3,2018-01-02,흥해대웅파크2차이주결정왜늦었나,http://www.hidomin.com/news/articleView.html?idxno=346994
4,2018-01-02,포항시지진피해위험판정대웅파크2차67가구추가대피,http://www.ajunews.com/view/20180102004434304
5,2018-01-02,위험판정흥해대웅파크2차67가구추가대피,http://www.kyongbuk.co.kr/?mod=news&act=articleView&idxno=1013522
6,2018-01-02,포항대웅파크2차67가구추가대피,http://www.ksmnews.co.kr/default/index_view_page.php?idx=194754&part_idx=289
7,2018-01-02,포항대웅2차아파트67가구대피지시,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20180102.010210939450001
8,2018-01-02,지진피해포항대웅파크2차67가구추가대피위험판정,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180102061900053&did=1195m
9,2018-01-02,대웅제약2018년매출1조원이상목표RD투자확대,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=213742
10,2018-01-02,대웅제약매출1조원이상목표‥RD투자확대,http://medipana.com/news/news_viewer.asp?NewsNum=213935&MainKind=A&NewsKind=5&vCount=12&vKind=1
11,2018-01-02,신년사이종욱대웅제약부회장글로벌헬스케어그룹되자”,http://www.newsway.co.kr/view.php?tp=1&ud=2018010210452192971
12,2018-01-02,대웅제약2018년매출1조원달성위해달리자,http://www.dailypharm.com/News/235216
13,2018-01-02,대웅제약2018년글로벌헬스케어그룹도약하겠다”,http://www.sedaily.com/NewsView/1RU9T9676K
14,2018-01-02,이종욱대웅제약부회장올해매출1조원달성목표,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180102076100017&did=1195m
15,2018-01-02,대웅제약2018년매출1조원이상달성목표로”,http://www.mhj21.com/sub_read.html?uid=111214§ion=sc243
16,2018-01-02,대웅제약2018년직원성장과글로벌경쟁력강화에총력,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018010211050713472
17,2018-01-02,신년사이종욱대웅제약부회장2018년매출1조원달성,http://www.newspim.com/news/view/20180102000124
18,2018-01-02,신년사이종욱대웅제약부회장개방형혁신으로회사직원동반성장하자,http://news.mk.co.kr/newsRead.php?year=2018&no=2466
19,2018-01-02,대웅제약2018년글로벌헬스케어그룹성장위해총력”,http://www.fnnews.com/news/201801021124197957
20,2018-01-02,신년사이종욱대웅제약대표2018년매출1조원이상달성,http://www.ebn.co.kr/news/view/924064
21,2018-01-02,대웅제약매출1조글로벌헬스케어그룹성장”,http://www.asiae.co.kr/news/view.htm?idxno=2018010211513285649
22,2018-01-02,대웅제약2018년글로벌헬스케어그룹성장위해총력”,http://www.mdtoday.co.kr/mdtoday/index.html?no=306890
23,2018-01-02,아파야챙길래대웅제약동아쏘시오그룹CJ헬스케어外,http://www.g-enews.com/ko-kr/news/article/news_all/201801021304454420e6a49afa8d_1/article.html
24,2018-01-02,대웅제약2018년글로벌헬스케어그룹성장위해총력,http://www.sportsseoul.com/news/read/586109
25,2018-01-02,이종욱대웅제약부회장2018년매출1조달성목표”,http://news.hankyung.com/article/201801026964f
26,2018-01-02,대웅제약글로벌헬스케어그룹성장위해총력,http://www.bosa.co.kr/news/articleView.html?idxno=2075596
27,2018-01-02,신년사이종욱대웅제약회장직원성장글로벌경쟁력강화,http://www.newsprime.co.kr/news/article.html?no=401016
28,2018-01-02,대웅제약2018년글로벌헬스케어그룹성장위해총력,http://www.metroseoul.co.kr/news/newsview?newscd=2018010200086
29,2018-01-02,대웅제약글로벌헬스케어그룹성장위해총력,http://www.newstomato.com/ReadNews.aspx?no=797821
30,2018-01-02,대웅제약2018년글로벌헬스케어기업도약,http://www.kormedi.com/news/news/drug_dist/1225678_2906.html
31,2018-01-02,대웅제약2018년글로벌헬스케어그룹성장에총력,http://www.techholic.co.kr/news/articleView.html?idxno=172864
32,2018-01-02,대웅제약새해매출1조목표글로벌헬스케어총력,http://www.asiatime.co.kr/news/articleView.html?idxno=162418
33,2018-01-02,이종욱대웅제약부회장글로벌경쟁력갖춰직원회사모두성장하자,http://www.edaily.co.kr/news/newspath.asp?newsid=03260326619073784
34,2018-01-02,이종욱대웅제약부회장올해매출1조달성목표,http://www.newsis.com/view/?id=NISX20180102_0000192563&cID=13001&pID=13000
35,2018-01-02,신년사이종욱대웅제약부회장글로벌헬스케어그룹으로”,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018010215388020949&outlink=1
36,2018-01-02,대웅제약연매출1조목표글로벌헬스케어그룹총력,http://www.seoulfn.com/news/articleView.html?idxno=296253
37,2018-01-02,이종욱대웅제약부회장매출1조원목표사명감가져야”,http://news.mt.co.kr/mtview.php?no=2018010215391179961
38,2018-01-02,신년사이종욱대웅제약부회장글로벌헬스케어그룹도약하자,http://www.dailian.co.kr/news/view/684224/?sc=naver
39,2018-01-02,대웅제약2018년글로벌헬스케어그룹성장위해총력,http://www.newscj.com/news/articleView.html?idxno=479938
40,2018-01-02,대웅제약글로벌헬스케어그룹으로성장하기위해최선다할것,http://www.k-health.com/news/articleView.html?idxno=33676
41,2018-01-02,대웅제약이종욱부회장2018년매출1조원달성하겠다,http://www.insight.co.kr/news/133246
42,2018-01-02,대웅제약2018년매출1조원달성위해달리자열정넘치는신년사,http://www.insight.co.kr/news/133237
43,2018-01-02,지진피해포항대웅파크67가구추가대피,http://www.idaegu.com?c=6&uid=377063
44,2018-01-02,포항흥해위험판정받은대웅파크2차아파트67가구기쁨의교회로추가이주,http://www.kbsm.net/default/index_view_page.php?idx=194953
45,2018-01-03,대웅제약2018년글로벌헬스케어그룹성장위해총력”,http://www.lawissue.co.kr/view.php?ud=201801022341327338d7f4c63cc6_12
46,2018-01-03,대웅제약항궤양제개발총력블록버스터급신약꿈꾼다,http://news.mk.co.kr/newsRead.php?year=2018&no=4236
47,2018-01-03,한올바이오파마김성욱부회장측지분매매대웅지배강화수순,http://www.mdtoday.co.kr/mdtoday/index.html?no=307000
48,2018-01-03,대웅제약올만기도래회사채비중240넘어상환능력고심,http://www.ceoscoredaily.com/news/article.html?no=36056
49,2018-01-03,포항시위험판정대웅파크2차67가구추가대피실시,http://www.anewsa.com/detail.php?number=1264376&thread=09r02
50,2018-01-03,빅데이터MSI시장심리톱5삼성전자대한항공대웅제약LGPOSCO,http://www.newsis.com/view/?id=NISX20180103_0000193025&cID=10401&pID=10400
51,2018-01-03,빅데이터MSI10시시장심리톱5삼성전자대한항공대웅제약LGPOSCO,http://www.newsis.com/view/?id=NISX20180103_0000193129&cID=10401&pID=10400
52,2018-01-04,대웅제약올해영업이익576억원양호한성장지속전망,http://www.nspna.com/news/?mode=view&newsid=259828
53,2018-01-04,대웅제약4분기실적보다올해실적주목신한금투,http://www.sedaily.com/NewsView/1RUAOWRC9M
54,2018-01-04,대웅제약올해양호한성장지속전망목표가↑,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018010408511089518
55,2018-01-04,대웅제약한올바이오파마지분가치상승목표가↑신한,http://www.edaily.co.kr/news/newspath.asp?newsid=01564566619074440
56,2018-01-04,신한금투대웅제약올해성장세지속목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180104038700008&did=1195m
57,2018-01-04,신한금융투자대웅제약올해실적호조전망목표가172↑”,http://www.g-enews.com/ko-kr/news/article/news_all/201801040853295813c16aa2f016_1/article.html
58,2018-01-04,일렉트릭40대웅전기공업,http://www.electimes.com/article.php?aid=1513669117151230065
59,2018-01-04,대웅제약매출1조클럽진입할까,http://www.kormedi.com/news/news/drug_dist/1225702_2906.html
60,2018-01-04,ET투자뉴스대웅제약4분기실적보다는TRADINGBUY유지신한금융투자,http://www.etnews.com/20180104000058
61,2018-01-04,특징주대웅제약한올바이오파마지분가치상승주목,http://www.sisaon.co.kr/news/articleView.html?idxno=67839
62,2018-01-04,대웅제약올해실적호조전망한올바이오파마지분가치상승주목,http://www.newspost.kr/news/articleView.html?idxno=60410
63,2018-01-04,대웅제약올해영업이익576억원으로양호한성장지속,http://www.newsworks.co.kr/news/articleView.html?idxno=159095
64,2018-01-04,포스트제품사수안간힘소송제약사된대웅제약,http://biz.newdaily.co.kr/news/article.html?no=10150174
65,2018-01-05,이종욱대웅제약부회장멀고먼글로벌그룹,http://www.datanews.co.kr/news/article.html?no=100083
66,2018-01-05,ET투자뉴스대웅_외국인투자자의거래참여활발거래비중1712,http://www.etnews.com/20180105000047
67,2018-01-05,국민연금대웅지분5보유,http://news.mt.co.kr/mtview.php?no=2018010511233910906
68,2018-01-05,ET투자뉴스대웅지분변동국민연금공단외1명501p증가501보유,http://www.etnews.com/20180105000115
69,2018-01-05,국민연금공단대웅지분501보유,http://www.mdtoday.co.kr/mdtoday/index.html?no=307335
70,2018-01-05,국민연금환인대웅지분매입종근당콜마는확대,http://www.dailypharm.com/News/235358
71,2018-01-08,클릭e종목대웅제약나보타美허가기대감목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2018010807061117192
72,2018-01-08,대웅제약나보타미국허가기대목표가↑NH,http://news.hankyung.com/article/2018010839496
73,2018-01-08,대웅제약2분기나보타미국허가기대,http://www.asiatoday.co.kr/view.php?key=20180108010003481
74,2018-01-08,NH투자대웅제약나보타미국진출기대목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180108025100008&did=1195m
75,2018-01-08,대웅제약보톡스올해미국출시가능목표주가올라,http://www.businesspost.co.kr/BP?command=article_view&num=69075
76,2018-01-08,대웅제약나보타미국진출기대NH,http://www.fnnews.com/news/201801080832518609
77,2018-01-08,NH투자대웅제약나보타美허가기대,http://news20.busan.com/controller/newsController.jsp?newsId=20180108000022
78,2018-01-08,아주종목분석대웅제약나보타미국출시로실적개선기대,http://www.ajunews.com/view/20180108092502354
79,2018-01-08,석천대웅재단석천나눔재단으로명칭변경,http://medipana.com/news/news_viewer.asp?NewsNum=214211&MainKind=A&NewsKind=5&vCount=12&vKind=1
80,2018-01-08,더벨대웅제약잇단관료영입강영철전규제조정실장도,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201801080100011590000695
81,2018-01-08,석천대웅재단석천나눔재단으로명칭변경나눔문화확산,http://www.asiae.co.kr/news/view.htm?idxno=2018010811060158299
82,2018-01-08,대웅제약첫석천나눔상수상자로스탠리토플애양원명예회장선정,http://news.mk.co.kr/newsRead.php?year=2018&no=15307
83,2018-01-08,대웅제약단기실적보다는나보타美허가기대감에주목,http://www.newsworks.co.kr/news/articleView.html?idxno=159645
84,2018-01-08,석천대웅재단석천나눔재단으로명칭변경,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=213938
85,2018-01-08,석천대웅재단→석천나눔재단명칭변경,http://www.dailymedi.com/detail.php?number=826219&thread=22r05
86,2018-01-08,석천대웅재단석천나눔재단으로명칭변경나눔문화확대,http://www.newsprime.co.kr/news/article.html?no=401701
87,2018-01-08,ET투자뉴스대웅제약2018년본격적인BUYINITIATE토러스투자증권,http://www.etnews.com/20180108000119
88,2018-01-08,대웅제약강영철전국무조정실실장고문으로영입,http://www.dailypharm.com/News/235426
89,2018-01-08,석천대웅재단석천나눔재단으로명칭변경,http://www.bosa.co.kr/news/articleView.html?idxno=2075964
90,2018-01-08,석천대웅재단대웅빠지고나눔들어간다,http://www.ajunews.com/view/20180108133308631
91,2018-01-08,석천대웅재단석천나눔재단으로명칭변경나눔문화확대,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801080338
92,2018-01-08,석천대웅재단석천나눔재단으로명칭변경1회석천나눔상신설,http://www.kukinews.com/news/article.html?no=515248
93,2018-01-08,ET투자뉴스대웅제약단기실적보단나매수유지NH투자증권,http://www.etnews.com/20180108000387
94,2018-01-08,대웅제약경영진쇄신3년내매출3조로,http://www.sedaily.com/NewsView/1RUCLGT1QK
95,2018-01-09,한미LG삼성에동아대웅유한까지미국行총출동,http://www.dailymedi.com/detail.php?number=826245&thread=22r05
96,2018-01-09,대웅제약메디톡스휴젤보톡스시장적응증늘리기경쟁,http://www.mdtoday.co.kr/mdtoday/index.html?no=307561
97,2018-01-09,더벨대웅한미법인세환급제약업계주목,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201801080100012290000733
98,2018-01-09,대웅제약1회석천나눔상에애양원스탠리토플박사,http://www.etoday.co.kr/news/section/newsview.php?idxno=1582475
99,2018-01-10,대웅제약이지듀새해첫프로모션골든위크진행,http://medipana.com/news/news_viewer.asp?NewsNum=214313&MainKind=A&NewsKind=5&vCount=12&vKind=1
100,2018-01-10,대웅제약전일대비약4상승한172000원,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801100246
101,2018-01-10,대웅글리아타민종근당글리아티린LG제미메트두각,http://www.dailymedi.com/detail.php?number=826314&thread=22r05
102,2018-01-10,대웅제약이지듀EGF골든위크빅세일,http://www.bosa.co.kr/news/articleView.html?idxno=2076105
103,2018-01-10,대웅52주신고가경신전일대비4상승,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801100392
104,2018-01-10,대웅제약이지듀새해첫프로모션EGF골든위크빅세일진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=307850
105,2018-01-11,대웅제약이지듀새해첫프로모션EGF골든위크빅세일,http://www.k-health.com/news/articleView.html?idxno=33845
106,2018-01-11,대웅제약이지듀16일까지최대50세일,http://sports.donga.com/3/all/20180110/88115279/3
107,2018-01-11,유한대웅종근당리더임기만료재임여부촉각,http://www.doctorsnews.co.kr/news/articleView.html?idxno=121107
108,2018-01-11,하이투자대웅제약에볼루스상장으로나보타가치부각목표가상향”,http://www.newsway.co.kr/view.php?tp=1&ud=2018011108325363721
109,2018-01-11,대웅제약나보타가치더높아질것하이투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018011108442073896
110,2018-01-11,STOCK대웅제약에볼루스상장으로나보타가치부각목표가↑,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018011109118075058&outlink=1
111,2018-01-11,fnRASSI대웅제약52주신고가226↑,http://www.fnnews.com/news/201801110921568337
112,2018-01-11,대웅제약나보타중국식약처임상시험신청승인,http://www.fnnews.com/news/201801110929410751
113,2018-01-11,대웅나보타중국시장진출탄력임상3상진행,http://www.dailypharm.com/News/235535
114,2018-01-11,대웅제약나보타中임상시험계획승인,http://www.asiae.co.kr/news/view.htm?idxno=2018011109373684713
115,2018-01-11,대웅제약보톡스나보타中임상시험허가,http://www.edaily.co.kr/news/newspath.asp?newsid=01744966619076736
116,2018-01-11,대웅제약나보타중국임상승인‥2020년발매목표,http://news.hankyung.com/article/201801117284f
117,2018-01-11,대웅제약보툴리눔톡신나보타중국임상시험승인,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180111051400017&did=1195m
118,2018-01-11,뉴스투데이E대웅제약나보타중국진출본격화,http://www.news2day.co.kr/97521
119,2018-01-11,대웅제약나보타2020년中발매목표”,http://www.newsway.co.kr/view.php?tp=1&ud=2018011109421408436
120,2018-01-11,대웅제약나보타CFDA승인중국본격진출,http://www.newsprime.co.kr/news/article.html?no=402188
121,2018-01-11,대웅제약나보타글로벌순항중국임상시험계획승인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214038
122,2018-01-11,대웅제약나보타임상시험중국식약처서승인,http://news20.busan.com/controller/newsController.jsp?newsId=20180111000045
123,2018-01-11,대웅제약나보타중국임상승인2020년발매목표,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018011109413879335
124,2018-01-11,비바100한미일동대웅3제복합제고혈압약시장서격돌,http://www.viva100.com/main/view.php?key=20180110010003643
125,2018-01-11,대웅제약나보타중국임상시험계획승인,http://news.mt.co.kr/mtview.php?no=2018011109383252665
126,2018-01-11,대웅제약나보타중국임상시험계획승인받아,http://www.mdtoday.co.kr/mdtoday/index.html?no=307907
127,2018-01-11,대웅제약나보타중국임상시험계획승인받아,http://medipana.com/news/news_viewer.asp?NewsNum=214372&MainKind=A&NewsKind=5&vCount=12&vKind=1
128,2018-01-11,대웅제약나보타중국임상시험계획승인받아,http://www.dailian.co.kr/news/view/686093/?sc=naver
129,2018-01-11,대웅제약주름개선제나보타中임상승인,http://news1.kr/articles/?3204183
130,2018-01-11,대웅제약보톡스나보타中임상시험신청승인,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801110100
131,2018-01-11,대웅제약나보타중국임상승인,http://www.newstomato.com/ReadNews.aspx?no=799641
132,2018-01-11,대웅제약나보타임상시험신청서중국식약처승인받아,http://www.enewstoday.co.kr/news/articleView.html?idxno=1144567
133,2018-01-11,대웅제약보툴리눔톡신나보타중국임상승인2020년발매목표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1583347
134,2018-01-11,대웅제약나보타중국임상시험계획CTA승인받아,http://www.asiatoday.co.kr/view.php?key=20180111010006236
135,2018-01-11,대웅제약나보타중국진출본격화,http://www.dt.co.kr/contents.html?article_no=2018011102109976029001&ref=naver
136,2018-01-11,대웅제약나보타중국임상시험계획CTA승인받아,http://www.medicaltimes.com/News/1116215
137,2018-01-11,대웅나보타중국임상시험계획승인,http://www.monews.co.kr/news/articleView.html?idxno=109838
138,2018-01-11,대웅제약나보타중국임상시험계획승인,http://www.etnews.com/20180111000096
139,2018-01-11,대웅제약나보타임상시험신청서中식약처승인받아,http://www.newsis.com/view/?id=NISX20180111_0000200358&cID=13001&pID=13000
140,2018-01-11,대웅제약나보타중국임상시험계획CTA승인,http://www.viva100.com/main/view.php?key=20180111010004206
141,2018-01-11,대웅제약보툴리눔톡신제제나보타중국임상승인받아2020년발매목표,http://biz.chosun.com/site/data/html_dir/2018/01/11/2018011101402.html
142,2018-01-11,대웅제약중국에서보톡스나보타임상승인받아,http://www.businesspost.co.kr/BP?command=article_view&num=69475
143,2018-01-11,대웅제약나보타중국임상시험계획승인받아,http://www.metroseoul.co.kr/news/newsview?newscd=2018011100033
144,2018-01-11,대웅제약중국서나보타임상3상승인,http://www.rapportian.com/news/articleView.html?idxno=108406
145,2018-01-11,에볼루스대웅제약나보타판매준비돌입나스닥상장신청,http://news.hankyung.com/article/201801118201f
146,2018-01-11,대웅제약에볼루스美상장으로나보타가치부각,http://www.newsworks.co.kr/news/articleView.html?idxno=160437
147,2018-01-11,대웅제약중국식약처나보타임상3상 허가,http://www.ebn.co.kr/news/view/925362
148,2018-01-11,대웅보톡스초거대시장中진출행보속도,http://www.dailymedi.com/detail.php?number=826359&thread=22r05
149,2018-01-11,대웅제약나보타중국임상시험계획승인,http://www.bosa.co.kr/news/articleView.html?idxno=2076177
150,2018-01-11,ET투자뉴스대웅제약에볼루스상장으로매수유지하이투자증권,http://www.etnews.com/20180111000150
151,2018-01-11,변화와혁신맞은대웅제약스마트오피스로구현,http://www.dailypharm.com/News/235549
152,2018-01-11,대웅제약나보타中진출잰걸음올해3상진행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1051331
153,2018-01-11,대웅제약나보타中임상시험계획승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=76686
154,2018-01-11,대웅제약나보타중국진출가시화,http://www.kormedi.com/news/news/drug_dist/1225785_2906.html
155,2018-01-11,대웅제약나보타중국임상시험계획CTA승인받아,http://news.mk.co.kr/newsRead.php?year=2018&no=24605
156,2018-01-11,대웅제약보툴리눔톡신나보타中임상계획승인,http://www.seoulfn.com/news/articleView.html?idxno=296944
157,2018-01-11,아파야챙길래대웅제약동아STGC녹십자,http://www.g-enews.com/ko-kr/news/article/news_all/20180111141948195e6a49afa8d_1/article.html
158,2018-01-11,뉴스콕대웅제약나보타中임상승인,http://www.newstomato.com/ReadNews.aspx?no=799684
159,2018-01-11,대웅제약중국서나보타임상시험진행승인받아,http://news.mk.co.kr/newsRead.php?year=2018&no=24825
160,2018-01-11,대웅제약52주신고가경신전일대비2상승,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801110332
161,2018-01-11,대웅제약나보타중국임상시험계획승인받아,http://www.kpinews.co.kr/news/articleView.html?idxno=63574
162,2018-01-11,대웅제약나보타중국임상시험계획승인올해3상돌입2020년발매,http://www.techholic.co.kr/news/articleView.html?idxno=173088
163,2018-01-11,中서부는보툴리눔톡신경쟁선두메디톡스후발대웅제약,http://biz.newdaily.co.kr/news/article.html?no=10150718
164,2018-01-11,대웅제약보툴리눔톡신나보타중국진출본격화,http://www.sportsseoul.com/news/read/589421
165,2018-01-11,대웅제약올해매출액1조원전망,http://biz.chosun.com/site/data/html_dir/2018/01/11/2018011102456.html
166,2018-01-11,대웅제약올해매츨1조원전망,http://www.newsis.com/view/?id=NISX20180111_0000200927&cID=10401&pID=10400
167,2018-01-11,대웅제약올해매출액1조원전망,http://www.edaily.co.kr/news/newspath.asp?newsid=03375126619076736
168,2018-01-11,공시대웅제약2018년매출1조원전망”,http://www.newsway.co.kr/view.php?tp=1&ud=2018011117001072760
169,2018-01-11,대웅제약올매출액1조전망”,http://www.sedaily.com/NewsView/1RUDYVIH7Z
170,2018-01-11,대웅제약나보타중국진출본격화임상시험계획승인완료,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201801111548002&code=900303
171,2018-01-11,대웅제약올해매출액1조원전망,http://www.enewstoday.co.kr/news/articleView.html?idxno=1144825
172,2018-01-11,대웅제약올해매출액1조원전망,http://www.newsworks.co.kr/news/articleView.html?idxno=160573
173,2018-01-11,中에발내딛는대웅제약나보타,http://www.sedaily.com/NewsView/1RUDYCREAJ
174,2018-01-11,대웅제약나보타중국임상시험계획CTA승인받아,http://www.lawissue.co.kr/view.php?ud=201801111810092942d7f4c63cc6_12
175,2018-01-11,대웅제약중국진출본격화보툴리눔톡신나보타중국임상시험승인,http://www.insight.co.kr/news/134786
176,2018-01-11,대웅제약나보타중국임상시험계획CTA승인,http://www.kukinews.com/news/article.html?no=516436
177,2018-01-11,대웅제약나보타중국임상승인2020년출시목표,http://www.newspim.com/news/view/20180111000296
178,2018-01-11,대웅제약보톡스나보타중국식약처임상시험승인,http://news.hankyung.com/article/2018011198661
179,2018-01-11,대웅제약올해매출액1조원전망,http://www.ekn.kr/news/article.html?no=336993
180,2018-01-11,대웅제약미국보톡스시장진출눈앞편리성과수익배분으로승부,http://www.businesspost.co.kr/BP?command=article_view&num=69599
181,2018-01-11,대웅제약나보타중국임상시험계획CTA승인받아,http://www.newscj.com/news/articleView.html?idxno=482810
182,2018-01-11,유가증권기업공시11일대웅제약등,http://news.hankyung.com/article/2018011109211
183,2018-01-11,대웅제약올해매츨1조원전망,http://www.econonews.co.kr/news/articleView.html?idxno=15898
184,2018-01-12,클릭e종목대웅제약한올바이오파마나보타가치부각목표가↑,http://www.asiae.co.kr/news/view.htm?idxno=2018011207340678948
185,2018-01-12,대웅제약나보타중국3상임상시작,http://www.ajunews.com/view/20180111115440410
186,2018-01-12,대웅제약나보타미국출시임박목표가↑”한국투자증권,http://www.dailian.co.kr/news/view/686300/?sc=naver
187,2018-01-12,대웅제약나보타자회사가치재평가목표가↑한국,http://news.hankyung.com/article/2018011212876
188,2018-01-12,대웅제약목표주가높아져보톡스나보타미국진출가시화,http://www.businesspost.co.kr/BP?command=article_view&num=69630
189,2018-01-12,대웅제약12년이종욱체제5연임은안되나,http://www.datanews.co.kr/news/article.html?no=100121
190,2018-01-12,대웅제약나보타한올바이오파마가치부각목표가↑한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1583712
191,2018-01-12,클릭e종목대웅제약목표주가23만원으로상향,http://www.asiae.co.kr/news/view.htm?idxno=2018011208350696802
192,2018-01-12,대웅제약올해매출액1조원전망,http://www.mdtoday.co.kr/mdtoday/index.html?no=308025
193,2018-01-12,대웅제약나보타미국출시임박한투,http://www.cstimes.com/?mod=news&act=articleView&idxno=265314
194,2018-01-12,대웅제약52주신고가경신전일대비5상승,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801120042
195,2018-01-12,대웅제약전일대비약6상승한189000원,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801120053
196,2018-01-12,대웅제약10급등전일보다18000원상승한197000원,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801120060
197,2018-01-12,특징주대웅제약신고가나보타자회사가치부각,http://news.hankyung.com/article/2018011215676
198,2018-01-12,특징주대웅제약中나보타임상시험승인소식에신고가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180112040600008&did=1195m
199,2018-01-12,대웅제약나보타미국출시임박52주신고가경신,http://www.sedaily.com/NewsView/1RUEDY1NZ1
200,2018-01-12,특징주대웅제약한올바이오파마나보타가치부각장초반강세,http://www.asiae.co.kr/news/view.htm?idxno=2018011209101346478
201,2018-01-12,특징주대웅제약나보타미국출시임박에급등,http://news.mt.co.kr/mtview.php?no=2018011209070940535
202,2018-01-12,특징주대웅제약급등보톡스나보타美출시임박,http://www.edaily.co.kr/news/newspath.asp?newsid=01551446619077064
203,2018-01-12,특징주대웅제약나보타가치부각에신고가경신,http://www.g-enews.com/ko-kr/news/article/news_all/201801120912401738581e5800d6_1/article.html
204,2018-01-12,ET투자뉴스대웅_외국인투자자의거래참여활발거래비중1656,http://www.etnews.com/20180112000025
205,2018-01-12,fnRASSI대웅52주신고가1198↑,http://www.fnnews.com/news/201801120915486312
206,2018-01-12,유대웅현재가557급등,http://www.sedaily.com/NewsView/1RUEDWW82Y
207,2018-01-12,대웅제약나보타출시기대감에강세,http://www.newsprime.co.kr/news/article.html?no=402343
208,2018-01-12,특징주대웅제약나보타미국출시임박기대감에52주신고가,http://www.ekn.kr/news/article.html?no=337018
209,2018-01-12,대웅제약나보타미국출시가능성에급등세,http://www.mdtoday.co.kr/mdtoday/index.html?no=308037
210,2018-01-12,fnRASSI대웅제약069620현재1816↑,http://www.fnnews.com/news/201801120924312597
211,2018-01-12,ET투자뉴스대웅제약예감이좋은201매수유지한국투자증권,http://www.etnews.com/20180112000030
212,2018-01-12,특징주대웅제약나보타美출시임박소식에급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1583741
213,2018-01-12,대웅제약이지엔젤서포터즈활동전개,http://medipana.com/news/news_viewer.asp?NewsNum=214430&MainKind=A&NewsKind=5&vCount=12&vKind=1
214,2018-01-12,유대웅전일대비856상승일일회전율은074기록,http://www.sedaily.com/NewsView/1RUED8TR7U
215,2018-01-12,유대웅제약전일대비1983상승일일회전율은152기록,http://www.sedaily.com/NewsView/1RUEEDC1PD
216,2018-01-12,특징주대웅제약한올바이오파마나보타가치부각에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=185753
217,2018-01-12,대웅제약이지엔6와함께한이지엔젤서포터즈활동성료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214076
218,2018-01-12,특징주대웅제약나보타미국출시임박52주신고가,http://www.newstomato.com/ReadNews.aspx?no=799910
219,2018-01-12,특징주대웅제약나보타미국출시기대감에장초반신고가,http://www.dailian.co.kr/news/view/686344/?sc=naver
220,2018-01-12,대웅이지엔젤서포터즈활동종료,http://www.kpanews.co.kr/article/show.asp?idx=190630&table=article&category=D
221,2018-01-12,대웅전일대비약7상승한21900원,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801120126
222,2018-01-12,ET투자뉴스대웅제약_거래비중기관1612외국인1853,http://www.etnews.com/20180112000047
223,2018-01-12,대웅제약이지엔젤서포터즈활동성료,http://www.bosa.co.kr/news/articleView.html?idxno=2076246
224,2018-01-12,대웅제약이지엔6대학생서포터즈해단식가져,http://www.dailypharm.com/News/235590
225,2018-01-12,대웅제약이지엔젤2기이지엔6서포터즈해단식성료,http://news.kmib.co.kr/article/view.asp?arcid=0012045196&code=61171911&cp=nv
226,2018-01-12,대웅제약중국나보타임상시험승인소식에신고가,http://daily.hankooki.com/lpage/economy/201801/dh20180112103035138110.htm
227,2018-01-12,특징주대웅제약나보타미국출시임박소식에강세,http://www.asiatoday.co.kr/view.php?key=20180112010006921
228,2018-01-12,대웅제약대학생마케팅서포터즈이지엔젤2기활동종료,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018011210278024732&outlink=1
229,2018-01-12,대웅제약이지엔젤서포터즈활동성료,http://www.wowtv.co.kr/newscenter/news/view.asp?bcode=T30001000&artid=A201801120166
230,2018-01-12,특징주대웅제약보톡스나보타미국출시임박에강세,http://www.fnnews.com/news/201801121119332895
231,2018-01-12,대웅제약나보타의美출시임박예감,http://www.newsworks.co.kr/news/articleView.html?idxno=160663
232,2018-01-12,베스트리포트대웅제약예감이좋은2018년,http://news.mt.co.kr/mtview.php?no=2018011209151116269
233,2018-01-12,제약산업소식대웅제약이지엔젤서포터즈활동종료外,http://www.kukinews.com/news/article.html?no=516566
234,2018-01-12,뉴스투데이E대웅제약이지엔6와함께한이지엔젤서포터즈활동성료”,http://www.news2day.co.kr/97584
235,2018-01-12,대웅제약나보타중국시장진출시동임상시험계획승인,http://www.kukinews.com/news/article.html?no=516571
236,2018-01-12,fnRASSI대웅00309052주신고가경신782↑,http://www.fnnews.com/news/201801121311332174
237,2018-01-12,대웅제약예감이좋은2018,http://daily.hankooki.com/lpage/economy/201801/dh20180112131525138110.htm
238,2018-01-12,fnRASSI대웅제약0696202207상승,http://www.fnnews.com/news/201801121321287265
239,2018-01-12,대웅제약나보타미국출시임박에목표가↑중국도임상시험승인,http://www.sisaweek.com/news/articleView.html?idxno=101504
240,2018-01-12,대웅제약이지엔6와함께한이지엔젤서포터즈활동성황리종료,http://www.mdtoday.co.kr/mdtoday/index.html?no=308071
241,2018-01-12,한국소비자포럼대웅제약이지엔6대학생서포터즈해단식개최,http://news.hankyung.com/article/201801122849a
242,2018-01-12,대웅제약이지엔젤2기활동마감,http://www.seoulfn.com/news/articleView.html?idxno=297036
243,2018-01-12,특징주대웅제약中나보타임상시험승인에신고가종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180112040651008&did=1195m
244,2018-01-12,대웅제약中나보타임상시험승인소식에강세마감,http://www.sedaily.com/NewsView/1RUEF8NL4B
245,2018-01-12,대웅제약이지엔젤2기4개월할동마치고해단식가져,http://news.mk.co.kr/newsRead.php?year=2018&no=28080
246,2018-01-12,개미들의착각천장맞히기대웅제약나보타진출목표가상향,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018011215082139207
247,2018-01-12,HotStock대웅제약,http://news.hankyung.com/article/2018011238321
248,2018-01-12,백문이불여일견대웅제약이지엔젤2기해단식,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201801121743002&code=900303
249,2018-01-12,대웅제약이지엔6와함께한이지엔젤서포터즈활동성황리에종료,http://www.lawissue.co.kr/view.php?ud=201801121824506574d7f4c63cc6_12
250,2018-01-12,대웅제약이지엔6와함께한이지엔젤서포터즈활동성료,http://www.newscj.com/news/articleView.html?idxno=483178
251,2018-01-13,에볼루스나스닥상장추진신바람난대웅,http://www.dailypharm.com/News/235609
252,2018-01-13,셀트리온삼성녹십자대웅올해美공략성과나올까,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1051420
253,2018-01-13,대웅제약진통제이지엔6대학생서포터즈해단식,http://www.edaily.co.kr/news/newspath.asp?newsid=01722006619077392
254,2018-01-14,대웅제약대학생마케팅서포터즈이지엔젤2기활동성황리마무리,http://www.insight.co.kr/news/135122
255,2018-01-14,대웅제약이지엔6서포터즈활동성황리종료,http://www.enewstoday.co.kr/news/articleView.html?idxno=1145435
256,2018-01-14,올매출1조목표대웅제약글로벌경쟁력강화나선다,http://www.dt.co.kr/contents.html?article_no=2018011502100976029001&ref=naver
257,2018-01-15,터치PeakBottom대웅제약中나보타임상시험승인소식에신고가,http://www.sedaily.com/NewsView/1RUFR82AL5
258,2018-01-15,더벨대웅제약7년만에실적전망공시매출1조목표,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201801120100024120001489
259,2018-01-15,대웅제약52주신고가경신나보타美출시임박,http://www.mdtoday.co.kr/mdtoday/index.html?no=308196
260,2018-01-15,빅데이터MSI시장심리톱5대웅제약삼성엔지니어링신세계GS이마트,http://www.newsis.com/view/?id=NISX20180115_0000202845&cID=10401&pID=10400
261,2018-01-15,대웅전일대비약5상승한21950원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801150059
262,2018-01-15,대웅제약전일대비약4상승한214000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801150146
263,2018-01-15,대웅제약5거래일연속상승전일대비3상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801150241
264,2018-01-15,복산나이스사장에대웅제약출신김병우씨취임,http://www.dailypharm.com/News/235672
265,2018-01-17,대웅제약이종욱부회장나보타올해글로벌진출원년,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214180
266,2018-01-17,대웅제약글로벌진출나보타열고신약뒷받침,http://www.bosa.co.kr/news/articleView.html?idxno=2076420
267,2018-01-18,대웅제약우루사58년만에새단장미국시장도도전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214249
268,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.kpanews.co.kr/article/show.asp?idx=190792&table=article&category=D
269,2018-01-18,주한인니대사대웅제약방문현지진출적극돕겠다,http://www.edaily.co.kr/news/newspath.asp?newsid=02007366619079032
270,2018-01-18,주한인도네시아대사대웅제약본사방문,http://medipana.com/news/news_viewer.asp?NewsNum=214678&MainKind=A&NewsKind=5&vCount=12&vKind=1
271,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214266
272,2018-01-18,대웅제약찾은인니대사,http://www.medical-tribune.co.kr/news/articleView.html?idxno=76841
273,2018-01-18,대웅EPO치료제에포디온인도네시아40점유,http://www.dailypharm.com/News/235810
274,2018-01-18,주한인니대사대웅제약방문현지투자에감사,http://www.dt.co.kr/contents.html?article_no=2018011802109976029002&ref=naver
275,2018-01-18,대웅제약주한인도네시아대사방문,http://www.newsprime.co.kr/news/article.html?no=403128
276,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.newsis.com/view/?id=NISX20180118_0000206499&cID=13001&pID=13000
277,2018-01-18,주한인니대사대웅제약방문투자확대지원,http://www.asiae.co.kr/news/view.htm?idxno=2018011810592503656
278,2018-01-18,주한인도네시아대사대웅제약방문,http://www.rapportian.com/news/articleView.html?idxno=108509
279,2018-01-18,주한인도네시아대사대웅제약본사방문인도네시아사업돕겠다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018011810035016673
280,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.bosa.co.kr/news/articleView.html?idxno=2076525
281,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.medigatenews.com/news/1337887467
282,2018-01-18,아파야챙길래대웅제약한국화이자제약GC녹십자,http://www.g-enews.com/ko-kr/news/article/news_all/201801181151531544e6a49afa8d_1/article.html
283,2018-01-18,인도네시아대사현지최초바이오기업세운대웅본사방문,http://news.mk.co.kr/newsRead.php?year=2018&no=40593
284,2018-01-18,주한인도네시아대사대웅제약방문,http://www.dailymedi.com/detail.php?number=826608&thread=22r05
285,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.enewstoday.co.kr/news/articleView.html?idxno=1147026
286,2018-01-18,대웅제약이종욱부회장후임에강영철고문하마평,http://www.newsway.co.kr/view.php?tp=1&ud=2018011811105086454
287,2018-01-18,강영철대웅제약고문은누구,http://www.newsway.co.kr/view.php?tp=1&ud=2018011811174581725
288,2018-01-18,주한인도네시아대사대웅제약본사방문,http://www.monews.co.kr/news/articleView.html?idxno=110172
289,2018-01-18,대웅제약주한인도네시아대사본사방문,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801180304
290,2018-01-18,주한인도네시아대사대웅제약방문,http://www.mdtoday.co.kr/mdtoday/index.html?no=308673
291,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.newscj.com/news/articleView.html?idxno=484886
292,2018-01-18,대웅제약대웅인피온발판으로인도네시아서승승장구,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201801181435002&code=900303
293,2018-01-18,대웅제약대표제품우루사미국시장노크,http://health.chosun.com/site/data/html_dir/2018/01/18/2018011801960.html
294,2018-01-18,인도네시아대사대웅제약방문인니사업확대지원,http://www.dailian.co.kr/news/view/687709/?sc=naver
295,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.newstomato.com/ReadNews.aspx?no=801214
296,2018-01-18,대웅제약주한인도네시아대사본사방문,http://www.metroseoul.co.kr/news/newsview?newscd=2018011800077
297,2018-01-18,뉴스투데이E대웅제약이종욱부회장대웅인피온인도네시아서존경받는기업되기를”,http://www.news2day.co.kr/97862
298,2018-01-18,주한인도네시아대사대웅제약본사방문해사업지원약속,http://www.insight.co.kr/news/135917
299,2018-01-18,대웅빈혈치료제에포디온인니서시장점유율40로1위,http://www.viva100.com/main/view.php?key=20180118020021965
300,2018-01-19,대웅제약주한인도네시아대사본사방문,http://www.lawissue.co.kr/view.php?ud=201801182359001129d7f4c63cc6_12
301,2018-01-19,대웅제약우루사올해하반기미국FDA허가도전,http://www.mdtoday.co.kr/mdtoday/index.html?no=308696
302,2018-01-19,대웅제약등제약사들경구용류마티스관절염치료제젤잔즈특허회피,http://www.mdtoday.co.kr/mdtoday/index.html?no=308730
303,2018-01-19,박근혜규제개혁얼굴강영철인사설에대웅제약은곤혹,http://www.lawissue.co.kr/view.php?ud=201801190922296786204ead0791_12
304,2018-01-19,대웅생명과학1월31일수까지기획부개발팀모집,http://www.ekn.kr/news/article.html?no=338492
305,2018-01-22,대웅제약두토끼잡기올해1조매출재도약이루나,http://www.ajunews.com/view/20180121125301713
306,2018-01-22,나보타美출시로환골탈태꿈꾸는대웅제약,http://news.mt.co.kr/mtview.php?no=2018012109492093959
307,2018-01-22,가치투자재야고수가대웅제약에투자한이유는,http://news.mt.co.kr/mtview.php?no=2018012110532908166
308,2018-01-22,대웅바이오지난해영업이익297억전년比33증가,http://news.mt.co.kr/mtview.php?no=2018012211094897085
309,2018-01-22,대웅바이오지난해영업익296억전년比32↑,http://www.asiae.co.kr/news/view.htm?idxno=2018012211125324480
310,2018-01-22,대웅자회사대웅바이오작년영업익297억원325↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180122073900008&did=1195m
311,2018-01-22,대웅자회사대웅바이오지난해영업익297억원전년比325↑,http://www.etoday.co.kr/news/section/newsview.php?idxno=1586507
312,2018-01-22,대웅바이오작년영업익296억전년比325증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=308949
313,2018-01-22,대웅바이오지난해영업이익297억전년比325↑,http://www.newsworks.co.kr/news/articleView.html?idxno=162468
314,2018-01-22,대웅자회사대웅바이오작년영업익297억전년比325↑,http://www.newsis.com/view/?id=NISX20180122_0000209504&cID=10401&pID=10400
315,2018-01-22,대웅영업이익297325증가,http://www.sedaily.com/NewsView/1RUIZSOEPP
316,2018-01-22,단독에볼루스대웅제약나보타소송우려감구상권청구가능성언급,http://www.newstomato.com/ReadNews.aspx?no=801410
317,2018-01-22,실적발표대웅바이오녹십자셀동서,http://www.businesspost.co.kr/BP?command=article_view&num=70587
318,2018-01-22,대웅바이오작년영업익297억원33↑완제의약품덕분,http://www.newspim.com/news/view/20180122000199
319,2018-01-22,대웅자회사대웅바이오작년영업익297억원33증가,http://www.insight.co.kr/news/136511
320,2018-01-23,나보타美출시임박소식에대웅제약웃는다,http://www.mdtoday.co.kr/mdtoday/index.html?no=309038
321,2018-01-23,셀트리온대웅제약한미약품등올해연매출1조클럽도전,http://www.mdtoday.co.kr/mdtoday/index.html?no=309037
322,2018-01-23,대웅바이오처방약순위10계단점프20위권눈앞,http://www.dailypharm.com/News/235948
323,2018-01-23,대웅제약글로벌제약사선포각종소송전이걸림돌,http://www.newsway.co.kr/view.php?tp=1&ud=2018012316184772287
324,2018-01-24,2018제약시장날아오를까③글로벌50위진입목표도약하는대웅제약,http://www.mdtoday.co.kr/mdtoday/index.html?no=309197
325,2018-01-24,ET투자뉴스대웅제약_외국인투자자의거래참여활발거래비중154,http://www.etnews.com/20180124000122
326,2018-01-24,단독대웅제약나보타FDA실사서무균시설결함지적받아,http://news.mt.co.kr/mtview.php?no=2018012412101723387
327,2018-01-24,美FDA대웅제약나보타공장무균시설결함지적,http://news.hankyung.com/article/201801242967f
328,2018-01-24,대웅제약나보타美진출지연가능성대두급락,http://news.mt.co.kr/mtview.php?no=2018012414071488971
329,2018-01-24,대웅제약나보타美진출지연우려에두자릿수하락세,http://www.mdtoday.co.kr/mdtoday/index.html?no=309280
330,2018-01-24,국산보톡스강자메디톡스휴젤대웅제약올해중국등해외시장날개단다,http://www.etnews.com/20180124000342
331,2018-01-24,대웅제약美FDA서나보타생산시설결함지적받아,http://news1.kr/articles/?3215885
332,2018-01-24,대웅FDA나보타시설결함언급은관찰사항일뿐,http://www.dailypharm.com/News/236041
333,2018-01-24,대웅제약나보타공정에심각한결함지적된것아니다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214468
334,2018-01-24,대웅제약미FDA공식문건관찰사항나열된것이지위반사항아냐,http://www.asiatoday.co.kr/view.php?key=20180124010013748
335,2018-01-24,대웅제약나보타FDA무균시설결함지적통상발행문서,http://www.sportsseoul.com/news/read/593596
336,2018-01-24,대웅제약나보타美FDA실사지적일반적인보완절차,http://www.newspim.com/news/view/20180124000220
337,2018-01-24,대웅제약FDA의나보타공장실사문건은통상적인것문제없어,http://news.hankyung.com/article/2018012438296
338,2018-01-24,대웅제약FDA실사지적사항심각한문제아냐,http://news.mt.co.kr/mtview.php?no=2018012415505282173
339,2018-01-24,나보타美판매지연루머에대웅제약11급락,http://news.mt.co.kr/mtview.php?no=2018012414352675790
340,2018-01-24,에볼루스대웅제약에손배청구가능성시사나보타美진출먹구름논란,http://www.lawissue.co.kr/view.php?ud=201801241522141006d48e16fff2_12
341,2018-01-24,대웅제약나보타FDA실사무균시설결함및제조공정위반보도사실과달라,http://www.g-enews.com/ko-kr/news/article/news_all/201801241612115825e6a49afa8d_1/article.html
342,2018-01-24,美FDA대웅제약보툴리눔톡신나보타생산시설결함지적,http://www.sedaily.com/NewsView/1RUJXBTBVG
343,2018-01-24,대웅제약나보타FDA실사무균시설결함사실과달라,http://www.mediapen.com/news/view/328737
344,2018-01-24,제약바이오대웅제약우루사UDCA함유한간기능개선제피로해소간손상예방효과,http://news.hankyung.com/article/2018012413271
345,2018-01-24,대웅제약나보타FDA실사서공장결함보도사실아니다”,http://www.edaily.co.kr/news/newspath.asp?newsid=03473526619081000
346,2018-01-24,대웅제약나보타美진출적신호설에문제없다”,http://www.mhj21.com/sub_read.html?uid=111762§ion=sc243
347,2018-01-24,대웅제약FDA의나보타공장지적사항심각한문제아니다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018012416064477746
348,2018-01-24,대웅FDA실사공정결함아냐,http://www.monews.co.kr/news/articleView.html?idxno=110436
349,2018-01-24,대웅제약2020년글로벌50위”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201801241616005&code=900303
350,2018-01-24,대웅제약FDA실사관련기사해명특별히결함있는것아냐,http://www.enewstoday.co.kr/news/articleView.html?idxno=1149245
351,2018-01-24,대웅제약美FDA서나보타공장결함지적통상적보완요청협의중”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1587601
352,2018-01-24,코스피기관순매도대웅제약LG전자KODEX코스닥150레버리지,http://www.newsway.co.kr/view.php?tp=1&ud=2018012416392560908
353,2018-01-24,대웅제약FDA나보타실사문건은통상적문건,http://www.bosa.co.kr/news/articleView.html?idxno=2076877
354,2018-01-24,대웅제약美FDA나보타결함지적에심각한결함아냐,http://www.newsis.com/view/?id=NISX20180124_0000212203&cID=13001&pID=13000
355,2018-01-24,대웅제약나보타FDA제조공정위반보도사실과달라”해명,http://www.mdtoday.co.kr/mdtoday/index.html?no=309315
356,2018-01-24,나보타제조공장FDA실사논란대웅제약통상절차,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180124152600017&did=1195m
357,2018-01-24,무균조제환경미비”美FDA대웅제약화성나보타공장결함지적,http://kpenews.com/Board.aspx?BoardNo=7604
358,2018-01-24,대웅제약FDA결함지적통상적인것”,http://www.newsway.co.kr/view.php?tp=1&ud=2018012417102827445
359,2018-01-24,美FDA대웅제약나보타공장무균시설결함대웅심각한문제아냐,http://biz.chosun.com/site/data/html_dir/2018/01/24/2018012402275.html
360,2018-01-24,신약RD가미래다대웅제약면역항암제등신약개발가속,http://www.sedaily.com/NewsView/1RUJXMRPRQ
361,2018-01-24,대웅제약주름개선제나보타미국허가순차진행중”,http://www.ajunews.com/view/20180124172731671
362,2018-01-24,대웅제약나보타FDA실사무균시설결함및제조공정위반는사실과달라해명나서,http://www.lawissue.co.kr/view.php?ud=201801241725282351d7f4c63cc6_12
363,2018-01-24,대웅제약FDA나보타관련문건통상적인절차,http://www.rapportian.com/news/articleView.html?idxno=108622
364,2018-01-24,대웅제약나보타FDA실사무균시설결함보도에사실과다르다해명,http://www.asiatime.co.kr/news/articleView.html?idxno=165157
365,2018-01-24,대웅제약미국FDA에서나보타생산시설결함지적,http://www.dt.co.kr/contents.html?article_no=2018012402109976029008&ref=naver
366,2018-01-24,대웅등5종목공매도과열종목지정,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180124176700008&did=1195m
367,2018-01-24,대웅제약나보타공정에결함없다美FDA실사지적반박,http://www.ebn.co.kr/news/view/927143
368,2018-01-24,대웅제약나보타미국출시지연우려,http://news.hankyung.com/article/2018012443851
369,2018-01-25,대웅제약우루사세계인간건강책임진다,http://www.edaily.co.kr/news/newspath.asp?newsid=01167686619081328
370,2018-01-25,대웅제약나보타2공장GMP위반논란,http://www.seoulfn.com/news/articleView.html?idxno=297856
371,2018-01-25,대웅제약주가정상화될것KTB투자증권,http://news.mt.co.kr/mtview.php?no=2018012507370814537
372,2018-01-25,대웅제약나보타노이즈좋은매수기회KTB,http://news.hankyung.com/article/2018012555716
373,2018-01-25,더벨대웅제약FDA나보타지적사항회신완료,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201801240100047920002939
374,2018-01-25,대웅제약FDA보완요구에나보타매출액감소전망DB,http://biz.chosun.com/site/data/html_dir/2018/01/25/2018012500649.html
375,2018-01-25,대웅제약OCI바디텍메드등5종목공매도과열종목지정,http://www.mdtoday.co.kr/mdtoday/index.html?no=309394
376,2018-01-25,특징주대웅제약美FDA실사관련회사측해명에반등,http://news.mt.co.kr/mtview.php?no=2018012509001673601
377,2018-01-25,대웅제약나보타출시지연우려에주가하락매수기회KTB투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1587738
378,2018-01-25,대웅제약나보타관련논란해명에주가진정세,http://www.mdtoday.co.kr/mdtoday/index.html?no=309404
379,2018-01-25,대웅제약주식살기회나보타미국판매지연우려는과도,http://www.businesspost.co.kr/BP?command=article_view&num=70929
380,2018-01-25,특징주대웅제약美FDA관련우려해소에하루만에반등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1587817
381,2018-01-25,대웅제약나보타美출시지연에대한우려는과도,http://www.newsworks.co.kr/news/articleView.html?idxno=163329
382,2018-01-25,ET투자뉴스대웅제약나보타노이즈가또매수KTB투자증권,http://www.etnews.com/20180125000133
383,2018-01-25,CJ대웅안플라그서방정홀로서기유한도개발,http://www.dailypharm.com/News/236077
384,2018-01-25,대웅FDA나보타실사무균시설결함등위반보도사실아냐,http://www.kpanews.co.kr/article/show.asp?idx=190999&table=article&category=D
385,2018-01-25,대웅제약나보타제2공장의약품제조관리기준GMP위반논란,http://www.insight.co.kr/news/136958
386,2018-01-25,대웅나보타FDA실사서보완요구공정문제없다”반박,http://health.chosun.com/site/data/html_dir/2018/01/25/2018012501700.html
387,2018-01-25,이병호대웅건설회장3년째탈북민자녀장학금후원,http://www.knnews.co.kr/news/articleView.php?idxno=1238634
388,2018-01-25,대웅제약FDA나보타실사관련결함보도사실과달라”,http://www.kukinews.com/news/article.html?no=520012
389,2018-01-25,ET투자뉴스대웅제약FDA실사최선HOLD하향DB금융투자,http://www.etnews.com/20180125000349
390,2018-01-25,미국식품의약국보고서는대웅제약주가에얼마나위협적인가,http://www.businesspost.co.kr/BP?command=article_view&num=70986
391,2018-01-25,이종목은왜오늘의특징주NAVERSK하이닉스삼성엔지니어링대웅제약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018012517243222676
392,2018-01-25,대웅제약나보타FDA품목허가늦어질듯,http://www.greened.kr/news/articleView.html?idxno=49363
393,2018-01-25,대웅제약나보타FDA논란발빠른대응에시장진정세,http://www.sisaweek.com/news/articleView.html?idxno=102160
394,2018-01-26,대웅약국에비타민D중요성흡수량알려나간다,http://www.dailypharm.com/News/236099
395,2018-01-26,㈜대웅건설회장탈북민자녀장학금후원,http://www.gnmaeil.com/news/articleView.html?idxno=362870
396,2018-01-26,제약톡톡미FDA나보타결함지적대웅문제있는것아냐”,http://news.heraldcorp.com/view.php?ud=20180126000104
397,2018-01-26,대웅제약안플원SR출시3년만에사포그릴레이트서방정평정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214527
398,2018-01-26,대웅안플원SR원외처방120억블록버스터대열합류,http://www.dailypharm.com/News/236112
399,2018-01-26,대웅제약나보타미국진출글렀나,http://www.kormedi.com/news/news/drug_dist/1225963_2906.html
400,2018-01-26,대웅제약안플원SR사포그릴레이트서방정원외처방1위,http://www.medical-tribune.co.kr/news/articleView.html?idxno=77014
401,2018-01-26,대웅제약안플원SR정사포그릴레이트서방정시장1위,http://www.enewstoday.co.kr/news/articleView.html?idxno=1149888
402,2018-01-26,대웅안플원SR출시3년사포그릴레이트시장평정,http://www.medicaltimes.com/News/1116496
403,2018-01-26,대웅제약항혈전제안플원서방정출시3년만에블록버스터반열,http://news.mk.co.kr/newsRead.php?year=2018&no=59752
404,2018-01-26,대웅제약안플원SR정작년원외처방122억서방정시장1위”,http://www.mdtoday.co.kr/mdtoday/index.html?no=309572
405,2018-01-26,대웅제약안플원SR정원외처방120억원블록버스터대열합류,http://www.dailian.co.kr/news/view/689435/?sc=naver
406,2018-01-26,제약산업소식대웅제약안플원SR작년원외처방액120억돌파外,http://www.kukinews.com/news/article.html?no=520263
407,2018-01-26,대웅제약안플원SR원외처방액120억원돌파,http://www.newsis.com/view/?id=NISX20180126_0000213913&cID=13001&pID=13000
408,2018-01-26,대웅제약안플원SR3년만에사포그릴레이트서방정시장1위,http://www.sisajournal-e.com/biz/article/179256
409,2018-01-26,대웅제약안플원SR정사포그릴레이트시장1위기록,http://www.mhj21.com/sub_read.html?uid=111812§ion=sc243
410,2018-01-26,대웅제약안플원SR정지난해원외처방122억원기록,http://www.newsprime.co.kr/news/article.html?no=404230
411,2018-01-26,대웅제약안플원SR출시3년만에시장평정,http://www.monews.co.kr/news/articleView.html?idxno=110531
412,2018-01-26,뉴스투데이E대웅제약안플원SR출시3년만에사포그릴레이트서방정시장1위,http://www.news2day.co.kr/98227
413,2018-01-26,대웅제약안플원SR출시3년만에관련시장평정,http://www.bosa.co.kr/news/articleView.html?idxno=2077018
414,2018-01-26,대웅안플원SR출시3년사포그릴레이트서방정리딩,http://www.kpanews.co.kr/article/show.asp?idx=191035&table=article&category=D
415,2018-01-26,수첩대웅나보타483문서미국행티켓될까,http://www.medicaltimes.com/News/1116463
416,2018-01-26,대웅제약항혈전제안플원SR출시3년만에블록버스터대열합류,http://www.etoday.co.kr/news/section/newsview.php?idxno=1588433
417,2018-01-26,대웅제약안플원SR사포그릴레이트서방정시장1위등극,http://www.techholic.co.kr/news/articleView.html?idxno=173459
418,2018-01-26,대웅제약안플원SR출시3년만에사포그릴레이트서방정시장평정,http://www.lawissue.co.kr/view.php?ud=201801261451285059d7f4c63cc6_12
419,2018-01-26,아파야챙길래대웅제약동국제약보령메디앙스,http://www.g-enews.com/ko-kr/news/article/news_all/201801261620469204e6a49afa8d_1/article.html
420,2018-01-26,대웅제약안플원SR원외처방액120억원돌파,http://www.econonews.co.kr/news/articleView.html?idxno=17056
421,2018-01-26,대웅제약항혈전제안플원SR정작년122억매출기록,http://www.rapportian.com/news/articleView.html?idxno=108676
422,2018-01-26,대웅제약안플원SR출시3년만에사포그릴레이트서방정시장평정,http://www.newscj.com/news/articleView.html?idxno=487428
423,2018-01-28,육아맘인기분유포트필립스대웅블레스쿠첸등보온정확성미흡,http://www.newspim.com/news/view/20180128000009
424,2018-01-29,안구건조증급증최대해외시장공략대웅휴온스,http://www.dailymedi.com/detail.php?number=826934&thread=22r05
425,2018-01-29,현대판문익점논란끝모르는메디톡스vs대웅제약보톡스전쟁,http://www.bizhankook.com/article/14768
426,2018-01-29,유한양행종근당대웅제약등대형제약사CEO줄줄이임기만료누가남을까,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=523460
427,2018-01-29,대웅제약나보타브라질이집트수출계약체결,http://www.dailypharm.com/News/236184
428,2018-01-29,대웅제약나보타브라질이집트와수출계약완료,http://www.newsway.co.kr/view.php?tp=1&ud=2018012909592434067
429,2018-01-29,대웅제약나보타브라질이집트에2100만달러규모수출계약,http://www.asiatoday.co.kr/view.php?key=20180129010015954
430,2018-01-29,대웅제약톡신나보타브라질이집트수출계약,http://medipana.com/news/news_viewer.asp?NewsNum=215108&MainKind=A&NewsKind=5&vCount=12&vKind=1
431,2018-01-29,대웅제약나보타2100만불규모브라질•이집트수출계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=214583
432,2018-01-29,대웅제약보툴리눔톡신나보타중동남미진출한다,http://www.edaily.co.kr/news/newspath.asp?newsid=02161526619082640
433,2018-01-29,아파야챙길래종근당건강대웅제약유유제약,http://www.g-enews.com/ko-kr/news/article/news_all/201801291007476250e6a49afa8d_1/article.html
434,2018-01-29,대웅제약브라질이집트제약기업과나보타공급계약체결,http://news.mk.co.kr/newsRead.php?year=2018&no=64735
435,2018-01-29,대웅제약브라질이집트와나보타수출계약,http://www.newsprime.co.kr/news/article.html?no=404424
436,2018-01-29,대웅제약나보타브라질이집트에2100만달러수출계약,http://www.newsis.com/view/?id=NISX20180129_0000215689&cID=13001&pID=13000
437,2018-01-29,대웅제약나보타브라질이집트에수출계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180129063800017&did=1195m
438,2018-01-29,대웅제약나보타브라질이집트수출계약,http://www.dailian.co.kr/news/view/689922/?sc=naver
439,2018-01-29,대웅제약브라질목샤8과5년간1600만달러규모나보타수출계약,http://www.fnnews.com/news/201801291030458384
440,2018-01-29,대웅제약보툴리눔톡신제제나보타브라질이집트수출,http://www.sisajournal-e.com/biz/article/179349
441,2018-01-29,대웅제약보툴리눔톡신나보타브라질이집트수출계약,http://www.asiae.co.kr/news/view.htm?idxno=2018012910401585472
442,2018-01-29,대웅제약나보타브라질이집트수출계약,http://www.newstomato.com/ReadNews.aspx?no=803164
443,2018-01-29,대웅제약보톨리눔톡신나보타브라질이집트2100만달러수출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=77055
444,2018-01-29,대웅제약나보타브라질이집트수출계약완료,http://www.enewstoday.co.kr/news/articleView.html?idxno=1150704
445,2018-01-29,대웅제약나보타브라질이집트수출계약체결,http://www.etnews.com/20180129000110
446,2018-01-29,대웅제약나보타브라질이집트수출계약체결,http://www.metroseoul.co.kr/news/newsview?newscd=2018012900031
447,2018-01-29,대웅제약나보타브라질이집트수출,http://www.dt.co.kr/contents.html?article_no=2018012902109976029002&ref=naver
448,2018-01-29,대웅제약나보타브라질이집트수출계약,http://news.hankyung.com/article/201801298661f
449,2018-01-29,대웅제약남미중동서주름잡는다,http://www.sedaily.com/NewsView/1RUM79OGFH
450,2018-01-29,대웅제약나보타브라질이집트수출계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=309751
451,2018-01-29,대웅제약나보타브라질이집트수출계약,http://news.mt.co.kr/mtview.php?no=2018012910545581879
452,2018-01-29,대웅제약나보타브라질이집트수출계약,http://www.medigatenews.com/news/769543491
453,2018-01-29,대웅제약나보타브라질이집트수출계약,http://daily.hankooki.com/lpage/economy/201801/dh20180129112807138080.htm
454,2018-01-29,대웅제약나보타브라질이집트에수출계약,http://news.mk.co.kr/newsRead.php?year=2018&no=65170
455,2018-01-29,대웅제약나보타브라질이집트수출계약,http://www.bosa.co.kr/news/articleView.html?idxno=2077108
456,2018-01-29,대웅제약나보타브라질이집트진출,http://www.kpinews.co.kr/news/articleView.html?idxno=65031
457,2018-01-29,대웅제약주름개선제나보타브라질이집트첫수출,http://news1.kr/articles/?3219776
458,2018-01-29,대웅제약나보타브라질이집트에2100만불수출계약,http://www.rapportian.com/news/articleView.html?idxno=108696
459,2018-01-29,뉴스투데이E대웅제약나보타브라질및이집트수출계약완료,http://www.news2day.co.kr/98323
460,2018-01-29,대웅나보타이번엔중동과중남미다,http://www.monews.co.kr/news/articleView.html?idxno=110611
461,2018-01-29,대웅제약주름개선제나보타브라질이집트수출길,http://kpenews.com/Board.aspx?BoardNo=7813
462,2018-01-29,대웅제약나보타브라질이집트수출계약,http://www.sportsseoul.com/news/read/595104
463,2018-01-29,ET투자뉴스대웅제약가끔오는매수타이매수유지토러스투자증권,http://www.etnews.com/20180129000303
464,2018-01-29,대웅제약나보타브라질이집트수출계약,http://www.viva100.com/main/view.php?key=20180129010011203
465,2018-01-29,대웅제약나보타브라질이집트수출계약체결,http://www.newspim.com/news/view/20180129000153
466,2018-01-29,대웅제약보톡스나보타브라질이집트수출계약,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201801290554
467,2018-01-29,대웅제약나보타브라질이집트에수출글로벌입지강화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018012915192344410
468,2018-01-29,대웅제약나보타브라질이집트수출5년간2100만달러규모,http://biz.chosun.com/site/data/html_dir/2018/01/29/2018012901749.html
469,2018-01-29,대웅제약허혈성동맥폐색증치료제안플원SR출시3년만에서방정시장압도,http://www.viva100.com/main/view.php?key=20180126020022026
470,2018-01-29,대웅제약브라질과이집트에보톡스나보타수출,http://www.businesspost.co.kr/BP?command=article_view&num=71331
471,2018-01-29,대웅제약브라질이집트224억수출계약,http://www.dailymedi.com/detail.php?number=826964&thread=22r05
472,2018-01-29,대웅제약브라질이집트에2100만달러규모나보타수출,http://www.techholic.co.kr/news/articleView.html?idxno=173506
473,2018-01-29,대웅제약나보타브라질•이집트수출계약,http://www.kpanews.co.kr/article/show.asp?idx=191095&table=article&category=D
474,2018-01-29,대웅제약나보타브라질이집트진출,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018012917448016874&outlink=1
475,2018-01-29,대웅제약나보타브라질이집트에2100달러수출계약,http://health.chosun.com/site/data/html_dir/2018/01/29/2018012902612.html
476,2018-01-29,대웅제약브라질이집트제약기업에보툴리눔톡신나보타공급계약체결,http://www.insight.co.kr/news/137693
477,2018-01-29,대웅안플원SR출시3년만에사포그릴레이트서방정시장평정,http://health.chosun.com/site/data/html_dir/2018/01/29/2018012902657.html
478,2018-01-29,대웅제약자체개발보툴리눔톡신제제나보타브라질•이집트수출계약,http://www.lawissue.co.kr/view.php?ud=201801292019585455d7f4c63cc6_12
479,2018-01-29,대웅제약나보타브라질이집트에수출계약,http://www.newscj.com/news/articleView.html?idxno=488144
480,2018-01-30,대웅제약브라질이집트에나보타수출계약,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1051980
481,2018-01-30,FDA실사폭탄맞은대웅제약사실과다르다”해명에급급,http://www.joseilbo.com/news/news_read.php?uid=345021&class=53&grp=
482,2018-01-30,대웅제약공장실사지적암초에나보타허가시점지연전망,http://www.mdtoday.co.kr/mdtoday/index.html?no=309849
483,2018-01-30,특징주대웅제약나보타브라질이집트수출계약소식에강세,http://news.mt.co.kr/mtview.php?no=2018013009134373076
484,2018-01-30,대웅제약나보타브라질이집트수출계약소식주가강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=309898
485,2018-01-30,특징주한미약품3대상승세대웅제약신라젠등도강세,http://biz.chosun.com/site/data/html_dir/2018/01/30/2018013000850.html
486,2018-01-30,유대웅제약전일대비729상승일일회전율은157기록,http://www.sedaily.com/NewsView/1RUMMU5XC9
487,2018-01-30,대웅제약6대상승세한미신라젠앱클론등강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=309906
488,2018-01-30,fnRASSI대웅제약전일대비845상승,http://www.fnnews.com/news/201801301044173324
489,2018-01-30,코스피6거래일만에약세한미대웅동성등제약업종강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=309917
490,2018-01-30,대웅제약나보타브라질이집트에2100만달러수출계약체결,http://www.kukinews.com/news/article.html?no=521146
491,2018-01-30,ET투자뉴스대웅_주가거래량투심모두적정주순,http://www.etnews.com/20180130000135
492,2018-01-30,특징주대웅제약나보타수출계약소식에강세,http://www.newsway.co.kr/view.php?tp=1&ud=2018013013280646359
493,2018-01-30,fnRASSI대웅제약069620전일대비845상승,http://www.fnnews.com/news/201801301522222586
494,2018-01-30,대웅제약1조원매출야망메디톡스소송이걸림돌,http://www.ekn.kr/news/article.html?no=340666
495,2018-01-30,코스피코스닥6거래일만에하락동성대웅희소식에주가급등,http://www.mdtoday.co.kr/mdtoday/index.html?no=309975
496,2018-01-31,윤영환대웅제약창업주공익실천은평생소원바이오헬스케어인재키울것,http://news.mk.co.kr/newsRead.php?year=2018&no=70026
497,2018-01-31,리보트릴대웅프리미돈아디녹스급여2월1일부터,http://www.dailypharm.com/News/236260
498,2018-01-31,대웅제약2020년글로벌50위진입목표신약연구개발가속화,http://www.viva100.com/main/view.php?key=20180131010012362
499,2018-02-01,로슈리보트릴정대웅프리미돈정등내달1일급여화,http://www.mdtoday.co.kr/mdtoday/index.html?no=310150
500,2018-02-01,대웅제약전일대비약5하락한172000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802010186
501,2018-02-01,미FDA483문서받은대웅셀트리온미국진출영향없다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1052118
502,2018-02-05,임기만료앞둔대웅유한일동종근당CEO거취관심,http://www.dailymedi.com/detail.php?number=827184&thread=22r05
503,2018-02-05,더벨thebellnote견고한대웅제약,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201802020100002680000169
504,2018-02-05,대웅제약현지투자확대로해외진출발판마련,http://www.kpinews.co.kr/news/articleView.html?idxno=65730
505,2018-02-07,보톡스라이벌대웅제약메디톡스중국시장서한판승부,http://www.ekn.kr/news/article.html?no=342266
506,2018-02-07,보톡스관련株상승곡선메디톡스휴젤대웅제약강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=310952
507,2018-02-07,유한양행종근당대웅제약CEO들연임과퇴임으로거취엇갈려,http://www.news2day.co.kr/98869
508,2018-02-08,소송이어지는메디톡스대웅제약과학적근거기반둔소명필요,http://www.mdtoday.co.kr/mdtoday/index.html?no=311059
509,2018-02-09,잠망경포시가판매대웅제약낙점슈글렛은품에서떠나,http://medipana.com/news/news_viewer.asp?NewsNum=215760&MainKind=A&NewsKind=5&vCount=12&vKind=1
510,2018-02-09,대웅제약선샤인액트시행맞춰증빙체계강화,http://medipana.com/news/news_viewer.asp?NewsNum=215775&MainKind=A&NewsKind=5&vCount=12&vKind=1
511,2018-02-11,대웅제약메디톡스중국서도보톡스경쟁예고,http://www.finomy.com/news/articleView.html?idxno=51750
512,2018-02-11,제약특집대웅제약임팩타민피로어깨결림구내염비타민충전으로훌훌,http://www.viva100.com/main/view.php?key=20180212010003947
513,2018-02-12,2000억우려잠재운대웅영업마케팅저력,http://www.dailymedi.com/detail.php?number=827443&thread=22r05
514,2018-02-12,대웅제약300억매출아스트라제네카당뇨병치료제포시가품을까,http://www.mdtoday.co.kr/mdtoday/index.html?no=311422
515,2018-02-12,대조약갈등빚은글리아티린시장판매량은대웅제약우위,http://www.dt.co.kr/contents.html?article_no=2018021302101076029001&ref=naver
516,2018-02-13,대웅제약이종욱부회장RD늘려글로벌50위제약사로”,http://news.donga.com/3/all/20180212/88645494/1
517,2018-02-13,대웅제약이지듀대한민국브랜드명예의전당선케어부문대상,http://www.dt.co.kr/contents.html?article_no=2018021302109976029003&ref=naver
518,2018-02-13,대웅제약이지듀대한민국브랜드명예의전당선케어부문대상,http://www.mdtoday.co.kr/mdtoday/index.html?no=311705
519,2018-02-13,대웅제약의이지듀2018대한민국브랜드명예의전당선케어부문대상,http://sports.chosun.com/news/ntype.htm?id=201802130100113460008214&servicedate=20180213
520,2018-02-13,대웅제약이지듀브랜드명예의전당대상,http://www.mhj21.com/sub_read.html?uid=112204§ion=sc243
521,2018-02-13,아파야챙길래대웅제약JW메디칼동국제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201802131124011099e6a49afa8d_1/article.html
522,2018-02-13,설사멈추는상비약대웅스멕타vs동성정로환,http://www.viva100.com/main/view.php?key=20180213020022152
523,2018-02-13,대웅제약안플원SR1회복용저렴한가격출시3년새1위,http://www.dt.co.kr/contents.html?article_no=2018021402101476029002&ref=naver
524,2018-02-13,대웅제약이지듀대한민국브랜드명예의전당선케어부문대상,http://www.insight.co.kr/news/140080
525,2018-02-14,제약사들CP위반엄벌추세대웅징계해고단행,http://www.dailypharm.com/News/236783
526,2018-02-14,대웅제약뷰티사업승승장구,http://www.sisaweek.com/news/articleView.html?idxno=103161
527,2018-02-19,매출유한대웅2조JW중외광동CJ1조한미RD선순환도전,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215214
528,2018-02-19,장수CEO이종욱대웅제약대표연임해해외진출진두지휘할까,http://www.businesspost.co.kr/BP?command=article_view&num=73406
529,2018-02-19,중기융합광주전남연합회장에강용선대웅에스앤티대표취임,http://www.jnilbo.com/read.php3?aid=1519041600542678003
530,2018-02-20,대웅제약신약나보타수출기대감↑목표가↑”유안타증권,http://www.dailian.co.kr/news/view/694883/?sc=naver
531,2018-02-20,대웅제약신약나보타수출기대감목표가↑유안타,http://news.mt.co.kr/mtview.php?no=2018022007470575629
532,2018-02-20,대웅제약신약나보타수출기대감유안타,http://www.cstimes.com/?mod=news&act=articleView&idxno=268521
533,2018-02-20,STOCK대웅제약나보타수출기대감목표가↑,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018022008118021135&outlink=1
534,2018-02-20,ET투자뉴스대웅제약나보타끝날때까매수유지유안타증권,http://www.etnews.com/20180220000006
535,2018-02-20,HotLine대웅제약잡음속에서도긍정적이슈이어져목표가↑,http://news.mk.co.kr/newsRead.php?year=2018&no=115705
536,2018-02-20,대웅제약나보타수출기대감목표가상향유안타,http://www.newstomato.com/ReadNews.aspx?no=807383
537,2018-02-20,특징주한올바이오대웅제약동반강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=200465
538,2018-02-20,대웅제약나보타의중국미국수출에대한기대감높아,http://www.newsworks.co.kr/news/articleView.html?idxno=168386
539,2018-02-20,특징주대웅제약나보타中임상시험승인소식에신고가,http://www.newsway.co.kr/view.php?tp=1&ud=2018022010222103363
540,2018-02-20,수급골든타임실시간수급시그널종목대웅제약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022011090190649
541,2018-02-20,대웅제약작년영업익446억전년比261↑,http://www.edaily.co.kr/news/newspath.asp?newsid=03214406619112488
542,2018-02-20,대웅제약작년4Q영업익64억전년比57↓,http://view.asiae.co.kr/news/view.htm?idxno=2018022016250879427
543,2018-02-20,공시대웅제약작년영업익446억원전년비261증가,http://www.newsway.co.kr/view.php?tp=1&ud=2018022016304422646
544,2018-02-20,대웅제약연매출1조근접실적9600억원달성,http://www.dailypharm.com/News/236943
545,2018-02-20,대웅제약지난해영업이익384억원전년比484↑,http://www.newsis.com/view/?id=NISX20180220_0000232828&cID=10401&pID=10400
546,2018-02-20,대웅제약연결기준9602억매출로86성장,http://medipana.com/news/news_viewer.asp?NewsNum=216082&MainKind=A&NewsKind=5&vCount=12&vKind=1
547,2018-02-20,대웅제약지난해영업익384억원전년比48증가,http://news1.kr/articles/?3240512
548,2018-02-20,공시대웅작년영업익841억전년비378증가,http://www.newsway.co.kr/view.php?tp=1&ud=2018022016400704197
549,2018-02-20,대웅지난해영업익841억전년比378↑,http://view.asiae.co.kr/news/view.htm?idxno=2018022016473469758
550,2018-02-20,대웅제약작년영업이익384억원전년比484↑,http://www.enewstoday.co.kr/news/articleView.html?idxno=1159263
551,2018-02-20,대웅제약작년영업이익384억전년比484↑,http://www.newsworks.co.kr/news/articleView.html?idxno=168524
552,2018-02-20,대웅작년연결영업익841억원전년比38↑,http://news.mt.co.kr/mtview.php?no=2018022016474788343
553,2018-02-20,대웅지난해영업익8407억전년비378↑,http://news.heraldcorp.com/view.php?ud=20180220000843
554,2018-02-20,대웅제약지난해영업익384억원전년대비484증가,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022016522754615
555,2018-02-20,대웅제약지난해영업익3843억전년비484↑,http://news.heraldcorp.com/view.php?ud=20180220000852
556,2018-02-20,대웅제약지난해영업익384억원전년비484증가,http://www.dailian.co.kr/news/view/695103/?sc=naver
557,2018-02-20,실적발표대웅제약대웅무림페이퍼,http://www.businesspost.co.kr/BP?command=article_view&num=73579
558,2018-02-20,대웅제약지난해영업이익446억원전년比261↑,http://www.ebn.co.kr/news/view/930764
559,2018-02-20,대웅제약작년영업익384억원484증가,http://www.dt.co.kr/contents.html?article_no=2018022002109976029009&ref=naver
560,2018-02-20,대웅제약지난해매출액8668억영업익446억원,http://daily.hankooki.com/lpage/economy/201802/dh20180220175832138080.htm
561,2018-02-20,대웅제약지난해영업익384억전년比48↑,http://www.newspim.com/news/view/20180220000273
562,2018-02-20,대웅제약지난해영업익384억전년대비484↑,http://www.betanews.net:8080/article/813132.html
563,2018-02-20,대웅제약작년영업이익384억원전년比48↑,http://www.seoulfn.com/news/articleView.html?idxno=299677
564,2018-02-21,대웅제약나보타신공장모멘텀본격화목표가↑NH,http://news.hankyung.com/article/2018022115716
565,2018-02-21,대웅제약4Q실적기대못미쳐올해실적은양호할것신한,http://news.mt.co.kr/mtview.php?no=2018022107415437781
566,2018-02-21,대웅제약1조원시대임박작년9천억대매출올려,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1052752
567,2018-02-21,신한금투대웅제약올해양호한성장목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180221028200008&did=1195m
568,2018-02-21,대웅제약나보타신공장모멘텀본격화목표가↑NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1596471
569,2018-02-21,NH투자대웅제약나보타신공장모멘텀목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180221030100008&did=1195m
570,2018-02-21,클릭e종목대웅제약올해나보타수출증가목표가↑,http://view.asiae.co.kr/news/view.htm?idxno=2018022108154824091
571,2018-02-21,대웅제약지난해연결영업익384억전년比484↑,http://www.ajunews.com/view/20180221082222800
572,2018-02-21,대웅제약4분기실적부진은1회성올해실적성장추세–한화,http://www.cstimes.com/?mod=news&act=articleView&idxno=268644
573,2018-02-21,대웅제약목표주가높아져전문의약품호조로수익좋아져,http://www.businesspost.co.kr/BP?command=article_view&num=73611
574,2018-02-21,신한금융투자대웅제약우루사10성장세지속올해매출견인할것,http://www.g-enews.com/ko-kr/news/article/news_all/201802210814459822c16aa2f016_1/article.html
575,2018-02-21,대웅제약실적부진에도상승모멘텀유효KTB,http://www.sedaily.com/NewsView/1RVSGAFRPL
576,2018-02-21,한화투자증권대웅제약나보타해외이벤트효과본격화,http://www.newsprime.co.kr/news/article.html?no=407072
577,2018-02-21,대웅제약지난해영업이익384억원전년比484↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=312457
578,2018-02-21,대웅제약4Q실적부진1회성올해본격반등한화證,http://www.seoulfn.com/news/articleView.html?idxno=299697
579,2018-02-21,대웅제약나보타신공장모멘텀본격화,http://www.newsworks.co.kr/news/articleView.html?idxno=168610
580,2018-02-21,대웅제약작년매출9602억원달성,http://www.sisajournal-e.com/biz/article/180457
581,2018-02-21,ET투자뉴스대웅제약4Q17실적부진매수유지한화투자증권,http://www.etnews.com/20180221000091
582,2018-02-21,ET투자뉴스대웅제약예상보다부진TRADINGBUY유지신한금융투자,http://www.etnews.com/20180221000097
583,2018-02-21,ET투자뉴스대웅제약실적저점확인매수유지NH투자증권,http://www.etnews.com/20180221000116
584,2018-02-21,제약업계1조클럽의신3인방대웅제약한미약품한국콜마유력,http://www.news2day.co.kr/99433
585,2018-02-21,대웅제약올해영업이익530억원으로양호한성장예상,http://www.newsworks.co.kr/news/articleView.html?idxno=168693
586,2018-02-21,대웅제약나보타해외이벤트효과본격적,http://www.newsworks.co.kr/news/articleView.html?idxno=168722
587,2018-02-21,대웅제약지난해영업익384억원전년비484↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802210436
588,2018-02-21,더벨콜마가상정한CJ헬스케어비교군종근당대웅제약유한양행,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201802210100036780002275
589,2018-02-21,대웅제약이종욱부회장연임위기감윤재승회장외부수혈불똥튀나,http://www.newspost.kr/news/articleView.html?idxno=61515
590,2018-02-21,대웅제약작년매출9603억1조클럽눈앞,http://www.rapportian.com/news/articleView.html?idxno=109100
591,2018-02-22,올해최대7개제약사매출1조원넘는다한미대웅종근당변수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215219
592,2018-02-22,지난해1조클럽유한녹십자올해대웅셀트리온도전中,http://www.mdtoday.co.kr/mdtoday/index.html?no=312605
593,2018-02-22,한미약품대웅제약종근당도올해매출1조간다,http://medipana.com/news/news_viewer.asp?NewsNum=216142&MainKind=A&NewsKind=5&vCount=12&vKind=1
594,2018-02-22,3년후매출덩치어느제약사가클까유한대웅2조원제시,http://www.kpanews.co.kr/article/show.asp?idx=191625&table=article&category=D
595,2018-02-22,ET투자뉴스대웅제약4Q실적은부진했매수유지KTB투자증권,http://www.etnews.com/20180222000088
596,2018-02-22,활성형비타민B로피로체력관리대웅제약임팩타민,http://www.asiatoday.co.kr/view.php?key=20180222010012609
597,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용공동연구위한MOU체결,http://www.digitaltoday.co.kr/news/articleView.html?idxno=116688
598,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터공동연구MOU체결,http://www.fnnews.com/news/201802221109590975
599,2018-02-22,네이버분당서울대병원대웅제약의료빅데이터맞손,http://www.inews24.com/php/news_view.php?g_serial=1078993&g_menu=020310&rrf=nv
600,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터연구협력,http://view.asiae.co.kr/news/view.htm?idxno=2018022211340853232
601,2018-02-22,네이버분당서울대병원대웅제약인공지능기술에헬스케어빅데이터접목시도,http://www.economytalk.kr/news/articleView.html?idxno=158871
602,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터공동연구키로,http://news.hankyung.com/article/201802227570g
603,2018-02-22,대웅제약5거래일연속상승전일대비1상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802220248
604,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용업무협약체결,http://www.bloter.net/archives/303088
605,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터공동연구MOU체결,http://www.enewstoday.co.kr/news/articleView.html?idxno=1160192
606,2018-02-22,네이버분당서울대병원대웅제약과의료빅데이터연구,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180222089100033&did=1195m
607,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용공동연구,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018022213508054911&outlink=1
608,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터공동연구맞손,http://daily.hankooki.com/lpage/ittech/201802/dh20180222140411138240.htm
609,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터공동연구MOU체결,http://www.asiatoday.co.kr/view.php?key=20180222010012842
610,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용공동연구나선다,http://biz.chosun.com/site/data/html_dir/2018/02/22/2018022201603.html
611,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용위해맞손,http://www.etnews.com/20180222000240
612,2018-02-22,네이버분당서울대병원대웅제약과의료빅데이터연구맞손,http://www.ekn.kr/news/article.html?no=345268
613,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용연구MOU,http://www.viva100.com/main/view.php?key=20180222010007976
614,2018-02-22,네이버분당서울대병원대웅제약과헬스케어공동연구,http://www.newspim.com/news/view/20180222000217
615,2018-02-22,美허가지연된대웅제약나보타풀어야할과제는,http://biz.newdaily.co.kr/news/article.html?no=10153924
616,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용공동연구,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022215091365309
617,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터공동연구MOU,http://www.datanet.co.kr/news/articleView.html?idxno=119989
618,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터공동연구MOU체결,http://www.newsway.co.kr/view.php?tp=1&ud=2018022216060017405
619,2018-02-22,네이버분당서울대학교병원대웅제약헬스케어빅데이터활용연구위해MOU체결,http://gamefocus.co.kr/detail.php?number=79376
620,2018-02-22,이탈파마코대웅제약글리아티린원료기술계열사로유출해,http://www.rapportian.com/news/articleView.html?idxno=109122
621,2018-02-22,의료데이터분석도AI로네이버분당서울대병원대웅제약빅데이터업무혁약체결,http://www.nextdaily.co.kr/news/article.html?id=20180222800041
622,2018-02-22,네이버분당서울대병원대웅제약손잡았다,http://www.dailymedi.com/detail.php?number=827763&thread=22r02
623,2018-02-22,네이버분당서울대병원대웅제약헬스케어빅데이터활용공동연구위한MOU체결,http://www.rpm9.com/news/article.html?id=20180222090041
624,2018-02-22,네이버서울대병원대웅제약헬스케어빅데이터연구하기로,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1447012
625,2018-02-22,네이버분당서울대병원대웅제약의료빅데이터활용협력,http://www.itdaily.kr/news/articleView.html?idxno=87678
626,2018-02-22,이탈파마코대웅제약이글리아티린기술유출,http://www.medical-tribune.co.kr/news/articleView.html?idxno=77526
627,2018-02-23,보톡스균주분쟁조만간결판승소시대웅에책임물을것,http://www.newstomato.com/ReadNews.aspx?no=807922
628,2018-02-23,골골대던골다공증치료제에숨불어넣은대웅한독,http://www.dailypharm.com/News/237035
629,2018-02-23,올해제약사매출1조클럽커진다한미대웅도전,http://www.newspim.com/news/view/20180223000126
630,2018-02-24,대웅2년차도입약덕봤네선구안영업력증명,http://www.dailypharm.com/News/237086
631,2018-02-25,주간추천종목유안타증권SOil우리은행대웅제약,http://www.fntimes.com/html/view.php?ud=201802250222455786f09e13944d_18
632,2018-02-25,미국FDA승인앞두고있는제약주셀트리온대웅제약삼성바이오로직스,http://news.hankyung.com/article/2018022569671
633,2018-02-26,대웅제약가스모틴서방정가격으로승부수,http://www.medicaltimes.com/News/1117053
634,2018-02-26,오늘의추천종목유안타증권우리은행대웅제약등,http://www.asiatoday.co.kr/view.php?key=20180226010014647
635,2018-02-26,대웅제약가스모틴SR정론칭500억육성포부,http://www.dailypharm.com/News/237119
636,2018-02-26,대웅제약가스모틴SR정런칭심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=216331&MainKind=A&NewsKind=5&vCount=12&vKind=1
637,2018-02-26,대웅제약복약순응도높인가스모틴SR정론칭심포지엄,http://www.dailian.co.kr/news/view/696454/?sc=naver
638,2018-02-26,대웅제약가스모틴SR정론칭심포지엄개최연매출500억원으로,http://news.mk.co.kr/newsRead.php?year=2018&no=130202
639,2018-02-26,대웅가스모틴SR정런칭심포지엄,http://news.mt.co.kr/mtview.php?no=2018022609241920448
640,2018-02-26,대웅제약가스모틴SR정론칭심포지엄개최,http://www.newsis.com/view/?id=NISX20180226_0000237040&cID=13001&pID=13000
641,2018-02-26,복약순응도잡은가스모틴SR대웅500억원대육성,http://www.monews.co.kr/news/articleView.html?idxno=111537
642,2018-02-26,대웅제약가스모틴SR정론칭심포지엄개최,http://www.m-i.kr/news/articleView.html?idxno=390098
643,2018-02-26,대웅제약가스모틴SR정론칭심포지엄개최,http://www.metroseoul.co.kr/news/newsview?newscd=2018022600034
644,2018-02-26,대웅제약특허기술로복약순응도높인가스모틴SR정런칭심포지엄개최,http://www.asiatime.co.kr/news/articleView.html?idxno=169435
645,2018-02-26,대웅제약소화불량치료제가스모틴SR정500억원대제품으로육성,http://view.asiae.co.kr/news/view.htm?idxno=2018022610491955898
646,2018-02-26,대웅제약가스모틴SR정런칭심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1161361
647,2018-02-26,대웅제약가스모틴SR정런칭심포지엄개최,http://www.joseilbo.com/news/news_read.php?uid=347079&class=27&grp=
648,2018-02-26,대웅제약가스모틴SR정런칭심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2078646
649,2018-02-26,대웅제약복약순응도높인가스모틴SR정론칭,http://www.mhj21.com/sub_read.html?uid=112392§ion=sc243
650,2018-02-26,대웅제약가스모틴SR정론칭심포지엄개최,http://www.newsprime.co.kr/news/article.html?no=407683
651,2018-02-26,대웅제약가스모틴SR정런칭심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=313070
652,2018-02-26,제약산업소식대웅제약가스모틴SR정런칭심포지엄개최外,http://www.kukinews.com/news/article.html?no=527777
653,2018-02-26,대웅제약복약순응도높인가스모틴SR정론칭,http://www.sportsseoul.com/news/read/606400
654,2018-02-26,대웅제약복약순응도높인가스모틴SR정론칭,http://www.kormedi.com/news/news/drug_dist/1226299_2906.html
655,2018-02-26,대웅제약소화불량치료제가스모틴SR정500억원대육성포부,http://www.sedaily.com/NewsView/1RVUSIWN11
656,2018-02-26,대웅제약가스모틴SR정런칭심포지엄개최,http://www.viva100.com/main/view.php?key=20180226010009095
657,2018-02-26,아파야챙길래종근당동아쏘시오홀딩스대웅제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201802261445294287e6a49afa8d_1/article.html
658,2018-02-26,대웅제약소화불량치료제가스모틴SR정론칭500억대품목육성포부,http://www.etoday.co.kr/news/section/newsview.php?idxno=1598482
659,2018-02-26,대웅제약특허받은기술로복약순응도높인가스모틴SR정런칭심포지엄개최,http://www.lawissue.co.kr/view.php?ud=201802261519089740d7f4c63cc6_12
660,2018-02-26,대웅제약소화불량치료제가스모틴서방정심포지엄개최,http://www.edaily.co.kr/news/newspath.asp?newsid=03384966619114456
661,2018-02-26,대웅제약기능성소화불량증치료제가스모틴SR정런칭심포지엄개최,http://www.fnnews.com/news/201802261542219821
662,2018-02-26,대웅제약가스모틴SR정론칭심포지엄개최,http://www.ciobiz.co.kr/news/article.html?id=20180226120030
663,2018-02-26,대웅제약가스모틴군500억대소화불량약키운다,http://www.seoulfn.com/news/articleView.html?idxno=300097
664,2018-02-26,대웅제약가스모틴SR정런칭심포지엄개최,http://www.newstomato.com/ReadNews.aspx?no=808605
665,2018-02-26,대웅제약종근당글리아티린은대조약기준부합하지않아,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215462
666,2018-02-26,대웅제약이탈파마코보도자료정면반박,http://medipana.com/news/news_viewer.asp?NewsNum=216368&MainKind=A&NewsKind=5&vCount=12&vKind=1
667,2018-02-26,대웅제약복약순응도높인가스모틴SR정론칭심포지엄개최,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018022616548088801&outlink=1
668,2018-02-26,대웅제약가스모틴SR정론칭심포지엄개최매출목표500억대,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022614532748644
669,2018-02-26,대웅종근당글리아티린대조약기준부적합제네릭,http://www.dailypharm.com/News/237148
670,2018-02-26,대웅제약가스모틴제품군시장규모500억원대로키운다,http://www.techholic.co.kr/news/articleView.html?idxno=174068
671,2018-02-26,대웅제약재반박종근당글리아티린은제네릭,http://www.medicaltimes.com/News/1117078
672,2018-02-26,대웅제약이탈파마코기술이전시기방법밝혀라,http://www.medical-tribune.co.kr/news/articleView.html?idxno=77582
673,2018-02-26,대웅제약가스모틴SR정런칭심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=496390
674,2018-02-27,대웅종근당글리아티린대조약부적합재반박,http://www.dailymedi.com/detail.php?number=827907&thread=22r05
675,2018-02-27,오늘의추천종목유안타증권대웅제약컴투스등,http://www.asiatoday.co.kr/view.php?key=20180227010015455
676,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://medipana.com/news/news_viewer.asp?NewsNum=216416&MainKind=A&NewsKind=5&vCount=12&vKind=1
677,2018-02-27,대웅제약항궤양제DWP14012정부신약개발선정,http://news.mt.co.kr/mtview.php?no=2018022710091954354
678,2018-02-27,집중필요하면1인실날씨맑으면한강보며대웅제약스마트오피스가보니,http://www.edaily.co.kr/news/newspath.asp?newsid=02158246619114784
679,2018-02-27,대웅DWP14012KDDF신약개발사업지원과제선정,http://www.dailypharm.com/News/237180
680,2018-02-27,대웅제약항궤양제신약DWP14012정부지원과제선정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215482
681,2018-02-27,대웅제약항궤양제신약정부지원과제선정협약,http://www.dailian.co.kr/news/view/696732/?sc=naver
682,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.medigatenews.com/news/2999706650
683,2018-02-27,대웅제약차세대항궤양제후보물질정부지원과제선정,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802270162
684,2018-02-27,대웅제약개발위장약범부처전주기신약개발과제선정,http://www.edaily.co.kr/news/newspath.asp?newsid=02279606619114784
685,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.bosa.co.kr/news/articleView.html?idxno=2078730
686,2018-02-27,대웅제약차세대항궤양제정부지원과제선정,http://www.sedaily.com/NewsView/1RVV7YI9FP
687,2018-02-27,대웅제약항궤양제신약DWP14012정부지원과제선정,http://www.ebn.co.kr/news/view/931622
688,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.enewstoday.co.kr/news/articleView.html?idxno=1161902
689,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.mdtoday.co.kr/mdtoday/index.html?no=313242
690,2018-02-27,대웅제약항궤양제신약DWP14012정부지원과제선정,http://www.mhj21.com/sub_read.html?uid=112420§ion=sc243
691,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.asiatoday.co.kr/view.php?key=20180227010015820
692,2018-02-27,대웅5거래일연속상승전일대비2상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802270281
693,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.kpanews.co.kr/article/show.asp?idx=191809&table=article&category=D
694,2018-02-27,식약처대웅제약등바이오의약품제조소11곳현장감시실시,http://www.yakup.com/news/index.html?mode=view&cat=11&nid=215493
695,2018-02-27,대웅제약항궤양제신약정부지원과제선정37억지원,http://www.newspim.com/news/view/20180227000151
696,2018-02-27,대웅제약항궤양제신약개발정부지원과제로선정,http://www.rapportian.com/news/articleView.html?idxno=109195
697,2018-02-27,대웅제약항궤양제신약정부지원과제선정,http://www.etnews.com/20180227000180
698,2018-02-27,대웅제약항궤양제신약정부지원과제선정,http://www.sportsseoul.com/news/read/606870
699,2018-02-27,대웅제약항궤양제신약범부처전주기신약개발사업지원과제선정,http://www.fnnews.com/news/201802271401599907
700,2018-02-27,뉴스투데이E대웅제약개발중인항궤양제DWP14012정부지원과제선정,http://www.news2day.co.kr/99735
701,2018-02-27,대웅제약차세대항궤양제정부지원과제선정,http://news.hankyung.com/article/201802275290f
702,2018-02-27,대웅제약항궤양신약DWP14012정부지원과제선정,http://www.newsis.com/view/?id=NISX20180227_0000238609&cID=13001&pID=13000
703,2018-02-27,대웅제약개발중인항궤양제신약정부지원과제선정,http://www.ajunews.com/view/20180227105450458
704,2018-02-27,대웅제약항궤양제신약후보물질정부지원과제선정,http://news.mk.co.kr/newsRead.php?year=2018&no=133954
705,2018-02-27,대웅제약항궤양제신약정부신약개발사업지원과제선정”,http://www.newsway.co.kr/view.php?tp=1&ud=2018022714511077701
706,2018-02-27,대웅제약항궤양제신약후보물질정부지원과제선정,http://view.asiae.co.kr/news/view.htm?idxno=2018022715054472196
707,2018-02-27,대웅항궤양제신약정부지원과제선정,http://www.monews.co.kr/news/articleView.html?idxno=111580
708,2018-02-27,대웅제약항궤양제신약정부지원과제선정,http://www.kormedi.com/news/news/drug_dist/1226313_2906.html
709,2018-02-27,KDDF대웅제약위산분비억제신약임상2상지원,http://news1.kr/articles/?3247083
710,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.dt.co.kr/contents.html?article_no=2018022702109976029008&ref=naver
711,2018-02-27,대웅제약항궤양제신약DWP14012정부지원과제선정,http://www.techholic.co.kr/news/articleView.html?idxno=174101
712,2018-02-27,대웅제약항궤양제신약정부지원과제선정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018022714513742995
713,2018-02-27,대웅제약항궤양제신약정부지원과제선정,http://www.newsprime.co.kr/news/article.html?no=407933
714,2018-02-27,코스피약보합셀트리온대웅제약급등,http://www.choicenews.co.kr/news/articleView.html?idxno=39609
715,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.ekn.kr/news/article.html?no=346112
716,2018-02-27,대웅제약개발신약정부지원과제선정,http://www.kpinews.co.kr/news/articleView.html?idxno=67506
717,2018-02-27,대웅제약위식도역류증치료신약정부지원과제선정,http://biz.chosun.com/site/data/html_dir/2018/02/27/2018022702642.html
718,2018-02-27,대웅제약항궤양신약정부지원과제선정,http://www.newstomato.com/ReadNews.aspx?no=808888
719,2018-02-27,대웅제약항궤양제DWP14012범부처신약과제선정,http://www.viva100.com/main/view.php?key=20180227020022243
720,2018-02-27,대웅제약신약DWP14012정부지원과제선정,http://www.newscj.com/news/articleView.html?idxno=496790
721,2018-02-28,유한양행대웅제약10성장제약계순위경쟁후끈,http://www.ajunews.com/view/20180226142621569
722,2018-02-28,대웅제약신약DWP14012정부지원과제선정,http://www.lawissue.co.kr/view.php?ud=20180227234547170d7f4c63cc6_12
723,2018-02-28,대웅제약항궤양제DWP14012정부지원과제선정,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053053
724,2018-02-28,ET투자뉴스대웅_관련종목들도하락우위금융업업종023,http://www.etnews.com/20180228000039
725,2018-02-28,대웅제약이지듀헬스뷰티스토어랄라블라입점,http://medipana.com/news/news_viewer.asp?NewsNum=216483&MainKind=A&NewsKind=5&vCount=12&vKind=1
726,2018-02-28,대웅제약이지듀헬스뷰티스토어랄라블라공식입점,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018022810098094117&outlink=1
727,2018-02-28,아스트라제네카대웅제약과포시가직듀오파트너십체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215535
728,2018-02-28,한국AZ대웅제약과포시가직듀오파트너십체결,http://medipana.com/news/news_viewer.asp?NewsNum=216489&MainKind=A&NewsKind=5&vCount=12&vKind=1
729,2018-02-28,대웅제약전일대비약4하락한183000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201802280222
730,2018-02-28,당뇨약포시가대웅제약품으로,http://www.medical-tribune.co.kr/news/articleView.html?idxno=77634
731,2018-02-28,AZ대웅제약포시가직듀오파트너십체결,http://www.monews.co.kr/news/articleView.html?idxno=111649
732,2018-02-28,당뇨약포시가직듀오CJ헬스케어→대웅,http://www.dailymedi.com/detail.php?number=827966&thread=22r05
733,2018-02-28,ET투자뉴스대웅제약_관련종목들사이에서변동성낮아도수익률은높아,http://www.etnews.com/20180228000151
734,2018-02-28,SGLT2억제제포시가CJ떠나대웅제약품으로,http://www.dailypharm.com/News/237242
735,2018-02-28,300억당뇨약포시가국내판권대웅품으로,http://www.medicaltimes.com/News/1117115
736,2018-02-28,AZ대웅제약포시가직듀오파트너십체결,http://www.bosa.co.kr/news/articleView.html?idxno=2078847
737,2018-02-28,아스트라제네카대웅제약포시가직듀오파트너십,http://www.kormedi.com/news/news/drug_dist/1226329_2906.html
738,2018-02-28,아스트라제네카대웅제약포시가직듀오파트너십체결,http://www.kpanews.co.kr/article/show.asp?idx=191841&table=article&category=D
739,2018-02-28,한국아스트라제네카대웅제약과포시가직듀오파트너십체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=313414
740,2018-02-28,대웅제약공동대표이사에윤재춘전승호내정,http://medipana.com/news/news_viewer.asp?NewsNum=216516&MainKind=A&NewsKind=5&vCount=12&vKind=1
741,2018-02-28,대웅제약아스트라제네포시가품었다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053101
742,2018-02-28,한국아스트라대웅제약과포시가공동판매계약체결,http://www.rapportian.com/news/articleView.html?idxno=109228
743,2018-02-28,대웅1주당100원현금배당결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1599508
744,2018-02-28,공시대웅주당100원현금배당결정,http://www.newsway.co.kr/view.php?tp=1&ud=2018022817291054859
745,2018-02-28,대웅주당100원현금배당,http://www.edaily.co.kr/news/newspath.asp?newsid=03958966619115112
746,2018-02-28,대웅제약주당600원현금배당,http://www.edaily.co.kr/news/newspath.asp?newsid=04057366619115112
747,2018-02-28,공시대웅제약주당600원현금배당결정,http://www.newsway.co.kr/view.php?tp=1&ud=2018022818014483292
748,2018-02-28,대웅윤재춘전승호신규선임이종욱부회장퇴임,http://www.dailypharm.com/News/237251
749,2018-02-28,지주사대웅41세이창재본부장신임등기이사내정,http://www.dailypharm.com/News/237252
750,2018-02-28,대웅주당100원현금배당,http://view.asiae.co.kr/news/view.htm?idxno=2018022818303764824
751,2018-02-28,대웅제약윤재춘전승호공동대표내정,http://news1.kr/articles/?3248653
752,2018-02-28,대웅제약이지듀헬스뷰티스토어랄라블라공식입점,http://www.mdtoday.co.kr/mdtoday/index.html?no=313537
753,2018-02-28,대웅제약주당600원현금배당,http://view.asiae.co.kr/news/view.htm?idxno=2018022820055463062
754,2018-02-28,대웅제약아스트라제네카SGLT2억제제포시가직듀오국내유통,http://www.viva100.com/main/view.php?key=20180228020022258
755,2018-03-02,GC녹십자대웅한미올해잭팟기대감만발,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215563
756,2018-03-02,대웅제약항궤양제신약DWP14012정부지원과제선정,http://www.kukinews.com/news/article.html?no=528743
757,2018-03-02,대웅제약주당600원현금결산배당실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=313574
758,2018-03-02,대웅제약주총서윤재춘전승호이사선임,http://www.kpanews.co.kr/article/show.asp?idx=191873&table=article&category=D
759,2018-03-02,대웅제약공동대표체제전환윤재춘전승호내정,http://www.rapportian.com/news/articleView.html?idxno=109243
760,2018-03-02,대웅제약전일대비약3하락한177500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803020158
761,2018-03-02,대웅제약항궤양제신약정부지원과제선정임상연구비지원,http://www.sisaweek.com/news/articleView.html?idxno=103967
762,2018-03-02,대웅제약윤재춘전승호공동대표내정,http://www.dailymedi.com/detail.php?number=828030&thread=22r05
763,2018-03-02,대웅제약글로벌에무게신임CEO에윤재춘사장전승호본부장내정,http://biz.newdaily.co.kr/news/article.html?no=10154499
764,2018-03-02,엘리퀴스물질특허무효성공총7개사대웅동아포함,http://www.dailypharm.com/News/237283
765,2018-03-02,1000억원대당뇨약손에쥔대웅제약,http://www.newstomato.com/ReadNews.aspx?no=809180
766,2018-03-02,전인CM대웅바이오향남공장CM수주,http://www.ikld.kr/news/articleView.html?idxno=89143
767,2018-03-02,한국아스트라제네카대웅제약2형당뇨치료제포시가직듀오유통파트너십체결,http://health.chosun.com/site/data/html_dir/2018/03/02/2018030201992.html
768,2018-03-02,대웅제약윤재춘전승호공동대표내정이종욱부회장퇴임,http://www.newspim.com/news/view/20180302000251
769,2018-03-03,종근당대웅글리아티린공방누구말이맞을까,http://www.medicaltimes.com/News/1117137
770,2018-03-03,주간추천종목유안타증권SOil선데이토즈대웅제약,http://www.viva100.com/main/view.php?key=20180303010000580
771,2018-03-04,주간추천종목유안타증권SOil선데이토즈대웅제약,http://www.fntimes.com/html/view.php?ud=201803032328544933f09e13944d_18
772,2018-03-04,주간추천종목유안타증권SOil선데이토즈대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/201803021810517876581e5800d6_1/article.html
773,2018-03-04,업다운주간추천종목S오일선데이토즈대웅제약유안타증권,http://www.updownnews.co.kr/news/articleView.html?idxno=86021
774,2018-03-04,주간추천종목에쓰오일대웅제약현대모비스선데이토즈,http://www.ajunews.com/view/20180302172136084
775,2018-03-04,여성용진통제시장에서독보적성장세보이는대웅제약이지엔6이브,http://www.insight.co.kr/news/143127
776,2018-03-05,대웅제약삼성바이오에피스삼페넷출시항암제시장본격진출,http://view.asiae.co.kr/news/view.htm?idxno=2018030509254753903
777,2018-03-05,대웅제약지난해매출9603억영업익순이익큰폭증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215605
778,2018-03-05,대웅제약삼페넷국내출시항암제라인업강화,http://www.newsprime.co.kr/news/article.html?no=408383
779,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷출시,http://medipana.com/news/news_viewer.asp?NewsNum=216611&MainKind=A&NewsKind=5&vCount=12&vKind=1
780,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷대형품목육성앞장,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215613
781,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.sportsseoul.com/news/read/608298
782,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.asiatoday.co.kr/view.php?key=20180305010000996
783,2018-03-05,대웅삼성바이오에피스항암제삼페넷출시,http://www.dailypharm.com/News/237321
784,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.medigatenews.com/news/1529696405
785,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.ekn.kr/news/article.html?no=347069
786,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.kukinews.com/news/article.html?no=529177
787,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.ebn.co.kr/news/view/932200
788,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.viva100.com/main/view.php?key=20180305010000957
789,2018-03-05,대웅제약삼성바이오에피스삼페넷국내출시항암제라인업강화,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018030509538045398&outlink=1
790,2018-03-05,대웅제약삼성에피스바이오시밀러삼페넷시판,http://news1.kr/articles/?3251231
791,2018-03-05,대웅제약삼성바이오에피스삼페넷국내출시,http://www.newsway.co.kr/view.php?tp=1&ud=2018030510165449102
792,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://news.hankyung.com/article/201803051420f
793,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷출시,http://www.medicaltimes.com/News/1117165
794,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.newsis.com/view/?id=NISX20180305_0000242364&cID=13001&pID=13000
795,2018-03-05,대웅제약항암제시장진출바이오시밀러삼페넷출시,http://www.rapportian.com/news/articleView.html?idxno=109269
796,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://news.mt.co.kr/mtview.php?no=2018030509395534834
797,2018-03-05,ET투자뉴스대웅_주요매물구간인15850원선이지지대로작용,http://www.etnews.com/20180305000086
798,2018-03-05,뉴스투데이E대웅제약합리적약가앞세운삼페넷국내출시임박,http://www.news2day.co.kr/99950
799,2018-03-05,대웅제약삼성바이오항암제삼페넷국내출시,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180305068900017&did=1195m
800,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.kpanews.co.kr/article/show.asp?idx=191907&table=article&category=D
801,2018-03-05,대웅삼페넷국내출시라인업강화나서,http://www.monews.co.kr/news/articleView.html?idxno=111755
802,2018-03-05,이종욱대표용퇴대웅제약물갈이예고,http://www.monews.co.kr/news/articleView.html?idxno=111761
803,2018-03-05,대웅제약삼성바이오에피스유방암바이오시밀러샴페넷판매,http://www.businesspost.co.kr/BP?command=article_view&num=74746
804,2018-03-05,대웅제약삼성바이오에피스삼페넷본격판매,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803050230
805,2018-03-05,대웅제약삼성바이오에피스삼페넷국내출시,http://www.bosa.co.kr/news/articleView.html?idxno=2079017
806,2018-03-05,대웅제약삼성바이오에피스항암제삼피넷국내출시,http://news20.busan.com/controller/newsController.jsp?newsId=20180305000081
807,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.ajunews.com/view/20180305114005172
808,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내첫출시,http://www.mhj21.com/sub_read.html?uid=112504§ion=sc243
809,2018-03-05,대웅제약항암제바이오시밀러삼페넷국내출시,http://biz.chosun.com/site/data/html_dir/2018/03/05/2018030501285.html
810,2018-03-05,대웅제약삼성바이오항암제삼페넷국내출시,http://www.sedaily.com/NewsView/1RWV1SAE73
811,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.metroseoul.co.kr/news/newsview?newscd=2018030500086
812,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=313807
813,2018-03-05,대웅제약삼성바이오항암제삼페넷국내출시,http://www.seoulfn.com/news/articleView.html?idxno=300584
814,2018-03-05,대웅제약삼성바이오항암제삼페넷국내출시,http://health.chosun.com/site/data/html_dir/2018/03/05/2018030501478.html
815,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷출시,http://www.kormedi.com/news/news/drug_dist/1226365_2906.html
816,2018-03-05,대웅제약유방암위암치료바이오시밀러삼페넷출시,http://news.mk.co.kr/newsRead.php?year=2018&no=145476
817,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.newstomato.com/ReadNews.aspx?no=809839
818,2018-03-05,대웅제약허셉틴바이오시밀러삼페넷출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053225
819,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018030514213078163
820,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.techholic.co.kr/news/articleView.html?idxno=174220
821,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.newscj.com/news/articleView.html?idxno=498569
822,2018-03-05,대웅제약삼성바이오에피스항암제삼페넷국내출시,http://www.lawissue.co.kr/view.php?ud=201803052018508080d7f4c63cc6_12
823,2018-03-06,대웅제약삼성바이오와손잡고항암제강화,http://www.dailymedi.com/detail.php?number=828130&thread=22r05
824,2018-03-06,오늘의추천종목유안타증권SK대웅제약등,http://www.asiatoday.co.kr/view.php?key=20180306010001691
825,2018-03-06,윤재승대웅제약젊은CEO로교체해해외진출에속도붙여,http://www.businesspost.co.kr/BP?command=article_view&num=74916
826,2018-03-07,대웅명문신신제약공장증설성장동력확보,http://www.dailymedi.com/detail.php?number=828176&thread=22r05
827,2018-03-07,코프로모션강자유한vs대웅또다시정면승부,http://www.dailypharm.com/News/237393
828,2018-03-07,HotLine대웅제약나보타이후에도시장성높은파이프라인다수,http://news.mk.co.kr/newsRead.php?year=2018&no=149547
829,2018-03-07,대웅제약주가오를가능성보톡스나보타앞세워수출본격화,http://www.businesspost.co.kr/BP?command=article_view&num=75005
830,2018-03-07,대웅제약올해나보타수출원년으로목표가24만원제시키움증권,http://www.sedaily.com/NewsView/1RWVYVEEIH
831,2018-03-07,전승호대웅제약글로벌사업본부장은누구,http://www.newsway.co.kr/view.php?tp=1&ud=2018030715212971839
832,2018-03-07,윤재승대웅제약회장40대젊은피전면에내세운이유,http://www.newsway.co.kr/view.php?tp=1&ud=2018030714581588564
833,2018-03-08,삼성바이오에피스국내시장유통유한대웅너로정했다,http://www.mdtoday.co.kr/mdtoday/index.html?no=314158
834,2018-03-08,보툴리눔톡신3총사메디톡스휴젤대웅긍정적기류,http://www.mdtoday.co.kr/mdtoday/index.html?no=314265
835,2018-03-08,세계최대담수설비제작한대웅엔지니어링,http://news.mk.co.kr/newsRead.php?year=2018&no=154268
836,2018-03-09,오늘의추천종목유안타증권SK대웅제약등,http://www.asiatoday.co.kr/view.php?key=20180309010004301
837,2018-03-09,대웅을떠나야더잘나간다대웅출신들승승장구,http://www.wolyo.co.kr/news/articleView.html?idxno=55538
838,2018-03-11,제약CEO떠나거나남거나대웅제약12년만에교체,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180310001000017&did=1195m
839,2018-03-11,주간추천종목유안타증권SK삼성전기대웅제약,http://www.fntimes.com/html/view.php?ud=201803110737499829f09e13944d_18
840,2018-03-11,대웅제약12년만에최고경영자CEO교체,http://www.insight.co.kr/news/144290
841,2018-03-11,대웅제약12년만에CEO교체,http://news.mk.co.kr/newsRead.php?year=2018&no=158819
842,2018-03-12,대웅제약12년만에수장교체이종욱부회장빈자리공동대표체제로,http://www.sisaweek.com/news/articleView.html?idxno=104481
843,2018-03-12,제약사CEO대부분연임대웅제약12년만에교체,http://www.metroseoul.co.kr/news/newsview?newscd=2018031200029
844,2018-03-12,윤동한한국콜마친정윤재승대웅제약앞지를까,http://www.nongaek.com/news/articleView.html?idxno=36319
845,2018-03-12,12년만에CEO교체대웅제약공동대표체제로전환,http://www.ekn.kr/news/article.html?no=348576
846,2018-03-13,수퍼주총데이앞둔제약업계대웅제약빼곤대부분오너家CEO재선임,http://biz.chosun.com/site/data/html_dir/2018/03/12/2018031202229.html
847,2018-03-13,바이오시밀러두고대웅VS유한격돌,http://www.monews.co.kr/news/articleView.html?idxno=112036
848,2018-03-13,크리스탈동아ST이어대웅제약과아셀렉스판매계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=215897
849,2018-03-13,대웅제약크리스탈지노믹스골관절염약아셀렉스시판,http://news1.kr/articles/?3258885
850,2018-03-13,대웅제약관절염신약아셀렉스클리닉영업전담,http://www.dailypharm.com/News/237585
851,2018-03-13,크리스탈지노믹스대웅제약과아셀렉스판매계약체결,http://news.mk.co.kr/newsRead.php?year=2018&no=162505
852,2018-03-13,크리스탈지노믹스아셀렉스대웅제약과판매계약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180313057000017&did=1195m
853,2018-03-13,대웅제약골관절염치료제아셀렉스블록버스터로키운다,http://www.mhj21.com/sub_read.html?uid=112653§ion=sc243
854,2018-03-13,크리스탈지노믹스대웅제약과관절염약판매계약,http://www.edaily.co.kr/news/newspath.asp?newsid=02069686619142992
855,2018-03-13,크리스탈지노믹스대웅제약과아셀렉스국내판권계약,http://www.edaily.co.kr/news/newspath.asp?newsid=02082806619142992
856,2018-03-13,대웅가세힘받는골관절염신약아셀렉스,http://www.dailymedi.com/detail.php?number=828375&thread=22r05
857,2018-03-13,크리스탈지노믹스아셀렉스대웅제약과판매계약,http://www.sportsseoul.com/news/read/610969
858,2018-03-13,크리스탈지노믹스대웅제약과아셀렉스판매계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1603052
859,2018-03-13,크리스탈지노믹스대웅제약과아셀렉스병의원판매계약체결,http://www.nextdaily.co.kr/news/article.html?id=20180313800011
860,2018-03-13,대웅제약크리스탈지노믹스와아셀렉스판매계약체결,http://www.ekn.kr/news/article.html?no=348854
861,2018-03-13,크리스탈지노믹스대웅제약과아셀렉스판매계약,http://www.dt.co.kr/contents.html?article_no=2018031302109976029004&ref=naver
862,2018-03-13,대웅제약크리스탈지노믹스골관절염약아셀렉스판매계약,http://www.insight.co.kr/news/144683
863,2018-03-14,크리스탈지노믹스아셀렉스국내판권계약대웅제약과체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=314864
864,2018-03-14,대웅5거래일연속상승전일대비1상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803140454
865,2018-03-14,대웅제약크리스탈아셀렉스재계약이유는,http://www.newstomato.com/ReadNews.aspx?no=811797
866,2018-03-15,대웅제약vs유한양행바이오시밀러놓고정면승부,http://www.ekn.kr/news/article.html?no=349158
867,2018-03-15,이지선인증하고SNS화제템대웅제약이지썬받자,http://www.cctvnews.co.kr/news/articleView.html?idxno=80641
868,2018-03-15,대웅제약5거래일연속상승전일대비1상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803150449
869,2018-03-15,대웅5거래일연속상승전일대비1상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803150451
870,2018-03-15,대웅제약이지듀디더블유이지썬출시기념이벤트진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=315039
871,2018-03-16,RD외부수혈붐‥유한한미대웅천억이상투자,http://medipana.com/news/news_viewer.asp?NewsNum=217204&MainKind=A&NewsKind=5&vCount=12&vKind=1
872,2018-03-16,이지선모여라대웅제약디더블유이지썬출시이벤트진행,http://www.datanet.co.kr/news/articleView.html?idxno=120685
873,2018-03-17,포항시흥해대웅파크맨션50세대이주지원나서,http://www.kyongbuk.co.kr/?mod=news&act=articleView&idxno=1020486
874,2018-03-17,지진피해포항대웅파크1차50가구추가대피기둥보불량,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180317020300053&did=1195m
875,2018-03-17,포항시흥해지진피해대웅파크맨션2개동50세대추가이주조치,http://www.gukjenews.com/news/articleView.html?idxno=891505
876,2018-03-17,포항흥해대웅파크맨션2차진단에서불량판정,http://news1.kr/articles/?3263396
877,2018-03-17,포항시흥해지진피해대웅파크맨션50세대추가이주,http://www.sisafocus.co.kr/news/articleView.html?idxno=182338
878,2018-03-18,주간추천종목유안타증권SK컴투스대웅제약,http://www.fntimes.com/html/view.php?ud=201803180913184760f09e13944d_18
879,2018-03-18,메디톡스휴젤대웅제약국내는너무좁다해외진출에사활걸어,http://www.businesspost.co.kr/BP?command=article_view&num=76188
880,2018-03-18,포항시지진피해대웅파크맨션50가구이주조치한다,http://www.newsis.com/view/?id=NISX20180318_0000255184&cID=10810&pID=10800
881,2018-03-18,대웅제약스마트오피스구현꽃피는자율소통,http://news.kmib.co.kr/article/view.asp?arcid=0923918854&code=11151400&cp=nv
882,2018-03-18,지진중대결함추가발견포항대웅맨션이주조치,http://www.segye.com/content/html/2018/03/18/20180318004006.html?OutUrl=naver
883,2018-03-18,흥해지진피해대웅파크맨션2개동50세대추가이주조,http://www.breaknews.com/sub_read.html?uid=566738§ion=sc2
884,2018-03-18,붕괴우려포항대웅파크맨션1차철거,http://www.idaegu.com?c=3&uid=381810
885,2018-03-18,포항시흥해대웅파크맨션50가구이주조치,http://www.kbsm.net/default/index_view_page.php?idx=201128&part_idx=279
886,2018-03-18,지진피해흥해대웅파크맨션2개동50세대추가이주조치,http://www.kbmaeil.com/news/articleView.html?idxno=439486
887,2018-03-18,지진피해포항대웅파크맨션중대결함발견,http://www.idaegu.co.kr/news.php?code=so01&mode=view&num=244772
888,2018-03-19,수십차례여진영향받았나흥해대웅파크도이주조치,http://www.hidomin.com/news/articleView.html?idxno=353219
889,2018-03-19,C→E대웅파크맨션철거된다,http://www.ksmnews.co.kr/default/index_view_page.php?idx=201842&part_idx=289
890,2018-03-19,아스트라포시가대웅vs베링거자디앙유한격돌,http://www.dailymedi.com/detail.php?number=828555&thread=22r05
891,2018-03-19,지진피해포항대웅파크구조체결함E등급2개동50가구장기이주결정,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20180319.010090732570001
892,2018-03-19,포항흥해대웅파크맨션50세대이주조치결정,http://www.anewsa.com/detail.php?number=1292174&thread=09r02
893,2018-03-19,포항시흥해지진피해대웅파크맨션2개동50세대추가이주,http://daily.hankooki.com/lpage/society/201803/dh20180319111649137890.htm
894,2018-03-19,여진으로포항대웅파크맨션중대결함추가발견이주지원,http://www.aptn.co.kr/news/articleView.html?idxno=57724
895,2018-03-19,라이프까톡대웅제약이지듀DWEGSUN,http://www.sedaily.com/NewsView/1RX1IJKX4R
896,2018-03-20,유한vs대웅2차전SGLT2계열경쟁돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=315429
897,2018-03-20,대웅5거래일연속상승전일대비2상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803200288
898,2018-03-20,온가족안심선크림대웅제약이지썬,http://news.hankyung.com/article/201803206801a
899,2018-03-20,온가족안심선크림대웅제약이지썬,http://news.hankyung.com/article/201803206830a
900,2018-03-20,환절기건강관리대웅제약임팩타민봄철혈관건강지키는고함량비타민B복합제,http://news.hankyung.com/article/2018032048911
901,2018-03-21,대웅제약5개국에글로벌연구네트워크가동,http://news.mk.co.kr/newsRead.php?year=2018&no=180636
902,2018-03-21,ET투자뉴스대웅_주가강세속에10일연속상승현재303,http://www.etnews.com/20180321000030
903,2018-03-21,대웅전일대비약6상승한20900원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803210168
904,2018-03-21,fnRASSI대웅581오르며거래량증가,http://www.fnnews.com/news/201803211006064678
905,2018-03-21,대웅제약나보타글로벌브랜드성장가능성입증,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216211
906,2018-03-21,대웅제약보툴리눔톡신나보타로두바이더마참가,http://www.dailypharm.com/News/237880
907,2018-03-21,대웅제약나보타두바이더마서성장가능성확인,http://medipana.com/news/news_viewer.asp?NewsNum=217430&MainKind=A&NewsKind=5&vCount=12&vKind=1
908,2018-03-21,유대웅전일대비707상승일일회전율은039기록,http://www.sedaily.com/NewsView/1RX2EJCQIH
909,2018-03-21,대웅제약나보타두바이더마2018서글로벌브랜드성장가능성입증,http://www.asiatoday.co.kr/view.php?key=20180321010011226
910,2018-03-21,대웅제약두바이더마서보톡스제제나보타소개,http://www.mhj21.com/sub_read.html?uid=112794§ion=sc243
911,2018-03-21,대웅제약두바이피부미용컨퍼런스서나보타홍보,http://news.mk.co.kr/newsRead.php?year=2018&no=181376
912,2018-03-21,대웅제약두바이더마2018에서나보타소개,http://www.medigatenews.com/news/3519649485
913,2018-03-21,대웅제약두바이국제피부미용행사서나보타소개,http://www.rapportian.com/news/articleView.html?idxno=109565
914,2018-03-21,대웅나보타중동아프라카진출모색,http://www.dailymedi.com/detail.php?number=828644&thread=22r05
915,2018-03-21,대웅제약보툴리눔톡신나보타두바이더마2018소개,http://www.joseilbo.com/news/news_read.php?uid=348848&class=27&grp=
916,2018-03-21,아파야챙길래대웅제약JW중외제약메디톡스,http://www.g-enews.com/ko-kr/news/article/news_all/201803211055352079e6a49afa8d_1/article.html
917,2018-03-21,대웅제약두바이컨퍼런스서나보타소개,http://www.newsis.com/view/?id=NISX20180321_0000258171&cID=13001&pID=13000
918,2018-03-21,대웅제약두바이더마참여나보타성장가능성입증,http://www.newsprime.co.kr/news/article.html?no=410490
919,2018-03-21,대웅제약나보타두바이더마2018서글로벌브랜드로성장가능성입증,http://www.ekn.kr/news/article.html?no=350584
920,2018-03-21,대웅제약두바이피부미용전시회에서나보타소개,http://news.hankyung.com/article/201803210458f
921,2018-03-21,대웅제약보톡스나보타두바이컨퍼런스서소개,http://www.edaily.co.kr/news/newspath.asp?newsid=02456726619145616
922,2018-03-21,대웅제약두바이더마2018참석나보타소개,http://www.bosa.co.kr/news/articleView.html?idxno=2080078
923,2018-03-21,대웅5거래일연속상승전일대비7상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803210285
924,2018-03-21,대웅제약나보타글로벌브랜드성장드라이브,http://www.monews.co.kr/news/articleView.html?idxno=112466
925,2018-03-21,대웅제약나보타글로벌브랜드성장가능성입증,http://www.kormedi.com/news/news/drug_dist/1226555_2906.html
926,2018-03-21,대웅제약나보타두바이더마2018참가글로벌마케팅진행,http://www.mdtoday.co.kr/mdtoday/index.html?no=315668
927,2018-03-21,대웅제약나보타두바이더마서글로벌브랜드가능성입증,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018032114538032281&outlink=1
928,2018-03-21,제약산업소식대웅제약나보타두바이서해외진출공략外,http://www.kukinews.com/news/article.html?no=533353
929,2018-03-21,대웅제약두바이더마서보툴리눔톡신나보타소개,http://www.dt.co.kr/contents.html?article_no=2018032102109976029005&ref=naver
930,2018-03-21,대웅제약두바이더마참가중동서나보타우수성홍보,http://biz.chosun.com/site/data/html_dir/2018/03/21/2018032102201.html
931,2018-03-21,대웅제약나보타두바이더마서성장가능성확인,http://www.metroseoul.co.kr/news/newsview?newscd=2018032100147
932,2018-03-21,대웅제약이지듀디더블유이지썬첫방송완판기염토해,http://www.nextdaily.co.kr/news/article.html?id=20180321800045
933,2018-03-21,대웅제약나보타두바이더마2018서글로벌브랜드성장가능성입증,http://www.techholic.co.kr/news/articleView.html?idxno=174717
934,2018-03-21,뉴스투데이L대웅제약두바이더마2018서자체개발나보타라인업소개,http://www.news2day.co.kr/100951
935,2018-03-21,대웅제약나보타글로벌브랜드성장가능성입증,http://www.anewsa.com/detail.php?number=1293441&thread=10r03
936,2018-03-21,대웅제약두바이더마서나보타소개,http://www.m-i.kr/news/articleView.html?idxno=397458
937,2018-03-21,대웅제약나보타두바이더마2018에서글로벌브랜드성장가능성입증,http://www.lawissue.co.kr/view.php?ud=201803212154188743d7f4c63cc6_12
938,2018-03-22,클릭e종목대웅제약1Q나보타국내판매호조전망목표가↑,http://view.asiae.co.kr/news/view.htm?idxno=2018032207271309507
939,2018-03-22,대웅제약1분기나보타국내판매호조기대목표가↑NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1606040
940,2018-03-22,대웅제약1분기나보타판매호조목표가↑NH투자증권,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018032208465213812
941,2018-03-22,NH투자대웅제약1분기호실적전망목표가↑,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180322042500008&did=1195m
942,2018-03-22,대웅제약나보타美진출호재목표주가상향,http://www.newspim.com/news/view/20180322000041
943,2018-03-22,오늘의종목대웅제약1분기나보타판매호조전망목표가↑,http://www.sedaily.com/NewsView/1RX2U9082E
944,2018-03-22,HotLine대웅제약실적성장에더해임상모멘텀도풍부목표가↑,http://news.mk.co.kr/newsRead.php?year=2018&no=183893
945,2018-03-22,대웅제약목표주가상향나보타판매늘고신약개발도순항,http://www.businesspost.co.kr/BP?command=article_view&num=76670
946,2018-03-22,특징주대웅제약1분기호실적기대에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180322050100008&did=1195m
947,2018-03-22,ET투자뉴스대웅제약1분기나보타국내매수유지NH투자증권,http://www.etnews.com/20180322000018
948,2018-03-22,특징주대웅제약실적성장기대감에주가도맑음,http://www.newsprime.co.kr/news/article.html?no=410621
949,2018-03-22,특징주대웅제약1분기나보타국내판매호조5↑,http://view.asiae.co.kr/news/view.htm?idxno=2018032209220549434
950,2018-03-22,대웅제약호실적전망에장초반4상승세,http://www.sedaily.com/NewsView/1RX2UESE8H
951,2018-03-22,ET투자뉴스대웅_기관과외국인모두순매수현재26211일연속올라,http://www.etnews.com/20180322000025
952,2018-03-22,대웅제약1분기실적호조기대감에장초반오름세,http://www.mdtoday.co.kr/mdtoday/index.html?no=315801
953,2018-03-22,대웅제약한국아스트라제네카와코프로모션계약체결,http://www.mhj21.com/sub_read.html?uid=112816§ion=sc243
954,2018-03-22,특징주대웅제약1Q실적호전망에상승세,http://www.seoulfn.com/news/articleView.html?idxno=301882
955,2018-03-22,대웅제약아스트라제네카포시가직듀오코프로모션계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216250
956,2018-03-22,대웅제약아스트라제네카당뇨병약포시가직듀오공동판매,http://view.asiae.co.kr/news/view.htm?idxno=2018032209541569609
957,2018-03-22,대웅제약아스트라제네카당뇨약공동프로모션,http://www.edaily.co.kr/news/newspath.asp?newsid=01925366619145944
958,2018-03-22,대웅AZSGLT2포시가직듀오코프로모션체결,http://www.dailypharm.com/News/237930
959,2018-03-22,대웅제약아스트라제네카와당뇨병약포시가직듀오공동판매계약체결,http://news.mk.co.kr/newsRead.php?year=2018&no=184210
960,2018-03-22,대웅나보타두바이더마2018참석,http://www.kpanews.co.kr/article/show.asp?idx=192326&table=article&category=D
961,2018-03-22,대웅AZ포시가직듀오코프로모션계약체결,http://medipana.com/news/news_viewer.asp?NewsNum=217512&MainKind=A&NewsKind=5&vCount=12&vKind=1
962,2018-03-22,대웅제약아스트라제네카와코프로모션계약체결,http://www.kpinews.co.kr/news/articleView.html?idxno=69434
963,2018-03-22,대웅제약당뇨병약포시가직듀오공동영업계약체결,http://news.hankyung.com/article/201803224642f
964,2018-03-22,대웅제약아스트라제네카당뇨병치료제포시가직듀오국내영업마케팅담당,http://biz.chosun.com/site/data/html_dir/2018/03/22/2018032201174.html
965,2018-03-22,아파야챙길래동아제약대웅제약유유제약,http://www.g-enews.com/ko-kr/news/article/news_all/201803221039212907e6a49afa8d_1/article.html
966,2018-03-22,대웅제약한국아스트라제네카포시가직듀오코프로모션,http://www.kpanews.co.kr/article/show.asp?idx=192337&table=article&category=D
967,2018-03-22,대웅제약한국아스트라제네카와포시가직듀오코프로모션계약체결,http://www.ekn.kr/news/article.html?no=350878
968,2018-03-22,대웅제약아스트라제네카와당뇨병치료제파트너십계약,http://www.newsway.co.kr/view.php?tp=1&ud=2018032211101122226
969,2018-03-22,특징주대웅제약1Q보톡스나보타실적2배증가전망에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=02400966619145944
970,2018-03-22,대웅제약아스트라제네카와당뇨약공동프로모션,http://www.m-i.kr/news/articleView.html?idxno=397693
971,2018-03-22,대웅제약한국아스트라제네카와제2형당뇨병치료제코프로모션계약,http://www.joseilbo.com/news/news_read.php?uid=348976&class=27&grp=
972,2018-03-22,대웅아스트라포시가직듀오코프로모션계약,http://www.dailymedi.com/detail.php?number=828703&thread=22r05
973,2018-03-22,대웅제약AZ포시가직듀오코프로모션계약,http://www.bosa.co.kr/news/articleView.html?idxno=2080160
974,2018-03-22,대웅제약아스트라제네카당뇨병치료제공동영업,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180322094400017&did=1195m
975,2018-03-22,대웅5거래일연속상승전일대비2상승,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803220303
976,2018-03-22,대웅제약한국아스트라제네카와당뇨약공동판매,http://news1.kr/articles/?3268124
977,2018-03-22,대웅제약아스트라제네카와포시가코프로모션,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053901
978,2018-03-22,대웅제약ETCOTC수출부문고른성장예상,http://www.newsworks.co.kr/news/articleView.html?idxno=174719
979,2018-03-22,대웅아스트라제네카포시가직듀오공동마케팅계약,http://news.mt.co.kr/mtview.php?no=2018032213035393296
980,2018-03-22,대웅제약한국아스트라제네카당뇨병치료제공동판매,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803220339
981,2018-03-22,대웅제약한국아스트라제네카와포시가직듀오판매계약체결,http://www.dt.co.kr/contents.html?article_no=2018032202109976029008&ref=naver
982,2018-03-22,대웅제약아스트라제네카와당뇨병치료제공동판매,http://www.etoday.co.kr/news/section/newsview.php?idxno=1606259
983,2018-03-22,대웅제약한국아스트라제네카포시가직듀오코프로모션계약체결,http://www.kukinews.com/news/article.html?no=533698
984,2018-03-22,대웅제약한국아스트라제네카와포시가직듀오코프로모션계약,http://www.mdtoday.co.kr/mdtoday/index.html?no=315847
985,2018-03-22,대웅제약한국아스트라제네카와포시가직듀오공동프로모션,http://www.techholic.co.kr/news/articleView.html?idxno=174757
986,2018-03-22,대웅아스트라포시가직듀오코프로모션계약,http://www.newsis.com/view/?id=NISX20180322_0000259955&cID=13001&pID=13000
987,2018-03-22,대웅제약한국아스트라제네카와당뇨병치료제공동판매,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018032214593435395
988,2018-03-22,대웅AZ포시가직듀오코프로모션계약체결,http://www.metroseoul.co.kr/news/newsview?newscd=2018032200174
989,2018-03-22,대웅제약한국아스트라제네카와코프로모션파트너십계약,http://www.fnnews.com/news/201803221617099366
990,2018-03-22,대웅제약아스트라제네카당뇨병약포시가직듀오공동판매,http://www.dailian.co.kr/news/view/701936/?sc=naver
991,2018-03-22,대웅제약아스트라제네카와당뇨병치료제공동영업,http://www.seoulfn.com/news/articleView.html?idxno=301943
992,2018-03-22,대웅제약두바이피부미용전시회서보톡스나보타홍보,http://www.insight.co.kr/news/146078
993,2018-03-22,대웅제약당뇨치료제포시가직듀오코프로모션계약체결,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018032217348043778&outlink=1
994,2018-03-22,대웅제약한국아스트라제네카와포시가직듀오코프로모션계약체결,http://www.newscj.com/news/articleView.html?idxno=504543
995,2018-03-22,대웅제약아스트라제네카당뇨병치료제공동영업,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3485973
996,2018-03-22,대웅제약한국아스트라제네카와포시가직듀오코프로모션계약체결,http://www.lawissue.co.kr/view.php?ud=20180322224300312d7f4c63cc6_12
997,2018-03-22,대웅제약아스트라제네카SGLT2억제제포시가직듀오공동판매,http://www.viva100.com/main/view.php?key=20180322020022383
998,2018-03-23,빅데이터MSI시장심리톱5OCI삼성전자대웅제약호텔신라POSCO,http://www.newsis.com/view/?id=NISX20180323_0000260515&cID=10401&pID=10400
999,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://view.asiae.co.kr/news/view.htm?idxno=2018032308501648842
1000,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.newsis.com/view/?id=NISX20180323_0000260545&cID=13001&pID=13000
1001,2018-03-23,대웅제약대사성질환예방하는비타민임팩타민케어출시,http://www.mhj21.com/sub_read.html?uid=112833§ion=sc243
1002,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.dt.co.kr/contents.html?article_no=2018032302109976029002&ref=naver
1003,2018-03-23,대웅제약전일대비약4하락한194000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803230084
1004,2018-03-23,독기품은포시가대웅손잡고자디앙뿌리치기,http://www.doctorsnews.co.kr/news/articleView.html?idxno=122494
1005,2018-03-23,대웅제약고함량기능성비타민임펙타민케어출시,http://news.mk.co.kr/newsRead.php?year=2018&no=186901
1006,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.asiatoday.co.kr/view.php?key=20180323010012851
1007,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.kpanews.co.kr/article/show.asp?idx=192365&table=article&category=D
1008,2018-03-23,대웅임팩타민케어출시로고함량비타민시장확대,http://www.dailypharm.com/News/237983
1009,2018-03-23,대웅제약기능성비타민임팩타민케어출시,http://www.rapportian.com/news/articleView.html?idxno=109611
1010,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216301
1011,2018-03-23,대웅포시가직듀오로당뇨병시장쌍끌이,http://www.monews.co.kr/news/articleView.html?idxno=112511
1012,2018-03-23,종근당VS행심위대웅제약대조약전쟁금명결론,http://www.nongaek.com/news/articleView.html?idxno=36800
1013,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.bosa.co.kr/news/articleView.html?idxno=2080231
1014,2018-03-23,대웅제약고함량비타민임팩타민케어출시,http://www.kpinews.co.kr/news/articleView.html?idxno=69556
1015,2018-03-23,대웅전일대비약4하락한19800원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803230294
1016,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.ekn.kr/news/article.html?no=351154
1017,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.lawissue.co.kr/view.php?ud=201803231212238136d7f4c63cc6_12
1018,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.techholic.co.kr/news/articleView.html?idxno=174777
1019,2018-03-23,대웅제약1800억고함량비타민시장출격,http://www.kormedi.com/news/news/drug_dist/1226581_2906.html
1020,2018-03-23,대웅제약임팩타민케어출시,http://www.metroseoul.co.kr/news/newsview?newscd=2018032300059
1021,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://news.mt.co.kr/mtview.php?no=2018032313192933586
1022,2018-03-23,대웅제약코프로모션강화매출1조원달성가시화,http://www.kpinews.co.kr/news/articleView.html?idxno=69599
1023,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.k-health.com/news/articleView.html?idxno=35227
1024,2018-03-23,대웅제약전승호윤재춘대표이사체제로변경,http://news.mt.co.kr/mtview.php?no=2018032316425328809
1025,2018-03-23,공시대웅제약전승호윤재춘대표이사체제로변경,http://www.newsway.co.kr/view.php?tp=1&ud=2018032316424771370
1026,2018-03-23,2018주총대웅제약윤재춘전승호공동대표체제확정,http://www.newsway.co.kr/view.php?tp=1&ud=2018032316482639665
1027,2018-03-23,대웅제약윤재춘전승호공동대표체제로전환,http://www.newsis.com/view/?id=NISX20180323_0000261085&cID=13001&pID=13000
1028,2018-03-23,대웅제약전승호윤재춘대표이사체제로변경,http://www.etoday.co.kr/news/section/newsview.php?idxno=1606823
1029,2018-03-23,대웅제약윤재춘전승호공동대표체제로전환,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803230630
1030,2018-03-23,공시대웅윤재승윤재춘대표이사체제로변경,http://www.newsway.co.kr/view.php?tp=1&ud=2018032316593065551
1031,2018-03-23,대웅제약윤재춘전승호공동대표체제확정,http://www.newstomato.com/ReadNews.aspx?no=813718
1032,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803230632
1033,2018-03-23,대웅제약새사령탑윤재춘전승호전문경영인체제시동,http://news1.kr/articles/?3269586
1034,2018-03-23,대웅그룹세대교체단행글로벌비전2020정중동,http://www.kpanews.co.kr/article/show.asp?idx=192386&table=article&category=D
1035,2018-03-23,대웅제약신임윤재춘전승호공동대표체제확정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018032316372250851
1036,2018-03-23,대웅제약세대교체단행윤재춘전승호공동대표체제확정,http://news.mt.co.kr/mtview.php?no=2018032316522665440
1037,2018-03-23,대웅제약윤재춘전승호공동대표체제,http://medipana.com/news/news_viewer.asp?NewsNum=217624&MainKind=A&NewsKind=5&vCount=12&vKind=1
1038,2018-03-23,대웅제약윤재춘전승호공동대표체제로,http://www.ciobiz.co.kr/news/article.html?id=20180323120018
1039,2018-03-23,대웅제약새사령탑윤재춘전승호공동대표체제,http://www.dailypharm.com/News/238018
1040,2018-03-23,세대교체대웅제약윤재춘전승호공동대표선임,http://news.mk.co.kr/newsRead.php?year=2018&no=188460
1041,2018-03-23,대웅병원경영혁신대상이병석세브란스병원장,http://www.doctorsnews.co.kr/news/articleView.html?idxno=122508
1042,2018-03-23,대웅제약윤재춘전승호공동대표체제확정세대교체단행,http://news.hankyung.com/article/201803231833f
1043,2018-03-23,주총대웅제약윤재춘전승호공동대표로경영진세대교체단행,http://www.news2day.co.kr/101110
1044,2018-03-23,대웅제약윤재춘전승호공동대표체제로,http://www.medical-tribune.co.kr/news/articleView.html?idxno=78115
1045,2018-03-23,대웅제약신임윤재춘전승호공동대표체제확정,http://www.dt.co.kr/contents.html?article_no=2018032302109976029010&ref=naver
1046,2018-03-23,대웅제약세대교체단행윤재춘전승호공동대표체제돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216320
1047,2018-03-23,대웅제약세대교체이종욱체제서윤재춘전승호체제로,http://www.mhj21.com/sub_read.html?uid=112858§ion=sc243
1048,2018-03-23,대웅세대교체글로벌비전2020정중동,http://www.bosa.co.kr/news/articleView.html?idxno=2080271
1049,2018-03-23,대웅제약전승호윤재춘대표이사체제로변경,http://www.newsis.com/view/?id=NISX20180323_0000261169&cID=10401&pID=10400
1050,2018-03-23,대웅제약신임대표에윤재춘전승호사장,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180323147000017&did=1195m
1051,2018-03-23,대웅제약젊은피수혈윤재춘전승호대표체제,http://www.seoulfn.com/news/articleView.html?idxno=302027
1052,2018-03-23,대웅윤재승윤재춘대표이사체제로변경,http://www.newsis.com/view/?id=NISX20180323_0000261219&cID=10401&pID=10400
1053,2018-03-23,대웅제약파격적세대교체단행43세전문CEO임명,http://www.rapportian.com/news/articleView.html?idxno=109637
1054,2018-03-23,대웅그룹세대교체단행윤재춘대표이사전승호사장선임,http://www.viva100.com/main/view.php?key=20180323010008706
1055,2018-03-23,주총대웅제약12년장수CEO이종욱물러나,http://www.ebn.co.kr/news/view/934936
1056,2018-03-23,대웅제약윤재춘전승호공동대표체제확정,http://www.sisajournal-e.com/biz/article/181852
1057,2018-03-23,대웅제약윤재춘전승호공동대표체제돌입,http://www.dailian.co.kr/news/view/702221/?sc=naver
1058,2018-03-23,대웅그룹경영진세대교체단행글로벌비전2020전념,http://www.ceoscoredaily.com/news/article.html?no=39331
1059,2018-03-23,대웅제약주총서신임윤재춘전승호공동대표체제확정,http://www.ekn.kr/news/article.html?no=351270
1060,2018-03-23,대웅제약윤재춘전승호체제로윤재승회장사임,http://www.edaily.co.kr/news/newspath.asp?newsid=04126246619146272
1061,2018-03-23,대웅윤재승이종욱→윤재춘전승호세대교체,http://www.dailymedi.com/detail.php?number=828765&thread=22r05
1062,2018-03-23,주총대웅제약윤재춘전승호공동대표선임,http://www.newspim.com/news/view/20180323000274
1063,2018-03-23,대웅제약윤재춘전승호신임공동대표선임,http://www.k-health.com/news/articleView.html?idxno=35235
1064,2018-03-23,대웅제약경영진세대교체윤재춘전승호공동대표체제확립,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018032317298054436&outlink=1
1065,2018-03-23,대웅제약40대대표발탁전문경영인체제로전환,http://biz.chosun.com/site/data/html_dir/2018/03/23/2018032302578.html
1066,2018-03-23,대웅제약세대교체단행윤재춘전승호공동대표체제확정,http://www.newsprime.co.kr/news/article.html?no=410887
1067,2018-03-23,대웅제약전승호윤재춘대표이사체제로변경,http://view.asiae.co.kr/news/view.htm?idxno=2018032318175342938
1068,2018-03-23,대웅윤재승윤재춘대표이사체제로변경,http://view.asiae.co.kr/news/view.htm?idxno=2018032318240796729
1069,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.viva100.com/main/view.php?key=20180323020022390
1070,2018-03-23,대웅제약고함량기능성비타민임팩타민케어출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=316027
1071,2018-03-23,대웅제약윤재춘전승호공동대표체제확정,http://www.mdtoday.co.kr/mdtoday/index.html?no=316028
1072,2018-03-23,대웅그룹세대교체윤재춘전승호공동대표체제확정,http://www.medicaltimes.com/News/1117607
1073,2018-03-23,73년된대웅제약파격행보40대CEO발탁배경은,http://news1.kr/articles/?3269603
1074,2018-03-23,대웅제약윤재춘전승호공동대표체제로전환,http://www.cstimes.com/?mod=news&act=articleView&idxno=271377
1075,2018-03-23,대웅제약신임대표에윤재춘전승호사장세대교체단행,http://www.asiatoday.co.kr/view.php?key=20180323010013138
1076,2018-03-24,대웅제약윤재춘전승호공동대표체제개막,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053976
1077,2018-03-24,대웅제약주주총회열고신임윤재춘전승호공동대표체제확정,http://www.lawissue.co.kr/view.php?ud=201803241131218174d7f4c63cc6_12
1078,2018-03-25,40대수장선택한대웅제약파격행보,http://www.edaily.co.kr/news/newspath.asp?newsid=01125046619146928
1079,2018-03-25,대웅제약윤재춘전승호공동대표1975년생젊은수장세대교체,http://view.asiae.co.kr/news/view.htm?idxno=2018032512480559354
1080,2018-03-25,대웅제약신임대표에윤재춘전승호사장공동선임,http://www.insight.co.kr/news/146677
1081,2018-03-25,대웅제약더존비즈온OCI목표가잇달아올리는까닭은,http://news.mk.co.kr/newsRead.php?year=2018&no=190752
1082,2018-03-26,경제계인사대웅제약대표윤재춘전승호사장外,http://news.donga.com/3/all/20180325/89292383/1
1083,2018-03-26,대웅제약새대표에윤재춘전승호사장,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3487978
1084,2018-03-26,세대교체대웅글로벌2020정조준,http://www.monews.co.kr/news/articleView.html?idxno=112577
1085,2018-03-26,대웅제약전승호역동적으로글로벌기업이끌것,http://medipana.com/news/news_viewer.asp?NewsNum=217675&MainKind=A&NewsKind=5&vCount=12&vKind=1
1086,2018-03-26,전승호대웅대표젊은문화역동적조직만들겠다,http://www.dailypharm.com/News/238061
1087,2018-03-26,전승호대웅제약대표글로벌헬스케어그룹성장위해혁신신약개발,http://view.asiae.co.kr/news/view.htm?idxno=2018032610260103738
1088,2018-03-26,대웅전승호신임대표글로벌헬스케어기업성장이끌겠다,http://www.medigatenews.com/news/1400033639
1089,2018-03-26,파격취임대웅제약전승호대표글로벌헬스케어기업전력,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216351
1090,2018-03-26,대웅제약윤재춘전승호공동대표선임40대수장파격행보,http://www.sisaweek.com/news/articleView.html?idxno=105269
1091,2018-03-26,대웅제약윤재춘전승호공동신임대표선임,http://news.heraldcorp.com/view.php?ud=20180326000269
1092,2018-03-26,대웅제약전승호신임대표역동적문화로글로벌헬스케어기업성장목표,http://www.sedaily.com/NewsView/1RX4P1QONU
1093,2018-03-26,40대전승호대웅제약대표역동적조직문화로회사비전달성,http://news.mk.co.kr/newsRead.php?year=2018&no=191901
1094,2018-03-26,40대CEO전승호대웅제약대표스타트업처럼젊어질것,http://www.newspim.com/news/view/20180326000074
1095,2018-03-26,대웅제약40대젊은CEO선임글로벌2020비전실천구체화,http://www.kukinews.com/news/article.html?no=534357
1096,2018-03-26,대웅제약전승호대표역동적인조직문화로글로벌헬스케어기업성장이끌것”,http://www.kukinews.com/news/article.html?no=534356
1097,2018-03-26,전승호대웅제약대표최고경쟁력보유한혁신신약개발에나설것,http://www.newsis.com/view/?id=NISX20180326_0000262518&cID=13001&pID=13000
1098,2018-03-26,전승호신임대표대웅제약젊은스타트업기업될것,http://www.kpanews.co.kr/article/show.asp?idx=192425&table=article&category=D
1099,2018-03-26,전승호대웅제약대표글로벌제약기업도약위해역동적기업문화구축,http://www.sisajournal-e.com/biz/article/181890
1100,2018-03-26,43세대웅제약CEO전승호사장젊은기업만들겠다,http://news.hankyung.com/article/201803267954f
1101,2018-03-26,대웅제약전승호신임대표지금보다역동적인조직문화로글로벌헬스케어기업성장이끌것”,http://www.lawissue.co.kr/view.php?ud=201803261101528849d7f4c63cc6_12
1102,2018-03-26,대웅제약전승호신임대표젊은문화역동적조직강조,http://www.bosa.co.kr/news/articleView.html?idxno=2080358
1103,2018-03-26,대웅제약이지듀DWEGF더블휩폼홈쇼핑첫론칭,http://www.mdtoday.co.kr/mdtoday/index.html?no=316168
1104,2018-03-26,대웅제약윤재춘전승호공동신임대표선임,http://www.viva100.com/main/view.php?key=20180326010009270
1105,2018-03-26,대웅제약전승호신임대표역동적인조직유연한기업문화강조,http://www.mdtoday.co.kr/mdtoday/index.html?no=316174
1106,2018-03-26,역동적인대웅제약만들겠다,http://www.monews.co.kr/news/articleView.html?idxno=112621
1107,2018-03-26,대웅제약글로벌2020비전달성총력,http://www.dailymedi.com/detail.php?number=828825&thread=22r05
1108,2018-03-26,전승호대웅제약사장젊은문화로글로벌시장정조준,http://www.rapportian.com/news/articleView.html?idxno=109656
1109,2018-03-26,대웅제약전승호신임대표역동적조직문화만들겠다,http://www.sportsseoul.com/news/read/615750
1110,2018-03-26,전승호대웅제약대표글로벌헬스케어기업성장이끌것,http://www.m-i.kr/news/articleView.html?idxno=398777
1111,2018-03-26,전승호대웅제약대표스타트업탄생지원글로벌헬스케어그룹목표,http://biz.chosun.com/site/data/html_dir/2018/03/26/2018032601372.html
1112,2018-03-26,대웅제약전승호대표취임전문경영인체제강화,http://www.newsprime.co.kr/news/article.html?no=411015
1113,2018-03-26,전승호대웅제약신임대표역동적인조직문화로글로벌헬스케어기업성장이끌것”,http://www.ekn.kr/news/article.html?no=351606
1114,2018-03-26,대웅전일대비약7상승한20700원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803260475
1115,2018-03-26,대웅제약전승호대표역동적이고유연한CEO될것,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1054044
1116,2018-03-26,신임전승호대웅제약대표혁신스타트업기업육성할것,http://www.etnews.com/20180326000314
1117,2018-03-26,대웅피부성형제품라인업확대,http://www.newstomato.com/ReadNews.aspx?no=814012
1118,2018-03-26,전승호대웅제약신임대표역동적조직문화로글로벌헬스케어기업도약,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803260490
1119,2018-03-26,40대전승호공동대표대웅변화예고,http://www.doctorsnews.co.kr/news/articleView.html?idxno=122537
1120,2018-03-26,전승호대웅제약신임대표글로벌기업성장이끌것,http://www.newstomato.com/ReadNews.aspx?no=814024
1121,2018-03-26,대웅제약전승호신임대표글로벌혁신신약개발하겠다,http://www.insight.co.kr/news/146854
1122,2018-03-26,대웅제약전승호대표역동적유연한기업문화필요,http://www.kormedi.com/news/news/drug_dist/1226610_2906.html
1123,2018-03-26,전승호대웅제약대표글로벌헬스케어기업성장이끌것”,http://www.newsway.co.kr/view.php?tp=1&ud=2018032616375524969
1124,2018-03-26,전승호대웅제약대표역동적이고유연한조직만들것,http://www.dailian.co.kr/news/view/702625/?sc=naver
1125,2018-03-26,전승호대웅제약신임대표이사역동적이고유연한기업문화강조,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018032613584729673
1126,2018-03-26,대웅제약전승호대표취임젊은CEO체제로비전2020노린다,http://www.ajunews.com/view/20180326170055392
1127,2018-03-26,전승호대웅제약신임대표역동적조직문화로글로벌헬스케어기업성장이끌것,http://www.techholic.co.kr/news/articleView.html?idxno=174845
1128,2018-03-26,40대CEO전승호대웅제약대표역동적조직문화로글로벌비전달성,http://www.etoday.co.kr/news/section/newsview.php?idxno=1607430
1129,2018-03-26,전승호대웅제약대표젊은문화역동적인조직돼야,http://www.kpinews.co.kr/news/articleView.html?idxno=69762
1130,2018-03-26,대웅제약휴젤젊은CEO변화신호탄,http://www.dt.co.kr/contents.html?article_no=2018032702101076029001&ref=naver
1131,2018-03-26,대웅제약40대젊은CEO전승호공동대표취임,http://www.fnnews.com/news/201803261817188144
1132,2018-03-26,젊은스타트업변신선언한대웅제약,http://news.hankyung.com/article/2018032602301
1133,2018-03-26,전승호대웅제약신임대표역동적인조직문화로글로벌헬스케어기업성장이끌것,http://www.newscj.com/news/articleView.html?idxno=505667
1134,2018-03-27,대웅주주제안안건주식배당3년째부결처리눈길,http://www.ceoscoredaily.com/news/article.html?no=39388
1135,2018-03-27,빅데이터MSI시장심리톱5대림산업카카오삼성SDI대웅제약CJ,http://www.newsis.com/view/?id=NISX20180327_0000263513&cID=10401&pID=10400
1136,2018-03-27,대웅제약주름개선제나보타2020년까지누적매출1조되나,http://www.ajunews.com/view/20180326133822140
1137,2018-03-27,취재수첩대웅제약의파격인사는과연혁신을이끌수있을까,http://biz.newdaily.co.kr/news/article.html?no=10156572
1138,2018-03-27,양재준기자의알투바이오은둔의제왕윤재승대웅제약이사회의장의경영실험,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201803270166
1139,2018-03-28,국무조정실장출신강영철대웅제약고문사임,http://www.dailypharm.com/News/238120
1140,2018-03-28,대웅대웅바이오기업가치크게상승골든브릿지,http://www.sedaily.com/NewsView/1RX5LSSDB5
1141,2018-03-28,대웅제약글로벌국내사업투트랙전략통할까,http://www.rapportian.com/news/articleView.html?idxno=109696
1142,2018-03-28,대웅제약엘러간보톡스이어벨카이라정조준,http://www.dailypharm.com/News/238176
1143,2018-03-28,ET투자뉴스의약품업종급락세_대웅제약약세흐름두드러져,http://www.etnews.com/20180328000169
1144,2018-03-28,석천나눔재단∙대웅재단과함께사회공헌나서,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216468
1145,2018-03-29,윤재춘전승호대웅제약대표글로벌새바람일으키나,http://www.datanews.co.kr/news/article.html?no=100460
1146,2018-03-29,대웅제약아스트라제네카당뇨병약포시가직듀오공동판매,http://www.ajunews.com/view/20180329115130743
1147,2018-03-30,ET투자뉴스대웅제약1Q실적은평이매수KTB투자증권,http://www.etnews.com/20180330000102
1148,2018-03-30,대웅바이오2017년2467억원매출올려,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1054226
1149,2018-03-30,대웅바이오작년영업익300억원전년대비34증가,http://www.mdtoday.co.kr/mdtoday/index.html?no=316927
1150,2018-04-02,주간한국대웅제약변화시동거나,http://daily.hankooki.com/lpage/economy/201804/dh20180402031306138060.htm
1151,2018-04-02,공시대웅제약2일기업설명회IR개최,http://www.viva100.com/main/view.php?key=20180402010000291
1152,2018-04-02,책산책최문영첫소설집대웅을기다린이차돈,http://kor.theasian.asia/archives/186468
1153,2018-04-03,대웅제약제품포트폴리오확장으로시장확대나서,http://www.mhj21.com/sub_read.html?uid=113025§ion=sc243
1154,2018-04-04,오늘의추천종목유안타증권대웅제약대명코퍼레이션등,http://www.asiatoday.co.kr/view.php?key=20180404010002255
1155,2018-04-04,더벨윤재승대웅그룹회장의용인술,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201804030100003250000196
1156,2018-04-04,대웅전일대비약5상승한22400원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804040160
1157,2018-04-04,fnRASSI대웅328오르며거래량증가,http://www.fnnews.com/news/201804041102040365
1158,2018-04-04,대웅제약의약품포트폴리오강화신규의약품4종추가,http://news1.kr/articles/?3280356
1159,2018-04-04,특징주보톡스대장주메디톡스신고가휴젤대웅제약도강세,http://news.mt.co.kr/mtview.php?no=2018040414532178844
1160,2018-04-04,메디톡스실적갱신기대감에강세마감휴젤대웅제약도,http://www.mdtoday.co.kr/mdtoday/index.html?no=317381
1161,2018-04-05,품목스위칭기우오리지널뺨친대웅글리아타민,http://www.medicaltimes.com/News/1117852
1162,2018-04-05,한미1706억1위GC녹십자대웅유한종근당順,http://www.dailymedi.com/detail.php?number=829229&thread=22r05
1163,2018-04-06,대웅제약임상시험최다최근3년간44건,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216824
1164,2018-04-06,DataScore대웅제약시가배당률절반이하로추락040,http://www.ceoscoredaily.com/news/article.html?no=39413
1165,2018-04-09,창간특집대웅제약유망신약파이프라인,http://www.bosa.co.kr/news/articleView.html?idxno=2081222
1166,2018-04-09,대웅제약글로벌헬스케어위해인재육성부터,http://www.sedaily.com/NewsView/1RY6U5D3Q8
1167,2018-04-09,대웅제약1천시간의몰입글로벌우수인재프로그램주목,http://www.getnews.co.kr/news/articleView.html?idxno=61075
1168,2018-04-09,대웅제약체계적인교육으로글로벌우수인재프로그램정착,http://www.viva100.com/main/view.php?key=20180409010003189
1169,2018-04-09,대웅제약글로벌우수인재프로그램운영,http://www.newsprime.co.kr/news/article.html?no=412667
1170,2018-04-09,대웅제약체계적글로벌우수인재프로그램주목,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=216910
1171,2018-04-09,대웅제약체계적인글로벌우수인재프로그램주목,http://medipana.com/news/news_viewer.asp?NewsNum=218415&MainKind=A&NewsKind=5&vCount=12&vKind=1
1172,2018-04-09,대웅제약글로벌우수인재프로그램성공적,http://www.bosa.co.kr/news/articleView.html?idxno=2081277
1173,2018-04-09,대웅제약1000시간의담금질글로벌인재양성프로그램눈길,http://www.k-health.com/news/articleView.html?idxno=35455
1174,2018-04-09,대웅제약글로벌우수인재프로그램운영성공적,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018040914542948436
1175,2018-04-09,대웅제약1천시간의몰입글로벌우수인재프로그램주목,http://www.newscj.com/news/articleView.html?idxno=510224
1176,2018-04-09,대웅제약인재선발프로그램통해해외근무자선발,http://www.dailymedi.com/detail.php?number=829347&thread=22r05
1177,2018-04-09,대웅제약글로벌우수인재발굴4년째성공적운영,http://www.dt.co.kr/contents.html?article_no=2018040902109976029007&ref=naver
1178,2018-04-09,대웅제약글로벌우수인재프로그램운영해외진출뒷받침,http://www.mdtoday.co.kr/mdtoday/index.html?no=317774
1179,2018-04-09,대웅글로벌우수인재프로그램동남아시장서두각,http://news.mk.co.kr/newsRead.php?year=2018&no=226081
1180,2018-04-09,대웅제약직원대상글로벌우수인재프로그램운영,http://www.fnnews.com/news/201804091554422009
1181,2018-04-09,대웅제약1000시간의몰입글로벌우수인재프로그램성공,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018040916058019808&outlink=1
1182,2018-04-09,글로벌우수인재프로그램대웅에주목하라,http://www.monews.co.kr/news/articleView.html?idxno=113265
1183,2018-04-10,대웅제약매년1천시간의몰입체계적인글로벌우수인재육성,http://www.lawissue.co.kr/view.php?ud=201804092350531112d7f4c63cc6_12
1184,2018-04-10,대웅제약올해나보타FDA승인기대SK증권,http://news.mt.co.kr/mtview.php?no=2018041008002011812
1185,2018-04-10,대웅제약나보타미FDA승인임박목표가↑SK,http://news.hankyung.com/article/2018041017396
1186,2018-04-10,대웅제약글로벌우수인재프로그램4년째순항,http://www.dailian.co.kr/news/view/705690/?sc=naver
1187,2018-04-10,대웅제약나보타FDA승인임박목표가26만원으로↑SK증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1612195
1188,2018-04-10,대웅시지바이오3D프린팅맞춤형인공광대뼈제조허가,http://www.viva100.com/main/view.php?key=20180409010003450
1189,2018-04-10,대웅제약올해나보타FDA승인예상SK증권,http://www.sedaily.com/NewsView/1RY795YU47
1190,2018-04-10,SK證대웅제약나보타미FDA승인임박목표가↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804100041&t=NN
1191,2018-04-10,ET투자뉴스대웅제약2018년부터나매수유지SK증권,http://www.etnews.com/20180410000021
1192,2018-04-10,특징주대웅제약나보타FDA승인기대오름세,http://www.seoulfn.com/news/articleView.html?idxno=303327
1193,2018-04-10,당뇨병치료제시장새로운라이벌이된대웅제약유한양행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1053214
1194,2018-04-10,대웅시지바이오3D프린팅맞춤형인공광대뼈제조허가받았다,http://www.insight.co.kr/news/149480
1195,2018-04-10,대웅제약올해중나보타FDA승인예상,http://www.newsworks.co.kr/news/articleView.html?idxno=179113
1196,2018-04-11,대웅매년1천시간의몰입글로벌우수인재프로그램주목,http://www.kpanews.co.kr/article/show.asp?idx=192898&table=article&category=D
1197,2018-04-11,대조약1심이긴식약처종근당고민대웅반격모색,http://www.dailymedi.com/detail.php?number=829420&thread=22r05
1198,2018-04-11,종근당대웅대조약공방원점행정소송각하,http://www.medicaltimes.com/News/1117983
1199,2018-04-11,대웅제약인도네시아바이오연구소개소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217010
1200,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.kpanews.co.kr/article/show.asp?idx=192914&table=article&category=D
1201,2018-04-11,대웅제약인도네시아에서연구소설립이슬람시장진출속도,http://www.sedaily.com/NewsView/1RY7QGJF2F
1202,2018-04-11,대웅제약인도네시아현지대웅인니연구소개소,http://www.dailypharm.com/News/238695
1203,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.viva100.com/main/view.php?key=20180411010004137
1204,2018-04-11,대웅제약인도네시아에바이오연구소개소,http://www.rapportian.com/news/articleView.html?idxno=109949
1205,2018-04-11,대웅제약인도네시아에바이오연구소개소,http://www.medigatenews.com/news/3768712242
1206,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.bosa.co.kr/news/articleView.html?idxno=2081446
1207,2018-04-11,대웅제약인니바이오연구소개소이슬람시장진출가속화,http://www.medisobizanews.com/news/articleView.html?idxno=52531
1208,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.newsis.com/view/?id=NISX20180411_0000278719&cID=13001&pID=13000
1209,2018-04-11,대웅제약인도네시아대학교내바이오연구소개소,http://view.asiae.co.kr/news/view.htm?idxno=2018041113354250338
1210,2018-04-11,대웅제약인도네시아바이오연구소개소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180411097500017&did=1195m
1211,2018-04-11,대웅제약인도네시아대와손잡고현지바이오연구소개소,http://news.mk.co.kr/newsRead.php?year=2018&no=230974
1212,2018-04-11,대웅제약인도네시아바이오연구소개소,http://www.asiatoday.co.kr/view.php?key=20180411010006602
1213,2018-04-11,아파야챙길래대웅제약코오롱제약광동제약,http://www.g-enews.com/ko-kr/news/article/news_all/201804111358157409e6a49afa8d_1/article.html
1214,2018-04-11,대웅현지화전략강화인니바이오연구소개설,http://medipana.com/news/news_viewer.asp?NewsNum=218556&MainKind=A&NewsKind=5&vCount=12&vKind=1
1215,2018-04-11,대웅제약인도네시아에바이오연구소설립,http://www.kormedi.com/news/news/drug_dist/1226823_2906.html
1216,2018-04-11,대웅제약올해1조클럽가나,http://www.ebn.co.kr/news/view/937435
1217,2018-04-11,대웅제약인도네시아에바이오연구소개소현지연구협력및인재육성,http://www.etoday.co.kr/news/section/newsview.php?idxno=1612818
1218,2018-04-11,대웅제약인도네시아에바이오연구소개소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804110263&t=NN
1219,2018-04-11,대웅제약인도네시아서바이오연구소개소,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018041111383484628
1220,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.getnews.co.kr/news/articleView.html?idxno=61742
1221,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.newspim.com/news/view/20180411000166
1222,2018-04-11,대웅제약인니에바이오의약품연구소설립,http://www.edaily.co.kr/news/newspath.asp?newsid=03299686619175136
1223,2018-04-11,대웅제약인도네시아에바이오연구소개소리버스이노베이션전략추진”,http://www.mdtoday.co.kr/mdtoday/index.html?no=318062
1224,2018-04-11,대웅제약대웅국립인도네시아대학바이오연구소설립,http://www.k-health.com/news/articleView.html?idxno=35511
1225,2018-04-11,대웅제약인도네시아에바이오연구소개소,http://www.dailian.co.kr/news/view/706155/?sc=naver
1226,2018-04-11,대웅제약국립인도네시아대학교바이오연구소설립,http://www.newsprime.co.kr/news/article.html?no=413024
1227,2018-04-11,대웅제약인니에바이오연구소개소,http://www.monews.co.kr/news/articleView.html?idxno=113403
1228,2018-04-11,대웅제약인도네시아바이오연구소개소리버스이노베이션추진,http://www.sportsseoul.com/news/read/622257
1229,2018-04-11,뉴스투데이L대웅제약인도네시아에서바이오연구소설립,http://www.news2day.co.kr/102174
1230,2018-04-11,대웅제약인도네시아바이오연구소개소글로벌연구네트워크확장,http://www.techholic.co.kr/news/articleView.html?idxno=175350
1231,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.ebn.co.kr/news/view/937471
1232,2018-04-11,유한대웅종근당연7000억원당뇨약시장주도권쟁탈전,http://news.mk.co.kr/newsRead.php?year=2018&no=231509
1233,2018-04-11,대웅제약인도네시아에서바이오연구소개소,http://www.etnews.com/20180411000309
1234,2018-04-11,대웅제약국립인도네시아대학에바이오연구소설립,http://news1.kr/articles/?3287059
1235,2018-04-11,대웅제약인도네시아바이오연구소개소,http://www.newstomato.com/ReadNews.aspx?no=817607
1236,2018-04-11,대웅제약인도네시아서바이오연구소개소,http://www.dt.co.kr/contents.html?article_no=2018041102109976029005&ref=naver
1237,2018-04-11,대웅제약인도네시아에바이오연구소개소,http://www.enewstoday.co.kr/news/articleView.html?idxno=1178128
1238,2018-04-11,대웅제약인도네시아바이오연구소개소,http://www.dailymedi.com/detail.php?number=829453&thread=22r05
1239,2018-04-11,대웅제약인도네시아에산학협력바이오연구소개소,http://www.moneyweek.co.kr/news/mwView.php?type=1&no=2018041117398036309&outlink=1
1240,2018-04-11,대웅제약인도네시아에바이오연구소열어,http://www.newspost.kr/news/articleView.html?idxno=62381
1241,2018-04-11,대웅제약인니바이오연구소개소전승호사장바이오의약품역진출추진,http://daily.hankooki.com/lpage/economy/201804/dh20180411184226138080.htm
1242,2018-04-11,대웅제약인도네시아바이오연구소개소,http://www.seoulfn.com/news/articleView.html?idxno=303502
1243,2018-04-11,CEO라이벌열전제약34위대웅전승호vs한미우종수권세창,http://www.bizhankook.com/article/15245
1244,2018-04-12,대웅제약인도네시아에서바이오연구소개소,http://www.lawissue.co.kr/view.php?ud=201804112334354341d7f4c63cc6_12
1245,2018-04-12,대웅제약인도네시아에바이오연구소만든다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1054713
1246,2018-04-12,대웅제약해외연구소설립하며글로벌시장진출본격시동,http://news.heraldcorp.com/view.php?ud=20180412000159
1247,2018-04-12,대웅제약인도네시아에글로벌바이오연구소개소,http://www.mhj21.com/sub_read.html?uid=113179§ion=sc243
1248,2018-04-12,대웅제약인도네시아연구소까지구축아세안공략기지化,http://www.ajunews.com/view/20180412103524828
1249,2018-04-12,대웅제약印尼연구소개소바이오실습등인재육성,http://www.munhwa.com/news/view.html?no=2018041201071727107001
1250,2018-04-12,제약산업소식대웅제약인도네시아에바이오연구소개소外,http://www.kukinews.com/news/article.html?no=539519
1251,2018-04-12,대웅제약전일대비약5하락한207000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804120305&t=NN
1252,2018-04-12,대웅제약인도네시아에서바이오연구소개소,http://www.anewsa.com/detail.php?number=1302959&thread=10r03
1253,2018-04-12,대웅전일대비약8하락한21400원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804120378&t=NN
1254,2018-04-12,제약산업대웅제약인도네시아에서바이오연구소개소外,http://www.kukinews.com/news/article.html?no=539587
1255,2018-04-12,중덕정덕법계품서식25일조계사대웅전서,http://www.ibulgyo.com/news/articleView.html?idxno=165536
1256,2018-04-13,급변하는당뇨약시장②한판붙는유한vs대웅복병종근당,http://www.mdtoday.co.kr/mdtoday/index.html?no=318256
1257,2018-04-13,종근당대웅제약대조약법정다툼종지부언제쯤고법소송각하,http://www.mdtoday.co.kr/mdtoday/index.html?no=318120
1258,2018-04-13,대웅제약이지듀DWEGF마스터마스크출시,http://www.finomy.com/news/articleView.html?idxno=53566
1259,2018-04-13,대웅제약인도네시아에바이오연구소개소,http://www.insight.co.kr/news/150070
1260,2018-04-16,오늘의추천종목유안타증권SK이노베이션대웅제약등,http://www.asiatoday.co.kr/view.php?key=20180416010008852
1261,2018-04-16,더벨대웅제약나보타글로벌시장겨냥,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201804130100026580001629
1262,2018-04-16,더벨대웅그룹베트남의약품사업확대노린다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201804120100025680001574
1263,2018-04-16,대웅떠난슈글렛한독품으로당뇨라인업강화,http://www.dailymedi.com/detail.php?number=829601&thread=22r05
1264,2018-04-17,쉴땐쉬고일할땐일하고대웅제약징검다리연휴일괄휴무,http://www.mhj21.com/sub_read.html?uid=113252§ion=sc243
1265,2018-04-17,대웅제약올해모든징검다리연휴를전사휴무일로지정,http://news.mk.co.kr/newsRead.php?year=2018&no=243804
1266,2018-04-17,대웅제약2018년모든징검다리연휴일괄휴무지정,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217190
1267,2018-04-17,대웅제약징검다리연휴일괄휴무워라밸확산,http://medipana.com/news/news_viewer.asp?NewsNum=218799&MainKind=A&NewsKind=5&vCount=12&vKind=1
1268,2018-04-17,대웅제약충분히쉬고몰입하여일하는문화강화,http://www.kpanews.co.kr/article/show.asp?idx=193068&table=article&category=D
1269,2018-04-17,대웅제약올해휴일사이낀평일쉰다,http://www.bosa.co.kr/news/articleView.html?idxno=2081743
1270,2018-04-17,대웅제약충분히쉬고몰입하여일하는문화강화,http://www.getnews.co.kr/news/articleView.html?idxno=63152
1271,2018-04-17,대웅제약올해징검다리연휴모두쉰다,http://www.dailymedi.com/detail.php?number=829654&thread=22r05
1272,2018-04-17,대웅제약올해모든징검다리연휴일괄휴무지정,http://www.newsis.com/view/?id=NISX20180417_0000283862&cID=13001&pID=13000
1273,2018-04-17,대웅제약올해모든징검다리연휴일괄휴무지정,http://www.newsprime.co.kr/news/article.html?no=413603
1274,2018-04-17,대웅모든징검다리연휴에쉰다업무몰입배가,http://www.dailypharm.com/News/238874
1275,2018-04-17,대웅제약올해징검다리연휴평일전사휴무로바꾼다,http://www.ajunews.com/view/20180417134248772
1276,2018-04-17,대웅제약잘쉬어야업무능률도올라징검다리연휴일괄휴무,http://www.rapportian.com/news/articleView.html?idxno=110054
1277,2018-04-17,대웅제약올해모든징검다리연휴일괄휴무지정,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018041714255577795
1278,2018-04-17,대웅제약올해모든징검다리연휴일괄휴무지정,http://www.metroseoul.co.kr/news/newsview?newscd=2018041700131
1279,2018-04-17,대웅제약징검다리연휴에전사휴무,http://www.kpinews.co.kr/news/articleView.html?idxno=71643
1280,2018-04-17,직장돋보기분석높은연봉과몰입문화가매력적인대웅제약,http://www.news2day.co.kr/102515
1281,2018-04-17,대웅제약올해모든징검다리연휴전사휴무로지정,http://www.newspost.kr/news/articleView.html?idxno=62468
1282,2018-04-17,대웅제약충분히쉬고열심히일하는문화장려,http://www.k-health.com/news/articleView.html?idxno=35612
1283,2018-04-17,대웅제약충분히쉬고몰입해일하는문화강화한다,http://www.mdtoday.co.kr/mdtoday/index.html?no=318622
1284,2018-04-18,대웅제약충분히쉬고몰입하여일하자자율적업무문화반영한다,http://www.lawissue.co.kr/view.php?ud=201804172344274002d7f4c63cc6_12
1285,2018-04-18,10대제약사①기부금대웅제약꼴찌55억원녹십자의08수준,http://www.sisaon.co.kr/news/articleView.html?idxno=72149
1286,2018-04-18,제약바이오의료기기이모저모대웅제약2018징검다리연휴일괄휴무,http://news.heraldcorp.com/view.php?ud=20180418000526
1287,2018-04-18,대웅제일니코틴패취상표무효특허심판원기각,http://www.dailypharm.com/News/238915
1288,2018-04-18,대웅전일대비약8하락한20100원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804180444&t=NN
1289,2018-04-18,덕성여대에서대웅제약이지듀로자외선고민스트라이크,http://news.hankyung.com/article/201804183143a
1290,2018-04-18,제약산업이모저모대웅제약충분히쉬고몰입하여일하는문화강화外,http://www.kukinews.com/news/article.html?no=541265
1291,2018-04-18,제8회글로벌헬스케어포럼김재영대웅제약박사인공지능으로신약개발성공률높여”,http://www.ajunews.com/view/20180418151439720
1292,2018-04-19,대웅제약제일약품상대로니코틴패치상표권무효기각,http://www.mdtoday.co.kr/mdtoday/index.html?no=318768
1293,2018-04-19,모닝오늘bhc전례없는나눔경영대웅제약10대제약사中기부금꼴찌,http://www.sisaon.co.kr/news/articleView.html?idxno=72196
1294,2018-04-19,대웅제약26억명의약신대륙인도네시아서제2성장,http://news.mt.co.kr/mtview.php?no=2018041810000115657
1295,2018-04-20,대웅제약아시아지역의사초청나보타마스터클래스스프링2018개최,http://www.asiatoday.co.kr/view.php?key=20180420010012059
1296,2018-04-20,대웅제약아시아지역의사들초청해보톡스정보공유,http://news.mk.co.kr/newsRead.php?year=2018&no=252628
1297,2018-04-20,대웅제약해외의사초청나보타마스터클래스스프링2018개최,http://www.getnews.co.kr/news/articleView.html?idxno=63972
1298,2018-04-20,아파야챙길래GC녹십자대웅제약한미약품,http://www.g-enews.com/ko-kr/news/article/news_all/201804201003261481e6a49afa8d_1/article.html
1299,2018-04-20,대웅제약亞의사초청나보타마스터클래스성료,http://news.mt.co.kr/mtview.php?no=2018042009551689176
1300,2018-04-20,대웅제약아시아의사초청나보타마스터클래스개최,http://www.dt.co.kr/contents.html?article_no=2018042002109976029005&ref=naver
1301,2018-04-20,대웅제약나보타마스터클래스실시,http://www.kpinews.co.kr/news/articleView.html?idxno=71920
1302,2018-04-20,대웅제약주름개선제보툴리눔톡신글로벌교류넓힌다,http://www.ajunews.com/view/20180420104549875
1303,2018-04-20,대웅亞의료진대상나보타시술법공유,http://www.dailymedi.com/detail.php?number=829788&thread=22r05
1304,2018-04-20,대웅제약나보타마스터클래스스프링2018개최,http://www.bosa.co.kr/news/articleView.html?idxno=2081990
1305,2018-04-20,대웅제약나보타마스터클래스참석한아시아의사들유용했다,http://www.medisobizanews.com/news/articleView.html?idxno=52743
1306,2018-04-20,대웅나보타마스터클래스스프링2018개최,http://www.kpanews.co.kr/article/show.asp?idx=193212&table=article&category=D
1307,2018-04-20,대웅제약亞의사대상나보타시술법등홍보,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055082
1308,2018-04-20,대웅제약나보타마스터클래스스프링2018진행,http://www.enewstoday.co.kr/news/articleView.html?idxno=1181605
1309,2018-04-20,대웅제약아시아지역의사초청나보타마스터클래스개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018042011131391527
1310,2018-04-20,대웅제약해외의사초청프로그램나보타마스터클래스진행,http://www.k-health.com/news/articleView.html?idxno=35654
1311,2018-04-20,대웅제약나보타마스터클래스2018개최,http://www.ciobiz.co.kr/news/article.html?id=20180420120008
1312,2018-04-20,대웅제약아시아지역의사초청나보타마스터클래스스프링2018개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=318979
1313,2018-04-20,대웅제약나보타마스터클래스스프링2018개최,http://www.monews.co.kr/news/articleView.html?idxno=113792
1314,2018-04-20,대웅제약올해징검다리연휴일괄휴무지정,http://www.techholic.co.kr/news/articleView.html?idxno=175609
1315,2018-04-20,대웅제약아시아지역의사초청나보타마스터클래스스프링2018개최,http://www.newscj.com/news/articleView.html?idxno=513859
1316,2018-04-20,대웅제약해외의사초청나보타마스터클래스스프링2018개최,http://www.lawissue.co.kr/view.php?ud=201804202324521647d7f4c63cc6_12
1317,2018-04-21,뉴스투데이L대웅제약나보타마스터클래스스프링2018서최신지견공유,http://www.news2day.co.kr/102765
1318,2018-04-21,대웅제약나보타해외진출집중2Q실적개선기대”,http://www.edaily.co.kr/news/newspath.asp?newsid=01476006619178416
1319,2018-04-21,대웅제약나보타글로벌화가능성에주목골든브릿지,http://www.choicenews.co.kr/news/articleView.html?idxno=40823
1320,2018-04-21,대웅제약나보타글로벌화가능성주목,http://www.newsprime.co.kr/news/article.html?no=414211
1321,2018-04-23,빅데이터MSI시장심리톱5KB금융아모레퍼시픽롯데정밀화학대웅제약한국전력,http://www.newsis.com/view/?id=NISX20180423_0000288719&cID=10401&pID=10400
1322,2018-04-23,대웅제약소화기학회서항궤양제DWP14012임상결과발표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1182097
1323,2018-04-23,대웅제약소화기학회서항궤양제신약후보물질임상발표,http://www.newstomato.com/ReadNews.aspx?no=819783
1324,2018-04-23,대웅제약소화기학회서DWP14012임상결과발표,http://www.mhj21.com/sub_read.html?uid=113364§ion=sc243
1325,2018-04-23,대웅제약소화기학회심포지엄서DWP14012발표,http://www.kpanews.co.kr/article/show.asp?idx=193254&table=article&category=D
1326,2018-04-23,차세대항궤양제가시화대웅소화기학회소개,http://medipana.com/news/news_viewer.asp?NewsNum=219083&MainKind=A&NewsKind=5&vCount=12&vKind=1
1327,2018-04-23,대웅제약소화기학회서항궤양제DWP14012임상결과발표,http://www.k-health.com/news/articleView.html?idxno=35679
1328,2018-04-23,대웅항궤양제신약PPI대비우수,http://www.monews.co.kr/news/articleView.html?idxno=113871
1329,2018-04-23,대웅제약소화기학회심포지엄서항궤양제신약후보물질발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=319057
1330,2018-04-23,대웅제약항궤양제신약DWP14012소화기학회심포지엄서발표,http://www.getnews.co.kr/news/articleView.html?idxno=64538
1331,2018-04-23,대웅제약소화기기능성운동학회서항궤양신약임상결과발표,http://news.mk.co.kr/newsRead.php?year=2018&no=257546
1332,2018-04-23,대웅제약DWP14012차세대항궤양제개발가능성↑,http://www.medisobizanews.com/news/articleView.html?idxno=52775
1333,2018-04-23,대웅제약소화기학회서항궤양제DWP14012임상결과발표,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018042310314246074
1334,2018-04-23,대웅제약차세대항궤양제신약임상결과발표,http://www.bosa.co.kr/news/articleView.html?idxno=2082071
1335,2018-04-23,대웅제약차세대항궤양제임상결과발표,http://www.newsprime.co.kr/news/article.html?no=414292
1336,2018-04-23,대웅전일대비약3하락한19850원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804230444&t=NN
1337,2018-04-23,ET투자뉴스대웅제약영업실적보다나보타매수유지골든브릿지투자증권,http://www.etnews.com/20180423000172
1338,2018-04-23,대웅제약소화기학회심포지엄서DWP14012발표,http://www.medigatenews.com/news/2314125991
1339,2018-04-23,대웅제약소화기학회서DWP14012소개,http://www.whosaeng.com/sub_read.html?uid=100878§ion=sc5
1340,2018-04-23,대웅제약APNM2018서차세대항궤양제임상결과발표,http://www.ciobiz.co.kr/news/article.html?id=20180423120030
1341,2018-04-23,대웅제약차세대궤양제개발본격착수,http://www.kormedi.com/news/news/drug_dist/1226986_2906.html
1342,2018-04-23,대웅항궤양제신약효과성안전성확인,http://www.dailymedi.com/detail.php?number=829873&thread=22r05
1343,2018-04-23,대웅제약소화기학회심포지엄서DWP14012발표,http://www.lawissue.co.kr/view.php?ud=201804231622229437d7f4c63cc6_12
1344,2018-04-23,뉴스투데이L대웅제약소화기학회심포지엄서차세대항궤양제DWP14012발표,http://www.news2day.co.kr/102858
1345,2018-04-23,대웅제약소화기학회심포지엄서DWP14012발표,http://www.newscj.com/news/articleView.html?idxno=514450
1346,2018-04-23,대웅제약소화기학회서항궤양제DWP14012임상결과발표,http://www.dailian.co.kr/news/view/708789/?sc=naver
1347,2018-04-23,퀵리포트대웅제약매수유지목표가47↑25만원골든브릿지證,http://www.itooza.com/common/iview.php?no=2018042307315448890
1348,2018-04-24,대웅제약스티렌제네릭뉴틸렌수익성없자포기선언,http://www.kpanews.co.kr/article/show.asp?idx=193221&table=article&category=D
1349,2018-04-24,대웅전일대비약3상승한20350원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804240088&t=NN
1350,2018-04-24,제약산업단신대웅제약소화기학회심포지엄서DWP14012발표外,http://www.kukinews.com/news/article.html?no=542899
1351,2018-04-24,10대제약사⑤CEO연령평균534세대웅제약전승호43세로최연소,http://www.sisaon.co.kr/news/articleView.html?idxno=72404
1352,2018-04-24,대웅제약장애인구분공개채용추진,http://www.ablenews.co.kr/News/NewsContent.aspx?CategoryCode=0036&NewsCode=003620180424170915251302
1353,2018-04-24,장애인고용공단경기지사대웅제약장애인고용증진협약체결,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1468361
1354,2018-04-24,장애인공단경기지사와대웅제약장애인고용증진협약체결,http://www.joongboo.com/?mod=news&act=articleView&idxno=1246259
1355,2018-04-25,제약바이오의료기기이모저모대웅제약해외의사초청나보타마스터클래스,http://news.heraldcorp.com/view.php?ud=20180425000542
1356,2018-04-26,원료의약품시장대웅바이오경보제약A학점,http://www.mdtoday.co.kr/mdtoday/index.html?no=319407
1357,2018-04-26,제약사국내특허등록수GC녹십자대웅동아에스티순,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055275
1358,2018-04-26,대웅제약이지듀투스텝마스크라인출시,http://www.sportsseoul.com/news/read/627822
1359,2018-04-26,출시4년대웅제약나보타2020년100개국발매목표,http://www.asiatoday.co.kr/view.php?key=20180426010015332
1360,2018-04-26,대웅제약이지듀투스텝마스크출시,http://www.ajunews.com/view/20180426101009246
1361,2018-04-26,미리보는바이오코리아2018영상글로벌2020VISION통해글로벌50위제약사진입노리는대웅제약,http://kr.aving.net/news/view.php?articleId=1385745&Branch_ID=kr&rssid=naver&mn_name=news
1362,2018-04-26,규정부실에대웅화재처리잘하고기록관리못해빛바래,http://news.mk.co.kr/newsRead.php?year=2018&no=267531
1363,2018-04-26,대웅제약이지듀투스텝마스크출시기념100원이벤트연다,http://www.insight.co.kr/news/152189
1364,2018-04-27,2018서울머니쇼의약품美시판허가앞둔대웅제약녹십자주목,http://news.mk.co.kr/newsRead.php?year=2018&no=268344
1365,2018-04-27,더벨전승호대웅제약대표나보타미국유럽허가원활,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201804260100054180003363
1366,2018-04-30,메디톡스美법원대웅제약등에대한미국소송유지결정대환영,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217645
1367,2018-04-30,보툴리눔톡신출처메디톡스대웅美소송계속된다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055410
1368,2018-04-30,메디톡스대웅제약상대영업비밀침범訴美법원유지결정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=78870
1369,2018-04-30,대웅제약메디톡스보톡스베꼈나미법원서소송,http://www.nongaek.com/news/articleView.html?idxno=38637
1370,2018-04-30,대웅전일대비약9하락한18600원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201804300584&t=NN
1371,2018-04-30,메디톡스대웅美법원訴유지판단서로유리한해석,http://www.dailypharm.com/News/239360
1372,2018-04-30,대웅제약메디톡스美법원제기민사소송종결,http://www.medisobizanews.com/news/articleView.html?idxno=52936
1373,2018-04-30,대웅메디톡스美민사종결,http://www.monews.co.kr/news/articleView.html?idxno=114159
1374,2018-04-30,대웅제약메디톡스와나보타미국민사소송종결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217654
1375,2018-04-30,대웅제약메디톡스와의美민사소송종결,http://medipana.com/news/news_viewer.asp?NewsNum=219387&MainKind=A&NewsKind=5&vCount=12&vKind=1
1376,2018-04-30,美법원보톡스등소송유지결정메디톡스대웅제약엇갈린반응,http://www.enewstoday.co.kr/news/articleView.html?idxno=1184996
1377,2018-04-30,메디톡스대웅제약끝나지않은보툴리눔톡신출처논란상보,http://news.mt.co.kr/mtview.php?no=2018043015170056868
1378,2018-04-30,대웅제약메디톡스미국소송재개되나미국법원보톡스균주소송유지결정,http://www.etnews.com/20180430000432
1379,2018-04-30,대웅메디톡스보툴리눔미국민사종결각하결정,http://www.medicaltimes.com/News/1118381
1380,2018-04-30,대웅제약美법원소송종결VS메디톡스소송유지,http://www.newsis.com/view/?id=NISX20180430_0000296023&cID=13001&pID=13000
1381,2018-04-30,대웅제약美법원메디톡스제기보톡스균주소송각하,http://www.dailymedi.com/detail.php?number=830104&thread=22r05
1382,2018-04-30,미국법원메디톡스가대웅제약에제기한민사소송각하판결,http://www.kukinews.com/news/article.html?no=544768
1383,2018-04-30,대웅제약메디톡스와의미국민사소송종결,http://health.chosun.com/site/data/html_dir/2018/04/30/2018043001654.html
1384,2018-04-30,메디톡스대웅제약보톡스美법원판단엇갈린반응,http://www.sedaily.com/NewsView/1RYGI2FEWT
1385,2018-04-30,대웅제약메디톡스와의미국민사소송각하판결,http://www.sportsseoul.com/news/read/629283
1386,2018-04-30,대웅메디톡스와미국민사소송종결,http://www.bosa.co.kr/news/articleView.html?idxno=2082496
1387,2018-04-30,대웅제약메디톡스보톡스균주美법원판단에상반된해석,http://view.asiae.co.kr/news/view.htm?idxno=2018043015594055077
1388,2018-04-30,美법원메디톡스제기보톡스소송대웅제약재소가능각하에볼루스유지,http://news.hankyung.com/article/201804304694f
1389,2018-04-30,대웅제약메디톡스美보톡스소송두고신경전,http://www.newsway.co.kr/view.php?tp=1&ud=2018043016054864827
1390,2018-04-30,Dismissedwithoutprejudice해석갈리는대웅제약메디톡스,http://www.mhj21.com/sub_read.html?uid=113533§ion=sc243
1391,2018-04-30,메디톡스美법원대웅제약파트너사에볼루스소송유지결정,http://www.medisobizanews.com/news/articleView.html?idxno=52939
1392,2018-04-30,메디톡스대웅제약또입장차美소송재소가능각하vs종결,http://biz.newdaily.co.kr/news/article.html?no=10159669
1393,2018-04-30,보톡스균주전쟁대웅제약메디톡스美법원판단해석제각각,http://www.newspim.com/news/view/20180430000244
1394,2018-04-30,대웅제약메디톡스美민사소송종결,http://www.newsprime.co.kr/news/article.html?no=415166
1395,2018-04-30,대웅제약메디톡스보톡스균주미국법원판단에상반된해석,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018043016260672203
1396,2018-04-30,대웅제약메디톡스와의보톡스미국소송종결,http://www.mediapen.com/news/view/351279
1397,2018-04-30,美법원보톡스소송각하대웅메디톡스아전인수해석,http://www.kpanews.co.kr/article/show.asp?idx=193460&table=article&category=D
1398,2018-04-30,美법원보툴리눔톡신소송유지결정대웅제약vs메디톡스법적공방끝까지간다,http://www.ekn.kr/news/article.html?no=359212
1399,2018-04-30,대웅제약美법원메디톡스가제기한보톡스소송종결,http://www.dailian.co.kr/news/view/710399/?sc=naver
1400,2018-04-30,美법원대웅제약피고인소송각하국내소송결과에주목,http://news1.kr/articles/?3304735
1401,2018-04-30,대웅제약메디톡스주름개선제美분쟁사실상종료,http://www.ajunews.com/view/20180430181805916
1402,2018-04-30,대웅제약메디톡스와의미국민사소송각하판결,http://www.getnews.co.kr/news/articleView.html?idxno=66418
1403,2018-04-30,메디톡스대웅제약보톡스균주출처美법원판단놓고상반된해석,http://www.etoday.co.kr/news/section/newsview.php?idxno=1618780
1404,2018-04-30,메디톡스대웅제약과보톡스균주소송국내에서이어간다,http://www.businesspost.co.kr/BP?command=article_view&num=80995
1405,2018-04-30,대웅제약VS메디톡스보톡스균주논란싸움재점화,http://www.edaily.co.kr/news/newspath.asp?newsid=05090566619181368
1406,2018-04-30,대웅제약메디톡스와의미국민사소송각하판결내려,http://www.lawissue.co.kr/view.php?ud=20180430223915740d7f4c63cc6_12
1407,2018-04-30,대웅제약vs메디톡스법적소송미국에서한국으로,http://medicalworldnews.co.kr/news/view.php?idx=1510925452
1408,2018-05-01,대웅메디톡스민사엇갈린해석판결문살펴보니,http://www.medicaltimes.com/News/1118392
1409,2018-05-01,생산실적최다제약사전문약녹십자일반약대웅제약,http://www.kpanews.co.kr/article/show.asp?idx=193463&table=article&category=D
1410,2018-05-01,미국서메디톡스와소송중인대웅제약미법원서소송종결”,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055415
1411,2018-05-01,대웅제약vs메디톡스美소송판결상반된해석,http://www.viva100.com/main/view.php?key=20180430010011444
1412,2018-05-01,대웅제약메디톡스보톡스美판결같은결정다른주장상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01866326619204656
1413,2018-05-01,대웅제약vs메디톡스보툴리늄전쟁한국법원결정중요,http://sports.khan.co.kr/news/sk_index.html?art_id=201805011454003&sec_id=561801&pt=nv
1414,2018-05-01,대웅제약미국보톡스소송종결,http://www.newstomato.com/ReadNews.aspx?no=821593
1415,2018-05-01,대웅제약GC녹십자올하반기美서신약시판전망바이오한류잇는다,http://www.ekn.kr/news/article.html?no=359392
1416,2018-05-02,보툴리눔톡신소송전메디톡스VS대웅제약美법원판결에서로다른해석,http://www.mdtoday.co.kr/mdtoday/index.html?no=319844
1417,2018-05-02,퀵리포트대웅제약매수유지목표가21만원유지케이프證,http://www.itooza.com/common/iview.php?no=2018050207452920609
1418,2018-05-02,대웅제약나보타美소송종료선진시장진출기대케이프,http://news.mt.co.kr/mtview.php?no=2018050207550115290
1419,2018-05-02,대웅제약나보타미국소송각하결정케이프證,http://news.mt.co.kr/mtview.php?no=2018050208114882498
1420,2018-05-02,대웅제약美소송사실상종료나보타기대감유효케이프,http://www.edaily.co.kr/news/newspath.asp?newsid=01748246619204984
1421,2018-05-02,대웅제약신약나보타선진국시장진출목표가↑,http://www.asiatoday.co.kr/view.php?key=20180502010000635
1422,2018-05-02,ET투자뉴스대웅제약나보타의행방이중매수KB증권,http://www.etnews.com/20180502000009
1423,2018-05-02,제약톡톡대웅vs메디톡스제약업계앙숙관계길어지나,http://news.heraldcorp.com/view.php?ud=20180502000093
1424,2018-05-02,대웅제약나보타美소송각하선진시장진출기대감유효케이프투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1619063
1425,2018-05-02,대웅제약메디톡스누구말이맞나,http://www.rapportian.com/news/articleView.html?idxno=110293
1426,2018-05-02,미국에튄보톡스불똥대웅제약메디톡스공방가열,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003189883
1427,2018-05-02,대웅제약메디톡스와의민사소송종결미법원각하판결,http://www.techholic.co.kr/news/articleView.html?idxno=175778
1428,2018-05-02,ET투자뉴스대웅제약나보타선진시장진매수유지케이프투자증권,http://www.etnews.com/20180502000275
1429,2018-05-02,다시불붙은메디톡스대웅제약신경전,http://www.newstomato.com/ReadNews.aspx?no=821787
1430,2018-05-02,맥쿼리證메디톡스대웅제약간분쟁은지속,http://news.mt.co.kr/mtview.php?no=2018050215462652152
1431,2018-05-02,메디톡스vs대웅제약끝나지않는보톡스출처전쟁,http://www.insightkorea.co.kr//news/articleView.html?idxno=24592
1432,2018-05-02,맥쿼리대웅제약메디톡스지적재산권분쟁은지속,http://www.asiatoday.co.kr/view.php?key=20180502010001303
1433,2018-05-02,대웅제약나보타관련미국민사소송각하결정,http://www.newsworks.co.kr/news/articleView.html?idxno=184167
1434,2018-05-03,뉴스텔링대웅제약vs제일약품상표권소송동전의양면,http://www.cnbnews.com/news/article.html?no=373524
1435,2018-05-03,대웅제약미국중남미학회에서나보타보톡스비교임상발표,http://www.medigatenews.com/news/2083830368
1436,2018-05-03,대웅제약나보타임상결과발표,http://www.dt.co.kr/contents.html?article_no=2018050302109976029003&ref=naver
1437,2018-05-03,대웅제약나보타보톡스와비교임상결과공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217769
1438,2018-05-03,대웅제약나보타미국및중남미학회에서보톡스와비교임상결과공개,http://www.fnnews.com/news/201805031004148485
1439,2018-05-03,대웅제약미국중남미학회서나보타와보톡스비교임상결과공개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050310071457290
1440,2018-05-03,대웅제약나보타보톡스와안전성유효성동등,http://news.mt.co.kr/mtview.php?no=2018050309582378628
1441,2018-05-03,대웅제약나보타원조보톡스와동등성입증,http://www.dailypharm.com/News/239465
1442,2018-05-03,대웅제약미국중남미학회서나보타최신임상결과발표,http://www.mhj21.com/sub_read.html?uid=113594§ion=sc243
1443,2018-05-03,대웅나보타보톡스에비열등성입증,http://www.medical-tribune.co.kr/news/articleView.html?idxno=78969
1444,2018-05-03,대웅제약미국중남미학회서나보타와보톡스비교임상결과공개,http://www.sisajournal-e.com/biz/article/183562
1445,2018-05-03,대웅제약미국미용성형외과학회서나보타보톡스비교임상결과발표,http://news.mk.co.kr/newsRead.php?year=2018&no=281767
1446,2018-05-03,대웅제약나보타미주학회서보톡스비교임상결과우수성공개,http://www.getnews.co.kr/news/articleView.html?idxno=67000
1447,2018-05-03,대웅제약미국중남미서나보타임상결과발표,http://www.dailian.co.kr/news/view/710979/?sc=naver
1448,2018-05-03,대웅제약보톡스나보타안전성유효성입증,http://www.sedaily.com/NewsView/1RZE04WQ7G
1449,2018-05-03,대웅제약나보타해외서보톡스비교임상,http://www.kormedi.com/news/news/drug_dist/1227141_2906.html
1450,2018-05-03,대웅제약나보타보톡스대비비열등성입증,http://www.bosa.co.kr/news/articleView.html?idxno=2082713
1451,2018-05-03,대웅제약美중남미학회서나보타보톡스간비교임상결과공개,http://www.ekn.kr/news/article.html?no=359880
1452,2018-05-03,뉴스투데이E대웅제약나보타보톡스와비교임상결과공개로해외시장청신호,http://www.news2day.co.kr/103409
1453,2018-05-03,맥쿼리증권메디톡스대웅제약지적재산권분쟁지속”,http://www.mhj21.com/sub_read.html?uid=113603§ion=sc243
1454,2018-05-03,대웅제약나보타미유럽임상서안전성입증,http://www.newsis.com/view/?id=NISX20180503_0000299311&cID=13001&pID=13000
1455,2018-05-03,대웅제약우루사캐나다생동시험완료연말FDA허가접수,http://www.newstomato.com/ReadNews.aspx?no=822129
1456,2018-05-03,대웅제약미국및중남미학회에서보톡스나보타최신임상결과공개,http://www.lawissue.co.kr/view.php?ud=201805031537533814d7f4c63cc6_12
1457,2018-05-03,대웅제약미국중남미학회서나보타와보톡스비교임상결과공개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1186207
1458,2018-05-03,대웅제약나보타미국및중남미학회서비교임상결과공개,http://www.metroseoul.co.kr/news/newsview?newscd=2018050300168
1459,2018-05-03,아파야챙길래대웅제약광동제약일동제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201805031642251324e6a49afa8d_1/article.html
1460,2018-05-03,대웅제약미국중남미학회에서나보타우수성입증,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805030570&t=NN
1461,2018-05-03,대웅나보타보톡스비교임상결과공개,http://www.monews.co.kr/news/articleView.html?idxno=114263
1462,2018-05-03,대웅제약나보타미국중남미해회학회서임상결과공개,http://www.kukinews.com/news/article.html?no=545769
1463,2018-05-03,대웅제약중남미피부과학회서나보타우수성알려,http://www.k-health.com/news/articleView.html?idxno=35925
1464,2018-05-03,대웅제약미국중남미학회서나보타임상결과공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=320066
1465,2018-05-03,대웅제약나보타미국및중남미학회에서보톡스와비교임상결과공개,http://www.newscj.com/news/articleView.html?idxno=517779
1466,2018-05-03,대웅보툴리눔톡신나보타엘러간보톡스대비비열등성입증,http://www.viva100.com/main/view.php?key=20180503010001485
1467,2018-05-04,대웅제약나보타세계학회서보톡스와비교임상결과공개,http://www.kpanews.co.kr/article/show.asp?idx=193580&table=article&category=D
1468,2018-05-04,대웅제약미국등서나보타와보톡스비교결과공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055520
1469,2018-05-04,대웅재단글로벌인재육성프로그램2018웅토링스쿨개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018050409414521797
1470,2018-05-04,대웅재단2018웅토링스쿨역량개발비수여식,http://medipana.com/news/news_viewer.asp?NewsNum=219610&MainKind=A&NewsKind=5&vCount=12&vKind=1
1471,2018-05-04,대웅재단글로벌인재육성웅토링스쿨토크콘서트개최,http://www.dt.co.kr/contents.html?article_no=2018050402109976029004&ref=naver
1472,2018-05-04,대웅재단글로벌인재육성프로그램2018웅토링스쿨,http://www.kpanews.co.kr/article/show.asp?idx=193591&table=article&category=D
1473,2018-05-04,대웅재단27개국장학생초청토크콘서트웅토링스쿨개최,http://www.medisobizanews.com/news/articleView.html?idxno=53029
1474,2018-05-04,대웅재단2018웅토링스쿨역량개발비수여식및토크콘서트개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217829
1475,2018-05-04,대웅재단글로벌인재육성프로그램2018웅토링스쿨도입,http://www.bosa.co.kr/news/articleView.html?idxno=2082788
1476,2018-05-04,대웅재단2018웅토링스쿨진행역량개발비수여식토크콘서트개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1186505
1477,2018-05-04,대웅재단글로벌인재육성프로그램2018웅토링스쿨진행,http://www.ekn.kr/news/article.html?no=360121
1478,2018-05-04,대웅재단웅토링스쿨개발비수여식토크콘서트진행,http://www.k-health.com/news/articleView.html?idxno=35948
1479,2018-05-04,대웅제약미국중남미학회서나보타보톡스비교임상발표,http://www.sisaweek.com/news/articleView.html?idxno=107550
1480,2018-05-04,더벨대웅그룹계열사3곳네이버기업집단제외언제쯤,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805030100004650000285
1481,2018-05-04,대웅재단글로벌인재육성웅토링스쿨토크콘서트개최,http://www.metroseoul.co.kr/news/newsview?newscd=2018050400051
1482,2018-05-04,뉴스투데이L대웅재단세계27개국장학생위한2018웅토링스쿨열어,http://www.news2day.co.kr/103521
1483,2018-05-04,단독10대제약사유리천장심각한미약품대웅제약보령제약등은선방,http://www.news2day.co.kr/103522
1484,2018-05-04,대웅재단2018웅토링스쿨개최,http://www.monews.co.kr/news/articleView.html?idxno=114323
1485,2018-05-04,보톡스전쟁대웅제약vs메디톡스국내소송전본격화,http://www.sisaweek.com/news/articleView.html?idxno=107582
1486,2018-05-05,대웅재단글로벌인재육성프로그램2018웅토링스쿨진행,http://www.lawissue.co.kr/view.php?ud=20180505143154803d7f4c63cc6_12
1487,2018-05-05,대웅재단체계적글로벌인재육성나서,http://www.kpinews.co.kr/news/articleView.html?idxno=73073
1488,2018-05-06,글로벌미용시장서자신감드러내는대웅제약나보타,http://www.ajunews.com/view/20180506124113876
1489,2018-05-08,대웅제약우루사미국진출도청신호,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055590
1490,2018-05-08,대웅제약전일대비약5상승한183500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805080200&t=NN
1491,2018-05-08,ET투자뉴스대웅_거래비중기관191외국인2458,http://www.etnews.com/20180508000170
1492,2018-05-08,컨센미달대웅제약올해1Q영업익80억컨센비219↓,http://www.itooza.com/common/iview.php?no=2018050817530615099
1493,2018-05-08,대웅제약1분기영업익80억전년동기비179↓,http://view.asiae.co.kr/news/view.htm?idxno=2018050817575203070
1494,2018-05-08,대웅제약올해1분기영업익80억전년比18↓,http://www.newsis.com/view/?id=NISX20180508_0000302815&cID=10401&pID=10400
1495,2018-05-08,공시대웅제약1Q영업익80억원전년比179↓,http://www.newsway.co.kr/view.php?tp=1&ud=2018050817554084844
1496,2018-05-08,대웅제약1Q영업익80억전년比18↓,http://news.mt.co.kr/mtview.php?no=2018050818003011755
1497,2018-05-08,대웅제약1분기영업익80억원전년比18감소,http://news1.kr/articles/?3311633
1498,2018-05-08,대웅제약1분기영업이익80억전년比179↓,http://www.newsworks.co.kr/news/articleView.html?idxno=185301
1499,2018-05-08,대웅제약단기비용증가에1분기수익성발목,http://www.newstomato.com/ReadNews.aspx?no=822842
1500,2018-05-08,대웅제약1Q영업익80억전년比18↓,http://www.seoulfn.com/news/articleView.html?idxno=305735
1501,2018-05-08,대웅제약1분기영업이익80억원기록179감소,http://www.dt.co.kr/contents.html?article_no=2018050802109976029011&ref=naver
1502,2018-05-09,대웅제약1Q영업익80억전년비18↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=320389
1503,2018-05-09,퀵리포트대웅제약매수유지목표가22만원유지유안타證,http://www.itooza.com/common/iview.php?no=2018050907331360832
1504,2018-05-09,퀵리포트대웅제약매수유지목표가21만5000원유지하이투자證,http://www.itooza.com/common/iview.php?no=2018050907372014767
1505,2018-05-09,대웅제약RD비용증가로1분기부진하반기기대하이,http://news.hankyung.com/article/2018050923936
1506,2018-05-09,대웅제약신공장감가상각비비용부담,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018050908230400388&LinkID=632&objId=A2018050908230400388&portalCode=naver
1507,2018-05-09,하이투자증권대웅제약RD비용증가로1분기부진하반기는기대돼”,http://www.newsway.co.kr/view.php?tp=1&ud=2018050908240495783
1508,2018-05-09,ET투자뉴스대웅제약미래투자비용증매수유지유안타증권,http://www.etnews.com/20180509000007
1509,2018-05-09,대웅제약1분기나보타매출호조로연간200억확대전망KTB,http://www.mdtoday.co.kr/mdtoday/index.html?no=320410
1510,2018-05-09,대웅제약상반기보다하반기가더기대나보타가중요하이투자증권,http://www.sedaily.com/NewsView/1RZGQOAGVX
1511,2018-05-09,STOCK대웅제약코프로모션제품라인업기대감,http://moneys.mt.co.kr/news/mwView.php?no=2018050908488081629
1512,2018-05-09,대웅제약3분기미국허가취득기대매수적기NH투자증권,http://www.ebn.co.kr/news/view/940697
1513,2018-05-09,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018050909312814758
1514,2018-05-09,대웅제약1분기매출2158억원전년比5증가,http://www.medisobizanews.com/news/articleView.html?idxno=53089
1515,2018-05-09,ET투자뉴스대웅제약하반기를보면지금매수유지NH투자증권,http://www.etnews.com/20180509000113
1516,2018-05-09,실적발표오가닉티코스메틱웅진씽크빅대웅제약,http://www.businesspost.co.kr/BP?command=article_view&num=81791
1517,2018-05-09,ET투자뉴스대웅제약실적보다나보타의HOLD유지DB금융투자,http://www.etnews.com/20180509000155
1518,2018-05-09,ET투자뉴스대웅제약상반기보다하반기매수유지하이투자증권,http://www.etnews.com/20180509000159
1519,2018-05-09,ET투자뉴스대웅제약양호한실적나보매수KTB투자증권,http://www.etnews.com/20180509000217
1520,2018-05-09,대웅제약하반기실적개선나보타승인RD성과모멘텀기대,http://www.newsworks.co.kr/news/articleView.html?idxno=185500
1521,2018-05-09,퀵리포트대웅제약매수유지목표가23만2000원유지KB證,http://www.itooza.com/common/iview.php?no=2018050915413519037
1522,2018-05-09,애널리포트대웅제약하반기실적개산전망투자의견매수,http://www.ezyeconomy.com/news/articleView.html?idxno=83099
1523,2018-05-09,대웅제약실적부진에도하반기기대감에주가껑충,http://www.newstomato.com/ReadNews.aspx?no=823130
1524,2018-05-09,NH투자증권대웅제약지금이매수기회,http://www.techholic.co.kr/news/articleView.html?idxno=175925
1525,2018-05-10,대웅아쉬운실적에도긍정평가하반기기대감반영,http://www.dailypharm.com/News/239645
1526,2018-05-10,대웅제약투자확대단기실적부진,http://www.nspna.com/news/?mode=view&newsid=283237
1527,2018-05-10,ET투자뉴스대웅제약하반기나보타FD매수유지KB증권,http://www.etnews.com/20180510000011
1528,2018-05-10,SK케미칼대웅제약과스카이조스터공동마케팅판매,http://medipana.com/news/news_viewer.asp?NewsNum=219822&MainKind=A&NewsKind=5&vCount=12&vKind=1
1529,2018-05-10,SK케미칼대웅제약과대상포진백신공동마케팅판매맞손,http://view.asiae.co.kr/news/view.htm?idxno=2018051010193497960
1530,2018-05-10,SK케미칼대웅국산대상포진백신마케팅손잡았다,http://www.dailypharm.com/News/239663
1531,2018-05-10,SK케미칼대웅제약과스카이조스터공동마케팅,http://www.medicaltimes.com/News/1118554
1532,2018-05-10,SK케미칼대웅제약과스카이조스터공동마케팅판매협약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=217990
1533,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터공동판매,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180510066700017&did=1195m
1534,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터공동판매,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=PYH20180510058100017&did=1196m
1535,2018-05-10,SK대웅대상포진백신스카이조스터공동판매,http://www.medical-tribune.co.kr/news/articleView.html?idxno=79100
1536,2018-05-10,SK케미칼대웅제약과대상포진백신스카이조스터공동판매,http://www.newsis.com/view/?id=NISX20180510_0000304633&cID=13001&pID=13000
1537,2018-05-10,SK케미칼대웅제약과스카이조스터마케팅판매협약,http://www.medisobizanews.com/news/articleView.html?idxno=53114
1538,2018-05-10,SK케미칼대웅제약과스카이조스터공동마케팅및판매협약,http://www.bokuennews.com/news/article.html?no=159395
1539,2018-05-10,SK케미칼대웅제약과대상포진백신스카이조스터공동마케팅및판매협약체결,http://www.fnnews.com/news/201805101043575351
1540,2018-05-10,ET투자뉴스대웅제약투자확대로단기TRADINGBUY유지신한금융투자,http://www.etnews.com/20180510000096
1541,2018-05-10,SK케미칼대웅제약스카이조스터대상포진백신공동판매돌입,http://www.sedaily.com/NewsView/1RZH7G27R0
1542,2018-05-10,SK케미칼대웅제약과스카이조스터공동마케팅및판매협약,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051011184152098
1543,2018-05-10,SK케미칼대웅제약국산대상포진백신공동마케팅,http://news1.kr/articles/?3313439
1544,2018-05-10,대웅제약스카이조스터공동판매나선다,http://www.monews.co.kr/news/articleView.html?idxno=114503
1545,2018-05-10,대웅제약SK케미칼대상포진백신스카이조스터함께판다,http://www.edaily.co.kr/news/newspath.asp?newsid=03188166619207608
1546,2018-05-10,SK케미칼대웅제약스카이조스터공동판매,http://www.kormedi.com/news/news/drug_dist/1227219_2906.html
1547,2018-05-10,더벨대웅제약IFRS1115호도입여파없었다,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805090100011800000720
1548,2018-05-10,SK케미칼대웅제약과스카이조스터공동마케팅및판매협약,http://www.asiatoday.co.kr/view.php?key=20180510010004996
1549,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터협업,http://wikileaks-kr.org/SK%EC%BC%80%EB%AF%B8%EC%B9%BC-%EB%8C%80%EC%9B%85%EC%A0%9C%EC%95%BD-%EB%8C%80%EC%83%81%ED%8F%AC%EC%A7%84%EB%B0%B1%EC%8B%A0-%EC%8A%A4%EC%B9%B4%EC%9D%B4%EC%A1%B0%EC%8A%A4%ED%84%B0
1550,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터공동판매,http://www.metroseoul.co.kr/news/newsview?newscd=2018051000150
1551,2018-05-10,SK케미칼대웅국산대상포진백신공동판매,http://www.dailymedi.com/detail.php?number=830425&thread=22r05
1552,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터공동판매,http://www.newspim.com/news/view/20180510000257
1553,2018-05-10,SK케미칼대웅제약과스카이조스터공동판매협약,http://news.heraldcorp.com/view.php?ud=20180510000709
1554,2018-05-10,SK케미칼대웅제약스카이조스터공동판매,http://www.dt.co.kr/contents.html?article_no=2018051002109976029011&ref=naver
1555,2018-05-10,SK케미칼대웅제약과대상포진백신스카이조스터공동판매,http://www.nextdaily.co.kr/news/article.html?id=20180510800040
1556,2018-05-10,SK케미칼대웅제약과대상포진백신공동마케팅및판매협약,http://www.sportsseoul.com/news/read/633218
1557,2018-05-10,SK케미칼대웅제약스카이조스터공동판매,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055699
1558,2018-05-10,SK케미칼대웅제약과스카이조스터공동판매계약,http://news.mt.co.kr/mtview.php?no=2018051014121815159
1559,2018-05-10,SK케미칼대웅제약대상포진백신협약,http://www.kpinews.co.kr/news/articleView.html?idxno=73415
1560,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터공동판매협약,http://www.kukinews.com/news/article.html?no=547764
1561,2018-05-10,SK케미칼대웅제약과스카이조스터공동판매,http://biz.chosun.com/site/data/html_dir/2018/05/10/2018051002363.html
1562,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터공동판매,http://www.newspost.kr/news/articleView.html?idxno=62925
1563,2018-05-10,SK케미칼대웅제약과스카이조스터공동판매점유율50목표,http://www.rapportian.com/news/articleView.html?idxno=110455
1564,2018-05-10,SK케미칼대웅제약대상포진백신공동판매협약,http://www.polinews.co.kr/news/article.html?no=355255
1565,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터판매협력,http://news.hankyung.com/article/201805100258f
1566,2018-05-10,SK케미칼대웅제약대상포진백신스카이조스터같이판다,http://www.ajunews.com/view/20180510175425621
1567,2018-05-10,SK케미칼자체개발한대상포진백신대웅제약과공동영업,http://www.businesspost.co.kr/BP?command=article_view&num=82036
1568,2018-05-11,녹십자대웅휴온스미국진출꿈올해이룬다,http://www.mdtoday.co.kr/mdtoday/index.html?no=320684
1569,2018-05-11,SK케미칼대웅제약과대상포진백신공동마케팅및판매협약,http://www.mdtoday.co.kr/mdtoday/index.html?no=320669
1570,2018-05-11,ET투자뉴스대웅제약_상장주식수대비거래량은065로적정수준,http://www.etnews.com/20180511000055
1571,2018-05-11,식약처대웅CJ제일아토르바스타틴메트포르민복합제허가,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1055734
1572,2018-05-11,대웅전일대비약5상승한20000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805110230&t=NN
1573,2018-05-11,SK케미칼대상포진백신스카이조스터대웅제약과공동마케팅,http://www.newsworks.co.kr/news/articleView.html?idxno=186105
1574,2018-05-11,ET투자뉴스대웅_주요매물구간인18700원선이지지대로작용,http://www.etnews.com/20180511000169
1575,2018-05-12,대웅이뽑은해외인재들우리도한국제약인이죠,http://www.dailypharm.com/News/239729
1576,2018-05-13,대웅제약오픈부2연패복지부마스터부첫우승,http://www.bosa.co.kr/news/articleView.html?idxno=2083158
1577,2018-05-13,프라이머대웅제약과헬스케어스타트업투자,http://news.mt.co.kr/mtview.php?no=2018051014593932736
1578,2018-05-14,SK케미칼대웅제약과스카이조스터공동마케팅및판매협약,http://www.kpanews.co.kr/article/show.asp?idx=193769&table=article&category=D
1579,2018-05-14,퀵리포트대웅제약매수목표가26만원신규제시이베스트證,http://www.itooza.com/common/iview.php?no=2018051409161315638
1580,2018-05-14,제약산업소식대웅제약나보타해외진출박차,http://www.kukinews.com/news/article.html?no=548588
1581,2018-05-14,대웅제약나보타미국소송각하사건종결재강조,http://www.bosa.co.kr/news/articleView.html?idxno=2083219
1582,2018-05-14,대웅제약나보타미국소송완전히종료거듭강조,http://medipana.com/news/news_viewer.asp?NewsNum=219988&MainKind=A&NewsKind=5&vCount=12&vKind=1
1583,2018-05-14,대웅메디톡스주장반박나보타美소송종료,http://www.dailymedi.com/detail.php?number=830542&thread=22r05
1584,2018-05-14,대웅나보타美소송완전히종료,http://www.mdtoday.co.kr/mdtoday/index.html?no=320935
1585,2018-05-15,대웅제약아이큐어등치매환자위한패치형치매치료제개발활발,http://www.mdtoday.co.kr/mdtoday/index.html?no=320918
1586,2018-05-15,대웅제약AMWCasia서아시아지역의사대상나보타최신임상결과발표,http://www.viva100.com/main/view.php?key=20180515010005047
1587,2018-05-15,대웅亞미용안티에이징학회AMWC참가,http://www.bosa.co.kr/news/articleView.html?idxno=2083309
1588,2018-05-15,대웅제약나보타고순도로빠르고긴효과장점,http://www.medisobizanews.com/news/articleView.html?idxno=53198
1589,2018-05-15,대웅제약미용안티에이징학회서나보타최신임상결과발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218159
1590,2018-05-15,대웅제약보톡스나보타아시아판촉활동본격화,http://www.dailypharm.com/News/239827
1591,2018-05-15,대웅제약미용안티에이징학회참여나보타우수성공유,http://www.joseilbo.com/news/news_read.php?uid=353022&class=27&grp=
1592,2018-05-15,대웅제약나보타우수성아시아에알리고영향력확대할것,http://www.k-health.com/news/articleView.html?idxno=36085
1593,2018-05-15,대만미용의사찾은대웅제약나보타임상소개,http://medipana.com/news/news_viewer.asp?NewsNum=220059&MainKind=A&NewsKind=5&vCount=12&vKind=1
1594,2018-05-15,뉴스투데이E대웅제약미용안티에이징학회AMWCasia서나보타우수성소개,http://www.news2day.co.kr/104017
1595,2018-05-15,대웅제약미용안티에이징학회참여나보타우수성공유,http://www.metroseoul.co.kr/news/newsview?newscd=2018051500148
1596,2018-05-15,대웅제약세계미용안티에이징학회참가나보타임상결과공유,http://www.mdtoday.co.kr/mdtoday/index.html?no=321065
1597,2018-05-15,대웅제약아시아첫세계미용안티에이징학회서나보타홍보,http://news.mk.co.kr/newsRead.php?year=2018&no=308992
1598,2018-05-15,실적속보대웅제약1Q영업이익53억전년비9↓,http://www.itooza.com/common/iview.php?no=2018051518385754503
1599,2018-05-15,실적속보대웅1Q영업이익186억전년비24↑,http://www.itooza.com/common/iview.php?no=2018051518434319205
1600,2018-05-15,대웅제약미용안티에이징학회AMWCasia참가,http://www.lawissue.co.kr/view.php?ud=201805152223348657d7f4c63cc6_12
1601,2018-05-16,한미약품대웅제약등제약사잘키운자회사덕보네,http://www.edaily.co.kr/news/newspath.asp?newsid=01207046619209576
1602,2018-05-16,정체된유한대웅한미뛰어가는동국일양대원동화,http://www.mdtoday.co.kr/mdtoday/index.html?no=321086
1603,2018-05-16,대웅제약전일대비약4상승한198000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805160197&t=NN
1604,2018-05-16,대웅전일대비약6상승한20250원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805160200&t=NN
1605,2018-05-16,대웅제약AMWCasia참가아시아미용안티에이징시장공략,http://www.getnews.co.kr/news/articleView.html?idxno=69594
1606,2018-05-16,보톡스분쟁메디톡스대웅제약중국진출속도차,http://www.finomy.com/news/articleView.html?idxno=54556
1607,2018-05-16,대웅제약나보타영향력확대나서,http://www.monews.co.kr/news/articleView.html?idxno=114735
1608,2018-05-16,대웅제약미용안티에이징학회서나보타홍보,http://www.whosaeng.com/sub_read.html?uid=101405§ion=sc5
1609,2018-05-16,대웅제약대만서나보타알리기총력전,http://www.kormedi.com/news/news/drug_dist/1227301_2906.html
1610,2018-05-16,대웅제약17일기업설명회IR개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1623672
1611,2018-05-16,헬스단신유한양행일동제약대웅제약,http://www.sportsseoul.com/news/read/635525
1612,2018-05-16,대웅제약등9개제약사ISO370016월이내인증추진,http://www.kukinews.com/news/article.html?no=549483
1613,2018-05-16,대웅제약보톡스나보타공장美FDA승인,http://www.edaily.co.kr/news/newspath.asp?newsid=05375926619209576
1614,2018-05-16,대웅제약나보타제조처미FDAcGMP승인획득,http://www.asiatoday.co.kr/view.php?key=20180516010008509
1615,2018-05-16,대웅제약나보타생산공장美FDAcGMP승인,http://news.hankyung.com/article/201805161353f
1616,2018-05-16,대웅제약나보타제조처美FDAcGMP승인획득,http://www.kpanews.co.kr/article/show.asp?idx=193897&table=article&category=D
1617,2018-05-16,대웅제약나보타제조처美FDAcGMP승인획득,http://www.bosa.co.kr/news/articleView.html?idxno=2083405
1618,2018-05-16,대웅제약나보타제조처美FDAcGMP승인획득,http://www.sportsseoul.com/news/read/635619
1619,2018-05-16,대웅제약나보타미FDAcGMP승인획득,http://www.mediapen.com/news/view/355208
1620,2018-05-16,대웅제약나보타제조시설美FDAcGMP승인획득”,http://www.newsway.co.kr/view.php?tp=1&ud=2018051617281112046
1621,2018-05-16,대웅제약보톡스나보타공장미국cGMP승인,http://www.dailypharm.com/News/239899
1622,2018-05-16,대웅제약나보타美허가지연FDA자료보완요구,http://www.biospectator.com/view/news_view.php?varAtcId=5490
1623,2018-05-16,대웅제약미FDA로부터나보타공장cGMP승인획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805160673&t=NN
1624,2018-05-16,대웅제약나보타제조처실사통과로FDA허가승인제품허가는보류,http://www.dt.co.kr/contents.html?article_no=2018051602109976029009&ref=naver
1625,2018-05-16,대웅제약나보타제조처美FDAcGMP승인획득,http://www.newsis.com/view/?id=NISX20180516_0000310650&cID=13001&pID=13000
1626,2018-05-16,대웅제약나보타제조처미FDAcGMP승인획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051617330410962
1627,2018-05-16,대웅제약나보타제조시설美FDAcGMP승인획득,http://www.mhj21.com/sub_read.html?uid=113871§ion=sc243
1628,2018-05-16,대웅제약나보타제조처美FDAcGMP승인획득,http://www.techholic.co.kr/news/articleView.html?idxno=176056
1629,2018-05-16,대웅제약나보타제조처美FDAcGMP승인획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1190616
1630,2018-05-16,대웅제약나보타제조시설美FDA승인획득,http://www.newsprime.co.kr/news/article.html?no=416814
1631,2018-05-16,대웅제약나보타제조시설美FDA승인획득,http://www.newsprime.co.kr/news/article.html?no=416814
1632,2018-05-16,대웅제약보톡스제제제조시설FDA인증제품허가는보류,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180516168500017&did=1195m
1633,2018-05-16,대웅나보타제조처미국cGMP승인획득,http://medipana.com/news/news_viewer.asp?NewsNum=220119&MainKind=A&NewsKind=5&vCount=12&vKind=1
1634,2018-05-16,대웅제약세계최대美보톡스시장집입장벽9부능선도달,http://news.mk.co.kr/newsRead.php?year=2018&no=312073
1635,2018-05-16,대웅제약나보타제조시설미국FDAcGMP승인획득,http://www.k-health.com/news/articleView.html?idxno=36103
1636,2018-05-16,대웅제약보툴리눔톡신나보타생산시설美FDA인증,http://biz.chosun.com/site/data/html_dir/2018/05/16/2018051602570.html
1637,2018-05-16,대웅나보타제조시설미FDA승인,http://www.medical-tribune.co.kr/news/articleView.html?idxno=79200
1638,2018-05-16,대웅제약나보타생산시설美인증품목허가만남아,http://news1.kr/articles/?3319399
1639,2018-05-16,대웅제약나보타제조시설FDA인증제품허가는보류,http://daily.hankooki.com/lpage/life/201805/dh20180516190431138950.htm
1640,2018-05-16,대웅제약나보타제조처美FDAcGMP승인획득,http://www.lawissue.co.kr/view.php?ud=201805161901465443d7f4c63cc6_12
1641,2018-05-16,대웅제약나보타제조처미국FDAcGMP승인획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218238
1642,2018-05-16,대웅제약나보타공장美FDA인증제품허가는보류,http://view.asiae.co.kr/news/view.htm?idxno=2018051619214711495
1643,2018-05-16,대웅제약나보타제조시설美FDA승인획득,http://www.viva100.com/main/view.php?key=20180516010005775
1644,2018-05-17,대웅제약美진출1차관문통과보툴리늄톡신나보타제조시설FDA승인받아,http://news.hankyung.com/article/2018051619421
1645,2018-05-17,대웅미국진출호재나보타제조처cGMP승인,http://www.dailymedi.com/detail.php?number=830632&thread=22r05
1646,2018-05-17,이베스트대웅제약목표가하향FDA나보타승인지연,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805170035&t=NN
1647,2018-05-17,퀵리포트대웅제약매수유지목표가21만5000원유지한화證,http://www.itooza.com/common/iview.php?no=2018051707540713968
1648,2018-05-17,대웅제약나보타제조시설FDA승인미국진출가시화한화,http://news.mt.co.kr/mtview.php?no=2018051707570870712
1649,2018-05-17,제약톡톡대웅나보타미국진출위한본궤도오르다,http://news.heraldcorp.com/view.php?ud=20180517000040
1650,2018-05-17,대웅제약나보타생산설비cGMP인증기대효과는,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018051708145700330&LinkID=632&objId=A2018051708145700330&portalCode=naver
1651,2018-05-17,퀵리포트대웅제약매수유지목표가25만원유지KTB證,http://www.itooza.com/common/iview.php?no=2018051708153812824
1652,2018-05-17,퀵리포트대웅제약매수유지목표가11↓23만원이베스트證,http://www.itooza.com/common/iview.php?no=2018051708143917465
1653,2018-05-17,대웅제약cGMP승인나보타품목허가가시성높아져”KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01603926619209904
1654,2018-05-17,대웅제약나보타美FDAcGMP승인품목허가가시성↑KTB,http://www.mdtoday.co.kr/mdtoday/index.html?no=321257
1655,2018-05-17,한화투자증권대웅제약나보타제조시설FDA승인모멘텀확보”,http://www.newsway.co.kr/view.php?tp=1&ud=2018051708273245550
1656,2018-05-17,대웅제약나보타제조시설美FDAcGMP승인획득,http://www.g-enews.com/ko-kr/news/article/news_all/201805170825222897e6a49afa8d_1/article.html
1657,2018-05-17,한화투자대웅제약나보타미국진출가시화,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180517032000008&did=1195m
1658,2018-05-17,대웅제약미파트너에볼루스나보타FDA승인불발,http://www.mdtoday.co.kr/mdtoday/index.html?no=321261
1659,2018-05-17,대웅제약나보타제조처미국FDAcGMP승인획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=321236
1660,2018-05-17,대웅제약나보타승인은내년봄으로추정DB금융투자,http://www.fnnews.com/news/201805170832545461
1661,2018-05-17,대웅제약나보타승인은내년봄으로지연추정DB,http://news.mt.co.kr/mtview.php?no=2018051708325104416
1662,2018-05-17,대웅제약나보타제조시설美FDA서cGMP승인,http://www.medisobizanews.com/news/articleView.html?idxno=53231
1663,2018-05-17,HotLine대웅제약cGMP승인으로나보타품목허가가시화,http://news.mk.co.kr/newsRead.php?year=2018&no=312895
1664,2018-05-17,대웅제약하반기나보타美허가가시성높아져매수기회,http://www.newspim.com/news/view/20180517000049
1665,2018-05-17,대웅제약cGMP승인으로나보타품목허가가시화KTB,http://www.cstimes.com/?mod=news&act=articleView&idxno=275945
1666,2018-05-17,대웅제약목표주가낮아져미국에서보톡스나보타출시늦춰져,http://www.businesspost.co.kr/BP?command=article_view&num=82687
1667,2018-05-17,대웅제약나보타제조시설美FDA승인획득,http://www.newspim.com/news/view/20180516000373
1668,2018-05-17,이베스트대웅제약나보타FDA승인지연목표가↓,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180517037800008&did=1195m
1669,2018-05-17,대웅제약보툴리눔톡신나보타제조처美FDAcGMP승인,http://www.viva100.com/main/view.php?key=20180516010005767
1670,2018-05-17,ET투자뉴스대웅제약나보타FDAc매수유지한화투자증권,http://www.etnews.com/20180517000007
1671,2018-05-17,대웅제약나보타내년미국진출가시화유럽시장허가도가시화전망한화투자증권,http://www.sedaily.com/NewsView/1RZKFIDVYU
1672,2018-05-17,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018051708584211830
1673,2018-05-17,대웅제약나보타하반기美허가가시화주가조정시매수기회NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1623933
1674,2018-05-17,대웅제약전일대비약3하락한194000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805170080&t=NN
1675,2018-05-17,특징주대웅제약나보타美판매지연전망에하락,http://news.mt.co.kr/mtview.php?no=2018051708595711300
1676,2018-05-17,특징주나보타FDA승인지연에대웅제약약세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180517041400008&did=1195m
1677,2018-05-17,특징주대웅제약나보타FDA승인지연주가흔들,http://www.newsprime.co.kr/news/article.html?no=416843
1678,2018-05-17,특징주대웅제약나보타美판매시점지연에급락,http://view.asiae.co.kr/news/view.htm?idxno=2018051709145592552
1679,2018-05-17,ET투자뉴스대웅제약Form483공매수유지NH투자증권,http://www.etnews.com/20180517000019
1680,2018-05-17,특징주대웅제약나보타美판매지연에하락세,http://www.seoulfn.com/news/articleView.html?idxno=306559
1681,2018-05-17,대웅제약나보타승인지연에장초반하락세,http://www.sedaily.com/NewsView/1RZKG0VTM8
1682,2018-05-17,특징주대웅제약나보타FDA승인지연에약세,http://www.ekn.kr/news/article.html?no=362486
1683,2018-05-17,대웅제약나보타美판매승인지연에장초반약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=321284
1684,2018-05-17,특징주대웅제약나보타FDA승인지연전망에약세,http://www.newsis.com/view/?id=NISX20180517_0000311058&cID=10401&pID=10400
1685,2018-05-17,특징주대웅제약나보타FDA승인지연소식에하락,http://www.newstomato.com/ReadNews.aspx?no=824680
1686,2018-05-17,특징주대웅제약나보타美FDA승인지연에약세,http://www.edaily.co.kr/news/newspath.asp?newsid=02046726619209904
1687,2018-05-17,특징주대웅제약나보타FDA승인지연에급락,http://www.ebn.co.kr/news/view/941816
1688,2018-05-17,특징주대웅제약나보타미국판매지연소식에하락세,http://www.g-enews.com/ko-kr/news/article/news_all/201805170924363213c16aa2f016_1/article.html
1689,2018-05-17,특징주대웅제약나보타승인내년봄으로연기6↓,http://www.edaily.co.kr/news/newspath.asp?newsid=02079526619209904
1690,2018-05-17,ET투자뉴스대웅제약나보타승인은19HOLD유지DB금융투자,http://www.etnews.com/20180517000033
1691,2018-05-17,대웅제약나보타미국FDA허가미뤄져자료보완요구,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003206345
1692,2018-05-17,대웅제약분기사상최대영업이익달성토러스,http://daily.hankooki.com/lpage/economy/201805/dh20180517095354138110.htm
1693,2018-05-17,특징주대웅제약나보타FDA승인지연소식에약세,http://moneys.mt.co.kr/news/mwView.php?no=2018051710028026899
1694,2018-05-17,대웅제약나보타미국진출호재악재겹쳤다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018051709014182238
1695,2018-05-17,대웅제약디엔컴퍼니이지듀대학생서포터즈뷰티메신저1기해단식개최,http://news.hankyung.com/article/201805173837a
1696,2018-05-17,ET투자뉴스대웅제약cGMP승인으로매수KTB투자증권,http://www.etnews.com/20180517000083
1697,2018-05-17,ET투자뉴스대웅제약나보타CRLClHOLDDOWNGRADE이베스트투자,http://www.etnews.com/20180517000099
1698,2018-05-17,대웅제약CRL통지사유는마이너이슈로판단,http://www.newsworks.co.kr/news/articleView.html?idxno=187425
1699,2018-05-17,셀트리온이어대웅제약도미국진출일시정지,http://www.finomy.com/news/articleView.html?idxno=54590
1700,2018-05-17,대웅나보타미국진출가능성높아질까,http://www.monews.co.kr/news/articleView.html?idxno=114816
1701,2018-05-17,대웅제약나보타美허가지연자료미비때문내년상반기출시예상,http://news.hankyung.com/article/201805174469f
1702,2018-05-17,대웅제약나보타미국진출연기FDA미국내판매보류,http://www.sisaweek.com/news/articleView.html?idxno=108175
1703,2018-05-17,대웅제약나보타미국진출지연,http://www.newstomato.com/ReadNews.aspx?no=824722
1704,2018-05-17,대웅전일대비약3하락한19450원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805170443&t=NN
1705,2018-05-17,대웅제약CRL이나보타승인에미치는영향,http://www.newsworks.co.kr/news/articleView.html?idxno=187521
1706,2018-05-17,대웅제약나보타美판매승인지연주가먹구름,http://news.mt.co.kr/mtview.php?no=2018051714023635690
1707,2018-05-17,대웅제약나보타제조시설에대한미국FDA의cGMP인증은획득,http://www.newsworks.co.kr/news/articleView.html?idxno=187547
1708,2018-05-17,대웅제약나보타제조시설에대한승인획득,http://www.newsworks.co.kr/news/articleView.html?idxno=187551
1709,2018-05-17,대웅제약나보타美판매승인지연에주가급락721％,http://www.mdtoday.co.kr/mdtoday/index.html?no=321341
1710,2018-05-17,대웅제약CRL수령으로나보타FDA승인지연,http://www.newsworks.co.kr/news/articleView.html?idxno=187589
1711,2018-05-17,1분기RD투자상위5대제약사한미약품대웅제약순,http://biz.newdaily.co.kr/news/article.html?no=10161123
1712,2018-05-17,대웅제약나보타제조처美FDAcGMP승인획득,http://www.getnews.co.kr/news/articleView.html?idxno=69976
1713,2018-05-18,빅데이터MSI시장심리톱5SK카카오대웅제약삼성SDI한국항공우주,http://www.newsis.com/view/?id=NISX20180518_0000312208&cID=10401&pID=10400
1714,2018-05-18,더벨대웅제약나보타FDA허가무슨단계,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201805170100029850001841
1715,2018-05-18,대웅제약미래성장동력적극홍보,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218303
1716,2018-05-18,대웅제약의미래성장동력은,http://www.monews.co.kr/news/articleView.html?idxno=114859
1717,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스서미래성장동력소개,http://www.k-health.com/news/articleView.html?idxno=36119
1718,2018-05-18,대웅제약인베스터즈콘퍼런스참가,http://www.dt.co.kr/contents.html?article_no=2018051802109976029005&ref=naver
1719,2018-05-18,대웅전승호사장나보타등성장동력소개주목,http://medipana.com/news/news_viewer.asp?NewsNum=220229&MainKind=A&NewsKind=5&vCount=12&vKind=1
1720,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스개최미래성장동력소개,http://www.getnews.co.kr/news/articleView.html?idxno=70130
1721,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스서회사미래성장동력설명,http://www.enewstoday.co.kr/news/articleView.html?idxno=1191264
1722,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스참여미래성장동력알려,http://www.mdtoday.co.kr/mdtoday/index.html?no=321423
1723,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스서미래성장동력홍보,http://www.sisajournal-e.com/biz/article/184109
1724,2018-05-18,대웅제약신성장동력공개글로벌헬스케어그룹으로거듭날것,http://www.newsprime.co.kr/news/article.html?no=417000
1725,2018-05-18,대웅제약삼성콘퍼런스서신약파이프라인소개,http://www.kpinews.co.kr/news/articleView.html?idxno=74061
1726,2018-05-18,대웅제약신약파이프라인등신성장동력알려,http://medipana.com/news/news_viewer.asp?NewsNum=220243&MainKind=A&NewsKind=5&vCount=12&vKind=1
1727,2018-05-18,대웅제약신약파이프라인등미래성장동력소개,http://www.newsis.com/view/?id=NISX20180518_0000312492&cID=13001&pID=13000
1728,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스참여,http://www.bosa.co.kr/news/articleView.html?idxno=2083534
1729,2018-05-18,대웅제약삼성IR컨퍼런스서회사소개특별세션진행,http://news.mk.co.kr/newsRead.php?year=2018&no=316733
1730,2018-05-18,대웅제약한국을넘어선글로벌헬스케어그룹으로거듭날것,http://www.medisobizanews.com/news/articleView.html?idxno=53264
1731,2018-05-18,대웅제약신성장동력신약파이프라인공개,http://www.kormedi.com/news/news/drug_dist/1227340_2906.html
1732,2018-05-18,대웅제약기관투자자500여명대상홍보전나서,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1056043
1733,2018-05-18,대웅제약삼성글로벌인베스터즈콘퍼런스제약대표로참여,http://www.etnews.com/20180518000196
1734,2018-05-18,대웅제약글로벌투자자대상컨퍼런스서회사나보타적극소개,http://www.ekn.kr/news/article.html?no=362866
1735,2018-05-18,전승호대웅제약사장글로벌헬스케어그룹비전강조,http://www.newsway.co.kr/view.php?tp=1&ud=2018051816230139096
1736,2018-05-18,ET투자뉴스대웅18년1분기실적발표당기순이익1647억원전년동기대비24,http://www.etnews.com/20180518000267
1737,2018-05-18,대웅제약1Q매출2394억전년비영업익9↓순익57↑,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218344
1738,2018-05-18,대웅제약삼성IR컨퍼런스서미래성장동력공개,http://www.dailian.co.kr/news/view/714256/?sc=naver
1739,2018-05-18,대웅제약매출액1314신약RD비용으로투자,http://www.rapportian.com/news/articleView.html?idxno=110619
1740,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스참석,http://www.whosaeng.com/sub_read.html?uid=101503§ion=sc5
1741,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스서미래성장동력알려,http://www.newscj.com/news/articleView.html?idxno=522053
1742,2018-05-18,대웅제약삼성글로벌인베스터즈컨퍼런스서미래성장동력알려,http://www.lawissue.co.kr/view.php?ud=201805182136262404d7f4c63cc6_12
1743,2018-05-21,대웅제약vs메디톡스끝나지않는보톡스전쟁,http://moneys.mt.co.kr/news/mwView.php?no=2018051717288084851
1744,2018-05-21,대웅삼성글로벌인베스터즈컨퍼런스서미래성장동력알려,http://www.kpanews.co.kr/article/show.asp?idx=193984&table=article&category=D
1745,2018-05-21,대웅제약안약레보플록사신부작용보고폐손상장애세계첫발생,http://www.getnews.co.kr/news/articleView.html?idxno=70355
1746,2018-05-21,한경로보뉴스대웅제약5이상상승전일기관대량순매수,http://news.hankyung.com/article/201805215530L
1747,2018-05-21,한경로보뉴스대웅5이상상승최근3일간외국인대량순매수,http://news.hankyung.com/article/201805215758L
1748,2018-05-21,대웅제약전일대비약9상승한210000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805210160&t=NN
1749,2018-05-21,대웅전일대비약6상승한20850원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805210166&t=NN
1750,2018-05-21,유대웅제약전일대비909상승일일회전율은086기록,http://www.sedaily.com/NewsView/1RZM9EW4K7
1751,2018-05-21,ET투자뉴스대웅_주가와투자심리는보통거래량은약세,http://www.etnews.com/20180521000053
1752,2018-05-21,대웅제약글로벌투자자대상컨퍼런스첫참여신성장동력홍보,http://www.sisaweek.com/news/articleView.html?idxno=108329
1753,2018-05-23,빅5제약1분기RD비한미GC녹십자대웅증가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218381
1754,2018-05-23,상주시이안면대웅스님이웃돕기성금100만원기탁,http://www.asiatoday.co.kr/view.php?key=20180523010010819
1755,2018-05-23,제주아라동사찰대웅전서화재,http://www.jejusori.net/?mod=news&act=articleView&idxno=205184
1756,2018-05-23,올1분기RD투자한미대웅녹십자종근당유한,http://www.dailymedi.com/detail.php?number=830795&thread=22r05
1757,2018-05-23,창간특집제약윤리경영사례대웅제약,http://www.bosa.co.kr/news/articleView.html?idxno=2083744
1758,2018-05-23,상주이안면가장리대웅스님，이웃돕기성금전달,http://www.kbsm.net/default/index_view_page.php?idx=207417&part_idx=238
1759,2018-05-24,상주이안면가장리대웅스님이웃돕기성금전달,http://www.hidomin.com/news/articleView.html?idxno=358850
1760,2018-05-24,대웅스님상주이안면에성금전달,http://www.kyongbuk.co.kr/?mod=news&act=articleView&idxno=1027197
1761,2018-05-24,상주이안면대웅스님면사무소에성금기탁,http://www.ksmnews.co.kr/default/index_view_page.php?idx=208717&part_idx=289
1762,2018-05-24,동아ST도대열합류대웅SGLT2억제제도전,http://www.dailymedi.com/detail.php?number=830816&thread=22r05
1763,2018-05-24,대웅제약나보타공장캐나다GMP인증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201805240108&t=NN
1764,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=321854
1765,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218468
1766,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://medipana.com/news/news_viewer.asp?NewsNum=220437&MainKind=A&NewsKind=5&vCount=12&vKind=1
1767,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.kpanews.co.kr/article/show.asp?idx=194065&table=article&category=D
1768,2018-05-24,대웅제약나보타공장캐나다GMP인증받아,http://news.mk.co.kr/newsRead.php?year=2018&no=328156
1769,2018-05-24,대웅제약나보타공장캐나다GMP획득,http://view.asiae.co.kr/news/view.htm?idxno=2018052409414407580
1770,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.dt.co.kr/contents.html?article_no=2018052402109976029003&ref=naver
1771,2018-05-24,대웅제약보톡스나보타공장캐나다정부인증,http://www.edaily.co.kr/news/newspath.asp?newsid=02200886619212200
1772,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018052409560287608
1773,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.newsway.co.kr/view.php?tp=1&ud=2018052410015772875
1774,2018-05-24,대웅제약보툴리눔톡신나보타공장캐나다GMP인증,http://news1.kr/articles/?3325374
1775,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.bosa.co.kr/news/articleView.html?idxno=2083795
1776,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://news.heraldcorp.com/view.php?ud=20180524000300
1777,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.newsis.com/view/?id=NISX20180524_0000316874&cID=13001&pID=13000
1778,2018-05-24,대웅나보타공장캐나다GMP승인획득,http://www.monews.co.kr/news/articleView.html?idxno=115047
1779,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.medicaltimes.com/News/1118806
1780,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.dailian.co.kr/news/view/715131/?sc=naver
1781,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.medisobizanews.com/news/articleView.html?idxno=53340
1782,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://news.hankyung.com/article/201805246675f
1783,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.medigatenews.com/news/1772204044
1784,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1192905
1785,2018-05-24,대웅제약나보타美이어캐나다GMP승인,http://www.kormedi.com/news/news/drug_dist/1227403_2906.html
1786,2018-05-24,대웅제약보톡스생산나보타공장캐나다GMP승인획득,http://www.newspim.com/news/view/20180524000129
1787,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.dailymedi.com/detail.php?number=830844&thread=22r05
1788,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.getnews.co.kr/news/articleView.html?idxno=71254
1789,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.metroseoul.co.kr/news/newsview?newscd=2018052400058
1790,2018-05-24,대웅제약나보타공장미국이어캐나다GMP인증,http://www.dailypharm.com/News/240121
1791,2018-05-24,대웅제약보툴리눔톡신제조시설캐나다서인증,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180524085400017&did=1195m
1792,2018-05-24,대웅제약보톡스캐나다수출길열리나,http://www.sedaily.com/NewsView/1RZNNRCABV
1793,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.newsprime.co.kr/news/article.html?no=417475
1794,2018-05-24,대웅제약나보타공장겹경사에화색,http://www.whosaeng.com/sub_read.html?uid=101582§ion=sc5
1795,2018-05-24,해외교두보마련대웅녹십자내년부터성장가속,http://www.medicaltimes.com/News/1118810
1796,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.lawissue.co.kr/view.php?ud=20180524125548780d7f4c63cc6_12
1797,2018-05-24,6월초개막보스톤바이오USA삼성바이오로직스대웅제약등전세계바이오기업들총집결,http://www.news2day.co.kr/104459
1798,2018-05-24,대웅제약나보타공장캐나다연방보건부GMP승인획득,http://www.k-health.com/news/articleView.html?idxno=36194
1799,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://news.mt.co.kr/mtview.php?no=2018052413100183621
1800,2018-05-24,대웅제약나보타공장미국이어캐나다GMP승인획득,http://www.mediapen.com/news/view/356932
1801,2018-05-24,대웅제약나보타공장캐나다승인,http://www.newstomato.com/ReadNews.aspx?no=825872
1802,2018-05-24,아파야챙길래대웅제약유한양행한미약품,http://www.g-enews.com/ko-kr/news/article/news_all/201805241353278580e6a49afa8d_1/article.html
1803,2018-05-24,대웅제약보툴리눔톡신제조시설캐나다서인증,http://www.asiatoday.co.kr/view.php?key=20180524010012009
1804,2018-05-24,과천시26일보광사대웅전서산사음악회무료개최,http://www.kyeongin.com/main/view.php?key=20180524010009162
1805,2018-05-24,대웅제약나보타생산공장캐나다GMP승인,http://www.biospectator.com/view/news_view.php?varAtcId=5527
1806,2018-05-24,대웅제약나보타공장캐나다GMP획득,http://www.etnews.com/20180524000297
1807,2018-05-24,대웅제약나보타공장캐나다GMP승인획득,http://www.techholic.co.kr/news/articleView.html?idxno=176166
1808,2018-05-24,과천시오는26일보광사대웅전서산사음악회개최,http://www.kyeonggi.com/?mod=news&act=articleView&idxno=1478982
1809,2018-05-24,대웅제약나보타생산공장캐나다GMP적합판정획득,http://www.rapportian.com/news/articleView.html?idxno=110709
1810,2018-05-24,상주이안면대웅스님이웃돕기성금전달,http://www.idaegu.co.kr/news.php?code=pe03&mode=view&num=250208
1811,2018-05-24,대웅제약보툴리눔톡신제조시설캐나다서인증,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3540634
1812,2018-05-25,대웅제약보툴리눔톡신캐나다수출파란불,http://www.seoulfn.com/news/articleView.html?idxno=307199
1813,2018-05-25,과천시26일보광사대웅전서산사음악회,http://www.ekn.kr/news/article.html?no=363909
1814,2018-05-25,대웅제약보툴리눔톡신나보타공장캐나다GMP승인,http://www.viva100.com/main/view.php?key=20180524010008509
1815,2018-05-25,CJ대웅제일일동격돌이종질환복합제후끈,http://www.dailymedi.com/detail.php?number=830895&thread=22r05
1816,2018-05-25,유가증권시장공시페이퍼코리아텔코웨어대웅제약등,http://news.mk.co.kr/newsRead.php?year=2018&no=332483
1817,2018-05-25,대웅제약나보타공장캐나다GMP승인획득,http://www.kukinews.com/news/article.html?no=551948
1818,2018-05-26,다케다대웅서방형전립선암치료제장외특허분쟁,http://www.dailypharm.com/News/240174
1819,2018-05-29,대웅제약나에게맞는비타민임팩타민으로골라드세요,http://www.getnews.co.kr/news/articleView.html?idxno=72275
1820,2018-05-29,한올바이오대웅제약안구건조증신약미국임상2상발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218616
1821,2018-05-29,한올바이오파마대웅제약안구건조증신약유효성입증,http://www.newsis.com/view/?id=NISX20180529_0000321527&cID=13001&pID=13000
1822,2018-05-29,한올바이오파마대웅제약안구건조증신약미국임상2상결과발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=322347
1823,2018-05-29,한올바이오파마대웅제약안구건조증신약임상2상서효과확인,http://news1.kr/articles/?3330202
1824,2018-05-29,대웅한올안구건조증바이오신약각막손상억제,http://www.medisobizanews.com/news/articleView.html?idxno=53434
1825,2018-05-29,대웅안구건조증바이오신약각막손상억제등효과,http://www.dailymedi.com/detail.php?number=831020&thread=22r05
1826,2018-05-29,대웅제약나보타美FDA제조처cGMP및HealthCanadaGMP승인,http://www.lawissue.co.kr/view.php?ud=201805292053272269d7f4c63cc6_12
1827,2018-05-30,동국대웅동화등제약사화장품해봤더니짭짤하네,http://www.edaily.co.kr/news/newspath.asp?newsid=01174246619214168
1828,2018-05-30,대웅루프린게섯거라오리지널넘보는루피어,http://www.mdtoday.co.kr/mdtoday/index.html?no=322406
1829,2018-05-30,대웅제약美FDA제조처cGMP및HealthCanadaGMP승인,http://www.viva100.com/main/view.php?key=20180530010010276
1830,2018-05-30,대웅제약나보타미국진출초읽기,http://www.kpinews.co.kr/news/articleView.html?idxno=74923
1831,2018-05-30,대웅제약나보타공장캐나다GMP승인획득,http://www.newstomato.com/ReadNews.aspx?no=827132
1832,2018-05-30,대웅제약나보타생산공장글로벌승인,http://www.dt.co.kr/contents.html?article_no=2018053102101031102001&ref=naver
1833,2018-05-31,대웅제약나보타선진국진출채비끝냈다,http://www.whosaeng.com/sub_read.html?uid=101734§ion=sc5
1834,2018-05-31,윤재춘전승호체제대웅제약수익성줄고부채비율늘고,http://www.datanews.co.kr/news/article.html?no=100711
1835,2018-05-31,대웅제약나보타잇달아GMP인증북미시장진출잰걸음,http://news1.kr/articles/?3332762
1836,2018-06-01,대웅제약대표품목잇딴성상변경약국주의하세요,http://www.kpanews.co.kr/article/show.asp?idx=194312&table=article&category=B
1837,2018-06-04,대웅제약자회사한올바이오파마안구건조증美임상성공적NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01476006619238440
1838,2018-06-04,대웅메퀴타진성분복합비염치료제코메키나출시,http://www.dailypharm.com/News/240456
1839,2018-06-04,아파야챙길래동아제약대웅제약한국화이자제약外,http://www.g-enews.com/ko-kr/news/article/news_all/201806040929184266e6a49afa8d_1/article.html
1840,2018-06-04,대웅제약목표가27만원유지전일종가20만7500원NH證,http://www.newspim.com/news/view/20180604000133
1841,2018-06-04,대웅제약졸음부작용개선한먹는비염약출시,http://biz.chosun.com/site/data/html_dir/2018/06/04/2018060401006.html
1842,2018-06-04,대웅제약졸음줄인알레르기비염약코메키나출시,http://www.edaily.co.kr/news/newspath.asp?newsid=02125446619238440
1843,2018-06-04,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018060409423869512
1844,2018-06-04,대웅제약졸음최소화한비염치료제코메키나출시,http://www.mhj21.com/sub_read.html?uid=114255§ion=sc243
1845,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://news.hankyung.com/article/201806046034f
1846,2018-06-04,대웅제약일반약비염치료제코메키나출시,http://www.rapportian.com/news/articleView.html?idxno=110871
1847,2018-06-04,대웅제약졸음부작용줄인비염치료제코메키나출시,http://news1.kr/articles/?3335304
1848,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.asiatoday.co.kr/view.php?key=20180604010001125
1849,2018-06-04,대웅제약OTC최초메퀴타진복합비염약발매,http://medipana.com/news/news_viewer.asp?NewsNum=220896&MainKind=A&NewsKind=5&vCount=12&vKind=1
1850,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=218803
1851,2018-06-04,대웅제약비염복합치료제코메키나출시,http://www.medisobizanews.com/news/articleView.html?idxno=53521
1852,2018-06-04,대웅제약졸음덜한비염치료제코메키나일반약으로출시,http://news.mk.co.kr/newsRead.php?year=2018&no=353187
1853,2018-06-04,대웅제약비염치료제코메키나출시,http://www.whosaeng.com/sub_read.html?uid=101825§ion=sc5
1854,2018-06-04,대웅제약나보타북미시장진출임박美FDA캐나다로부터제조시설GMP인증,http://www.etoday.co.kr/news/section/newsview.php?idxno=1628961
1855,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.metroseoul.co.kr/news/newsview?newscd=2018060400012
1856,2018-06-04,대웅제약복합비염치료제코메키나출시국내최고브랜드로키울것,http://www.enewstoday.co.kr/news/articleView.html?idxno=1196832
1857,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.viva100.com/main/view.php?key=20180604010000856
1858,2018-06-04,대웅제약최초메퀴타진복합비염치료제출시,http://www.bosa.co.kr/news/articleView.html?idxno=2084415
1859,2018-06-04,대웅제약복합비염치료제코메키나출시,http://www.newsway.co.kr/view.php?tp=1&ud=2018060411274835349
1860,2018-06-04,대웅제약비염약코메키나출시,http://www.kpinews.co.kr/news/articleView.html?idxno=75253
1861,2018-06-04,대웅복합비염치료제코메키나,http://www.medical-tribune.co.kr/news/articleView.html?idxno=79584
1862,2018-06-04,ET투자뉴스대웅제약안구건조증치료제매수유지NH투자증권,http://www.etnews.com/20180604000139
1863,2018-06-04,대웅제약메퀴타진성분복합비염치료제코메키나출시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018060413332380344
1864,2018-06-04,인터뷰정현호메디톡스대표대웅제약과소송에서이길것자신 ,http://www.insightkorea.co.kr//news/articleView.html?idxno=25526
1865,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.getnews.co.kr/news/articleView.html?idxno=73835
1866,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://news.mt.co.kr/mtview.php?no=2018060414325973699
1867,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.dailian.co.kr/news/view/717584/?sc=naver
1868,2018-06-04,대웅제약메퀴타진성분복합비염치료제코메키나출시,http://www.techholic.co.kr/news/articleView.html?idxno=176340
1869,2018-06-04,오늘Who윤재승한울바이오파마인수대웅제약에게신의한수,http://www.businesspost.co.kr/BP?command=article_view&num=84571
1870,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.lawissue.co.kr/view.php?ud=201806041733391382d7f4c63cc6_12
1871,2018-06-04,대웅제약복합비염치료제코메키나출시,http://www.k-health.com/news/articleView.html?idxno=36366
1872,2018-06-04,대웅제약메퀴타진복합비염치료제코메키나출시,http://www.newscj.com/news/articleView.html?idxno=526943
1873,2018-06-05,대웅제약경구용비염치료제코메키나출시,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1056583
1874,2018-06-05,대웅제약메퀴타진복합비염치료제코메키나선봬,http://www.kpanews.co.kr/article/show.asp?idx=194388&table=article&category=D
1875,2018-06-05,건강한픽템대웅제약환절기알레르기졸음없이안녕코메키나,http://www.etoday.co.kr/news/section/newsview.php?idxno=1629287
1876,2018-06-05,대웅전일대비약3하락한19200원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806050418&t=NN
1877,2018-06-08,대웅우루사연질캡슐50mg100캅셀제품단종,http://www.kpanews.co.kr/article/show.asp?idx=194434&table=article&category=D
1878,2018-06-08,대웅제약목표가25만원유지전일종가20만4500원골든브릿지證,http://www.newspim.com/news/view/20180608000039
1879,2018-06-08,퀵리포트대웅제약매수유지목표가25만원유지골든브릿지證,http://www.itooza.com/common/iview.php?no=2018060807305450155
1880,2018-06-08,대웅제약공장준공비용증가로수익성정체,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018060808450100447&LinkID=632&objId=A2018060808450100447&portalCode=naver
1881,2018-06-08,ET투자뉴스대웅제약나보타의글로벌상매수유지골든브릿지투자증권,http://www.etnews.com/20180608000051
1882,2018-06-08,대웅제약지금은나보타글로벌사업가치반영시기,http://www.newsworks.co.kr/news/articleView.html?idxno=192185
1883,2018-06-11,종근당대웅제약유한양행등품목도입에열올리는국내사,http://www.medigatenews.com/news/1378978057
1884,2018-06-11,주간PER변동대웅164배제약바이오하락률1위,http://www.itooza.com/common/iview.php?no=2018060818190534852
1885,2018-06-11,대웅제약6월13일수까지2018상반기전문연구요원모집,http://www.ekn.kr/news/article.html?no=367243
1886,2018-06-11,오늘의JOB속보롯데칠성코오롱생명대웅제약대명外,http://www.news2day.co.kr/105367
1887,2018-06-12,stock피플굴곡많았던윤재승대웅제약회장한올바이오파마날개달고재도약,http://www.newsway.co.kr/news/view?tp=1&ud=2018061117093238527
1888,2018-06-12,등돌린대웅제약2세윤재승윤재훈형제내부거래도뚝,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=526026
1889,2018-06-14,퀵리포트대웅매수유지목표가2만9000원유지골든브릿지證,http://www.itooza.com/common/iview.php?no=2018061408513618393
1890,2018-06-14,대웅목표가2만9000원유지전일종가1만8950원골든브릿지證,http://www.newspim.com/news/view/20180614000101
1891,2018-06-18,대웅제약신약개발에힘싣는다‥연구조직개편,http://medipana.com/news/news_viewer.asp?NewsNum=221416&MainKind=A&NewsKind=5&vCount=12&vKind=1
1892,2018-06-18,대웅제약연구조직개편팀체제로전문성강화,http://www.dailian.co.kr/news/view/720110/?sc=naver
1893,2018-06-18,대웅제약연구조직개편단행센터장체제돌입,http://www.dailypharm.com/News/240844
1894,2018-06-18,대웅제약신약개발중심연구조직개편,http://www.sportsseoul.com/news/read/648078
1895,2018-06-18,신약개발익스트림팀꾸린대웅제약,http://www.sedaily.com/NewsView/1S0UTSW0UO
1896,2018-06-18,대웅제약연구조직개편신약개발집중,http://www.asiatoday.co.kr/view.php?key=20180618010008325
1897,2018-06-18,대웅제약연구조직개편신약개발에힘싣는다,http://www.mediapen.com/news/view/362592
1898,2018-06-18,대웅제약연구조직개편신약개발가속화,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018061809170443453
1899,2018-06-18,대웅제약연구조직개편신약개발에힘싣는다,http://www.newsway.co.kr/view.php?tp=1&ud=2018061809234957672
1900,2018-06-18,아파야챙길래종근당대웅제약유한양행外,http://www.g-enews.com/ko-kr/news/article/news_all/201806180939064412e6a49afa8d_1/article.html
1901,2018-06-18,더이상일감못줘대웅제약형제갈등고조,http://news.mk.co.kr/v2/economy/view.php?year=2018&no=382484
1902,2018-06-18,대웅제약TFT연구조직신설신약개발전문성강화,http://biz.chosun.com/site/data/html_dir/2018/06/18/2018061800859.html
1903,2018-06-18,대웅제약연구조직신약바이오신제품3센터로센터장체제전환,http://view.asiae.co.kr/news/view.htm?idxno=2018061809504972599
1904,2018-06-18,대웅제약연구조직개편프로젝트팀체제강화,http://www.newspim.com/news/view/20180618000100
1905,2018-06-18,대웅제약신약개발위해연구조직개편,http://news.hankyung.com/article/201806184527f
1906,2018-06-18,대웅제약연구조직개편완료∙신약개발전문성강화,http://www.getnews.co.kr/news/articleView.html?idxno=77089
1907,2018-06-18,대웅3센터2팀으로연구조직개편익스트림팀통해속도전문성↑,http://news.mk.co.kr/newsRead.php?year=2018&no=382555
1908,2018-06-18,대웅제약신약개발가속화위해연구조직개편,http://www.newspost.kr/news/articleView.html?idxno=63706
1909,2018-06-18,대웅제약프로젝트별연구팀구성센터장체제전환,http://www.biospectator.com/view/news_view.php?varAtcId=5662
1910,2018-06-18,대웅제약신약개발가속화전문성강화위해연구조직개편,http://www.k-health.com/news/articleView.html?idxno=36524
1911,2018-06-18,대웅연구조직3센터2팀체제로,http://www.medical-tribune.co.kr/news/articleView.html?idxno=79791
1912,2018-06-18,대웅제약연구조직개편신약개발효율성↑,http://www.newstomato.com/ReadNews.aspx?no=830324
1913,2018-06-18,대웅제약연구조직개편신약개발속도낸다,http://www.newsis.com/view/?id=NISX20180618_0000338788&cID=13001&pID=13000
1914,2018-06-18,대웅제약연구조직개편신약개발힘싣는다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219195
1915,2018-06-18,대웅제약익스트림팀신설RD역량극대화,http://news.mt.co.kr/mtview.php?no=2018061810291473993
1916,2018-06-18,대웅제약프로젝트중심연구조직개편신약개발강화,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180618061700017&did=1195m
1917,2018-06-18,건강도우미대웅제약나보타발매허가초읽기,http://view.asiae.co.kr/news/view.htm?idxno=2018061810281350039
1918,2018-06-18,대웅제약연구조직개편통해신약개발에힘싣는다,http://www.mdtoday.co.kr/mdtoday/index.html?no=323972
1919,2018-06-18,대웅제약연구조직정비신약개발속도,http://www.newsprime.co.kr/news/article.html?no=419854
1920,2018-06-18,대웅제약신약개발성공률높이기위해연구조직개편,http://www.news2day.co.kr/105625
1921,2018-06-18,대웅제약연구조직개편신약개발에힘싣는다,http://www.bosa.co.kr/news/articleView.html?idxno=2085080
1922,2018-06-18,대웅제약연구조직정비신약개발주력,http://www.seoulfn.com/news/articleView.html?idxno=311838
1923,2018-06-18,대웅제약연구조직개편신약개발에박차,http://www.bokuennews.com/news/article.html?no=161125
1924,2018-06-18,대웅제약연구조직개편신약개발집중,http://www.sisajournal-e.com/biz/article/185331
1925,2018-06-18,대웅제약신약개발연구조직3센터2팀체제로변경,http://www.rapportian.com/news/articleView.html?idxno=111111
1926,2018-06-18,신약개발드라이브대웅연구조직개편,http://www.monews.co.kr/news/articleView.html?idxno=115845
1927,2018-06-18,대웅제약신약개발강화위해연구조직개편,http://www.kukinews.com/news/article.html?no=558073
1928,2018-06-18,대웅제약연구조직개편3센터2팀체체로,http://www.whosaeng.com/sub_read.html?uid=102162§ion=sc5
1929,2018-06-18,대웅제약연구조직개편신약개발승부수,http://www.kormedi.com/news/news/drug_dist/1227795_2906.html
1930,2018-06-18,대웅제약신약센터등연구조직개편익스트림팀신설,http://www.medisobizanews.com/news/articleView.html?idxno=53733
1931,2018-06-18,대웅신약개발극대화연구조직대대적개편,http://www.dailymedi.com/detail.php?number=831595&thread=22r05
1932,2018-06-18,대웅제약연구조직개편완료전문성강화,http://www.kpinews.co.kr/news/articleView.html?idxno=76189
1933,2018-06-18,대웅제약신약개발위해연구조직개편,http://www.viva100.com/main/view.php?key=20180618010005383
1934,2018-06-18,대웅제약이달초조직개편신약개발탄력,http://www.segye.com/content/html/2018/06/18/20180618001179.html?OutUrl=naver
1935,2018-06-18,대웅제약연구조직개편3센터2팀체제,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1057047
1936,2018-06-18,대웅제약연구조직개편신약개발박차,http://www.econovill.com/news/articleView.html?idxno=339923
1937,2018-06-18,대웅제약연구조직개편신약개발전문성강화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1201478
1938,2018-06-18,제약산업소식대웅제약연구조직개편外,http://www.kukinews.com/news/article.html?no=558127
1939,2018-06-18,단독공정위18일오전대웅제약현장조사,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1057072
1940,2018-06-18,대웅제약연구조직개편통해신약개발역량강화,http://www.techholic.co.kr/news/articleView.html?idxno=176522
1941,2018-06-18,대웅제약신약개발중심으로조직개편,http://news.mk.co.kr/newsRead.php?year=2018&no=383641
1942,2018-06-18,대웅제약연구조직개편신약개발드라이브건다,http://www.metroseoul.co.kr/news/newsview?newscd=2018061800155
1943,2018-06-18,공정위오늘18일대웅제약본사현장조사,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018061815435927854
1944,2018-06-18,공정위대웅제약조사중지식재산권남용여부확인,http://www.kpanews.co.kr/article/show.asp?idx=194671&table=article&category=D
1945,2018-06-18,대웅제약연구조직개편프로젝트중심으로효율성높여,http://www.mhj21.com/sub_read.html?uid=114581§ion=sc243
1946,2018-06-18,공정위대웅제약현장조사왜,http://www.kormedi.com/news/news/drug_dist/1227807_2906.html
1947,2018-06-18,공정위대웅제약공정거래법위반여부현장조사,http://www.wolyo.co.kr/news/articleView.html?idxno=62899
1948,2018-06-18,공정위대웅제약본사조사지식재산권침해여부확인”,http://www.newspim.com/news/view/20180618000473
1949,2018-06-18,대웅제약예고없던공정위현장조사왜,http://www.ntoday.co.kr/news/articleView.html?idxno=62118
1950,2018-06-18,대웅제약연구조직개편신약개발에힘싣는다,http://www.newscj.com/news/articleView.html?idxno=530670
1951,2018-06-18,대웅제약연구조직개편신약개발에힘싣는다,http://www.lawissue.co.kr/view.php?ud=201806182004167302d7f4c63cc6_12
1952,2018-06-18,대웅제약프로젝트중심연구조직개편,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3561871
1953,2018-06-19,공정위CP등급최고점받은대웅제약현장조사왜,http://www.dailypharm.com/News/240879
1954,2018-06-19,대웅제약나보타美시장진출속도전,http://www.mdtoday.co.kr/mdtoday/index.html?no=324047
1955,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219252
1956,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.dailian.co.kr/news/view/720424/?sc=naver
1957,2018-06-19,대웅제약나보타공장cGMP이어EUGMP승인,http://medipana.com/news/news_viewer.asp?NewsNum=221525&MainKind=A&NewsKind=5&vCount=12&vKind=1
1958,2018-06-19,대웅제약나보타공장유럽의약품청EUGMP승인획득,http://www.fnnews.com/news/201806190955169050
1959,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.bosa.co.kr/news/articleView.html?idxno=2085156
1960,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.newspim.com/news/view/20180619000159
1961,2018-06-19,대웅제약나보타유럽의약품제조관리기준획득,http://biz.chosun.com/site/data/html_dir/2018/06/19/2018061901227.html
1962,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://view.asiae.co.kr/news/view.htm?idxno=2018061910073863670
1963,2018-06-19,대웅제약북미이어유럽서도나보타공장의GMP인증획득,http://news.mk.co.kr/newsRead.php?year=2018&no=385587
1964,2018-06-19,대웅제약나보타공장유럽연합EUGMP승인,http://news.hankyung.com/article/201806199293f
1965,2018-06-19,대웅제약나보타공장미국이어유럽승인획득,http://www.dailypharm.com/News/240894
1966,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.newsis.com/view/?id=NISX20180619_0000340043&cID=13001&pID=13000
1967,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.metroseoul.co.kr/news/newsview?newscd=2018061900037
1968,2018-06-19,대웅제약나보타공장EUGMP인증획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806190213&t=NN
1969,2018-06-19,대웅제약나보타공장EUGMP인증품목허가탄력,http://www.medisobizanews.com/news/articleView.html?idxno=53757
1970,2018-06-19,대웅나보타공장EUGMP획득유럽진출가시화,http://www.monews.co.kr/news/articleView.html?idxno=115904
1971,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018061911271287423
1972,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1201857
1973,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://news.heraldcorp.com/view.php?ud=20180619000480
1974,2018-06-19,대웅제약보툴리눔톡신나보타공장유럽GMP인증,http://news1.kr/articles/?3349051
1975,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.newstomato.com/ReadNews.aspx?no=830603
1976,2018-06-19,대웅나보타공장EUGMP획득그랜드슬램달성,http://www.dailymedi.com/detail.php?number=831642&thread=22r05
1977,2018-06-19,대웅제약나보타공장유럽의약품청으로루��EUGMP승인획득,http://www.k-health.com/news/articleView.html?idxno=36558
1978,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.g-enews.com/ko-kr/news/article/news_all/201806191327036045e6a49afa8d_1/article.html
1979,2018-06-19,뉴스투데이E대웅제약나보타공장그랜드슬램달성,http://www.news2day.co.kr/105723
1980,2018-06-19,대웅제약나보타공장EUGMP승인유럽진출탄력,http://www.rapportian.com/news/articleView.html?idxno=111146
1981,2018-06-19,대웅나보타유럽시판초읽기돌입,http://www.whosaeng.com/sub_read.html?uid=102227§ion=sc5
1982,2018-06-19,대웅나보타생산공장EUGMP승인획득,http://www.doctorsnews.co.kr/news/articleView.html?idxno=124036
1983,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.mhj21.com/sub_read.html?uid=114608§ion=sc243
1984,2018-06-19,대웅제약전일대비약6하락한178500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806190523&t=NN
1985,2018-06-19,대웅제약나보타공장유럽GMP승인획득나보타품목허가진행중,http://www.kukinews.com/news/article.html?no=558632
1986,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.bokuennews.com/news/article.html?no=161229
1987,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.newsprime.co.kr/news/article.html?no=420075
1988,2018-06-19,공정위대웅제약현장조사부당한특허권행사확인,http://www.100ssd.co.kr/news/articleView.html?idxno=54480
1989,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=324164
1990,2018-06-19,대웅제약나보타공장EUGMP승인유럽시판카운트다운,http://www.techholic.co.kr/news/articleView.html?idxno=176551
1991,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.newscj.com/news/articleView.html?idxno=531017
1992,2018-06-19,대웅제약나보타공장EUGMP승인획득,http://www.lawissue.co.kr/view.php?ud=201806192101318379d7f4c63cc6_12
1993,2018-06-20,대웅제약보툴리눔톡신나보타공장EUGMP인증,http://www.viva100.com/main/view.php?key=20180620010006169
1994,2018-06-20,대웅제약메디톡스소송은별개세계시장선점경쟁올인,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219277
1995,2018-06-20,한경로보뉴스대웅제약5이상상승나보타의글로벌상업적결실가시화기대골든브릿지투자증권매수유지,http://news.hankyung.com/article/201806204170L
1996,2018-06-20,대웅제약전일대비약7상승한192000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806200373&t=NN
1997,2018-06-20,ET투자뉴스대웅_거래비중기관2098외국인2336,http://www.etnews.com/20180620000128
1998,2018-06-20,한경로보뉴스대웅5이상상승20181Q매출액2880억96영업이익186억242,http://news.hankyung.com/article/201806205006L
1999,2018-06-20,메디톡스대웅제약보톡스전쟁재판부포자감정결정,http://www.nongaek.com/news/articleView.html?idxno=40947
2000,2018-06-20,건강하게월드컵즐기기대웅제약나보타북미유럽등글로벌보톡스영토확장가속,http://www.sedaily.com/NewsView/1S0VS3KXFH
2001,2018-06-20,대웅제약수상한공시작성투자자기만,http://www.ftoday.co.kr/news/articleView.html?idxno=100435
2002,2018-06-20,대웅제약나보타공장EUGMP승인획득,http://www.kpanews.co.kr/article/show.asp?idx=194746&table=article&category=D
2003,2018-06-20,대웅제약나보타공장EUGMP승인획득유럽시판임박,http://www.getnews.co.kr/news/articleView.html?idxno=77839
2004,2018-06-21,오늘의추천종목유안타증권삼성전기대웅제약등,http://www.asiatoday.co.kr/view.php?key=20180621010010533
2005,2018-06-21,대웅제약NABOTASEOUL2018개최,http://medipana.com/news/news_viewer.asp?NewsNum=221640&MainKind=A&NewsKind=5&vCount=12&vKind=1
2006,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219368
2007,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.newsis.com/view/?id=NISX20180621_0000342292&cID=13001&pID=13000
2008,2018-06-21,대웅제약다음달5일나보타공장cGMP인증기념심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2018&no=391259
2009,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062109375326558
2010,2018-06-21,대웅제약내달나보타제2공장cGMP승인기념심포지엄개최,http://www.sisajournal-e.com/biz/article/185504
2011,2018-06-21,아파야챙길래동아쏘시오그룹삼성바이오로직스대웅제약,http://www.g-enews.com/ko-kr/news/article/news_all/201806211024029478e6a49afa8d_1/article.html
2012,2018-06-21,대웅제약나보타제2공장승인기념심포지엄개최,http://news.hankyung.com/article/201806218677f
2013,2018-06-21,뉴스투데이E대웅제약나보타제2공장cGMP승인기념글로벌심포지엄개최,http://www.news2day.co.kr/105874
2014,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=324394
2015,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1202864
2016,2018-06-21,대웅제약나보타제2공장cGMP승인기념NABOTASEOUL2018개최,http://www.viva100.com/main/view.php?key=20180621010006819
2017,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.k-health.com/news/articleView.html?idxno=36629
2018,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.getnews.co.kr/news/articleView.html?idxno=77979
2019,2018-06-21,대웅제약나보타2공장cGMP승인기념심포지엄개최,http://www.ceoscoredaily.com/news/article.html?no=42557
2020,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2085347
2021,2018-06-21,대웅제약나보타공장EUGMP승인획득그랜드슬램달성,http://www.segye.com/content/html/2018/06/21/20180621003326.html?OutUrl=naver
2022,2018-06-21,대웅제약내달5일나보타글로벌심포지엄개최,http://view.asiae.co.kr/news/view.htm?idxno=2018062114153683828
2023,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.dt.co.kr/contents.html?article_no=2018062102109960102004&ref=naver
2024,2018-06-21,대웅제약NABOTASEOUL2018개최,http://www.monews.co.kr/news/articleView.html?idxno=116030
2025,2018-06-21,대웅제약내달5일나보타서울2018개최,http://www.dailymedi.com/detail.php?number=831746&thread=22r05
2026,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.joseilbo.com/news/news_read.php?uid=355587&class=27&grp=
2027,2018-06-21,대웅제약나보타제2공장cGMP승인기념NABOTASEOUL2018심포지엄개최,http://www.lawissue.co.kr/view.php?ud=201806211649021156d7f4c63cc6_12
2028,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄열어,http://www.kpanews.co.kr/article/show.asp?idx=194784&table=article&category=D
2029,2018-06-21,대웅제약보톡스나보타우수성알리는국제심포지움열기로,http://www.businesspost.co.kr/BP?command=article_view&num=86397
2030,2018-06-21,대웅제약나보타제2공장cGMP승인기념심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=531664
2031,2018-06-22,대웅제약전일대비약4상승한199500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806220178&t=NN
2032,2018-06-22,대웅제약이지듀자외선차단기능이지썬스패셜세트출시,http://sports.khan.co.kr/news/sk_index.html?art_id=201806221133003&sec_id=561901&pt=nv
2033,2018-06-22,한경로보뉴스대웅5이상상승최근3일간외국인대량순매수,http://news.hankyung.com/article/201806224339L
2034,2018-06-22,대웅제약NABOTASEOUL2018개최,http://www.bokuennews.com/news/article.html?no=161397
2035,2018-06-23,주간추천종목유안타증권SK하이닉스대웅제약호텔신라,http://www.g-enews.com/ko-kr/news/article/news_all/201806221638227351c16aa2f016_1/article.html
2036,2018-06-24,주간추천종목유안타증권SK하이닉스대웅제약호텔신라,http://www.fntimes.com/html/view.php?ud=201806232332581807f09e13944d_18
2037,2018-06-25,A급SK텔레시스대웅제약회사채발행추진,http://news.einfomax.co.kr/news/articleView.html?idxno=3454905
2038,2018-06-25,대웅제약전일대비약3하락한199500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806250161&t=NN
2039,2018-06-25,ET투자뉴스대웅_주가와투자심리는약세거래량은침체,http://www.etnews.com/20180625000072
2040,2018-06-25,대웅제약이지듀이지썬스페셜세트출시,http://www.metroseoul.co.kr/news/newsview?newscd=2018062500170
2041,2018-06-25,대웅이지듀랄라블라서이지썬스페셜세트출시,http://www.bokuennews.com/news/article.html?no=161499
2042,2018-06-26,윤재승회장의대웅제약나보타글로벌리딩의약품도전,http://moneys.mt.co.kr/news/mwView.php?no=2018062611238045254
2043,2018-06-26,대웅제약윤재승회장창문밖으로뛰어내려라”갑질의혹,http://www.betanews.net:8080/article/872678.html
2044,2018-06-26,윤재승대웅제약회장회의중창문에서뛰어내리라상습폭언논란,http://www.ilemonde.com/news/articleView.html?idxno=8839
2045,2018-06-26,대웅제약또다시불거진형제간갈등설에곤혹,http://www.ekn.kr/news/article.html?no=370399
2046,2018-06-26,판커지는코스메슈티컬시장동국제약과대웅제약앞서나가,http://www.businesspost.co.kr/BP?command=article_view&num=86815
2047,2018-06-27,대웅제약해외실적날개잘키운자회사가효자,http://www.ajunews.com/view/20180626135730613
2048,2018-06-27,대웅제약나보타제2공장승인기념심포지엄NABOTASEOUL2018개최,http://www.segye.com/content/html/2018/06/26/20180626001748.html?OutUrl=naver
2049,2018-06-27,대웅제약임팩타민약국직거래포기도매공급전환되나,http://www.kpanews.co.kr/article/show.asp?idx=194856&table=article&category=D
2050,2018-06-27,더벨A대웅제약공모채900억발행착수,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201806260100039050002381
2051,2018-06-27,대웅제약삼페넷런칭유방암전문의심포지엄개최,http://www.lawissue.co.kr/view.php?ud=201806270942222969d7f4c63cc6_12
2052,2018-06-27,대웅제약항암바이오시밀러삼페넷론칭심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2018&no=404288
2053,2018-06-27,대웅허셉틴바이오시밀러삼페넷론칭심포지엄,http://www.dailypharm.com/News/241184
2054,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219601
2055,2018-06-27,아파야챙길래대웅제약삼성바이오로직스보령바이오파마,http://www.g-enews.com/ko-kr/news/article/news_all/201806271009197475e6a49afa8d_1/article.html
2056,2018-06-27,대웅제약삼페넷론칭심포지엄개최3상임상등정보공유,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018062710085671848
2057,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.ftoday.co.kr/news/articleView.html?idxno=100644
2058,2018-06-27,대웅제약삼페넷론칭심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=324938
2059,2018-06-27,대웅제약유방암바이오시밀러삼페넷런칭심포지엄개최,http://www.edaily.co.kr/news/newspath.asp?newsid=02332086619245984
2060,2018-06-27,대웅제약바이오시밀러삼페넷런칭심포지엄성료,http://www.rapportian.com/news/articleView.html?idxno=111298
2061,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=116230
2062,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.dailymedi.com/detail.php?number=831925&thread=22r05
2063,2018-06-27,대웅제약유방암치료제삼페넷런칭심포지엄개최,http://www.mhj21.com/sub_read.html?uid=114829§ion=sc243
2064,2018-06-27,대웅제약허셉틴바이오시밀러삼페넷3상임상등정보공유,http://www.medigatenews.com/news/2110336946
2065,2018-06-27,대웅제약유방암치료제삼페넷런칭심포지엄성료,http://www.getnews.co.kr/news/articleView.html?idxno=79199
2066,2018-06-27,대웅제약유방암치료제삼페넷런칭심포지엄개최,http://medipana.com/news/news_viewer.asp?NewsNum=221923&MainKind=A&NewsKind=5&vCount=12&vKind=1
2067,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.bosa.co.kr/news/articleView.html?idxno=2085645
2068,2018-06-27,대웅제약샴페넷론칭심포지엄개최3상임상결과소개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1205098
2069,2018-06-27,대웅제약삼성바이오에피스개발삼페넷런칭심포지엄개최,http://www.ceoscoredaily.com/news/article.html?no=42772
2070,2018-06-27,대웅제약삼페넷론칭심포지엄개최,http://www.polinews.co.kr/news/article.html?no=359808
2071,2018-06-27,대웅제약유방암치료제삼페넷출시심포지엄개최,http://www.econovill.com/news/articleView.html?idxno=340483
2072,2018-06-27,뉴스투데이E대웅제약삼페넷런칭심포지엄개최유방암전문의100여명이참석,http://www.news2day.co.kr/106235
2073,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.newsway.co.kr/view.php?tp=1&ud=2018062714413088409
2074,2018-06-27,대웅제약2223일삼페넷런칭심포지엄개최,http://www.wolyo.co.kr/news/articleView.html?idxno=63509
2075,2018-06-27,대웅제약바이오시밀러삼페넷심포지엄개최,http://www.kormedi.com/news/news/drug_dist/1227963_2906.html
2076,2018-06-27,대웅제약삼페넷론칭심포지엄개최,http://news.heraldcorp.com/view.php?ud=20180627000756
2077,2018-06-27,대웅제약유방암전문의대상삼페넷출시심포지엄개최,http://www.nextdaily.co.kr/news/article.html?id=20180627800065
2078,2018-06-27,대웅제약바이오시밀러삼페넷심포지엄개최임상정보공유,http://www.dt.co.kr/contents.html?article_no=2018062702109931102003&ref=naver
2079,2018-06-27,대웅제약전이성유방암치료제삼페넷론칭심포지엄개최,http://www.k-health.com/news/articleView.html?idxno=36712
2080,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.betanews.net:8080/article/873401.html
2081,2018-06-27,대웅제약삼페넷론칭심포지엄개최,http://www.dailian.co.kr/news/view/722345/?sc=naver
2082,2018-06-27,대웅제약삼페넷런칭심포지엄개최,http://www.newscj.com/news/articleView.html?idxno=533134
2083,2018-06-28,대웅제약삼페넷런칭심포지엄개최3상임상정보공유,http://www.segye.com/content/html/2018/06/27/20180627005377.html?OutUrl=naver
2084,2018-06-28,대웅제약나보타발매4년글로벌보툴리눔톡신성장가능성주목,http://www.asiatoday.co.kr/view.php?key=20180623010011791
2085,2018-06-28,대웅바이오계열사대웅제약도움받아매출액쑥쑥,http://www.ceoscoredaily.com/news/article.html?no=42744
2086,2018-06-28,대웅제약목표가20↑26만원제시한화證,http://www.newspim.com/news/view/20180628000067
2087,2018-06-28,퀵리포트대웅제약매수유지목표가20↑26만원한화證,http://www.itooza.com/common/iview.php?no=2018062807365615861
2088,2018-06-28,I리포트대웅제약나보타미국시장출시기대목표가↑한화證,http://www.inews24.com/php/news_view.php?g_serial=1104822&g_menu=022300&rrf=nv
2089,2018-06-28,HotLine대웅제약나보타가이끌고RD가받쳐줘목표가↑,http://news.mk.co.kr/newsRead.php?year=2018&no=406988
2090,2018-06-28,대웅제약나보타본격성장기대목표가상향한화,http://www.newstomato.com/ReadNews.aspx?no=832488
2091,2018-06-28,ET투자뉴스대웅제약나보타가이끌고BUY유지한화투자증권,http://www.etnews.com/20180628000004
2092,2018-06-28,대웅제약나보타미국유럽진출가시화목표가↑한화,http://www.edaily.co.kr/news/newspath.asp?newsid=01567846619246312
2093,2018-06-28,한화투자증권대웅제약나보타가미국유럽시장진출코앞에목표가↑”,http://www.newsway.co.kr/view.php?tp=1&ud=2018062808465813504
2094,2018-06-28,한화투자증권대웅제약나보타효과로실적기대감↑,http://www.newsprime.co.kr/news/article.html?no=420951
2095,2018-06-28,한화證대웅제약나보타미국진출가시화목표가↑,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806280059&t=NN
2096,2018-06-28,대웅제약나보타미국진출가까워졌다한화증권,http://www.choicenews.co.kr/news/articleView.html?idxno=42518
2097,2018-06-28,대웅제약HER2유방암표적치료제삼페넷심포지엄개최,http://www.viva100.com/main/view.php?key=20180628010009142
2098,2018-06-28,발매4년차대웅제약보톡스나보타해외진출본격화,http://www.edaily.co.kr/news/newspath.asp?newsid=02476406619246312
2099,2018-06-28,대웅제약미국캐나다에이어유럽GMP인증,http://www.newsworks.co.kr/news/articleView.html?idxno=196819
2100,2018-06-28,제약산업소식대웅제약삼페넷런칭심포지엄개최外,http://www.kukinews.com/news/article.html?no=561811
2101,2018-06-29,빅데이터MSI시장심리톱5삼성엔지니어링이마트롯데푸드대웅제약한화,http://www.newsis.com/view/?id=NISX20180629_0000349768&cID=10401&pID=10400
2102,2018-06-29,대웅제약전일대비약3하락한190000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201806290194&t=NN
2103,2018-06-30,대웅이봉용부사장사직바이오텍설립제2인생,http://www.dailypharm.com/News/241300
2104,2018-07-01,대웅제약나보타글로벌리딩의약품도전,http://www.metroseoul.co.kr/news/newsview?newscd=2018070100039
2105,2018-07-01,일본최대의약품전시회InterphexJapan에대웅제약등44개사참여,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219738
2106,2018-07-03,대웅제약오너2세윤재승체제서남의약비중급증,http://www.datanews.co.kr/news/article.html?no=100821
2107,2018-07-04,대웅제약10년간매출18배↑연구개발비는37배↑윤재승회장취임후껑충,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=526416
2108,2018-07-04,ET투자뉴스대웅제약지분변동국민연금공단외1명105p증가82보유,http://www.etnews.com/20180704000084
2109,2018-07-04,경계심리에도메디톡스휴젤대웅제약주가빵빵,http://news.mt.co.kr/mtview.php?no=2018070411160970860
2110,2018-07-05,유한대웅우루사겨냥한UDCA간장약출격임박,http://www.kpanews.co.kr/article/show.asp?idx=195095&table=article&category=D
2111,2018-07-05,미생물학회대웅제약에발끈왜,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1057737
2112,2018-07-05,대웅제약나보타우수한품질가격경쟁력미용성형네트워크삼박자조화,http://www.asiatoday.co.kr/view.php?key=20180705010003026
2113,2018-07-05,부자들은경제신문을읽는다경계심리에도메디톡스휴젤대웅제약주가빵빵外,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018070511231174039
2114,2018-07-05,대웅제약나보타글로벌진출앞두고9년만에해외IR,http://biz.chosun.com/site/data/html_dir/2018/07/05/2018070502160.html
2115,2018-07-05,단독울산A병원의약품리베이트제공제약사는대웅등4곳,http://www.sisajournal-e.com/biz/article/186128
2116,2018-07-05,직업이야기38직원적성찾아주는대웅제약CDP제도,http://www.news2day.co.kr/106730
2117,2018-07-06,미생물학회대웅제약에사과요구내용증명왜,http://www.mdtoday.co.kr/mdtoday/index.html?no=325882
2118,2018-07-06,국민연금광폭투자행보한미대웅등주식대거취득,http://www.dailypharm.com/News/241480
2119,2018-07-06,메디톡스수출호재에보톡스매출압도적1위2위휴젤3위대웅제약,http://www.ceoscoredaily.com/news/article.html?no=43127
2120,2018-07-06,퀵리포트대웅제약매수유지목표가13↑25만원유안타證,http://www.itooza.com/common/iview.php?no=2018070607312684080
2121,2018-07-06,대웅제약목표가13↑25만원제시유안타證,http://www.newspim.com/news/view/20180706000034
2122,2018-07-06,대웅제약신약과나보타모멘텀기대유안타증권,http://news.mt.co.kr/mtview.php?no=2018070607341863764
2123,2018-07-06,더벨대웅제약최다해외법인보유실적개선과제,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201807040100007310000458
2124,2018-07-06,대웅제약나보타불확실성해소미유럽선점효과↑,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018070608303200387&LinkID=632&objId=A2018070608303200387&portalCode=naver
2125,2018-07-06,HotLine대웅제약나보타수출과신약모멘텀기대목표가↑,http://news.mk.co.kr/newsRead.php?year=2018&no=425639
2126,2018-07-06,STOCK대웅제약ETC통한실적개선기대,http://moneys.mt.co.kr/news/mwView.php?no=2018070608558080932
2127,2018-07-06,대웅제약신약나보타모멘텀기대유안타,http://www.ebn.co.kr/news/view/947616
2128,2018-07-06,대웅제약목표주가높아져전문의약품호조에보톡스수출가시화,http://www.businesspost.co.kr/BP?command=article_view&num=87986
2129,2018-07-06,ET투자뉴스대웅제약본업은거들뿐BUYM유안타증권,http://www.etnews.com/20180706000101
2130,2018-07-06,대웅제약나보타수출과신약개발에목표주가25만원으로상향,http://www.insight.co.kr/news/164692
2131,2018-07-06,국민연금공단올2분기한미대원대웅제약등주식대거취득,http://www.mdtoday.co.kr/mdtoday/index.html?no=325952
2132,2018-07-06,대웅제약NABOTASEOUL2018심포지엄성료,http://www.kpanews.co.kr/article/show.asp?idx=195178&table=article&category=D
2133,2018-07-06,대웅제약NABOTASEOUL2018심포지엄성황,http://medipana.com/news/news_viewer.asp?NewsNum=222399&MainKind=A&NewsKind=5&vCount=12&vKind=1
2134,2018-07-06,대웅제약나보타서울2018심포지엄성료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=219968
2135,2018-07-06,대웅제약NABOTASEOUL2018성료,http://www.monews.co.kr/news/articleView.html?idxno=116628
2136,2018-07-06,대웅나보타보톡스보다효과면에서우월,http://www.medicaltimes.com/News/1119766
2137,2018-07-06,대웅제약나보타서울2018성료국내외미용성형전문의참석,http://www.enewstoday.co.kr/news/articleView.html?idxno=1209027
2138,2018-07-06,대웅제약NABOTASEOUL2018심포지엄성료,http://www.bosa.co.kr/news/articleView.html?idxno=2086242
2139,2018-07-06,대웅제약나보타서울2018심포지엄개최,http://www.fnnews.com/news/201807061438198537
2140,2018-07-06,대웅제약NABOTASEOUL2018심포지엄성료,http://www.getnews.co.kr/news/articleView.html?idxno=81462
2141,2018-07-06,전승호대웅제약사장나보타글로벌브랜드로성장시킬것,http://www.rapportian.com/news/articleView.html?idxno=111530
2142,2018-07-06,대웅제약나보타서울2018심포지엄성료,http://www.mdtoday.co.kr/mdtoday/index.html?no=325970
2143,2018-07-06,대웅제약NABOTASEOUL2018심포지엄열어,http://www.seoulwire.com/news/articleView.html?idxno=17896
2144,2018-07-06,대웅제약미국EUGMP인증기념나보타서울심포지엄성료,http://news.mk.co.kr/newsRead.php?year=2018&no=427198
2145,2018-07-06,대웅제약나보타서울2018심포지엄효능안전성발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1638991
2146,2018-07-06,대웅제약나보타서울2018심포지엄성료,http://www.dailymedi.com/detail.php?number=832255&thread=22r05
2147,2018-07-06,대웅제약전문의약품매출증가로인한실적개선기대,http://www.newsworks.co.kr/news/articleView.html?idxno=198823
2148,2018-07-06,대웅제약나보타글로벌보툴리눔톡신브랜드로성장예고,http://www.newsprime.co.kr/news/article.html?no=422092
2149,2018-07-06,대웅제약나보타서울2018심포지엄성료,http://www.dailian.co.kr/news/view/724338/?sc=naver
2150,2018-07-06,대웅제약나보타서울2018심포지엄성료,http://www.wolyo.co.kr/news/articleView.html?idxno=64060
2151,2018-07-06,대웅제약나보타서울2018심포지엄성료,http://www.techholic.co.kr/news/articleView.html?idxno=176851
2152,2018-07-06,대웅제약NABOTASEOUL2018심포지엄성료,http://www.ftoday.co.kr/news/articleView.html?idxno=100952
2153,2018-07-06,대웅제약NABOTASEOUL2018심포지엄성료,http://www.newscj.com/news/articleView.html?idxno=535612
2154,2018-07-06,대웅제약NABOTASEOUL2018심포지엄진행,http://www.k-health.com/news/articleView.html?idxno=36852
2155,2018-07-08,대불련동문행동조계사대웅전서설정퇴진,http://www.newsrep.co.kr/news/articleView.html?idxno=53982
2156,2018-07-09,대웅전일대비약4상승한18200원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807090383&t=NN
2157,2018-07-09,ET투자뉴스대웅_거래비중기관2682외국인1997,http://www.etnews.com/20180709000219
2158,2018-07-09,아트페이스대웅제약관계사디엔컴퍼니와MOU체결,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=759243
2159,2018-07-09,국민연금대웅한미등주식매입규모↑제약株주목,http://www.viva100.com/main/view.php?key=20180709010003040
2160,2018-07-09,메디톡스휴온스대웅제약중남미에K뷰티바람일으키다,http://www.insightkorea.co.kr//news/articleView.html?idxno=26542
2161,2018-07-09,대웅제약NABOTASEOUL2018심포지엄성료,http://www.lawissue.co.kr/view.php?ud=201807091952327246d7f4c63cc6_12
2162,2018-07-10,기업톡톡대웅제약NABOTASEOUL2018심포지엄성료,http://www.segye.com/content/html/2018/07/09/20180709002958.html?OutUrl=naver
2163,2018-07-10,RD톺아보기대웅제약초기연구부터외부검증개방형혁신추진,http://www.etoday.co.kr/news/section/newsview.php?idxno=1639844
2164,2018-07-11,연속순매수기관대웅제약9일째매수,http://www.itooza.com/common/iview.php?no=2018071017155398504
2165,2018-07-11,인물탐구윤재승대웅회장①경력기업실적전쟁서승리한검사출신2세경영인,http://www.news2day.co.kr/107037
2166,2018-07-12,메디톡스휴젤대웅제약올해신고가경신보톡스株주목,http://www.mdtoday.co.kr/mdtoday/index.html?no=326523
2167,2018-07-13,일동제약아로나민비타민시장최강자유한양행대웅제약큰차이로따돌려,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=526586
2168,2018-07-13,더벨대웅제약나보타글로벌진출잰걸음,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201807120100021750001359
2169,2018-07-13,대웅제약소비자친근감강화메이킹필름제작,http://medipana.com/news/news_viewer.asp?NewsNum=222665&MainKind=A&NewsKind=5&vCount=12&vKind=1
2170,2018-07-13,대웅제약추성훈•추사랑이지덤화보메이킹필름공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220170
2171,2018-07-13,대웅제약습윤드레싱이지덤화보메이킹필름공개,http://www.bokuennews.com/news/article.html?no=162342
2172,2018-07-13,대웅제약추성훈사랑부녀이지덤화보메이킹필름공개,http://www.sisaon.co.kr/news/articleView.html?idxno=75229
2173,2018-07-13,대웅제약추성훈부녀이지덤화보메이킹필름공개,http://www.sisajournal-e.com/biz/article/186469
2174,2018-07-13,대웅제약추성훈사랑부녀이지덤화보메이킹공개,http://www.seoulwire.com/news/articleView.html?idxno=18615
2175,2018-07-13,대웅제약추성훈추사랑부녀이지덤화보메이킹필름공개,http://www.wolyo.co.kr/news/articleView.html?idxno=64378
2176,2018-07-13,대웅재단27개국외국인유학생한국에서글로벌인재로성장하다,http://news.heraldcorp.com/view.php?ud=20180713000415
2177,2018-07-13,대웅제약추블리부녀이지덤화보메이킹영상공개,http://www.medisobizanews.com/news/articleView.html?idxno=54193
2178,2018-07-13,추블리부녀대웅제약습윤드레싱광고모델로발탁,http://www.rapportian.com/news/articleView.html?idxno=111651
2179,2018-07-13,대웅제약추블리부녀이지덤메이킹필름공개,http://www.whosaeng.com/sub_read.html?uid=102906§ion=sc5
2180,2018-07-13,대웅제약이지덤모델추성훈부녀의화보메이킹필름공개,http://news.mk.co.kr/newsRead.php?year=2018&no=442559
2181,2018-07-13,대웅제약추성훈추사랑이지덤화보메이킹필름공개,http://www.ebn.co.kr/news/view/948448
2182,2018-07-13,대웅제약추성훈추사랑부녀와함께한이지덤메이킹필름공개,http://www.k-health.com/news/articleView.html?idxno=36939
2183,2018-07-13,대웅제약추성훈추사랑부녀함께한이지덤화보메이킹필름공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=326625
2184,2018-07-13,대웅제약이지덤화보메이킹필름공개,http://www.newsprime.co.kr/news/article.html?no=422739
2185,2018-07-13,대웅제약추성훈추사랑부녀와함께한이지덤화보메이킹필름공개,http://www.asiatime.co.kr/news/articleView.html?idxno=188245
2186,2018-07-13,대웅제약추성훈부녀등장이지덤메이킹필름공개”,http://www.econovill.com/news/articleView.html?idxno=341591
2187,2018-07-13,뉴스투데이L대웅제약추블리부녀의이지덤화보메이킹필름공개,http://www.news2day.co.kr/107213
2188,2018-07-13,대웅제약추블리부녀와함께한이지덤광고촬영현장공개,http://www.polinews.co.kr/news/article.html?no=361518
2189,2018-07-14,대웅제약추성훈추블리부녀와함께한이지덤화보메이킹필름공개,http://www.lawissue.co.kr/view.php?ud=201807132354441420d7f4c63cc6_12
2190,2018-07-14,대웅제약이지덤화보메이킹필름공개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058098
2191,2018-07-16,대웅제약추성훈추사랑부녀이지덤화보메이킹필름공개,http://www.sportsworldi.com/content/html/2018/07/15/20180715001690.html?OutUrl=naver
2192,2018-07-16,대웅제약이지듀SBS그녀로말할것같으면제작지원,http://sports.chosun.com/news/ntype.htm?id=201807160100142690010894&servicedate=20180716
2193,2018-07-16,대웅제약메디톡스간소송리스크해소긍정적신호감지,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018071608383900402&LinkID=632&objId=A2018071608383900402&portalCode=naver
2194,2018-07-16,HotLine대웅제약국내보톡스플레이어중미국진출가장빨라,http://news.mk.co.kr/newsRead.php?year=2018&no=446031
2195,2018-07-16,대웅제약한국보톡스플레이어중美진출가장빨라NH투자증권,http://www.sedaily.com/NewsView/1S23UNN844
2196,2018-07-16,대웅제약나보타잠재력에주목영업이익률이50↑NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1641756
2197,2018-07-16,NH투자증권대웅제약마진높은신약나보타주목투자자홍보와소송이관건”,http://www.lawissue.co.kr/view.php?ud=2018071609242558559817d053b9_12
2198,2018-07-16,ET투자뉴스대웅제약한국톡신플레이어BUY유지NH투자증권,http://www.etnews.com/20180716000050
2199,2018-07-16,윤재승대웅제약회장신약개발광폭행보2020년글로벌Top50진입,http://www.dailian.co.kr/news/view/726046/?sc=naver
2200,2018-07-16,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018071610381714507
2201,2018-07-16,대웅제약추성훈•추사랑부녀이지덤화보메이킹필름공개,http://www.getnews.co.kr/news/articleView.html?idxno=83514
2202,2018-07-16,대웅제약이지듀SBS그녀로말할것같으면제작지원,http://www.asiatoday.co.kr/view.php?key=20180716010009174
2203,2018-07-16,대웅제약5에불과한외국인지분율문제는소통부족,http://www.newsworks.co.kr/news/articleView.html?idxno=200947
2204,2018-07-16,대웅제약회사채수요예측서인기3천400억몰려,http://news.einfomax.co.kr/news/articleView.html?idxno=3458311
2205,2018-07-17,윤영환대웅제약회장의수상한손주사랑,http://www.sisajournal-e.com/biz/article/186628
2206,2018-07-18,대웅재단고유목적사업비수입13억중11억지출,http://www.ceoscoredaily.com/news/article.html?no=43462
2207,2018-07-18,더벨대웅제약올로스타CMO기술이전해외진출박차,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201807170100030300001934
2208,2018-07-18,더벨A대웅제약공모채수요예측4배오버부킹,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201807160100028900001849
2209,2018-07-18,퀵리포트대웅제약매수유지목표가26만원유지한화證,http://www.itooza.com/common/iview.php?no=2018071809121019774
2210,2018-07-18,대웅제약목표가26만원유지전일종가20만1000원한화證,http://www.newspim.com/news/view/20180718000124
2211,2018-07-18,대웅제약나보타IMCASASIA2018서최신임상결과시술법발표,http://www.k-health.com/news/articleView.html?idxno=37012
2212,2018-07-18,대웅제약나보타국제미용성형학회에서최신임상결과공개,http://news.heraldcorp.com/view.php?ud=20180718000126
2213,2018-07-18,대웅제약주가상승여력충분미국과유럽에서보톡스판매가시권,http://www.businesspost.co.kr/BP?command=article_view&num=89365
2214,2018-07-18,뉴스투데이L대웅제약나보타국제미용성형학회IMCASASIA2018참가,http://www.news2day.co.kr/107382
2215,2018-07-18,대웅제약나보타국제미용성형학회IMCASASIA참가최신임상결과공개,http://www.wsobi.com/news/articleView.html?idxno=62709
2216,2018-07-18,대웅제약나보타국제미용성형학회참가임상결과소개,http://www.newsis.com/view/?id=NISX20180718_0000366824&cID=13001&pID=13000
2217,2018-07-18,아시아학회찾은대웅나보타최신임상소개,http://medipana.com/news/news_viewer.asp?NewsNum=222841&MainKind=A&NewsKind=5&vCount=12&vKind=1
2218,2018-07-18,아파야챙길래대웅제약유유건강생활코오롱생명과학,http://www.g-enews.com/ko-kr/news/article/news_all/201807180944496220e6a49afa8d_1/article.html
2219,2018-07-18,대웅제약나보타국제미용성형학회서임상결과시술법공개,http://www.seoulwire.com/news/articleView.html?idxno=19271
2220,2018-07-18,대웅제약국제미용성형학회서보툴리눔톡신나보타홍보박차,http://news.mk.co.kr/newsRead.php?year=2018&no=451690
2221,2018-07-18,대웅제약태국국제미용성형학회참가나보타효능안전성입증됐다”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1642694
2222,2018-07-18,제약산업소식대웅제약국제미용성형학회서나보타임상결과소개外,http://www.kukinews.com/news/article.html?no=567769
2223,2018-07-18,대웅제약나보타이번엔방콕서효능시술법파상공세,http://www.medisobizanews.com/news/articleView.html?idxno=54266
2224,2018-07-18,대웅제약나보타국제미용성형학회서시술법전파,http://www.medicaltimes.com/News/1119967
2225,2018-07-18,대웅제약나보타국제미용성형학회서임상결과시술법공개,http://www.newsprime.co.kr/news/article.html?no=423200
2226,2018-07-18,대웅제약나보타국제미용성형학회서임상결과공개,http://www.asiatime.co.kr/news/articleView.html?idxno=188993
2227,2018-07-18,대웅제약나보타국제미용성형학회서최신임상결과공개,http://www.dailian.co.kr/news/view/726601/?sc=naver
2228,2018-07-18,대웅제약나보타IMCASASIA2018서최신임상결과∙시술법공개,http://www.getnews.co.kr/news/articleView.html?idxno=84041
2229,2018-07-18,대웅제약나보타아시아성형의대상임상소개,http://www.bosa.co.kr/news/articleView.html?idxno=2086909
2230,2018-07-18,대웅제약태국국제미용성형학회서나보타임상발표,http://www.ceoscoredaily.com/news/article.html?no=43557
2231,2018-07-18,대웅제약나보타IMCASASIA2018세계시장입지구축나서,http://www.doctorsnews.co.kr/news/articleView.html?idxno=124517
2232,2018-07-18,대웅제약나보타태국서글로벌임상공개,http://www.kormedi.com/news/news/drug_dist/1228311_2906.html
2233,2018-07-18,대웅제약나보타미국시장진출막바지작업박차,http://www.rapportian.com/news/articleView.html?idxno=111756
2234,2018-07-18,대웅제약나보타IMCASASIA2018서최신임상결과시술법공개,http://www.mdtoday.co.kr/mdtoday/index.html?no=327014
2235,2018-07-18,ET투자뉴스대웅제약여전히밸류에이션BUY유지한화투자증권,http://www.etnews.com/20180718000086
2236,2018-07-18,대웅제약나보타최신임상결과공개,http://www.monews.co.kr/news/articleView.html?idxno=116995
2237,2018-07-18,대웅제약나보타국제미용성형학회IMCASASIA2018서최신임상결과및시술법공개,http://www.lawissue.co.kr/view.php?ud=201807181404282828d7f4c63cc6_12
2238,2018-07-18,대웅제약나보타IMCASASIA2018서최신임상결과시술법공개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1213176
2239,2018-07-18,인물탐구윤재승대웅회장②성과승부사기질발휘해연구개발역량급강화,http://www.news2day.co.kr/107407
2240,2018-07-18,대웅제약미국캐나다에이어유럽GMP인증,http://www.newsworks.co.kr/news/articleView.html?idxno=201548
2241,2018-07-18,대웅제약나보타국제미용성형학회참가,http://www.sedaily.com/NewsView/1S24SGKPVZ
2242,2018-07-18,대웅나보타IMCASASIA2018서최신임상결과및시술법공개,http://www.bokuennews.com/news/article.html?no=162597
2243,2018-07-18,대웅제약나보타국제미용성형학회참가,http://www.metroseoul.co.kr/news/newsview?newscd=2018071800210
2244,2018-07-18,대웅제약나보타국제미용성형학회서최신임상결과및시술법공개,http://sports.hankooki.com/lpage/life/201807/sp20180718173259136800.htm
2245,2018-07-18,대웅제약국제미용성형학회서나보타임상소개,http://www.100ssd.co.kr/news/articleView.html?idxno=55072
2246,2018-07-18,대웅제약국제미용성형학회서나보타효능발표,http://www.wolyo.co.kr/news/articleView.html?idxno=64638
2247,2018-07-18,대웅제약나보타IMCASASIA2018서최신임상결과시술법공개,http://www.newscj.com/news/articleView.html?idxno=538671
2248,2018-07-19,대웅제약나보타IMCASASIA2018에서최신임상결과및시술법공개,http://www.ftoday.co.kr/news/articleView.html?idxno=101298
2249,2018-07-19,대웅제약전일대비약3하락한188000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807190292&t=NN
2250,2018-07-19,신약개발사활건제약사대웅제약매출액10RD투입합성바이오신약개발,http://www.sedaily.com/NewsView/1S259HHJ1C
2251,2018-07-20,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2018072007375419097
2252,2018-07-20,대웅제약목표가26만원유지전일종가19만원SK證,http://www.newspim.com/news/view/20180720000056
2253,2018-07-20,대웅제약개선되는하반기실적”SK증권,http://www.sedaily.com/NewsView/1S25OQ0O9K
2254,2018-07-20,ET투자뉴스대웅제약1분기보다좋아지매수유지SK증권,http://www.etnews.com/20180720000018
2255,2018-07-20,대웅제약전승호대표직원들과점심비어파티등산소통경영눈길,http://www.ceoscoredaily.com/news/article.html?no=43657
2256,2018-07-20,대웅제약오너CEO수평적이고자유로운소통경영가속,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220403
2257,2018-07-20,대웅제약수평적이고자유로운소통경영실천,http://www.newsis.com/view/?id=NISX20180720_0000369314&cID=13001&pID=13000
2258,2018-07-20,대웅제약소통경영,http://www.medical-tribune.co.kr/news/articleView.html?idxno=80419
2259,2018-07-20,대웅제약임직원자유로운소통문화강화,http://medipana.com/news/news_viewer.asp?NewsNum=222983&MainKind=A&NewsKind=5&vCount=12&vKind=1
2260,2018-07-20,대웅제약비어파티통해수평적소통경영실천,http://www.asiatime.co.kr/news/articleView.html?idxno=189481
2261,2018-07-20,대웅제약수평적이고자유로운소통경영실천,http://www.getnews.co.kr/news/articleView.html?idxno=84664
2262,2018-07-20,아파야챙길래종근당대웅제약광동제약,http://www.g-enews.com/ko-kr/news/article/news_all/201807201043347849e6a49afa8d_1/article.html
2263,2018-07-20,대웅제약수평적조직문화조성위해노력,http://www.rapportian.com/news/articleView.html?idxno=111815
2264,2018-07-20,대웅제약수평적이고자유로운소통경영,http://www.bosa.co.kr/news/articleView.html?idxno=2087082
2265,2018-07-20,대웅제약CEO직원소통확대경영실천,http://www.dailymedi.com/detail.php?number=832757&thread=22r05
2266,2018-07-20,대웅제약비어파티소통점심등으로소통경영실천,http://www.medisobizanews.com/news/articleView.html?idxno=54329
2267,2018-07-20,대웅제약수평적자유로운소통경영실천나서,http://www.seoulwire.com/news/articleView.html?idxno=19614
2268,2018-07-20,대웅제약수평적이고자유로운소통경영,http://www.edaily.co.kr/news/newspath.asp?newsid=02840486619276488
2269,2018-07-20,대웅제약전승호사장임직원소통경영이어갈것,http://www.wolyo.co.kr/news/articleView.html?idxno=64742
2270,2018-07-20,대웅제약최고경영진수평적소통경영으로기업문화에활기넣는다,http://www.techholic.co.kr/news/articleView.html?idxno=177059
2271,2018-07-20,대웅제약수평적이고자유로운소통경영,http://www.ekn.kr/news/article.html?no=375589
2272,2018-07-20,대웅제약수평적조직문화앞장소통경영눈길,http://www.newsprime.co.kr/news/article.html?no=423600
2273,2018-07-20,대웅제약전승호윤재춘사장소통경영위해비어파티소통점심진행,http://news.mk.co.kr/newsRead.php?year=2018&no=458061
2274,2018-07-20,대웅제약수평적이고자유로운소통경영,http://www.ftoday.co.kr/news/articleView.html?idxno=101352
2275,2018-07-20,대웅제약수평적이고자유로운소통경영눈길,http://www.bokuennews.com/news/article.html?no=162729
2276,2018-07-20,대웅제약임원직원들과자유로운소통위한이벤트눈길,http://www.k-health.com/news/articleView.html?idxno=37064
2277,2018-07-20,대웅제약신규도입제품의본격적인매출창출은2분기부터,http://www.newsworks.co.kr/news/articleView.html?idxno=202138
2278,2018-07-20,대웅제약소통경영눈길비어파티통해회사방향성등논의,http://www.100ssd.co.kr/news/articleView.html?idxno=55137
2279,2018-07-20,대웅제약수평적소통경영소통점심비어파티로실천,http://www.ntoday.co.kr/news/articleView.html?idxno=62539
2280,2018-07-20,소통점심비어파티등수평적이고자유로운대웅제약소통경영화제,http://www.businesskorea.co.kr/news/articleView.html?idxno=23818
2281,2018-07-20,오늘의JOB속보빅텍기아자동차대웅제약外,http://www.news2day.co.kr/107588
2282,2018-07-20,대웅제약수평적이고자유로운소통경영,http://www.wsobi.com/news/articleView.html?idxno=62818
2283,2018-07-20,대웅제약수평적이고자유로운소통경영,http://www.newscj.com/news/articleView.html?idxno=539288
2284,2018-07-21,通하였습니다대웅제약수평적이고자유로운소통경영,http://www.segye.com/content/html/2018/07/20/20180720001050.html?OutUrl=naver
2285,2018-07-21,뉴스투데이L대웅제약수평적자유로운소통경영펼쳐,http://www.news2day.co.kr/107556
2286,2018-07-22,대웅제약임직원과함꼐하는소통경영실천,http://www.metroseoul.co.kr/news/newsview?newscd=2018072000024
2287,2018-07-22,대웅제약수평적이고자유로운소통경영,http://www.kpanews.co.kr/article/show.asp?idx=195586&table=article&category=D
2288,2018-07-22,대웅제약수평적이고자유로운소통문화이어간다,http://www.lawissue.co.kr/view.php?ud=201807221603285362d7f4c63cc6_12
2289,2018-07-23,대웅글리아타민1위한미로수젯증가율톱,http://www.dailymedi.com/detail.php?number=832819&thread=22r05
2290,2018-07-23,인물탐구윤재승대웅회장③철학개방성이성장을이끈다,http://www.news2day.co.kr/107644
2291,2018-07-23,대웅제약7월27일금까지신입사원정규직계약직모집,http://www.ekn.kr/news/article.html?no=376132
2292,2018-07-24,오늘의추천종목유안타증권대웅제약아우딘퓨쳐스등,http://www.asiatoday.co.kr/view.php?key=20180724010013184
2293,2018-07-24,제약기업대해부대웅①형들제친윤재승회장경영능력입증은별개,http://www.newsway.co.kr/news/view?tp=1&ud=2018070515273009360
2294,2018-07-24,대웅제약아세트아미노펜함유이지엔6에이스시판승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=327466
2295,2018-07-24,대웅제약이지듀특별한선크림선보여,http://sports.chosun.com/news/ntype.htm?id=201807240100220510016811&servicedate=20180724
2296,2018-07-24,대웅제약이지듀이지썬2종출시,http://www.metroseoul.co.kr/news/newsview?newscd=2018072400022
2297,2018-07-24,대웅제약이지듀특별한선크림이지썬2종출시,http://news.donga.com/3/all/20180724/91192772/2
2298,2018-07-24,대웅제약이지듀멀티자외선차단제2종출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=327618
2299,2018-07-25,제약기업대해부대웅②윤재승회장개인회사만10여개대웅과거래로돈방석,http://www.newsway.co.kr/news/view?tp=1&ud=2018070916080466686
2300,2018-07-25,대웅제약전일대비약3하락한174500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807250190&t=NN
2301,2018-07-25,대웅제약이지듀이지썬2종출시,http://www.bokuennews.com/news/article.html?no=162910
2302,2018-07-25,베트남제약사트라파코대웅제약지사장이사선임,http://www.ceoscoredaily.com/news/article.html?no=43870
2303,2018-07-25,대웅제약베트남BIG2제약사트라파코사투자협력통해현지사업혁신주도,http://www.asiatime.co.kr/news/articleView.html?idxno=190295
2304,2018-07-25,대웅제약베트남빅2제약사트라파코와투자협력,http://www.medicaltimes.com/News/1120103
2305,2018-07-25,대웅베트남2대제약사투자협력,http://www.bosa.co.kr/news/articleView.html?idxno=2087328
2306,2018-07-25,대웅베트남BIG2제약사트라파코社투자협력,http://www.kpanews.co.kr/article/show.asp?idx=195742&table=article&category=D
2307,2018-07-25,대웅제약베트남투자제약사트라파코경영참여현지서제품생산등사업혁신,http://www.businesskorea.co.kr/news/articleView.html?idxno=23884
2308,2018-07-25,대웅제약베트남빅2제약트라파코社투자현지사업혁신,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220554
2309,2018-07-25,대웅제약베트남상위사지분인수사업운영참여,http://medipana.com/news/news_viewer.asp?NewsNum=223178&MainKind=A&NewsKind=5&vCount=12&vKind=1
2310,2018-07-25,대웅제약베트남현지회사경영참여,http://www.medical-tribune.co.kr/news/articleView.html?idxno=80492
2311,2018-07-25,대웅제약베트남지사장트라파코社이사진합류경영참여,http://www.newspim.com/news/view/20180725000388
2312,2018-07-25,대웅제약베트남메이저제약사와투자협력현지사업혁신가속도,http://www.segye.com/content/html/2018/07/25/20180725003214.html?OutUrl=naver
2313,2018-07-25,대웅제약트라파코투자협력통해베트남시장공략,http://www.k-health.com/news/articleView.html?idxno=37119
2314,2018-07-25,대웅제약베트남제약사트라파코경영참여현지사업확장추진,http://www.viva100.com/main/view.php?key=20180725010009330
2315,2018-07-25,대웅제약전략적투자한베트남2위제약사이사회감리위참여키로,http://news.mk.co.kr/newsRead.php?year=2018&no=467661
2316,2018-07-25,뉴스투데이E대웅제약베트남제약사트라파코社투자협력으로현지사업혁신,http://www.news2day.co.kr/107785
2317,2018-07-25,대웅제약베트남2위제약사트라파코와투자협력,http://news.hankyung.com/article/2018072577766
2318,2018-07-25,대웅제약전략적투자한베트남제약사이사회감리위참여,http://view.asiae.co.kr/news/view.htm?idxno=2018072514362711502
2319,2018-07-25,대웅제약베트남2위제약사경영참여동남아시장공략가속화,http://biz.chosun.com/site/data/html_dir/2018/07/25/2018072501642.html
2320,2018-07-25,대웅제약베트남최대제약사트라파코투자협력,http://www.mdtoday.co.kr/mdtoday/index.html?no=327699
2321,2018-07-25,대웅제약베트남제약사트라파코와투자협력사업혁신,http://www.medisobizanews.com/news/articleView.html?idxno=54411
2322,2018-07-25,대웅제약베트남제약사에전략투자현지사업혁신,http://www.wolyo.co.kr/news/articleView.html?idxno=65019
2323,2018-07-25,대웅제약베트남빅2제약사트라파코와투자협력,http://www.dailian.co.kr/news/view/728377/?sc=naver
2324,2018-07-25,대웅제약베트남BIG2제약사트라파코社투자협력통해현지사업혁신,http://www.getnews.co.kr/news/articleView.html?idxno=85829
2325,2018-07-25,대웅제약베트남제약사트라파코社에투자협력,http://www.mhj21.com/sub_read.html?uid=115360§ion=sc243
2326,2018-07-25,대웅제약베트남상위제약사트라파코경영참여,http://news1.kr/articles/?3381670
2327,2018-07-25,대웅제약베트남최대제약사경영참여혁신성장”,http://www.sisa-news.com/news/article.html?no=113671
2328,2018-07-25,대웅제약베트남2위제약사트라파코와투자협력2020년1위도약목표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1645396
2329,2018-07-25,대웅제약베트남현지사업강화나서,http://www.monews.co.kr/news/articleView.html?idxno=117358
2330,2018-07-25,대웅제약베트남상위제약사투자나서,http://www.ajunews.com/view/20180725153720543
2331,2018-07-25,대웅제약베트남빅2제약사트라파코와투자협력혁신성장새모델,http://moneys.mt.co.kr/news/mwView.php?no=2018072516188042446
2332,2018-07-25,대웅제약베트남2위제약사트라파코와투자협력,http://www.newsway.co.kr/news/view?tp=1&ud=2018072516305488702
2333,2018-07-25,대웅제약베트남제약사트라파코투자협력현지사업혁신,http://www.enewstoday.co.kr/news/articleView.html?idxno=1215631
2334,2018-07-25,대웅제약베트남2위제약사트라파코투자협력현지사업혁신본격화,http://www.g-enews.com/ko-kr/news/article/news_all/20180725164458350e6a49afa8d_1/article.html
2335,2018-07-25,대웅제약베트남2위제약사트라파코경영참여,http://www.kormedi.com/news/news/drug_dist/1228431_2906.html
2336,2018-07-25,대웅제약베트남유명제약사트라파코社와투자협력통해현지사업혁신모색,http://www.newsbrite.net/news/view.php?no=17433
2337,2018-07-25,대웅베트남2위제약사와투자협력확대,http://www.dailymedi.com/detail.php?number=832937&thread=22r05
2338,2018-07-25,대웅제약베트남2위제약사와투자협력현지화박차,http://www.edaily.co.kr/news/newspath.asp?newsid=05156166619278128
2339,2018-07-25,대웅제약베트남현지업체트라파코경영참여한다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=124615
2340,2018-07-25,대웅제약베트남Big2제약사트라파코투자협력통해현지사업혁신,http://www.ftoday.co.kr/news/articleView.html?idxno=101510
2341,2018-07-25,대웅제약베트남트라파코투자협력해외사업혁신모델제시,http://www.newstomato.com/ReadNews.aspx?no=837954
2342,2018-07-25,대웅제약베트남현지제약사혁신지원,http://www.whosaeng.com/sub_read.html?uid=103239§ion=sc5
2343,2018-07-26,대웅제약베트남BIG2제약사트라파코社투자협력통해현지사업혁신,http://www.lawissue.co.kr/view.php?ud=201807252324052382d7f4c63cc6_12
2344,2018-07-26,OCI바이오진출사령탑에최수진전대웅연구소장,http://www.dailypharm.com/News/242227
2345,2018-07-26,제약기업대해부대웅③윤재승회장때아닌갑질논란기업이미지실추불가피,http://www.newsway.co.kr/news/view?tp=1&ud=2018071111441974393
2346,2018-07-26,오락가락글리아타민상표소송대웅최종승소,http://medipana.com/news/news_viewer.asp?NewsNum=223250&MainKind=A&NewsKind=5&vCount=12&vKind=1
2347,2018-07-26,대웅바이오글리아타민상표권등록무효소송상고심에서승소,http://www.k-health.com/news/articleView.html?idxno=37158
2348,2018-07-26,대웅바이오글리아타민상표권상고심승소,http://www.newsprime.co.kr/news/article.html?no=424231
2349,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://www.newspim.com/news/view/20180726000406
2350,2018-07-26,대웅바이오글리아타민상표권상고심勝법원글리아타민글리아티린유사하지않아,http://www.segye.com/content/html/2018/07/26/20180726002353.html?OutUrl=naver
2351,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.bosa.co.kr/news/articleView.html?idxno=2087414
2352,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.kukinews.com/news/article.html?no=570447
2353,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.bosa.co.kr/news/articleView.html?idxno=2087414
2354,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://www.businesskorea.co.kr/news/articleView.html?idxno=23925
2355,2018-07-26,대웅바이오글리아타민상표권소송상고심서승소,http://www.medisobizanews.com/news/articleView.html?idxno=54435
2356,2018-07-26,한숨돌린대웅바이오글리아타민상표권되찾았다,http://www.medicaltimes.com/News/1120143
2357,2018-07-26,대웅바이오글리아타민상표권소송승소,http://www.polinews.co.kr/news/article.html?no=362796
2358,2018-07-26,글리아타민상표권두고대웅바이오상고심서승소,http://www.mdtoday.co.kr/mdtoday/index.html?no=327800
2359,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://news.hankyung.com/article/2018072620886
2360,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018072611400695452
2361,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.newsway.co.kr/news/view?tp=1&ud=2018072613335386519
2362,2018-07-26,대웅바이오글리아타민상표권승소,http://www.100ssd.co.kr/news/articleView.html?idxno=55237
2363,2018-07-26,대웅바이오뇌기능개선제글리아타민명칭계속쓴다,http://www.ceoscoredaily.com/news/article.html?no=43956
2364,2018-07-26,대웅바이오글리아타민상표권상고심승소,http://www.etoday.co.kr/news/section/newsview.php?idxno=1645868
2365,2018-07-26,대웅바이오글리아타민상표권상고심승소,http://www.dt.co.kr/contents.html?article_no=2018072602109931102001&ref=naver
2366,2018-07-26,대웅바이오손들어준法글리아티린글리아타민다르다”,http://www.mhj21.com/sub_read.html?uid=115378§ion=sc243
2367,2018-07-26,대웅바이오글리아타민상표권상고심서이탈파마코에승소,http://moneys.mt.co.kr/news/mwView.php?no=2018072613538070998
2368,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.mediapen.com/news/view/371894
2369,2018-07-26,대법원간글리아타민상표권소송대웅승勝,http://www.dailymedi.com/detail.php?number=832968&thread=22r05
2370,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://news.mt.co.kr/mtview.php?no=2018072614040735240
2371,2018-07-26,대웅바이오글리아타민상표권분쟁상고심서승소,http://www.wolyo.co.kr/news/articleView.html?idxno=65104
2372,2018-07-26,대웅바이오글리아타민상표권상소심승소,http://www.kormedi.com/news/news/drug_dist/1228451_2906.html
2373,2018-07-26,대웅바이오상표권상고심승소글리아타민써도된다,http://news1.kr/articles/?3382759
2374,2018-07-26,대웅바이오글리아타민상표권소송승리,http://www.medical-tribune.co.kr/news/articleView.html?idxno=80521
2375,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.bokuennews.com/news/article.html?no=162993
2376,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.edaily.co.kr/news/newspath.asp?newsid=04145926619278456
2377,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://www.enewstoday.co.kr/news/articleView.html?idxno=1216015
2378,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.sisaon.co.kr/news/articleView.html?idxno=75706
2379,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.metroseoul.co.kr/news/newsview?newscd=2018072600127
2380,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.rapportian.com/news/articleView.html?idxno=111944
2381,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://www.etnews.com/20180726000384
2382,2018-07-26,대웅바이오글리아타민상표권소송최종승소,http://www.whosaeng.com/sub_read.html?uid=103269§ion=sc5
2383,2018-07-26,대웅바이오뇌기능개선제상표권소송서오리지널사에승소,http://news.mk.co.kr/newsRead.php?year=2018&no=470971
2384,2018-07-26,대웅바이오양병국대표글리아타민상표권상고심승소는향후제네릭기준될것,http://www.news2day.co.kr/107870
2385,2018-07-26,대웅바이오글리아타민상표권상고심에서승소,http://www.ajunews.com/view/20180726140037100
2386,2018-07-26,대웅바이오글리아타민상표권분쟁승소,http://www.monews.co.kr/news/articleView.html?idxno=117443
2387,2018-07-26,대웅바이오글리아타민상표권소송승소,http://www.finomy.com/news/articleView.html?idxno=56645
2388,2018-07-26,편법증여구설오른대웅제약윤영환회장일가,http://www.sisajournal.com/article/176537
2389,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807260499&t=NN
2390,2018-07-26,대웅바이오글리아타민상표권상고심서승소,http://www.betanews.net:8080/article/886992.html
2391,2018-07-26,대웅바이오글리아타민상표권상고심서이탈리아제약사에승소,http://www.seoulwire.com/news/articleView.html?idxno=20459
2392,2018-07-26,대웅바이오뇌기능개선제상표권소송서승소,http://www.dailian.co.kr/news/view/728831/?sc=naver
2393,2018-07-26,대웅바이오글리아타민상표권관련상고심에서승소해,http://www.tourtimes.net/sub_read.html?uid=49326§ion=sc40
2394,2018-07-26,대법원대웅글리아타민상표권침해아니다,http://news.hankyung.com/article/201807263507f
2395,2018-07-26,대웅바이오글리아타민상표권상고심승소,http://www.ftoday.co.kr/news/articleView.html?idxno=101541
2396,2018-07-26,대웅제약자회사대웅바이오뇌기능개선제상표권소송에서이겨,http://www.businesspost.co.kr/BP?command=article_view&num=90503
2397,2018-07-26,대웅바이오글리아타민상표권상고심이겼다,http://www.seoulfn.com/news/articleView.html?idxno=315335
2398,2018-07-26,대웅바이오손들어준대법원글리아타민과글리아티린달라,http://www.wsobi.com/news/articleView.html?idxno=63018
2399,2018-07-27,대웅바이오글리아타민상표권상고심에서승소,http://www.lawissue.co.kr/view.php?ud=201807262326024301d7f4c63cc6_12
2400,2018-07-27,대웅바이오글리아타민상표권상고심에서승소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220638
2401,2018-07-27,대웅제약베트남공략현지제약사경영참여,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058570
2402,2018-07-27,플러스알파가필요한대웅제약한국,http://news.hankyung.com/article/2018072746586
2403,2018-07-27,대웅제약목표가23만원유지전일종가17만8000원한투證,http://www.newspim.com/news/view/20180727000048
2404,2018-07-27,퀵리포트대웅제약매수유지목표가23만원유지한투證,http://www.itooza.com/common/iview.php?no=2018072707343593030
2405,2018-07-27,대웅제약2분기영업익기대치하회나보타효과지연,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018072708054100361&LinkID=632&objId=A2018072708054100361&portalCode=naver
2406,2018-07-27,제약톡톡글리아타민특허소송대웅바이오최종승소,http://news.heraldcorp.com/view.php?ud=20180727000029
2407,2018-07-27,대웅제약베트남2위제약사트라파코와투자협력,http://www.viva100.com/main/view.php?key=20180726010010109
2408,2018-07-27,대웅전일대비약4상승한15300원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807270284&t=NN
2409,2018-07-27,한경로보뉴스대웅제약5이상상승20181Q매출액2394억60영업이익54억90,http://news.hankyung.com/article/201807276324L
2410,2018-07-27,ET투자뉴스대웅제약지금은알파가필요매수유지한국투자증권,http://www.etnews.com/20180727000177
2411,2018-07-27,제약업계올해상반기3286명신규채용GC녹십자한미대웅順,http://www.newsis.com/view/?id=NISX20180727_0000376200&cID=13001&pID=13000
2412,2018-07-27,대웅바이오글리아티민상표권상고심서승소,http://www.newspost.kr/news/articleView.html?idxno=64588
2413,2018-07-28,제약업계올해상반기3286명신규채용GC녹십자한미대웅휴온스종근당順,http://www.econonews.co.kr/news/articleView.html?idxno=30571
2414,2018-07-30,윤재승회장의대웅제약글로벌도전14년다양한비즈니스모델과로컬라이제이션펼쳐,http://www.lawissue.co.kr/view.php?ud=20180730104636305d7f4c63cc6_12
2415,2018-07-30,인물탐구윤재승대웅회장④쟁점메디톡스와의나보타전쟁향배,http://www.news2day.co.kr/108032
2416,2018-07-30,메디톡스대웅제약보톡스균주출처소송4차변론감정기관선정관심사,http://www.etnews.com/20180730000449
2417,2018-07-30,대웅바이오글리아타민상표권상고심에서승소,http://www.asiatime.co.kr/news/articleView.html?idxno=191139
2418,2018-07-30,윤재승대웅제약회장나보타로글로벌리딩의약품도전,http://www.newspim.com/news/view/20180730000559
2419,2018-07-30,국고처김종철종목상담대웅제약069620,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201807280035&t=NNv
2420,2018-07-31,CJ헬스케어이노베이션센터장에한용해전대웅제약본부장,http://www.medisobizanews.com/news/articleView.html?idxno=54520
2421,2018-07-31,윤재승대웅제약회장글로벌50위권진입목표신약개발거침없는도전,http://www.g-enews.com/ko-kr/news/article/news_all/201807301046215858c176748603_1/article.html
2422,2018-07-31,대웅출신1조원대기업회장의대웅출신RD책임자발탁,http://www.yakup.com/news/index.html?mode=view&cat=15&nid=220781
2423,2018-08-01,영월영월군대웅생명과학100억투자이행하라”,http://www.kado.net/?mod=news&act=articleView&idxno=923667
2424,2018-08-01,대웅전일대비약4상승한15250원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808010182&t=NN
2425,2018-08-01,한경로보뉴스대웅5이상상승이시간비교적거래활발34649주거래중,http://news.hankyung.com/article/201808010109L
2426,2018-08-02,대웅제약메디톡스보톡스균주논쟁감정기관선정에관심쏠려,http://www.mdtoday.co.kr/mdtoday/index.html?no=328436
2427,2018-08-03,대웅제약나보타내년2월미국허가기대NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1648723
2428,2018-08-03,대웅제약나보타미국허가유력,http://www.asiatoday.co.kr/view.php?key=20180803010001420
2429,2018-08-03,대웅제약나보타미국허가시점은늦어도내년2월”,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018080308072000255&LinkID=632&objId=A2018080308072000255&portalCode=naver
2430,2018-08-03,I리포트대웅제약나보타미국허가유력–NH證,http://www.inews24.com/php/news_view.php?g_serial=1114448&g_menu=022300&rrf=nv
2431,2018-08-03,아주종목분석대웅제약나보타미국허가유력,http://www.ajunews.com/view/20180803082207898
2432,2018-08-03,퀵리포트대웅제약매수유지목표가17↑27만원이베스트證,http://www.itooza.com/common/iview.php?no=2018080308330015749
2433,2018-08-03,대웅제약목표가17↑27만원제시이베스트證,http://www.newspim.com/news/view/20180803000081
2434,2018-08-03,HotLine대웅제약나보타의미국시판허가가능성80이상,http://news.mk.co.kr/newsRead.php?year=2018&no=487379
2435,2018-08-03,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018080308484013666
2436,2018-08-03,대웅제약목표가27만원유지전일종가18만500원NH證,http://www.newspim.com/news/view/20180803000093
2437,2018-08-03,대웅제약전일대비약5상승한190000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808030076&t=NN
2438,2018-08-03,ET투자뉴스대웅제약나보타DWP45BUY유지NH투자증권,http://www.etnews.com/20180803000018
2439,2018-08-03,특징주대웅제약美나보타판매허가가능성높아져강세,http://news.mt.co.kr/mtview.php?no=2018080309032202035
2440,2018-08-03,대웅제약내년초나보타FDA승인예상목표가↑”이베스트,http://www.dailian.co.kr/news/view/730296/?sc=naver
2441,2018-08-03,한경로보뉴스대웅제약5이상상승NH투자미래에셋등매수창구상위에랭킹,http://news.hankyung.com/article/201808037018L
2442,2018-08-03,한경로보뉴스대웅5이상상승20181Q매출액2880억96영업이익186억242,http://news.hankyung.com/article/201808037017L
2443,2018-08-03,대웅제약나보타내년2월미국허가유력NH,http://www.edaily.co.kr/news/newspath.asp?newsid=01744966619303712
2444,2018-08-03,대웅전일대비약6상승한15900원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808030084&t=NN
2445,2018-08-03,특징주대웅제약美나보타판매허가가능성에상승세NH,http://www.fnnews.com/news/201808030852062004
2446,2018-08-03,대웅제약나보타내년2월미국허가기대NH,http://www.cstimes.com/?mod=news&act=articleView&idxno=282404
2447,2018-08-03,대웅제약나보타미국허가유력NH투자증권,http://www.ebn.co.kr/news/view/950804
2448,2018-08-03,대웅제약주가오른다미국에서보톡스나보타판매임박,http://www.businesspost.co.kr/BP?command=article_view&num=91394
2449,2018-08-03,특징주대웅제약나보타의美허가유력소식에강세,http://www.newsis.com/view/?id=NISX20180803_0000381637&cID=10401&pID=10400
2450,2018-08-03,특징주대웅제약나보타美판매허가가능성에상승,http://www.edaily.co.kr/news/newspath.asp?newsid=01872886619303712
2451,2018-08-03,특징주대웅제약美나보타2월허가가능성에주가방긋,http://www.newsprime.co.kr/news/article.html?no=425149
2452,2018-08-03,ET투자뉴스대웅제약_거래비중기관2352외국인2443,http://www.etnews.com/20180803000038
2453,2018-08-03,유대웅전일대비867상승일일회전율은017기록,http://www.sedaily.com/NewsView/1S37TECTHV
2454,2018-08-03,대웅제약에볼루스FDA허가보류보완자료제출소식에강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=328594
2455,2018-08-03,특징주대웅제약나보타의美허가유력소식에오름세,http://www.seoulfn.com/news/articleView.html?idxno=315989
2456,2018-08-03,대웅제약나보타미국시장진출본격돌입,http://www.seoulwire.com/news/articleView.html?idxno=21462
2457,2018-08-03,대웅13급등전일보다1950원상승한16950원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808030155&t=NN
2458,2018-08-03,특징주대웅제약나보타미국허가기대감에강세,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018080310050800838&LinkID=632&objId=A2018080310050800838&portalCode=naver
2459,2018-08-03,대웅제약FDA에나보타보완자료제출심사재개,http://www.dailypharm.com/News/242506
2460,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://medipana.com/news/news_viewer.asp?NewsNum=223599&MainKind=A&NewsKind=5&vCount=12&vKind=1
2461,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.medicaltimes.com/News/1120285
2462,2018-08-03,유대웅제약전일대비1053상승일일회전율은087기록,http://www.sedaily.com/NewsView/1S37TPM8RY
2463,2018-08-03,대웅제약美FDA에나보타보완자료제출내년상반기허가예상,http://www.newspim.com/news/view/20180803000158
2464,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=220871
2465,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.newsis.com/view/?id=NISX20180803_0000381705&cID=13001&pID=13000
2466,2018-08-03,대웅제약나보타시판허가보완자료FDA제출,http://www.newsprime.co.kr/news/article.html?no=425163
2467,2018-08-03,대웅제약나보타FDA허가보완자료제출내년상반기허가여부결정,http://www.ceoscoredaily.com/news/article.html?no=44362
2468,2018-08-03,대웅제약보툴리눔톡신나보타美FDA보완자료제출,http://biz.chosun.com/site/data/html_dir/2018/08/03/2018080301045.html
2469,2018-08-03,대웅제약나보타FDA심사재개신청,http://www.kpinews.co.kr/news/articleView.html?idxno=78673
2470,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.biospectator.com/view/news_view.php?varAtcId=5955
2471,2018-08-03,대웅제약나보타FDA허가보완자료제출미국진출막바지단계,http://www.etoday.co.kr/news/section/newsview.php?idxno=1648882
2472,2018-08-03,ET투자뉴스대웅제약나보타ResubmBUYUPGRADE이베스트투자증권,http://www.etnews.com/20180803000096
2473,2018-08-03,특징주대웅제약나보타美판매허가기대에강세,http://biz.chosun.com/site/data/html_dir/2018/08/03/2018080301113.html
2474,2018-08-03,대웅제약나보타미국진출막바지돌입,http://jedam15.koreafree.co.kr/news/view.html?section=1&category=3&item=&no=43639
2475,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808030181&t=NN
2476,2018-08-03,대웅제약보톡스나보타FDA심사재개신청,http://www.edaily.co.kr/news/newspath.asp?newsid=02335366619303712
2477,2018-08-03,대웅제약나보타미국허가위한최종보완자료제출,http://news.mk.co.kr/newsRead.php?year=2018&no=487821
2478,2018-08-03,대웅나보타미FDA승인내년상반기결정,http://www.medical-tribune.co.kr/news/articleView.html?idxno=80638
2479,2018-08-03,대웅제약나보타美FDA허가보완자료제출완료,http://www.ftoday.co.kr/news/articleView.html?idxno=101768
2480,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://news.mt.co.kr/mtview.php?no=2018080310541342985
2481,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.asiatoday.co.kr/view.php?key=20180803010001557
2482,2018-08-03,나보타미국시판가를FDA허가심사재개대웅제약보완자료제출완료,http://www.businesskorea.co.kr/news/articleView.html?idxno=24089
2483,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.asiatime.co.kr/news/articleView.html?idxno=191923
2484,2018-08-03,대웅제약나보타FDA허가보완자료제출,http://www.sisajournal-e.com/biz/article/187389
2485,2018-08-03,대웅제약나보타미국시장진출막바지돌입,http://www.viva100.com/main/view.php?key=20180803020023093
2486,2018-08-03,대웅제약나보타미국FDA허가보완자료제출완료,http://moneys.mt.co.kr/news/mwView.php?no=2018080311178058664
2487,2018-08-03,대웅제약美FDA에나보타보완자료제출내년상반기허가,http://www.medisobizanews.com/news/articleView.html?idxno=54596
2488,2018-08-03,대웅제약나보타美FDA허가심사재개,http://www.dailymedi.com/detail.php?number=833223&thread=22r05
2489,2018-08-03,대웅제약나보타FDA허가보완자료제출,http://www.wolyo.co.kr/news/articleView.html?idxno=65614
2490,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.medigatenews.com/news/1470982488
2491,2018-08-03,대웅제약나보타美FDA허가보완자료제출,http://news1.kr/articles/?3389718
2492,2018-08-03,대웅제약나보타미국시판보완자료제출,http://www.choicenews.co.kr/news/articleView.html?idxno=43510
2493,2018-08-03,대웅제약나보타미국시판허가내년상반기결정전망,http://www.seoulfn.com/news/articleView.html?idxno=316019
2494,2018-08-03,대웅제약나보타미국시장진출막바지단계돌입,http://www.kpanews.co.kr/article/show.asp?idx=195957&table=article&category=D
2495,2018-08-03,대웅제약FDA에나보타허가보완자료제출,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058884
2496,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.bosa.co.kr/news/articleView.html?idxno=2087858
2497,2018-08-03,대웅제약보툴리눔톡신나보타美FDA보완자료제출,http://view.asiae.co.kr/news/view.htm?idxno=2018080313070264412
2498,2018-08-03,대웅제약나보타美시장진출막바지단계돌입FDA허가보완자료제출완료,http://www.enewstoday.co.kr/news/articleView.html?idxno=1218552
2499,2018-08-03,대웅제약FDA에나보타허가보완자료제출완료,http://www.newstomato.com/ReadNews.aspx?no=839606
2500,2018-08-03,대웅제약나보타심사재개신청내년2월초승인예상,http://www.newsworks.co.kr/news/articleView.html?idxno=205362
2501,2018-08-03,대웅제약보완자료제출완료CMC이슈해소,http://www.newsworks.co.kr/news/articleView.html?idxno=205369
2502,2018-08-03,대웅제약나보타美FDA허가보완자료제출완료,http://www.mdtoday.co.kr/mdtoday/index.html?no=328625
2503,2018-08-03,특징주대웅제약나보타美허가가능성에강세,http://www.sporbiz.co.kr/news/articleView.html?idxno=259858
2504,2018-08-03,대웅제약나보타FDA허가보완자료제출,http://www.fnnews.com/news/201808031137495903
2505,2018-08-03,대웅제약나보타내년초FDA승인기대,http://www.econovill.com/news/articleView.html?idxno=343090
2506,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.ekn.kr/news/article.html?no=378315
2507,2018-08-03,대웅제약FDA에나보타허가보완자료제출완료,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018080314274147290
2508,2018-08-03,대웅제약내년초나보타FDA승인예상,http://www.etnews.com/20180803000225
2509,2018-08-03,대웅제약FDA에나보타보완자료제출,http://www.100ssd.co.kr/news/articleView.html?idxno=55454
2510,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.metroseoul.co.kr/news/newsview?newscd=2018080300061
2511,2018-08-03,대웅제약나보타美판매허가내년상반기결판,http://www.finomy.com/news/articleView.html?idxno=56886
2512,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.m-i.kr/news/articleView.html?idxno=440467
2513,2018-08-03,대웅제약나보타美판매허가보완자료제출,http://www.sporbiz.co.kr/news/articleView.html?idxno=259892
2514,2018-08-03,대웅제약나보타FDA허가보완자료제출완료내년허가예상,http://www.getnews.co.kr/news/articleView.html?idxno=87747
2515,2018-08-03,대웅제약나보타美FDA허가보완자료제출,http://www.dailian.co.kr/news/view/730443/?sc=naver
2516,2018-08-03,대웅제약나보타FDA허가보완자료제출미국진출막바지,http://www.newspost.kr/news/articleView.html?idxno=64718
2517,2018-08-03,NH투자증권대웅제약나보타美시판허가임박,http://www.newsprime.co.kr/news/article.html?no=425233
2518,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.newsbrite.net/news/view.php?no=17579
2519,2018-08-03,뉴스투데이E대웅제약나보타FDA시판허가내년상반기가능허가보완자료제출완료,http://www.news2day.co.kr/108372
2520,2018-08-03,대웅제약보톡스나보타美FDA허가보완자료제출완료,http://www.insight.co.kr/news/170184
2521,2018-08-03,대웅제약나보타FDA허가보완자료제출완료,http://www.wsobi.com/news/articleView.html?idxno=63182
2522,2018-08-03,대웅제약나보타미국진출막바지,http://www.monews.co.kr/news/articleView.html?idxno=117724
2523,2018-08-04,대웅잇몸에붙이는구순포진치료제시타빅허가,http://www.dailypharm.com/News/242519
2524,2018-08-04,대웅제약잇몸에부착하는구순포진치료제내놓는다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058922
2525,2018-08-04,대웅제약보툴리눔톡신나보타FDA허가보완자료제출완료,http://www.econonews.co.kr/news/articleView.html?idxno=31299
2526,2018-08-05,대웅제약나보타美FDA허가보완자료제출내년상반기허가예상,http://www.segye.com/content/html/2018/08/04/20180804001376.html?OutUrl=naver
2527,2018-08-06,영월영월군대웅생명과학에100억투자촉구공문,http://www.kado.net/?mod=news&act=articleView&idxno=924271
2528,2018-08-06,대웅제약나보타FDA승인마지막고비,http://www.sportsworldi.com/content/html/2018/08/05/20180805541440.html
2529,2018-08-06,대웅제약FDA에나보타시판허가위한보완자료제출,http://www.k-health.com/news/articleView.html?idxno=37254
2530,2018-08-06,빅데이터MSI시장심리톱5대림산업동원FB삼성전자SK텔레콤대웅제약,http://www.newsis.com/view/?id=NISX20180806_0000383118&cID=10401&pID=10400
2531,2018-08-06,대웅제약나보타美FDA허가보완자료제출완료,http://www.kukinews.com/news/article.html?no=573512
2532,2018-08-06,대웅제약나보타내년상반기FDA허가기대,http://www.bokuennews.com/news/article.html?no=163230
2533,2018-08-06,대웅제약나보타2019년상반기미국진출,http://www.rapportian.com/news/articleView.html?idxno=112087
2534,2018-08-06,유한GC녹십자연매출1조달성할듯한미종근당대웅은,http://www.sisajournal-e.com/biz/article/187488
2535,2018-08-06,대웅제약소통경영으로수평적조직문화만들기매진,http://www.koreaittimes.com/news/articleView.html?idxno=84953
2536,2018-08-06,잠정실적대웅제약올해2Q영업익100억전년비284↓,http://www.itooza.com/common/iview.php?no=2018080617221317566
2537,2018-08-06,대웅제약2분기영업익100억원283감소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180806130900008&did=1195m
2538,2018-08-06,대웅제약2Q영업익100억원전년比28감소,http://view.asiae.co.kr/news/view.htm?idxno=2018080617254490060
2539,2018-08-06,대웅제약올해2Q영업익100억전년비284↓,http://www.newspim.com/news/view/20180806000433
2540,2018-08-06,대웅제약2Q영업익100억원전년比28↓,http://www.edaily.co.kr/news/newspath.asp?newsid=04139366619304696
2541,2018-08-06,대웅제약2분기영업익100억원전년比283↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1649700
2542,2018-08-06,대웅제약2분기영업익100억원전년대비28감소,http://www.dailypharm.com/News/242565
2543,2018-08-06,대웅제약올해2분기영업이익100억원전년比283↓,http://news.mt.co.kr/mtview.php?no=2018080617340532675
2544,2018-08-06,대웅제약2분기영업익100억원전년비283감소,http://www.dailian.co.kr/news/view/730865/?sc=naver
2545,2018-08-06,공시대웅제약2분기영업이익100억원전년比283↓,http://www.newsway.co.kr/news/view?tp=1&ud=2018080617402233795
2546,2018-08-06,대웅제약2Q영업익100억전년比283↓,http://www.wolyo.co.kr/news/articleView.html?idxno=65719
2547,2018-08-06,우여곡절대웅제약나보타미국보톡스시장잡을까,http://www.sporbiz.co.kr/news/articleView.html?idxno=260413
2548,2018-08-06,대웅제약올2분기영업익100억원전년比283↓,http://daily.hankooki.com/lpage/economy/201808/dh20180806180507138080.htm
2549,2018-08-06,대웅제약2분기영업이익100억전년比24↓,http://www.newsis.com/view/?id=NISX20180806_0000383979&cID=10401&pID=10400
2550,2018-08-06,대웅제약2분기영업이익100억전년比283↓,http://www.newsworks.co.kr/news/articleView.html?idxno=205890
2551,2018-08-06,대웅제약2분기영업익100억원작년대비283감소,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018080617555296155
2552,2018-08-06,대웅제약2분기영업이익100억전년동기比28↓,http://www.nspna.com/news/?mode=view&newsid=298244
2553,2018-08-06,대웅제약2Q매출7늘고영업익28줄고,http://news1.kr/articles/?3391978
2554,2018-08-06,실적발표제이브이엠대웅제약코리아오토글라스,http://www.businesspost.co.kr/BP?command=article_view&num=91717
2555,2018-08-06,대웅제약2분기영업이익100억원전년비283↓,http://www.cstimes.com/?mod=news&act=articleView&idxno=282655
2556,2018-08-06,대웅제약2분기영업이익100억전년동기대비24감소,http://www.econonews.co.kr/news/articleView.html?idxno=31557
2557,2018-08-07,대웅제약붙이는구순포진치료제시타빅시판허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=328743
2558,2018-08-07,대웅제약2분기실적시장예상치하회목표가↓신한,http://news.hankyung.com/article/2018080768046
2559,2018-08-07,퀵리포트대웅제약매수유지목표가25만원유지유안타證,http://www.itooza.com/common/iview.php?no=2018080707312770571
2560,2018-08-07,대웅제약목표가25만원유지전일종가19만1000원유안타證,http://www.newspim.com/news/view/20180807000028
2561,2018-08-07,대웅제약실적개선은4분기에나신한금융투자,http://news.mt.co.kr/mtview.php?no=2018080707360693242
2562,2018-08-07,대웅제약내년나보타미국품목허가가능KTB투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1649790
2563,2018-08-07,퀵리포트대웅제약중립으로유지목표가미제시미래에셋대우,http://www.itooza.com/common/iview.php?no=2018080707421411363
2564,2018-08-07,퀵리포트대웅제약매수유지목표가25만원유지KTB證,http://www.itooza.com/common/iview.php?no=2018080708012910867
2565,2018-08-07,대웅제약목표가25만원유지전일종가19만1000원KTB證,http://www.newspim.com/news/view/20180807000053
2566,2018-08-07,퀵리포트대웅제약매수유지목표가27만원유지이베스트證,http://www.itooza.com/common/iview.php?no=2018080708050426971
2567,2018-08-07,대웅제약목표가27만원유지전일종가19만1000원이베스트證,http://www.newspim.com/news/view/20180807000056
2568,2018-08-07,대웅제약사상최고분기매출수익성은기대치하회,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018080708115800244&LinkID=632&objId=A2018080708115800244&portalCode=naver
2569,2018-08-07,대웅제약목표주가낮아져영업이익뒷걸음3분기도계속,http://www.businesspost.co.kr/BP?command=article_view&num=91724
2570,2018-08-07,대웅제약나보타미국진출로4분기영업이익증가예상신한,http://biz.chosun.com/site/data/html_dir/2018/08/07/2018080700493.html
2571,2018-08-07,I리포트대웅제약자회사RD성과기대미래에셋대우,http://www.inews24.com/php/news_view.php?g_serial=1115253&g_menu=022300&rrf=nv
2572,2018-08-07,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018080708325129902
2573,2018-08-07,대웅제약목표가27만원유지전일종가19만1000원NH證,http://www.newspim.com/news/view/20180807000077
2574,2018-08-07,대웅제약실적부진장기화할듯신한금융투자,http://www.sedaily.com/NewsView/1S39NYGZQ1
2575,2018-08-07,대웅제약3분기수익성부진전망목표가하향신한금투,http://www.newstomato.com/ReadNews.aspx?no=840093
2576,2018-08-07,대웅제약한올바이오파마RD기대주가엔이미반영미래에셋대우,http://www.fnnews.com/news/201808070844158752
2577,2018-08-07,대웅제약영업익3분기연속감소목표가↓신한투자,http://www.dailian.co.kr/news/view/730897/?sc=naver
2578,2018-08-07,대웅제약2분기영업이익100억2000만원283↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=328816
2579,2018-08-07,대웅제약나보타허가후사도늦지않다DB금융투자,http://www.fnnews.com/news/201808070858356990
2580,2018-08-07,ET투자뉴스대웅제약단기실적보다는BUYKTB투자증권,http://www.etnews.com/20180807000018
2581,2018-08-07,대웅제약2Q역대최고매출나보타보완서류긍정적DB,http://www.edaily.co.kr/news/newspath.asp?newsid=01790886619305024
2582,2018-08-07,특징주대웅제약2분기영업이익감소에하락세,http://www.ekn.kr/news/article.html?no=378834
2583,2018-08-07,ET투자뉴스대웅제약실적개선은4분기TRADINGBUY유지신한금융투자,http://www.etnews.com/20180807000023
2584,2018-08-07,ET투자뉴스대웅제약사상최대매출액BUY유지NH투자증권,http://www.etnews.com/20180807000028
2585,2018-08-07,특징주대웅제약2분기실적부진에하락,http://www.sporbiz.co.kr/news/articleView.html?idxno=260667
2586,2018-08-07,대웅제약영업익하락에도목표주가유지유안타證,http://www.ebn.co.kr/news/view/951109
2587,2018-08-07,ET투자뉴스대웅제약갈수록고조되는나BUYM유안타증권,http://www.etnews.com/20180807000041
2588,2018-08-07,대웅제약나보타美진출로4분기영업이익증가할것,http://www.insight.co.kr/news/170784
2589,2018-08-07,NH證대웅제약2분기사상최대매출액시현수익성감소에도하반기신약기대”,http://www.lawissue.co.kr/view.php?ud=2018080709185469139817d053b9_12
2590,2018-08-07,ET투자뉴스대웅제약2Q18실적매출BUYMAINTAIN이베스트투자증권,http://www.etnews.com/20180807000055
2591,2018-08-07,대웅제약역대최고분기매출,http://www.nspna.com/news/?mode=view&newsid=298321
2592,2018-08-07,ET투자뉴스대웅제약실적보다나보타HOLD유지DB금융투자,http://www.etnews.com/20180807000090
2593,2018-08-07,MSI급락주대웅제약2분기실적부진에시장심리급락,http://www.newsis.com/view/?id=NISX20180807_0000384471&cID=10401&pID=10400
2594,2018-08-07,신한금융투자대웅제약부진한수익성실적개선은4분기,http://www.newsprime.co.kr/news/article.html?no=425514
2595,2018-08-07,대웅제약2분기수익저조증권가하반기기대,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1058993
2596,2018-08-07,대웅1조클럽가입임박최대매출기록,http://www.dailymedi.com/detail.php?number=833332&thread=22r05
2597,2018-08-07,2Q잠정대웅제약사상최대매출영업익순익은컨센하회,http://www.itooza.com/common/iview.php?no=2018080712555634628
2598,2018-08-07,종목대웅제약역대최대매출에도주가시큰둥나보타에만쏠린눈,http://news.hankyung.com/article/2018080780906
2599,2018-08-07,대웅제약2분기매출액은기대치에부합영업이익은하회,http://www.newsworks.co.kr/news/articleView.html?idxno=206054
2600,2018-08-07,대웅제약CRL보완서류제출로美제품승인기대감고조,http://www.newsworks.co.kr/news/articleView.html?idxno=206067
2601,2018-08-07,대웅제약2분기실적호조에도약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=328879
2602,2018-08-07,대웅제약2018년누계매출액1조원돌파기대감↑,http://www.mdtoday.co.kr/mdtoday/index.html?no=328882
2603,2018-08-07,대웅제약실적개선은4분기,http://www.newsworks.co.kr/news/articleView.html?idxno=206108
2604,2018-08-07,대웅제약덩치는커지고수익성은악화2분기영업이익당기순이익감소,http://sports.khan.co.kr/news/sk_index.html?art_id=201808071551003&sec_id=561801&pt=nv
2605,2018-08-07,대웅제약역대최고분기매출영업이익은컨센서스하회,http://www.newsworks.co.kr/news/articleView.html?idxno=206139
2606,2018-08-07,대웅제약단기실적보다는나보타美진출현실화가우선,http://www.newsworks.co.kr/news/articleView.html?idxno=206145
2607,2018-08-07,3Q연속영업익감소대웅제약주가안떨어진이유는,http://www.edaily.co.kr/news/newspath.asp?newsid=03840886619305024
2608,2018-08-07,제약사2분기실적희비동아보령웃고녹십자대웅울고,http://www.finomy.com/news/articleView.html?idxno=56952
2609,2018-08-07,아주종목분석대웅제약나보타승인기대감커져,http://www.ajunews.com/view/20180807084747407
2610,2018-08-08,퀵리포트대웅제약매수유지목표가25만원유지골든브릿지證,http://www.itooza.com/common/iview.php?no=2018080807310149352
2611,2018-08-08,대웅제약목표가25만원유지전일종가19만2000원골든브릿지證,http://www.newspim.com/news/view/20180808000028
2612,2018-08-08,대웅제약하반기신약기대감↑NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1650234
2613,2018-08-08,HotLine대웅제약2분기수익성악화는글로벌진출투자개념,http://news.mk.co.kr/newsRead.php?year=2018&no=496118
2614,2018-08-08,더벨분기최대실적대웅제약9000억돌파가시화,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808070100011440000739
2615,2018-08-08,승승장구K바이오②대웅제약나보타내년상반기미국진출청신호,http://news.heraldcorp.com/view.php?ud=20180808000150
2616,2018-08-08,대웅제약신공장가동률상승으로수익성점차개선전망,http://www.newsworks.co.kr/news/articleView.html?idxno=206309
2617,2018-08-08,대웅제약2분기역대최고분기매출달성,http://www.kormedi.com/news/news/drug_dist/1228645_2906.html
2618,2018-08-08,보령겔포스대웅스멕타편의점판매안갯속,http://www.seoulfn.com/news/articleView.html?idxno=316375
2619,2018-08-09,치매치료제시장라이벌대웅종근당신약개발도후끈,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059111
2620,2018-08-09,오늘의JOB속보롯데건설대웅바이오한화손해보험현대자동차外,http://www.news2day.co.kr/108764
2621,2018-08-09,부음정원웅대웅건설대표씨모친상,http://www.cnews.co.kr/uhtml/read.jsp?idxno=201808091900003700355
2622,2018-08-10,윤재승대웅제약회장개인회사4곳소속은네이버내부거래도존재,http://www.ceoscoredaily.com/news/article.html?no=44539
2623,2018-08-10,2분기영업이익뚝떨어진대웅제약하반기엔내실다지기에주력,http://www.kpinews.co.kr/news/articleView.html?idxno=79151
2624,2018-08-11,대웅보령등제약株상승전망은편의점상비약혼조속반등,http://www.fnnews.com/news/201808091104168744
2625,2018-08-12,대웅제약쿨비즈룩으로무더위이겨낸다,http://www.edaily.co.kr/news/newspath.asp?newsid=01095526619306664
2626,2018-08-13,대웅제약종근당인지기능개선제시장두고경쟁본격화,http://www.mdtoday.co.kr/mdtoday/index.html?no=329265
2627,2018-08-14,고지혈당뇨복합제CJ대웅제일유한LG5파전,http://medipana.com/news/news_viewer.asp?NewsNum=223945&MainKind=A&NewsKind=5&vCount=12&vKind=1
2628,2018-08-14,한미강세한독유유대웅삼진동국약세,http://www.dailymedi.com/detail.php?number=833598&thread=22r05
2629,2018-08-14,실적속보대웅제약2Q영업이익85억전년비22↓,http://www.itooza.com/common/iview.php?no=2018081420421327003
2630,2018-08-14,대웅제약2분기연결영업이익85억전년비22↓,http://www.newspim.com/news/view/20180814001483
2631,2018-08-14,실적속보대웅2Q영업이익251억전년비3↑,http://www.itooza.com/common/iview.php?no=2018081420452592093
2632,2018-08-14,대웅2분기연결영업이익251억전년비3↑,http://www.newspim.com/news/view/20180814001517
2633,2018-08-15,대웅제약의한올바이오파마상반기영업이익19억흑자전환,http://www.econonews.co.kr/news/articleView.html?idxno=32656
2634,2018-08-16,대웅제약나보타글로벌시장서곰처럼일어설까,http://www.econovill.com/news/articleView.html?idxno=343915
2635,2018-08-16,겔포스스멕타편의점약지정되면보령대웅제약혜택볼까,http://www.sisajournal-e.com/biz/article/187913
2636,2018-08-17,대웅제약등8개업체금연치료제챔픽스염변경허가받아,http://www.mdtoday.co.kr/mdtoday/index.html?no=329648
2637,2018-08-17,제약업계는지금한미약품대웅제약종근당올해1조클럽합류할까,http://www.etoday.co.kr/news/section/newsview.php?idxno=1653707
2638,2018-08-17,7월원외처방한미종근당대웅유한양행順,http://www.dailymedi.com/detail.php?number=833731&thread=22r05
2639,2018-08-17,메디톡스대웅제약보톡스분쟁새국면,http://www.finomy.com/news/articleView.html?idxno=57289
2640,2018-08-20,영월대웅생명과학영월버섯사업투자방침,http://www.kado.net/?mod=news&act=articleView&idxno=926276
2641,2018-08-20,퀵리포트대웅매수유지목표가2만9000원유지골든브릿지證,http://www.itooza.com/common/iview.php?no=2018082007304435698
2642,2018-08-20,대웅목표가2만9000원유지전일종가1만5950원골든브릿지證,http://www.newspim.com/news/view/20180820000018
2643,2018-08-20,대웅제약예상보다빨랐던나보타캐나다승인업종최선호주NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1654021
2644,2018-08-20,대웅제약나보타캐나다서허가취득,http://www.asiatoday.co.kr/view.php?key=20180820010009332
2645,2018-08-20,I리포트대웅제약나보타캐나다허가획득주목NH證,http://www.inews24.com/php/news_view.php?g_serial=1118468&g_menu=022300&rrf=nv
2646,2018-08-20,더벨대웅제약간판제품우루사글로벌시장공략탄력,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808170100029110001830
2647,2018-08-20,대웅제약나보타캐나다허가성공매수유지NH證,http://news.mt.co.kr/mtview.php?no=2018082008140282701
2648,2018-08-20,대웅제약나보타캐나다허가NH,http://www.fnnews.com/news/201808200822264922
2649,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.newspim.com/news/view/20180820000076
2650,2018-08-20,NH투자증권대웅제약나보타캐나다허가호재”,http://www.newsway.co.kr/news/view?tp=1&ud=2018082008533736123
2651,2018-08-20,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018082008541110496
2652,2018-08-20,대웅제약목표가27만원유지전일종가19만원NH證,http://www.newspim.com/news/view/20180820000078
2653,2018-08-20,대웅제약전일대비약4상승한197500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808200084&t=NN
2654,2018-08-20,대웅제약나보타톡신최초캐나다허가획득,http://medipana.com/news/news_viewer.asp?NewsNum=224106&MainKind=A&NewsKind=5&vCount=12&vKind=1
2655,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.viva100.com/main/view.php?key=20180820010005730
2656,2018-08-20,대웅제약보툴리눔톡신나보타캐나다품목허가,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180820027300017&did=1195m
2657,2018-08-20,한경로보뉴스대웅5이상상승전일기관대량순매도,http://news.hankyung.com/article/201808206309L
2658,2018-08-20,대웅제약보톡스나보타加시장첫진출,http://www.sedaily.com/NewsView/1S3FMOBXG1
2659,2018-08-20,한경로보뉴스대웅제약5이상상승20182Q매출액2616억67영업이익86억227,http://news.hankyung.com/article/201808206336L
2660,2018-08-20,대웅제약보툴리눔톡신나보타캐나다판매허가획득,http://biz.chosun.com/site/data/html_dir/2018/08/20/2018082000609.html
2661,2018-08-20,대웅전일대비약6상승한16900원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808200098&t=NN
2662,2018-08-20,특징주대웅제약나보타캐나다허가소식에강세,http://www.edaily.co.kr/news/newspath.asp?newsid=01846646619309288
2663,2018-08-20,ET투자뉴스대웅_주가거래량투심모두적정주순,http://www.etnews.com/20180820000010
2664,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.m-i.kr/news/articleView.html?idxno=444705
2665,2018-08-20,특징주대웅제약나보타캐나다승인소식에강세,http://news.mt.co.kr/mtview.php?no=2018082009080789805
2666,2018-08-20,특징주대웅제약나보타캐나다허가소식에급등,http://view.asiae.co.kr/news/view.htm?idxno=2018082009114148013
2667,2018-08-20,대웅제약보툴리눔톡신나보타캐나다허가획득,http://www.edaily.co.kr/news/newspath.asp?newsid=01876166619309288
2668,2018-08-20,특징주대웅제약나보타캐나다허가소식에상승세,http://www.fnnews.com/news/201808200911178116
2669,2018-08-20,특징주대웅제약나보타캐나다품목허가에강세,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180820029300008&did=1195m
2670,2018-08-20,대웅제약나보타캐나다허가소식에↑,http://www.sedaily.com/NewsView/1S3FN3NDW2
2671,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.dailian.co.kr/news/view/733460/?sc=naver
2672,2018-08-20,대웅제약나보타캐나다연방보건부품목허가승인,http://www.k-health.com/news/articleView.html?idxno=37407
2673,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.fnnews.com/news/201808200914106015
2674,2018-08-20,대웅제약나보타캐나다품목허가승인,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018082008545185804
2675,2018-08-20,특징주대웅제약나보타캐나다서승인받아강세,http://news.hankyung.com/article/2018082063796
2676,2018-08-20,대웅제약나보타캐나다품목허가승인선진시장포문,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221265
2677,2018-08-20,ET투자뉴스대웅제약_거래비중기관2738외국인2464,http://www.etnews.com/20180820000013
2678,2018-08-20,특징주대웅제약나보타캐나다승인에주가↑,http://www.newsprime.co.kr/news/article.html?no=426807
2679,2018-08-20,대웅제약나보타캐나다허가선진시장진출포문,http://www.medisobizanews.com/news/articleView.html?idxno=54841
2680,2018-08-20,특징주대웅제약나보다캐나다품목허가취득급등,http://www.etoday.co.kr/news/section/newsview.php?idxno=1654132
2681,2018-08-20,특징주대웅제약나보타캐나다허가에강세,http://www.newsway.co.kr/news/view?tp=1&ud=2018082009241505458
2682,2018-08-20,특징주대웅제약나보타캐나다허가성공에강세,http://www.newsis.com/view/?id=NISX20180820_0000394452&cID=10401&pID=10400
2683,2018-08-20,대웅제약나보타국산보톡스최초캐나다품목허가받아,http://www.ceoscoredaily.com/news/article.html?no=44859
2684,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.newsway.co.kr/news/view?tp=1&ud=2018082009292468725
2685,2018-08-20,특징주대웅제약나보타제약선진국캐나다진출주가쑥쑥,http://www.g-enews.com/ko-kr/news/article/news_all/201808200927078350c16aa2f016_1/article.html
2686,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.bokuennews.com/news/article.html?no=163773
2687,2018-08-20,대웅제약나보타캐나다판매허가획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808200128&t=NN
2688,2018-08-20,대웅제약나보타캐나다품목허가승인내년상반기판매목표,http://www.enewstoday.co.kr/news/articleView.html?idxno=1222979
2689,2018-08-20,대웅제약나보타캐나다진출내년상반기판매,http://news.bizwatch.co.kr/article/consumer/2018/08/20/0005/naver
2690,2018-08-20,특징주대웅제약나보다캐나다품목허가소식에상승,http://www.newstomato.com/ReadNews.aspx?no=842184
2691,2018-08-20,대웅제약나보타꿈은이루어진다,http://www.whosaeng.com/sub_read.html?uid=103711§ion=sc5
2692,2018-08-20,대웅제약캐나다당국으로부터나보타품목허가받아,http://news.mk.co.kr/newsRead.php?year=2018&no=520520
2693,2018-08-20,대웅제약나보타캐나다시판허가국산보툴리눔톡신최초,http://news1.kr/articles/?3402491
2694,2018-08-20,대웅제약보툴리눔톡신나보타캐나다품목허가승인,http://view.asiae.co.kr/news/view.htm?idxno=2018082009480442789
2695,2018-08-20,ET투자뉴스대웅제약나보타DWP45BUY유지NH투자증권,http://www.etnews.com/20180820000038
2696,2018-08-20,캐나다판매승인받은대웅제약나보타가이룬두가지쾌거,http://www.news2day.co.kr/109287
2697,2018-08-20,대웅제약나보타16일캐나다품목허가승인,http://www.seoulwire.com/news/articleView.html?idxno=23250
2698,2018-08-20,대웅제약나보타캐나다품목허가승인내년출시,http://www.biospectator.com/view/news_view.php?varAtcId=6041
2699,2018-08-20,대웅제약나보타캐나다판매허가글로벌진출스타트,http://news.mt.co.kr/mtview.php?no=2018082009564431518
2700,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.100ssd.co.kr/news/articleView.html?idxno=55781
2701,2018-08-20,대웅제약나보타캐나다품목허가美허가시기는,http://paxnetdaily.moneta.co.kr/Service/stock/ShellView.asp?ArticleID=2018082010063700975&LinkID=632&objId=A2018082010063700975&portalCode=naver
2702,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.sisajournal-e.com/biz/article/187999
2703,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.koreaittimes.com/news/articleView.html?idxno=85289
2704,2018-08-20,대웅제약보툴리눔톡신나보타캐나다품목허가,http://www.dailypharm.com/News/242899
2705,2018-08-20,캐나다시장포문대웅제약나보타현지품목허가승인,http://www.wolyo.co.kr/news/articleView.html?idxno=66388
2706,2018-08-20,대웅제약나보타캐나다연방보건부품목허가승인,http://www.newsprime.co.kr/news/article.html?no=426827
2707,2018-08-20,대웅제약나보타캐나다품목허가승인2019년선진국진출,http://www.econovill.com/news/articleView.html?idxno=344164
2708,2018-08-20,대웅제약나보타캐나다판매허가내년상반기부터시판,http://www.rapportian.com/news/articleView.html?idxno=112327
2709,2018-08-20,대웅제약나보타캐나다품목허가승인획득내년상반기판매돌입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1654210
2710,2018-08-20,대웅제약나보타캐나다서미간주름적응증품목허가승인,http://www.medigatenews.com/news/1846427258
2711,2018-08-20,캐나다진출한대웅제약나보타캐나다품목허가승인,http://news.hankyung.com/article/201808206634f
2712,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.ekn.kr/news/article.html?no=381140
2713,2018-08-20,대웅나보타캐나다품목허가선진시장공략시동,http://www.medicaltimes.com/News/1120562
2714,2018-08-20,대웅제약나보타로캐나다진출품목허가승인,http://www.polinews.co.kr/news/article.html?no=365054
2715,2018-08-20,대웅제약나보타캐나다품목허가승인본격수출개시,http://www.getnews.co.kr/news/articleView.html?idxno=90709
2716,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.bosa.co.kr/news/articleView.html?idxno=2088615
2717,2018-08-20,대웅제약나보타캐나다품목허가승인국산보톡스제품최초,http://moneys.mt.co.kr/news/mwView.php?no=2018082010368047848
2718,2018-08-20,제약산업대웅제약나보타캐나다품목허가승인外,http://www.kukinews.com/news/article.html?no=577669
2719,2018-08-20,대웅제약보톡스나보타캐나다품목허가,http://news.mk.co.kr/newsRead.php?year=2018&no=520883
2720,2018-08-20,대웅제약나보타캐나다연방보건부품목허가승인소식에상승세,http://www.mdtoday.co.kr/mdtoday/index.html?no=329918
2721,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.metroseoul.co.kr/news/newsview?newscd=2018082000056
2722,2018-08-20,대웅제약나보타캐나다서품목허가승인자체개발의약품중최초,http://www.businesskorea.co.kr/news/articleView.html?idxno=24402
2723,2018-08-20,대웅제약보툴리눔톡신나보타캐나다품목허가,http://www.asiatoday.co.kr/view.php?key=20180820010009594
2724,2018-08-20,대웅제약나보타캐나다품목허가승인북미지역에빠르게진출해나갈것,http://www.sisafocus.co.kr/news/articleView.html?idxno=190535
2725,2018-08-20,대웅제약보툴리눔톡신나보타캐나다허가,http://www.dailymedi.com/detail.php?number=833799&thread=22r05
2726,2018-08-20,대웅나보타캐나다품목허가승인국산제제최초,http://www.doctorsnews.co.kr/news/articleView.html?idxno=124918
2727,2018-08-20,대웅제약나보타캐나다품목허가내년상반기현지판매,http://www.sporbiz.co.kr/news/articleView.html?idxno=264231
2728,2018-08-20,대웅제약나보타캐나다품목허가획득,http://www.seoulfn.com/news/articleView.html?idxno=317231
2729,2018-08-20,대웅제약보툴리눔톡신나보타캐나다품목허가승인,http://www.wikileaks-kr.org/news/articleView.html?idxno=32076
2730,2018-08-20,제약오늘대웅제약나보타캐나다품목허가승인대원제약남북이산가족상봉행사에보청기지원,http://www.sisaon.co.kr/news/articleView.html?idxno=76435
2731,2018-08-20,대웅제약캐나다에서보톡스나보타판매허가받아,http://www.businesspost.co.kr/BP?command=article_view&num=93143
2732,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.etnews.com/20180820000262
2733,2018-08-20,대웅제약보툴리눔톡신나보타캐나다품목허가승인,http://www.mdtoday.co.kr/mdtoday/index.html?no=329967
2734,2018-08-20,대웅제약나보타캐나다시장진출,http://www.sisa-news.com/news/article.html?no=114033
2735,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.newstomato.com/ReadNews.aspx?no=842301
2736,2018-08-20,대웅제약나보타캐나다품목허가획득,http://sports.khan.co.kr/news/sk_index.html?art_id=201808201624013&sec_id=561801&pt=nv
2737,2018-08-20,대웅제약지난주금요일나보타의캐나다허가성공,http://www.newsworks.co.kr/news/articleView.html?idxno=209046
2738,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.ftoday.co.kr/news/articleView.html?idxno=102153
2739,2018-08-20,대웅제약나보타글로벌진출본격화에주가회복시동,http://www.edaily.co.kr/news/newspath.asp?newsid=03466966619309288
2740,2018-08-20,대웅제약주름개선제나보타캐나다허가승인,http://www.ajunews.com/view/20180820173404236
2741,2018-08-20,대웅제약나보타북미시장첫발디뎠다,http://news.hankyung.com/article/2018082087781
2742,2018-08-20,대웅제약나보타캐나다승인,http://www.dt.co.kr/contents.html?article_no=2018082102101631102001&ref=naver
2743,2018-08-20,주목받는대웅제약신약나보타1년여만에의약선진국캐나다뚫어,http://www.iminju.net/news/articleView.html?idxno=37763
2744,2018-08-20,대웅제약나보타캐나다품목허가승인받아,http://www.wsobi.com/news/articleView.html?idxno=63775
2745,2018-08-20,대웅제약나보타캐나다의약품품목허가승인,http://www.lawissue.co.kr/view.php?ud=201808202054473831d7f4c63cc6_12
2746,2018-08-20,대웅제약보툴리눔톡신나보타캐나다서품목허가,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3613938
2747,2018-08-20,대웅제약나보타캐나다품목허가승인,http://www.newscj.com/news/articleView.html?idxno=547900
2748,2018-08-21,대웅제약주름개선제나보타캐나다서판매승인,http://biz.chosun.com/site/data/html_dir/2018/08/20/2018082003435.html?utm_source=naver&utm_medium=original&utm_campaign=biz
2749,2018-08-21,대웅제약나보타加품목허가,http://www.medical-tribune.co.kr/news/articleView.html?idxno=80827
2750,2018-08-21,대웅제약나보타캐나다품목허가승인의약품선진국시장본격진출,http://www.segye.com/content/html/2018/08/20/20180820003753.html?OutUrl=naver
2751,2018-08-21,대웅제약나보타캐나다서품목허가승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059415
2752,2018-08-21,대웅제약50억규모상생펀드운영헬스케어스타트업지원,http://view.asiae.co.kr/news/view.htm?idxno=2018082109163308543
2753,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221319
2754,2018-08-21,대웅제약상생펀드조성해헬스케어스타트업육성,http://www.edaily.co.kr/news/newspath.asp?newsid=01820406619309616
2755,2018-08-21,대웅제약50억출연상생펀드통해스타트업지원,http://www.dailypharm.com/News/242944
2756,2018-08-21,대웅펀드조성해헬스케어스타트업지원투수,http://medipana.com/news/news_viewer.asp?NewsNum=224178&MainKind=A&NewsKind=5&vCount=12&vKind=1
2757,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업육성,http://www.medicaltimes.com/News/1120601
2758,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.fnnews.com/news/201808210939437679
2759,2018-08-21,대웅제약50억규모펀드조성국내헬스케어스타트업지원,http://biz.chosun.com/site/data/html_dir/2018/08/21/2018082100791.html
2760,2018-08-21,대웅제약헬스케어스타트업육성위한상생펀드조성,http://www.dailian.co.kr/news/view/733813/?sc=naver
2761,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018082109471748017
2762,2018-08-21,대웅제약나보타캐나다품목허가승인,http://www.monews.co.kr/news/articleView.html?idxno=118103
2763,2018-08-21,한미약품대웅제약종근당올해매출1조클럽가입할까,http://www.ekn.kr/news/article.html?no=381236
2764,2018-08-21,대웅제약50억상생펀드조성스타트업육성,http://www.dailymedi.com/detail.php?number=833846&thread=22r05
2765,2018-08-21,대웅제약50억상생펀드통해헬스케어스타트업육성,http://www.mhj21.com/sub_read.html?uid=115783§ion=sc243
2766,2018-08-21,창업청년돕자대웅제약상생펀드로헬스케어스타트업지원,http://www.medisobizanews.com/news/articleView.html?idxno=54865
2767,2018-08-21,대웅제약50억상생펀드통해헬스케어스타트업지원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808210214&t=NN
2768,2018-08-21,대웅제약상생펀드조성으로헬스케어스타트업집중육성,http://www.getnews.co.kr/news/articleView.html?idxno=91003
2769,2018-08-21,대웅제약보톡스나보타캐나다시장진출한다,http://www.sisaweek.com/news/articleView.html?idxno=112402
2770,2018-08-21,대웅제약헬스케어스타트업육성,http://www.100ssd.co.kr/news/articleView.html?idxno=55806
2771,2018-08-21,대웅제약상생펀드조성헬스케어스타트업집중육성,http://www.koreaittimes.com/news/articleView.html?idxno=85337
2772,2018-08-21,대웅제약50억규모상생펀드조성헬스케어스타트업육성,http://www.newsis.com/view/?id=NISX20180821_0000395776&cID=13001&pID=13000
2773,2018-08-21,대웅제약헬스케어스타트업육성50억상생펀드운영,http://www.sisajournal-e.com/biz/article/188073
2774,2018-08-21,대웅제약헬스케어스타트업집중육성나서,http://www.seoulwire.com/news/articleView.html?idxno=23418
2775,2018-08-21,대웅제약상생펀드조성헬스케어스타트업육성,http://www.bosa.co.kr/news/articleView.html?idxno=2088711
2776,2018-08-21,상반기일반의약품판매제약사순위일동동국제약한독대웅제약,http://www.iminju.net/news/articleView.html?idxno=37794
2777,2018-08-21,대웅제약상생펀드통해헬스케어스타트업육성,http://www.choicenews.co.kr/news/articleView.html?idxno=43919
2778,2018-08-21,대웅제약상생펀드로헬스케어스타트업육성,http://news.mk.co.kr/newsRead.php?year=2018&no=524204
2779,2018-08-21,대웅제약상생펀드로헬스케어스타트업집중육성,http://www.newsway.co.kr/news/view?tp=1&ud=2018082113594240328
2780,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.kukinews.com/news/article.html?no=578114
2781,2018-08-21,대웅제약상생펀드만들어헬스케어스타트업육성,http://www.econovill.com/news/articleView.html?idxno=344279
2782,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.wsobi.com/news/articleView.html?idxno=63819
2783,2018-08-21,대웅제약프라이머와함께유망헬스케어스타트업발굴육성,http://news.mk.co.kr/newsRead.php?year=2018&no=524494
2784,2018-08-21,대웅제약50억상생펀드헬스케어스타트업지원,http://www.etnews.com/20180821000227
2785,2018-08-21,대웅제약헬스케어스타트업육성나서,http://www.whosaeng.com/sub_read.html?uid=103792§ion=sc5
2786,2018-08-21,대웅제약50억규모상생펀드운영헬스케어스타트업육성,http://www.wolyo.co.kr/news/articleView.html?idxno=66497
2787,2018-08-21,대웅제약상생펀드로헬스케어스타트업집중육성한다,http://www.k-health.com/news/articleView.html?idxno=37443
2788,2018-08-21,대웅제약헬스케어스타트업집중육성,http://www.sporbiz.co.kr/news/articleView.html?idxno=264774
2789,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.mdtoday.co.kr/mdtoday/index.html?no=330093
2790,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.newspim.com/news/view/20180821000504
2791,2018-08-21,대웅제약헬스케어스타트업육성나선다,http://www.sisa-news.com/news/article.html?no=114065
2792,2018-08-21,대웅제약상생펀드로헬스케어스타트업키운다,http://moneys.mt.co.kr/news/mwView.php?no=2018082117468086343
2793,2018-08-21,폭염뒤건강관리대웅제약임팩타민쉬어도피곤한당신비타민10종으로쌩쌩,http://www.sedaily.com/NewsView/1S3G4R4YAQ
2794,2018-08-21,대웅제약상생펀드로헬스케어스타트업집중육성,http://www.viva100.com/main/view.php?key=20180821020023164
2795,2018-08-21,대웅제약상생펀드로헬스케어스타트업집중육성,http://www.ajunews.com/view/20180821142532768
2796,2018-08-21,대웅제약50억규모상생펀드조성헬스케어스타트업육성,http://www.wikileaks-kr.org/news/articleView.html?idxno=32254
2797,2018-08-21,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.newscj.com/news/articleView.html?idxno=548136
2798,2018-08-22,헬스케어스타트업대웅제약의노하우를활용해라,http://www.news2day.co.kr/109420
2799,2018-08-22,대웅제약상생펀드조성통해헬스케어스타트업집중육성,http://www.lawissue.co.kr/view.php?ud=201808212351196000d7f4c63cc6_12
2800,2018-08-22,IR라운지③애널리스트가본대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=01121766619309944
2801,2018-08-22,IR라운지①글로벌진출10년본격결실준비하는대웅제약,http://www.edaily.co.kr/news/newspath.asp?newsid=01115206619309944
2802,2018-08-22,대웅제약상생펀드조성헬스케어스타트업집중육성,http://www.segye.com/content/html/2018/08/21/20180821004329.html?OutUrl=naver
2803,2018-08-22,더벨대웅제약의글로벌시장공략법,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808210100032960002081
2804,2018-08-23,판촉물없애는외자사유한대웅종근당보령행보주목,http://www.dailymedi.com/detail.php?number=833939&thread=22r05
2805,2018-08-23,윤재춘전승호새수장이끈대웅제약성적표는신통찮아”,http://www.sisajournal-e.com/biz/article/188210
2806,2018-08-24,대웅제약이자보상배율4년만에119배→47배추락이익줄고이자비용증가,http://www.consumernews.co.kr/?mod=news&act=articleView&idxno=527275
2807,2018-08-24,대웅전일대비약5상승한17400원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808240148&t=NN
2808,2018-08-24,한경로보뉴스대웅5이상상승전일기관대량순매수,http://news.hankyung.com/article/201808243839L
2809,2018-08-24,ET투자뉴스대웅_주가와거래량은강세투자심리는보통,http://www.etnews.com/20180824000155
2810,2018-08-24,유대웅전일대비721상승일일회전율은034기록,http://www.sedaily.com/NewsView/1S3HH0OAS9
2811,2018-08-24,GC녹십자대웅JW홀딩스브라질로눈돌리는이유,http://www.newsway.co.kr/news/view?tp=1&ud=2018082414381507245
2812,2018-08-25,대웅톡신나보타글로벌시장출시가시권진입,http://medipana.com/news/news_viewer.asp?NewsNum=224397&MainKind=A&NewsKind=5&vCount=12&vKind=1
2813,2018-08-25,올해매출1조달성제약바이오사는대웅제약종근당도가능성,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018082511342733695
2814,2018-08-27,단독미친XX야대웅제약윤재승회장상습욕설폭언논란,http://www.ytn.co.kr/_ln/0103_201808270518473189
2815,2018-08-27,자막뉴스미친XX대웅제약윤재승회장막말논란,http://www.ytn.co.kr/_ln/0103_201808270619284802
2816,2018-08-27,단독미친XX야대웅제약윤재승회장상습욕설폭언논란,http://www.ytn.co.kr/_ln/0103_201808270733467205
2817,2018-08-27,단독미친XX야대웅제약윤재승회장상습욕설폭언논란,http://www.ytn.co.kr/_ln/0103_201808270733467205
2818,2018-08-27,대웅제약윤재승회장누구윤영환셋째아들로6년간검사생활,http://news20.busan.com/controller/newsController.jsp?newsId=20180827000010
2819,2018-08-27,대웅제약윤재승회장미친XX야”정신병자XX”상습욕설폭언비난쇄도,http://www.mydaily.co.kr/new_yk/html/read.php?newsid=201808270744455525&ext=na
2820,2018-08-27,대웅제약윤재승회장직원에게상습욕설파문,http://www.sportsseoul.com/news/read/673874
2821,2018-08-27,대웅제약윤재승회장직원에폭언욕설의혹상처받은사람들에죄송,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180827.99099012198
2822,2018-08-27,대웅제약나보타캐나다허가성공새삼눈길,http://www.topstarnews.net/news/articleView.html?idxno=471274
2823,2018-08-27,대웅제약윤재승회장상습욕설폭언논란상처받았다면죄송,http://www.kyeongin.com/main/view.php?key=20180827000755378
2824,2018-08-27,대웅제약회장윤재승병XXX잡X미친X살인충동을느끼게하는XX충격폭언에누리꾼들소름,http://www.joongdo.co.kr/main/view.php?key=20180827000801335
2825,2018-08-27,대웅제약윤재승회장직원들에상습폭언논란감정이격양돼서사과드리겠다,http://www.asiatoday.co.kr/view.php?key=20180827000757443
2826,2018-08-27,욕설논란윤재승회장대웅제약잘못인정하고사과,http://www.edaily.co.kr/news/newspath.asp?newsid=01387446619311584
2827,2018-08-27,영상정신병자XX”살인충동느낀다는윤재승대웅제약회장녹취록공개,http://news.kmib.co.kr/article/view.asp?arcid=0012633193&code=61121211&cp=nv
2828,2018-08-27,더벨대웅제약확고한오너체제윤재승회장방향타역할,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808230100038220002427
2829,2018-08-27,대웅제약윤재승회장정신병자XX아니야”상습폭언욕설의혹,http://news.donga.com/3/all/20180827/91689520/2
2830,2018-08-27,대웅제약윤재승회장미친XX야직원에상습욕설논란,http://news.hankyung.com/article/201808279230I
2831,2018-08-27,욕설논란윤재승대웅제약회장의경영철학결국허풍이었나,http://www.sisunnews.co.kr/news/articleView.html?idxno=89013
2832,2018-08-27,윤재승대웅제약회장미친XX야”상습욕설폭언논란,http://www.newsway.co.kr/news/view?tp=1&ud=2018082708233975204
2833,2018-08-27,욕설논란윤재승대웅제약회장경영철학허풍에불과,http://www.dailian.co.kr/news/view/735101/?sc=naver
2834,2018-08-27,윤재승대웅제약회장직원에상습욕설폭언논란,http://moneys.mt.co.kr/news/mwView.php?no=2018082708118083689
2835,2018-08-27,대웅제약윤재승회장상습욕설폭언논란,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201808270827011&code=920100
2836,2018-08-27,대웅제약윤재승회장죽이고싶게만드는XX100여명퇴사관련있나,http://www.greened.kr/news/articleView.html?idxno=73015
2837,2018-08-27,대웅제약윤재승회장미친XX야직원에게상습욕설파문,http://www.sedaily.com/NewsView/1S3IU5HSR4
2838,2018-08-27,대웅제약윤재승회장상습욕설폭언정신병자아니야,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=3618915
2839,2018-08-27,욕설논란대웅제약윤재승회장누구검사출신2세경영인,http://www.etoday.co.kr/news/section/newsview.php?idxno=1656304
2840,2018-08-27,미친XX야”대웅제약윤재승회장상습욕설폭언논란충격,http://www.sedaily.com/NewsView/1S3IURNAWX
2841,2018-08-27,뉴스SCENE대웅제약윤재승회장욕설담긴육성파일공개관계자말끝마다이XX저XX,http://chicnews.mk.co.kr/article.php?aid=1535326561208255018
2842,2018-08-27,여기서뛰어내려대웅제약윤재승회장직원에상습폭언논란,http://sports.hankooki.com/lpage/sisa/201808/sp20180827083104137040.htm
2843,2018-08-27,윤재승회장욕설논란대웅제약잘못인정하고사과상보,http://www.edaily.co.kr/news/newspath.asp?newsid=01492406619311584
2844,2018-08-27,대웅제약윤재승회장갑질논란주인공되나욕설녹취록공개,http://news20.busan.com/controller/newsController.jsp?newsId=20180827000019
2845,2018-08-27,상습폭언욕설논란대웅제약윤재승회장그는누구,http://www.sedaily.com/NewsView/1S3IUF30LL
2846,2018-08-27,대웅제약윤재승회장미친XX병X”상습욕설폭언논란에사과,http://sports.khan.co.kr/news/sk_index.html?art_id=201808270839013&sec_id=560101&pt=nv
2847,2018-08-27,대웅제약윤재승회장상습욕설”비난봇물,http://news.heraldcorp.com/view.php?ud=20180827000054
2848,2018-08-27,대웅제약윤재승회장직원에게욕설병XXX미친X사과입장밝혀,http://www.slist.kr/news/articleView.html?idxno=43675
2849,2018-08-27,대웅제약윤재승회장100여명퇴사원인됐나죽이고싶게만드는XX막말도,http://viewers.heraldcorp.com/news/articleView.html?idxno=18728
2850,2018-08-27,욕설폭언논란대웅제약윤재승회장창업주윤영환명예회장3남검사출신,http://news.donga.com/3/all/20180827/91689822/2
2851,2018-08-27,폭언욕설한대웅제약윤재승회장은누구누리꾼불매운동선언,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0300&key=20180827.99099012199
2852,2018-08-27,영상대웅제약윤재승회장도갑질논란직원들에게정신병자XX아냐,http://www.ajunews.com/view/20180827082706565
2853,2018-08-27,윤재승대웅제약회장직원들에상습욕설갑질논란,http://www.newsworks.co.kr/news/articleView.html?idxno=210446
2854,2018-08-27,윤재승대웅제약회장직원에상습욕설폭언논란,http://news.hankyung.com/article/2018082793887
2855,2018-08-27,윤재승대웅제약회장욕설폭언처음아니다과거창문에서뛰어내려라,http://news.imaeil.com/Society/2018082709075721495
2856,2018-08-27,대웅제약주가장초반부터하락세윤재승회장상습욕설폭언논란,http://www.econonews.co.kr/news/articleView.html?idxno=33964
2857,2018-08-27,윤재승대웅제약회장상습폭언욕설로구설수,http://www.enewstoday.co.kr/news/articleView.html?idxno=1225084
2858,2018-08-27,특징주대웅제약윤재승회장욕설파문에↓,http://news.mt.co.kr/mtview.php?no=2018082709113592569
2859,2018-08-27,특징주대웅제약윤재승회장폭언논란에하락,http://www.edaily.co.kr/news/newspath.asp?newsid=01846646619311584
2860,2018-08-27,대웅제약윤재승회장의거친입23년간100명은퇴사했다,http://www.readersnews.com/news/articleView.html?idxno=81629
2861,2018-08-27,윤재승대웅제약회장정신병자XX미친X상습욕설논란,http://biz.chosun.com/site/data/html_dir/2018/08/27/2018082700775.html
2862,2018-08-27,특징주대웅제약오너리스크불확실성주가하락세,http://www.g-enews.com/ko-kr/news/article/news_all/201808270912013328c16aa2f016_1/article.html
2863,2018-08-27,대웅제약윤재승회장직원에상습욕설폭언말끝마다이XX저XX”,http://www.viva100.com/main/view.php?key=20180827010008098
2864,2018-08-27,대웅제약갑질논란윤재승정신병자아냐폭언이일상폭로,http://www.inews24.com/php/news_view.php?g_serial=1120529&g_menu=050300&rrf=nv
2865,2018-08-27,윤재승욕설논란대웅제약직원들칼갈았나,http://theleader.mt.co.kr/articleView.html?no=2018082709257822039
2866,2018-08-27,특징주대웅제약윤재승회장폭언논란에장초반약세,http://www.newsway.co.kr/news/view?tp=1&ud=2018082709251757182
2867,2018-08-27,특징주대웅제약윤재승회장폭언논란에약세,http://view.asiae.co.kr/news/view.htm?idxno=2018082709274978149
2868,2018-08-27,대웅제약윤재승회장욕설파문에주가하락오늘주가크게하락하나,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180827.99099012215
2869,2018-08-27,특징주대웅제약윤재승회장폭언논란에하락세,http://www.seoulfn.com/news/articleView.html?idxno=317765
2870,2018-08-27,특징주대웅제약윤재승회장폭언파문확산↓,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808270132&t=NN
2871,2018-08-27,윤재승욕설논란에대웅꺼안산다불매운동,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=3618986
2872,2018-08-27,대웅제약회장윤재승욕설논란에경영철학허풍들통,http://www.betanews.net:8080/article/899707.html
2873,2018-08-27,대웅제약윤재승회장상습욕설폭언논란,http://www.sportsseoul.com/news/read/673917
2874,2018-08-27,대웅제약윤재승욕설논란나정말너정신병자랑일하는거같아서”,http://www.hkbs.co.kr/news/articleView.html?idxno=481243
2875,2018-08-27,특징주대웅제약회장욕설갑질파문에약세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1656361
2876,2018-08-27,수평적조직문화만든다던대웅제약회장은상습폭언,http://www.edaily.co.kr/news/newspath.asp?newsid=02053286619311584
2877,2018-08-27,폭언욕설논란대웅제약윤재승경영철학은허풍이었나,http://www.sedaily.com/NewsView/1S3IUE5SVI
2878,2018-08-27,특징주대웅제약윤재승회장폭언논란에하락,http://news.hankyung.com/article/2018082796936
2879,2018-08-27,윤재승욕설논란대웅제약직원에게정신병자X미친XX욕설퍼부어,http://www.ggilbo.com/news/articleView.html?idxno=539658
2880,2018-08-27,이번엔대웅제약윤재승회장상습폭언욕설논란,http://www.sporbiz.co.kr/news/articleView.html?idxno=266424
2881,2018-08-27,윤재승대웅제약회장상습욕설폭언논란,http://www.fetv.co.kr/news/article.html?no=11470
2882,2018-08-27,윤재승대웅제약회장직원에폭언녹음파일공개돼논란,http://www.m-i.kr/news/articleView.html?idxno=446789
2883,2018-08-27,윤재승대웅제약직원들에게폭언논란에휩싸여,http://www.businesspost.co.kr/BP?command=article_view&num=93895
2884,2018-08-27,대웅제약윤재승회장직원들에상습욕설따라하기어려울정도충격,http://www.sjbnews.com/news/articleView.html?idxno=616678
2885,2018-08-27,대웅제약윤재승회장누구창업주3남6년간검사생활,http://www.edaily.co.kr/news/newspath.asp?newsid=02269766619311584
2886,2018-08-27,정신병자XX대웅제약윤재승회장폭언욕설논란경영일선서사퇴사과,http://news.chosun.com/site/data/html_dir/2018/08/27/2018082700934.html?utm_source=naver&utm_medium=original&utm_campaign=news
2887,2018-08-27,미친XX야다리몽둥리부러뜨린다대웅제약윤재승회장직원들에상습욕설파문,http://www.greened.kr/news/articleView.html?idxno=73041
2888,2018-08-27,대웅제약윤재승직원모욕으로구설수직원의행복이회사의경쟁력이라던신조는어디갔나,http://www.ekn.kr/news/article_lab.html?no=382499
2889,2018-08-27,또윤재승대웅회장폭언논란우루사불매움직임도,http://www.newsway.co.kr/news/view?tp=1&ud=2018082709574049730
2890,2018-08-27,특징주대웅제약윤재승회장폭언논란에하락세,http://www.fetv.co.kr/news/article.html?no=11480
2891,2018-08-27,직원모욕대웅제약윤재승지키지못한신조회사경쟁력은직원의행복에서나온다,http://www.ilyosisa.co.kr/news/articleView.html?idxno=151124
2892,2018-08-27,윤재승우루사대웅제약폭언욕설해명감정이격앙됐다잘못인정,http://www.inews24.com/php/news_view.php?g_serial=1120560&g_menu=050300&rrf=nv
2893,2018-08-27,윤재승대웅제약회장직원에상습폭언논란,http://www.wikileaks-kr.org/news/articleView.html?idxno=32880
2894,2018-08-27,윤재승대웅제약회장직원에상습폭언논란,http://www.wikileaks-kr.org/news/articleView.html?idxno=32880
2895,2018-08-27,미친XX네검사출신대웅제약윤재승회장직원들에게욕설폭언논란,http://news.hankyung.com/article/2018082798617
2896,2018-08-27,특징주대웅제약윤재승회장욕설논란에약세,http://moneys.mt.co.kr/news/mwView.php?no=2018082710088041896
2897,2018-08-27,욕설논란윤재승대웅제약회장경영일선에서물러난다,http://www.edaily.co.kr/news/newspath.asp?newsid=02335366619311584
2898,2018-08-27,제약업계또터진오너갑질이번엔대웅제약,http://www.mediapen.com/news/view/378582
2899,2018-08-27,하태경대웅제약윤재승회장우루사많이먹어간이부었나,http://www.goodmorningcc.com/news/articleView.html?idxno=96132
2900,2018-08-27,윤재승대웅제약회장인격살인적모독녹취파일로또드러난재벌가민낯,http://biz.heraldcorp.com/culture/view.php?ud=201808271007244461894_1
2901,2018-08-27,검사출신윤재승대웅제약회장상습욕설폭언논란,http://www.greenpostkorea.co.kr/news/articleView.html?idxno=95505
2902,2018-08-27,폭언논란대웅제약윤재승회장경영일선물러날것,http://www.medicaltimes.com/News/1120722
2903,2018-08-27,폭언논란대웅제약윤재승회장진심으로죄송경영일선서물러나겠다,http://www.newsis.com/view/?id=NISX20180827_0000400893&cID=13001&pID=13000
2904,2018-08-27,윤재승대웅제약회장경영일선물러나자숙할것,http://www.enewstoday.co.kr/news/articleView.html?idxno=1225182
2905,2018-08-27,대웅제약윤재승회장폭언파문확산226↓,http://www.segyefn.com/newsView/20180827001244?OutUrl=naver
2906,2018-08-27,갑질논란윤재승대웅제약회장경영에서물러나기로,http://www.mediapen.com/news/view/378585
2907,2018-08-27,대웅윤재승회장경영일선서물러나겠다공식사과,http://medipana.com/news/news_viewer.asp?NewsNum=224421&MainKind=A&NewsKind=5&vCount=12&vKind=1
2908,2018-08-27,대웅제약윤재승회장폭언욕설의혹에하태경우루사먹지말아야,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0100&key=20180827.99099012299
2909,2018-08-27,정신병자XX윤재승대웅제약회장상습욕설폭언파문,http://news.mt.co.kr/mtview.php?no=2018082709355391148
2910,2018-08-27,대웅제약윤재승회장상처받은사람들에게죄송경영일선사퇴,http://www.sisaon.co.kr/news/articleView.html?idxno=76691
2911,2018-08-27,대웅제약윤재승회장직원에게상습폭언욕설논란,http://www.ebn.co.kr/news/view/953119
2912,2018-08-27,특징주윤재승회장욕설논란에대웅제약약세,http://biz.chosun.com/site/data/html_dir/2018/08/27/2018082701020.html
2913,2018-08-27,전문폭언논란윤재승대웅제약경영서물러난다전문경영인체제로”,http://news.donga.com/3/all/20180827/91691398/2
2914,2018-08-27,대웅제약윤재승회장갑질물의경영일선사퇴,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180827054100017&did=1195m
2915,2018-08-27,인격살인수준윤재승대웅제약회장녹취파일에담긴재벌가민낯,http://www.youngnong.co.kr/news/articleView.html?idxno=14916
2916,2018-08-27,전문폭언논란윤재승대웅제약경영서물러난다전문경영인체제로”,http://news.donga.com/3/all/20180827/91691398/2
2917,2018-08-27,윤재승대웅제약회장경영일선에서물러난다공식사과,http://www.wikileaks-kr.org/news/articleView.html?idxno=32887
2918,2018-08-27,폭언논란윤재승대웅제약회장경영일선물러나경솔한언행죄송,http://www.newspim.com/news/view/20180827000165
2919,2018-08-27,폭언논란윤재승대웅제약회장경영일선에서물러나겠다,http://view.asiae.co.kr/news/view.htm?idxno=2018082710305554632
2920,2018-08-27,폭언의혹대웅제약윤재승회장경영일선사퇴”,http://www.hankookilbo.com/v/5a2e5fb231ba4626894f666f7af86931
2921,2018-08-27,대웅윤재승회장진심으로사과경영일선퇴진,http://www.dailypharm.com/News/243122
2922,2018-08-27,대웅제약은어떤회사제약업체빅5해방둥이우루사,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180827.99099012311
2923,2018-08-27,윤재승대웅제약회장폭언갑질3년간퇴사자100여명,http://www.kpinews.co.kr/news/articleView.html?idxno=80042
2924,2018-08-27,윤재승대웅제약회장직원에상습폭언욕설의혹경영일선에서물러난다,http://www.ekn.kr/news/article.html?no=382513
2925,2018-08-27,막말논란대웅제약윤재승회장결국경영에서물러나자숙,http://www.ajunews.com/view/20180827102013746
2926,2018-08-27,정신병자XX윤재승대웅제약회장직원에상습욕설갑질논란,http://stoo.asiae.co.kr/news/naver_view.htm?idxno=2018082710321592087
2927,2018-08-27,폭언논란윤재승대웅제약회장경영물러나겠다,http://www.sedaily.com/NewsView/1S3IUFM3FM
2928,2018-08-27,대웅제약윤재승회장경솔한언행경영일선물러나겠다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221488
2929,2018-08-27,욕설파문윤재승대웅제약회장경영일선서물러나겠다,http://news.hankyung.com/article/2018082700366
2930,2018-08-27,우루사대웅제약윤재승회장이XX야미친XX네”상습폭언욕설논란,http://www.vop.co.kr/A00001325422.html
2931,2018-08-27,폭언논란윤재승대웅회장경영일선서물러날것,http://news.mk.co.kr/newsRead.php?year=2018&no=536755
2932,2018-08-27,욕설파일파문대웅제약윤재승회장물러난다자숙의시간가질것전문,http://www.g-enews.com/ko-kr/news/article/news_all/201808271033135337581e9b5a60_1/article.html
2933,2018-08-27,상습욕설논란윤재승대웅제약회장지난23년간100여명의직원퇴사,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20180827.990011035554959
2934,2018-08-27,상습욕설논란윤재승대웅제약회장지난23년간100여명의직원퇴사,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20180827.990011035554959
2935,2018-08-27,대웅제약윤재승회장직원유린한말말말죽이고싶게만드는XX,http://www.ecomedia.co.kr/news/newsview.php?ncode=1065576707584542
2936,2018-08-27,욕설논란윤재승대웅제약회장오늘즉시경영일선에서물러나겠다,http://news20.busan.com/controller/newsController.jsp?newsId=20180827000048
2937,2018-08-27,전문대웅제약윤재승회장물러난다경영일선사퇴‥자숙할것,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808270240&t=NN
2938,2018-08-27,욕설논란대웅윤재승회장경영일선물러날것,http://www.kpanews.co.kr/article/show.asp?idx=196374&table=article&category=D
2939,2018-08-27,폭언욕설갑질논란에대웅제약윤재승회장경영일선물러나겠다,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180827.99099012323
2940,2018-08-27,폭언논란윤재승대웅제약회장진심으로죄송경영일선서물러나겠다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018082710214145278
2941,2018-08-27,윤재승대웅제약회장욕설논란에공식사과경영일선에서물러나자숙”,http://www.cstimes.com/?mod=news&act=articleView&idxno=284101
2942,2018-08-27,욕설파문윤재승대웅제약회장경영일선물러나자숙,http://www.newsprime.co.kr/news/article.html?no=427665
2943,2018-08-27,대웅제약윤재승회장경영일선물러나자숙,http://www.kormedi.com/news/news/drug_dist/1228931_2906.html
2944,2018-08-27,우루사로유명한대웅제약주가하락세윤재승회장폭언영향,http://news20.busan.com/controller/newsController.jsp?newsId=20180827000047
2945,2018-08-27,욕설파문윤재승대웅제약회장경영에서물러나자숙하겠다,http://www.sedaily.com/NewsView/1S3IUXG4T7
2946,2018-08-27,대웅제약윤재승회장자숙의시간갖겠다,http://www.bosa.co.kr/news/articleView.html?idxno=2089007
2947,2018-08-27,윤재승대웅제약회장경솔한언행경영일선물러나자숙”,http://biz.chosun.com/site/data/html_dir/2018/08/27/2018082701085.html
2948,2018-08-27,상습욕설윤재승대웅제약회장자숙의시간갖겠다”,http://www.polinews.co.kr/news/article.html?no=365725
2949,2018-08-27,정신병자XX”막말윤재승대웅제약회장경영에서물러나겠다”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201808271043001&code=920100
2950,2018-08-27,윤재승대웅제약회장갑질물의경영일선사퇴,http://www.asiatoday.co.kr/view.php?key=20180827010013822
2951,2018-08-27,윤재승대웅제약회장욕설갑질논란에경영일선서물러나겠다,http://www.newsworks.co.kr/news/articleView.html?idxno=210518
2952,2018-08-27,대웅제약윤재승회장갑질논란에주가약세,http://www.kpinews.co.kr/news/articleView.html?idxno=80049
2953,2018-08-27,대웅제약윤재승회장들끓는잡음어떤말했기에많은이들공분자아내게만들어,http://www.ksilbo.co.kr/news/articleView.html?idxno=655241
2954,2018-08-27,대웅제약윤재승회장욕설폭언논란에주가뚝뚝경영일선서물러난다”,http://news.donga.com/3/all/20180827/91691755/2
2955,2018-08-27,갑질물의대웅제약윤재승회장경영일선사퇴”,http://sports.khan.co.kr/news/sk_index.html?art_id=201808271047003&sec_id=564001&pt=nv
2956,2018-08-27,대웅제약윤재승욕설논란결국사임23년간퇴사한직원100여명,http://www.anewsa.com/detail.php?number=1361304&thread=09r02
2957,2018-08-27,대웅제약윤재승회장욕설논란에사과경영일선서물러나겠다,http://www.slist.kr/news/articleView.html?idxno=43699
2958,2018-08-27,상습폭언논란윤재승대웅제약회장경영서물러나겠다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808270239&t=NN
2959,2018-08-27,대웅제약윤재승녹취록에서드러난재벌가의민낯불매운동까지,http://www.sedaily.com/NewsView/1S3IUX42YJ
2960,2018-08-27,대웅제약윤재승회장폭언욕설소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=330559
2961,2018-08-27,글로벌진출계획대웅제약오너리스크로울상,http://www.m-i.kr/news/articleView.html?idxno=446878
2962,2018-08-27,대웅제약윤재승회장상습욕설폭언녹음파일공개논란불매운동”의견도,http://medicalworldnews.co.kr/news/view.php?idx=1510927153
2963,2018-08-27,대웅제약윤재승직원모욕논란일어잃어버린신조직원의행복이회사경쟁력이라더니,http://www.thegolftimes.co.kr/news/articleView.html?idxno=36021
2964,2018-08-27,욕설논란대웅제약윤재승회장경영일선사퇴,http://www.ytn.co.kr/_ln/0103_201808271051261883
2965,2018-08-27,대웅제약윤재승회장폭언논란에경영물러나자숙할것”,http://www.seoul.co.kr/news/newsView.php?id=20180827500026&wlog_tag3=naver
2966,2018-08-27,윤재승대웅제약회장경영일선물러나자숙의시간갖겠다”,http://moneys.mt.co.kr/news/mwView.php?no=2018082710348050068
2967,2018-08-27,대웅제약윤재승회장폭언논란에경영일선서물러나겠다,http://www.medisobizanews.com/news/articleView.html?idxno=54960
2968,2018-08-27,윤재승대웅제약회장직원상습폭언등갑질경영일선에서물러나겠다,http://www.ceoscoredaily.com/news/article.html?no=45144
2969,2018-08-27,윤재승대웅제약회장모든책임지고경영일선에서물러나자숙하겠다,http://www.viva100.com/main/view.php?key=20180827010008170
2970,2018-08-27,욕설논란윤재승대웅제약회장경영일선서물러나겠다,http://www.m-i.kr/news/articleView.html?idxno=446899
2971,2018-08-27,미친XX야”욕설인정한윤재승대웅제약회장경영일선서물러나겠다”,http://www.sisajournal-e.com/biz/article/188303
2972,2018-08-27,욕설논란대웅제약윤재승회장제책임자숙시간갖겠다”,http://chicnews.mk.co.kr/article.php?aid=1535334105208296018
2973,2018-08-27,대웅제약윤재승회장즉시경영물러나자숙시간갖겠다,http://www.ebn.co.kr/news/view/953135
2974,2018-08-27,욕설논란대웅제약윤재승회장경영일선즉시물러나자숙하겠다”전문,http://www.etoday.co.kr/news/section/newsview.php?idxno=1656443
2975,2018-08-27,욕설파문윤재승대웅제약회장경영일선서물러나겠다,http://www.segyefn.com/newsView/20180827001471?OutUrl=naver
2976,2018-08-27,윤재승대웅제약회장욕설파문에경영일선에서물러나겠다”,http://www.newsway.co.kr/news/view?tp=1&ud=2018082710281130722
2977,2018-08-27,폭언논란윤재승대웅제약회장경영일선물러날것,http://www.fntimes.com/html/view.php?ud=201808270929293966902857eb1a_18
2978,2018-08-27,직원에폭언폭행파문일으킨윤재승회장은검사하다가회장님이된대웅제약2세,http://monthly.chosun.com/client/mdaily/daily_view.asp?idx=4902&Newsnumb=2018084902
2979,2018-08-27,윤재승대웅제약회장경영일선에서물러나자숙하겠다”,http://www.sporbiz.co.kr/news/articleView.html?idxno=266443
2980,2018-08-27,대웅제약윤재승회장입장문전문,http://www.newsway.co.kr/news/view?tp=1&ud=2018082711062401529
2981,2018-08-27,경영서물러난다”윤재승회장사과했지만대웅제약불매운동움직임,http://news.donga.com/3/all/20180827/91692131/2
2982,2018-08-27,대웅제약윤재승회장욕설논란에주가흔들,http://www.whitepaper.co.kr/news/articleView.html?idxno=111383
2983,2018-08-27,욕설논란대웅제약윤재승회장진심으로사죄경영일선사퇴,http://news.hankyung.com/article/201808270406I
2984,2018-08-27,대웅윤재승회장경영일선퇴진자숙하겠다,http://www.medical-tribune.co.kr/news/articleView.html?idxno=80916
2985,2018-08-27,대웅제약윤재승회장회사경영손뗀다,http://www.dailymedi.com/detail.php?number=834058&thread=22r05
2986,2018-08-27,대웅제약윤재승회장물러난다모든책임은저에게공동대표전문경영인체제로운영,http://www.ltn.kr/news/articleView.html?idxno=11189
2987,2018-08-27,직원갑질윤재승대웅제약회장경영일선즉시사퇴,http://www.inews24.com/php/news_view.php?g_serial=1120595&g_menu=022620&rrf=nv
2988,2018-08-27,대웅제약윤재승회장상습폭언논란에경영물러나겠다,http://news1.kr/articles/?3409069
2989,2018-08-27,대웅제약윤재승회장갑질물의경영일선사퇴종합,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180827054151017&did=1195m
2990,2018-08-27,윤재승대웅제약회장갑질논란에주가226급락,http://www.econovill.com/news/articleView.html?idxno=344712
2991,2018-08-27,욕설갑질대웅제약윤재승회장경영대권잡고트러블메이커된까닭,http://www.newsfc.co.kr/news/articleView.html?idxno=33441
2992,2018-08-27,미친X”직원에욕설퍼부은윤재승대웅제약회장,http://www.breaknews.com/sub_read.html?uid=597388§ion=sc3
2993,2018-08-27,정신병자XX욕설파문윤재승대웅제약회장경영일선사퇴,http://www.insight.co.kr/news/174777
2994,2018-08-27,정신병자랑일하는거같아”대웅제약윤재승회장상습욕설파장,http://www.kukinews.com/news/article.html?no=579658
2995,2018-08-27,폭언욕설놀란대웅제약윤재승회장경영일선에서물러나겠다고밝혀상처를줬다,http://www.topstarnews.net/news/articleView.html?idxno=471402
2996,2018-08-27,폭언욕설윤재승대웅제약회장사과도꼼수,http://news.bizwatch.co.kr/article/consumer/2018/08/27/0005/naver
2997,2018-08-27,대웅제약윤재승회장갑질물의경영일선사퇴,https://news.sbs.co.kr/news/endPage.do?news_id=N1004907510&plink=ORI&cooper=NAVER
2998,2018-08-27,쿠키영상상습욕설논란대웅제약윤재승회장정신병자랑일하는것같아서”사과문즉시경영에서물러나겠다”,http://www.kukinews.com/news/article.html?no=579633
2999,2018-08-27,직원에정신병자XX막말윤재승대웅제약회장경영에서물러나겠다,http://www.newsfc.co.kr/news/articleView.html?idxno=33443
3000,2018-08-27,대웅제약윤재승상습욕설논란신동욱대웅제약불매운동하자,http://news20.busan.com/controller/newsController.jsp?newsId=20180827000056
3001,2018-08-27,대웅제약윤재승회장폭언논란진심으로사과자숙의시간갖겠다,http://www.medigatenews.com/news/1453606483
3002,2018-08-27,윤재승대웅제약회장소통경영강조했지만사퇴불명예,http://www.sporbiz.co.kr/news/articleView.html?idxno=266473
3003,2018-08-27,폭언논란윤재승대웅제약회장경영일선퇴진자숙시간갖겠다,http://www.wolyo.co.kr/news/articleView.html?idxno=66790
3004,2018-08-27,갑질욕설물의윤재승대웅제약회장경영일선서사퇴”,http://news.heraldcorp.com/view.php?ud=20180827000369
3005,2018-08-27,대웅제약윤재승욕설음성파일보니살인충동느끼게하는XX,http://www.starseoultv.com/news/articleView.html?idxno=505311
3006,2018-08-27,욕설파문윤재승대웅제약회장경영일선에서물러나겠다,http://www.ezyeconomy.com/news/articleView.html?idxno=85144
3007,2018-08-27,정신병자XX직원상대상습욕설윤재승대웅제약회장경영물러나자숙사과,http://www.segye.com/content/html/2018/08/27/20180827002052.html?OutUrl=naver
3008,2018-08-27,윤재승대웅제약회장폭언갑질의혹에사과후＂사임하겠다＂밝혀,http://www.nspna.com/news/?mode=view&newsid=302254
3009,2018-08-27,직원에욕설윤재승대웅제약회장경영일선사퇴,http://www.meconomynews.com/news/articleView.html?idxno=16759
3010,2018-08-27,폭언논란대웅제약윤재승회장진심죄송경영일선사퇴∙자숙하겠다,http://www.getnews.co.kr/news/articleView.html?idxno=92065
3011,2018-08-27,상습욕설폭언대웅제약윤재승회장비난쇄도하자경영에서물러나겠다”공식입장,http://www.mydaily.co.kr/new_yk/html/read.php?newsid=201808271129703676&ext=na
3012,2018-08-27,상습갑질윤재승대웅제약회장일선사퇴,http://www.obsnews.co.kr/news/articleView.html?idxno=1112828
3013,2018-08-27,대웅제약윤재승회장미친X정신병자상습폭언경영일선후퇴,http://www.dailypop.kr/news/articleView.html?idxno=34962
3014,2018-08-27,대웅제약윤재승회장이직원에게폭언하는녹음파일이공개됐다,https://www.huffingtonpost.kr/entry/story_kr_5b8342efe4b0729515140e59?utm_id=naver
3015,2018-08-27,취재N팩트미친XX대웅제약윤재승회장상습욕설경영사퇴,http://www.ytn.co.kr/_ln/0103_201808271150256957
3016,2018-08-27,욕설논란윤재승대웅제약회장경영물러나자숙의시간갖겠다,http://www.nbnnews.co.kr/news/articleView.html?idxno=170322
3017,2018-08-27,대웅제약윤재승회장갑질에신동욱남자조현아찰떡궁합꼴,http://www.whitepaper.co.kr/news/articleView.html?idxno=111394
3018,2018-08-27,대웅제약윤재승회장갑질신동욱불매운동제안,http://daily.hankooki.com/lpage/society/201808/dh20180827115137137780.htm
3019,2018-08-27,상습폭언욕설논란대웅제약윤재승회장경영일선서물러나겠다”,http://www.vop.co.kr/A00001325457.html
3020,2018-08-27,대웅제약윤재승회장폭언논란에죄송하다경영일선서사퇴,http://www.mdtoday.co.kr/mdtoday/index.html?no=330571
3021,2018-08-27,욕설논란대웅제약윤재승회장임직원에사과경영일선서사퇴,http://www.rapportian.com/news/articleView.html?idxno=112476
3022,2018-08-27,막말논란윤재승대웅제약회장경영일선물러나,http://www.doctorsnews.co.kr/news/articleView.html?idxno=125016
3023,2018-08-27,윤재승대웅제약직원폭언사죄하고경영일선에서물러나,http://www.businesspost.co.kr/BP?command=article_view&num=93923
3024,2018-08-27,대웅제약윤재승직원모욕으로논란직원의행복이회사의경쟁력이라던신조는,http://www.newscj.com/news/articleView.html?idxno=549595
3025,2018-08-27,윤재승대웅제약회장진심으로사과경영일선에서물러나자숙,http://www.seoulwire.com/news/articleView.html?idxno=24077
3026,2018-08-27,하태경욕설의혹대웅제약윤재승회장비판윤회장진심으로사과”,http://news.donga.com/3/all/20180827/91693802/2
3027,2018-08-27,대웅제약윤재승녹취록파문측근언제가는곪아터질줄알았다,http://news20.busan.com/controller/newsController.jsp?newsId=20180827000081
3028,2018-08-27,대웅제약윤재승욕설논란에신동욱정신병자가만든우루X,http://www.nextdaily.co.kr/news/article.html?id=20180827800035
3029,2018-08-27,폭언논란대웅제약윤재승회장진심으로죄송경영일선서물러나겠다,http://www.economytalk.kr/news/articleView.html?idxno=167622
3030,2018-08-27,대웅제약윤재승회장욕설논란보수적인제약업계오너리스크또나올까,http://www.whitepaper.co.kr/news/articleView.html?idxno=111393
3031,2018-08-27,상습욕설폭언윤재승대웅제약회장퇴진제약사오너23세도갑질논란,http://www.4th.kr/news/articleView.html?idxno=5615
3032,2018-08-27,욕설논란대웅제약윤재승회장경영서물러나겠다,http://www.yonhapnewstv.co.kr/MYH20180827005800038/?did=1825m
3033,2018-08-27,대웅제약윤재승회장곪아터진공포의직접보고檢출신탓에쉬쉬,http://www.seoulwire.com/news/articleView.html?idxno=24080
3034,2018-08-27,대웅제약윤재승회장공포의직접보고곪아터졌다檢출신탓에,http://www.sisamagazine.co.kr/news/articleView.html?idxno=141392
3035,2018-08-27,대웅제약윤재승회장올것이오고터질게터졌다법잘알아폭언욕설일삼아,http://www.econonews.co.kr/news/articleView.html?idxno=34013
3036,2018-08-27,신동욱대웅제약윤재승회장논란정신병자가만든우루사곰발정,http://www.inews24.com/php/news_view.php?g_serial=1120633&g_menu=050300&rrf=nv
3037,2018-08-27,대웅제약고막테러법적용해야엄중잣대로책상물리기,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=765985
3038,2018-08-27,대웅제약윤재승회장시대가변해도갑질은여전한씁쓸한현실,http://www.namdonews.com/news/articleView.html?idxno=487686
3039,2018-08-27,폭언논란대웅제약윤재승회장경영일선물러난다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059680
3040,2018-08-27,직원상습욕설대웅제약윤재승회장에질타이어져,http://www.k-health.com/news/articleView.html?idxno=37546
3041,2018-08-27,대웅제약고막테러법아시나요엄중잣대책상물리기로,http://www.ccdn.co.kr/news/articleView.html?idxno=536692
3042,2018-08-27,미친XX야부하직원에욕설폭언의혹대웅제약윤재승회장진심으로죄송경영일선서물러날것,http://www.joongboo.com/news/articleView.html?idxno=1281614
3043,2018-08-27,갑질물의윤재승대웅제약회장경영일선사퇴,http://www.fetv.co.kr/news/article.html?no=11504
3044,2018-08-27,갑질논란대웅제약윤재승회장경영사퇴입장밝혀전문경영인체제로운영,http://www.topstarnews.net/news/articleView.html?idxno=471481
3045,2018-08-27,폭언논란대웅제약윤재승회장즉시경영일선에서물러나겠다,http://star.mt.co.kr/stview.php?no=2018082713220233422
3046,2018-08-27,대웅제약윤재승회장기억안나→직위내려놓겠다반나절만에사의,http://www.greened.kr/news/articleView.html?idxno=73090
3047,2018-08-27,욕설논란윤재승대웅제약회장경영일선물러난다종합,http://www.edaily.co.kr/news/newspath.asp?newsid=03148806619311584
3048,2018-08-27,상습폭언논란대웅제약윤재승회장경영물러나겠다,http://www.sedaily.com/NewsView/1S3IVNCUSV
3049,2018-08-27,대웅제약윤재승회장직위내려놓을것사의반나절채못돼무릎,http://viewers.heraldcorp.com/news/articleView.html?idxno=18762
3050,2018-08-27,경영사퇴윤재승대웅제약회장네이버커넥트재단이사장직유지,http://daily.hankooki.com/lpage/economy/201808/dh20180827135424138060.htm
3051,2018-08-27,욕설파문윤재승대웅제약회장경영일선사퇴,http://www.nocutnews.co.kr/news/5021801
3052,2018-08-27,상습폭언대웅제약윤재승회장경영일선사퇴,http://news.kbs.co.kr/news/view.do?ncd=4029985&ref=A
3053,2018-08-27,업다운이슈폭언갑질대웅제약윤재승회장경영일선사퇴한다지만직원모독의짙은그림자,http://www.updownnews.co.kr/news/articleView.html?idxno=96186
3054,2018-08-27,＂대웅제약윤재승회장의욕설과폭언독재자나폭군을연상시켰다＂,http://www.nspna.com/news/?mode=view&newsid=302314
3055,2018-08-27,윤재승회장욕설에대웅제약불벼락누리꾼불매운동시작하자,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0300&key=20180827.99099012452
3056,2018-08-27,윤재승회장욕설논란대웅제약주가휘청불매운동노조경영권위협우려↑,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180827.99099012433
3057,2018-08-27,특징주대웅제약윤재승회장갑질물의에하락,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180827098200008&did=1195m
3058,2018-08-27,하태경대웅제약윤재승회장향해간수치검사의무화해야하나”,http://news.heraldcorp.com/view.php?ud=20180827000568
3059,2018-08-27,윤재승대웅제약회장갑질논란에네이버커넥트재단재조명,http://biz.newdaily.co.kr/site/data/html/2018/08/27/2018082700093.html
3060,2018-08-27,상습폭언윤재승대웅제약회장경영일선서물러난다,http://news.kmib.co.kr/article/view.asp?arcid=0012634109&code=61121111&cp=nv
3061,2018-08-27,특징주대웅제약윤재승회장폭언논란에하락세지속,http://www.asiatime.co.kr/news/articleView.html?idxno=195869
3062,2018-08-27,우루사대웅제약도회장갑질파문,http://www.shinailbo.co.kr/news/articleView.html?idxno=1100593
3063,2018-08-27,대웅제약윤재승회장갑질논란욕설로백명넘게관뒀다기억못하지만죄송,http://www.dtnews24.com/news/articleView.html?idxno=523691
3064,2018-08-27,곪아터질줄알았다대웅제약윤재승측근이본욕설파문,http://www.sedaily.com/NewsView/1S3IVO2BTE
3065,2018-08-27,직원폭언논란윤재승대웅제약회장경영일선에서물러난다”,http://www.etnews.com/20180827000221
3066,2018-08-27,특징주욕설논란윤재승경영일선물러날것”대웅제약↓,http://www.edaily.co.kr/news/newspath.asp?newsid=03299686619311584
3067,2018-08-27,영상갑질물의대웅제약윤재승회장경영일선사퇴,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180827101700704&did=1195m
3068,2018-08-27,대웅제약윤재승회장말끝마다늘어놓는말보니경악대체뭐라고했길래다수의근로자들스트레스엄청받아,http://www.ujnews.co.kr/news/articleView.html?idxno=421701
3069,2018-08-27,대웅제약윤재승회장갑질논란으로경영에서물러나,http://www.techholic.co.kr/news/articleView.html?idxno=177766
3070,2018-08-27,대웅제약윤재승회장폭언논란,http://www.iloveorganic.co.kr/news/articleView.html?idxno=216372
3071,2018-08-27,곪았던게터졌다윤재승대웅제약회장욕설기업이미지실추,http://biz.newdaily.co.kr/site/data/html/2018/08/27/2018082700120.html
3072,2018-08-27,대웅제약윤재승회장직위내려놓겠다녹음파일후폭풍에사의,http://www.ecomedia.co.kr/news/newsview.php?ncode=1065592004459470
3073,2018-08-27,대웅제약불매운동확대윤재승회장경영서물러나자숙의시간가지겠다”,http://medicalworldnews.co.kr/news/view.php?idx=1510927155
3074,2018-08-27,대웅제약윤재승회장결국모든책임나에게”갑질의최후,http://www.betanews.net:8080/article/900056.html
3075,2018-08-27,직원에갑질윤재승대웅제약회장경영일선사퇴,http://www.seoulfn.com/news/articleView.html?idxno=317820
3076,2018-08-27,특징주대웅제약윤재승회장갑질폭언녹취록공개되자주가하락,http://www.kukinews.com/news/article.html?no=579737
3077,2018-08-27,모든책임나에게대웅제약윤재승갑질의말로,http://www.youngnong.co.kr/news/articleView.html?idxno=14940
3078,2018-08-27,대웅제약윤재승폭로보니폭언때문에토하기도예견됐던일,http://www.starseoultv.com/news/articleView.html?idxno=505345
3079,2018-08-27,하태경대웅제약윤재승회장욕설갑질논란에우루사많이먹으면간이붓는부작용,http://www.inews24.com/php/news_view.php?g_serial=1120680&g_menu=050300&rrf=nv
3080,2018-08-27,대웅제약 고막테러법적용해야엄중잣대로책상물리기따가운시선이,http://www.incheonnews.com/news/articleView.html?idxno=110527
3081,2018-08-27,소통경영강조하던대웅제약윤재승회장갑질논란일파만파,http://www.etoday.co.kr/news/section/newsview.php?idxno=1656562
3082,2018-08-27,윤재승대웅제약회장갑질논란상습모욕혐의처벌가능할까,http://www.fnnews.com/news/201808271329576891
3083,2018-08-27,거친입으로갑질윤재승대웅제약회장사임,http://www.straightnews.co.kr/news/articleView.html?idxno=34428
3084,2018-08-27,윤재승대웅제약회장경영일선서물러나겠다,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003312952
3085,2018-08-27,윤재승대웅제약회장임직원에게욕설등갑질경영일선서물러날것,http://www.fnnews.com/news/201808271518140286
3086,2018-08-27,폭언욕설갑질대웅제약윤재승경영일선물러나겠다파문반나절만에백기,http://www.joseilbo.com/news/news_read.php?uid=359612&class=33&grp=
3087,2018-08-27,대웅제약윤재승회장사과자숙하겠다,http://www.monews.co.kr/news/articleView.html?idxno=118240
3088,2018-08-27,대웅제약회장도넘은갑질처벌여론높아,http://www.kntimes.co.kr/news/articleView.html?idxno=27210
3089,2018-08-27,하태경윤재승대웅제약회장갑질에우루사먹지말아야겠다,http://www.newsworks.co.kr/news/articleView.html?idxno=210660
3090,2018-08-27,대웅제약윤재승회장의애매한사과문어떤직위를내려놓나,http://www.mediasr.co.kr/news/articleView.html?idxno=49308
3091,2018-08-27,대웅제약윤재승회장갑질물의경영일선사퇴종합2보,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180827054152017&did=1195m
3092,2018-08-27,윤재승회장욕설에대웅제약주가하락세로마감내일추가하락이어지나,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180827.99099012561
3093,2018-08-27,대웅제약윤재승회장폭언보도에경영일선퇴진,http://www.upinews.kr/news/newsview.php?ncode=1065595656825987
3094,2018-08-27,대웅제약윤재승회장폭언욕설에주가도하락제발등찍기비판쏟아져,http://www.sedaily.com/NewsView/1S3IW5WKJX
3095,2018-08-27,SS이슈욕설파문대웅제약윤재승회장경영일선서즉각물러나겠다,http://www.sportsseoul.com/news/read/674113
3096,2018-08-27,대웅제약윤재승회장막말공식사과경영일선물러나자숙하겠다”,http://kpenews.com/Board.aspx?BoardNo=18177
3097,2018-08-27,대웅제약윤재승회장갑질논란에관둔사원多기억안나지만사과전하겠다,http://www.tfnews.co.kr/news/article.html?no=52251
3098,2018-08-27,8월27일월요일특징주대웅제약,http://www.leaders.kr/news/articleView.html?idxno=73083
3099,2018-08-27,대웅제약윤재승회장경영일선사퇴”회장직사퇴관심,http://www.kukinews.com/news/article.html?no=579817
3100,2018-08-27,정신병자XX대웅제약윤재승회장논란으로본재벌들그때그막말,http://news.hankyung.com/article/2018082711337
3101,2018-08-27,잊을만하면오너갑질대웅제약논란에주주발끈,http://biz.chosun.com/site/data/html_dir/2018/08/27/2018082702361.html
3102,2018-08-27,대웅제약윤재승모든책임나에게있다”갑질로잃은것,http://biz.heraldcorp.com/culture/view.php?ud=201808271642107109075_1
3103,2018-08-27,대웅제약윤재승회장공포의직접보고檢이력에쉬쉬했나,http://www.nbnnews.co.kr/news/articleView.html?idxno=170474
3104,2018-08-27,윤재승대웅제약회장갑질논란상습모욕혐의처벌가능할까,http://www.fnnews.com/news/201808271656121333
3105,2018-08-27,윤재승대웅회장물러난다고경영사퇴놓고커지는의문,http://www.newsway.co.kr/news/view?tp=1&ud=2018082716520688517
3106,2018-08-27,하태경대웅제약윤재승회장우루사먹고간이부었나욕설논란조롱,http://news.hankyung.com/article/2018082720557
3107,2018-08-27,대웅제약윤재승회장갑질논란경영일선사퇴,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10297973
3108,2018-08-27,갑질논란윤재승대웅제약회장퇴진의사에도진정성의구심,http://www.newspim.com/news/view/20180827000422
3109,2018-08-27,신동욱총재대웅제약윤재승욕설논란에정신병자가만든우루사꼴,http://www.ggilbo.com/news/articleView.html?idxno=539868
3110,2018-08-27,대웅제약윤재승회장직원에상습막말욕설미친XX야,http://golfhankook.hankooki.com/01_news/NewsView.php?category=37&gsno=10224662
3111,2018-08-27,윤재승대웅회장갑질논란일파만파폭언욕설로경영일선사퇴,http://www.nextdaily.co.kr/news/article.html?id=20180827800075
3112,2018-08-27,대웅윤재승회장의추악한언행주가폭락으로개미투자자들만손실,http://www.hkbs.co.kr/news/articleView.html?idxno=481367
3113,2018-08-27,단독폭언논란대웅제약윤재승어제기습출국퇴진진성성의문,http://www.ytn.co.kr/_ln/0103_201808271726020939
3114,2018-08-27,잊을만하면오너갑질윤재승대웅제약회장경영일선물러나겠다”,http://www.todaykorea.co.kr/news/view.php?no=256209
3115,2018-08-27,단독폭언논란대웅제약윤재승어제기습출국퇴진진정성의문,http://www.ytn.co.kr/_ln/0103_201808271726020939
3116,2018-08-27,갑질물의윤재승대웅제약회장경영물러나,https://cnbc.sbs.co.kr/article_hub/10000913019?division=NAVER
3117,2018-08-27,아주종목분석회장갑질대웅제약2넘게하락,http://www.ajunews.com/view/20180827172623202
3118,2018-08-27,오너갑질대웅혁신제약기업취소될까,http://www.sedaily.com/NewsView/1S3IV6OUPF
3119,2018-08-27,대웅제약윤재승회장갑질여파하루만에시가총액521억원증발,http://news.hankyung.com/article/2018082722557
3120,2018-08-27,대웅제약윤재승회장정신병자XX막말갑질,http://www.weeklytoday.com/news/articleView.html?idxno=67368
3121,2018-08-27,윤재승대웅제약회장갑질”경영일선서사퇴”,http://www.hankookilbo.com/v/85f35efd46c54ca99bc6712233d69d8a
3122,2018-08-27,윤재승대웅제약회장사퇴임직원욕설갑질여론악화,http://news.mk.co.kr/newsRead.php?year=2018&no=538236
3123,2018-08-27,윤재승대웅제약회장폭언논란제약업계곪은게터졌다,http://www.wolyo.co.kr/news/articleView.html?idxno=66819
3124,2018-08-27,윤재승대웅제약회장경영물러난다기업이미지손상불가피,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018082714483233001
3125,2018-08-27,대웅제약윤재승회장논란에재조명미스터피자등막말의역사,http://news.hankyung.com/article/2018082724307
3126,2018-08-27,양재준기자의알투바이오벌써두번째윤재승대웅제약회장와신상담행,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808270454&t=NN
3127,2018-08-27,심심하면터지는재벌가욕설이번엔대웅제약회장,http://www.yonhapnewstv.co.kr/MYH20180827012700038/?did=1825m
3128,2018-08-27,대웅경영권분쟁불씨살아나나,http://news.hankyung.com/article/2018082722941
3129,2018-08-27,정치부회의복부장의한컷정치윤재승대웅제약회장갑질논란경영일선사퇴,http://www.topstarnews.net/news/articleView.html?idxno=471750
3130,2018-08-27,대웅제약회장갑질논란에시가총액523억증발,http://www.econovill.com/news/articleView.html?idxno=344751
3131,2018-08-27,오늘이슈특검드루킹댓글조작사실대웅제약윤재승회장욕설논란경영계떠나자숙집값대폭오른서울4개구투기지역지정전두환첫재판끝내불출석전국폭우피해속출문대통령국가,http://www.econovill.com/news/articleView.html?idxno=344744
3132,2018-08-27,욕설갑질윤재승대웅제약회장사퇴,http://www.seoul.co.kr/news/newsView.php?id=20180828011008&wlog_tag3=naver
3133,2018-08-27,복부장의한컷정치오너품격은어디로대웅제약회장갑질논란,http://news.jtbc.joins.com/html/890/NB11686890.html
3134,2018-08-27,단독욕설물의대웅제약윤재승돌연출국경영퇴진꼼수논란,http://www.ytn.co.kr/_ln/0103_201808271857162300
3135,2018-08-27,대웅제약윤재승회장폭언욕설갑질물의경영일선사퇴,http://imnews.imbc.com/news/2018/society/article/4788086_22673.html
3136,2018-08-27,대웅제약윤재승회장폭언욕설에직원들공포에덜덜,http://www.insightkorea.co.kr//news/articleView.html?idxno=29960
3137,2018-08-27,검사출신윤재승대웅제약회장욕설파문에사의표명,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1191303
3138,2018-08-27,욕설갑질대웅제약윤재승회장경영퇴진”,http://www.ichannela.com/news/main/news_detailPage.do?publishId=000000109534
3139,2018-08-27,EBN오늘27일이슈종합정부827부동산대책발표대웅제약윤재승회장갑질물의경영일선사퇴아프리카돼지열병바이러스유전자확진,http://www.ebn.co.kr/news/view/953202
3140,2018-08-27,SR인권욕설갑질대웅제약윤재승회장경영퇴진선언하고돌연출국,http://www.srtimes.kr/news/articleView.html?idxno=23114
3141,2018-08-27,터질게터졌다대웅제약회장갑질파문경영일선사퇴,http://news.jtbc.joins.com/html/957/NB11686957.html
3142,2018-08-27,갑질파문윤재승대웅제약회장사퇴,http://www.segye.com/content/html/2018/08/27/20180827005483.html?OutUrl=naver
3143,2018-08-27,보고하는직원에이XX야대웅제약윤재승회장폭언논란,http://news.tvchosun.com/site/data/html_dir/2018/08/27/2018082790110.html
3144,2018-08-27,심심하면터지는재벌가욕설이번엔대웅제약회장,http://www.yonhapnewstv.co.kr/MYH20180827017900038/?did=1825m
3145,2018-08-27,욕설막말윤재승대웅제약회장경영에서물러나겠다”,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201808272134025&code=920101
3146,2018-08-27,단독대웅제약윤재승직원에상습폭언욕설논란,http://www.ytn.co.kr/_ln/0103_201808272234052895
3147,2018-08-27,단독돌연출국한대웅제약윤재승꼼수퇴진논란,http://www.ytn.co.kr/_ln/0103_201808272236135951
3148,2018-08-27,갑질물의대웅제약윤재승회장경영일선사퇴상습적폭언욕설안겪어본직원없어,http://www.kyeongin.com/main/view.php?key=20180827010008744
3149,2018-08-27,폭언욕설처음이아니다대웅제약윤재승회장경영일선사퇴직원들중갑질겪지않는사람없어논란,http://www.topdaily.kr/news/articleView.html?idxno=54984
3150,2018-08-27,욕설막말파문대웅제약윤재승회장경영일선물러나자숙,http://www.civicnews.com/news/articleView.html?idxno=17488
3151,2018-08-27,폭언논란대웅제약윤재승회장진심으로죄송경영일선서물러나겠다,http://www.newscj.com/news/articleView.html?idxno=549836
3152,2018-08-28,정신병자XX부하직원에욕설폭언의혹대웅제약윤재승회장은누구윤영환아들검사출신,http://www.joongboo.com/news/articleView.html?idxno=1281612
3153,2018-08-28,대웅제약자숙으로한발을물리면책상빼기로대처,http://www.ccdn.co.kr/news/articleView.html?idxno=536885
3154,2018-08-28,대웅제약자숙으로한발을빼면책상빼기인가,http://www.kihoilbo.co.kr/?mod=news&act=articleView&idxno=766167
3155,2018-08-28,윤재승회장욕설논란속대웅제약주가심상찮다불매운동경영권위협노림수,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180828.99099012682
3156,2018-08-28,대웅제약윤재승회장직원들에상습폭언욕설의혹녹취록공개정신병자XX미친XX네,http://www.joongboo.com/news/articleView.html?idxno=1281596
3157,2018-08-28,폭언욕설갑질논란에대웅제약윤재승회장죄송경영일선물러나겠다,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180828.99099012333
3158,2018-08-28,대웅제약윤재승직원들더고개숙였던이유,http://www.greened.kr/news/articleView.html?idxno=73167
3159,2018-08-28,대웅제약윤재승폭언에더고개숙였던직원들,http://www.econovill.com/news/articleView.html?idxno=344768
3160,2018-08-28,대웅제약윤재승자숙으로한발을빼면책상빼기인가미국출국설,http://www.incheonnews.com/news/articleView.html?idxno=110583
3161,2018-08-28,정신병자같은XX대웅제약윤재승회장폭언욕설논란퇴진,http://news.chosun.com/site/data/html_dir/2018/08/28/2018082800116.html?utm_source=naver&utm_medium=original&utm_campaign=news
3162,2018-08-28,직원에욕설윤재승대웅제약회장퇴진,http://news.donga.com/3/all/20180828/91705783/1
3163,2018-08-28,갑질파문대웅제약윤재승회장지난주말미국행도피성출국의혹,http://news.kmib.co.kr/article/view.asp?arcid=0012635823&code=61121211&cp=nv
3164,2018-08-28,대웅제약윤재승녹취록공개전도피성출국의혹,http://news20.busan.com/controller/newsController.jsp?newsId=20180828000006
3165,2018-08-28,욕설갑질논란윤재승대웅제약회장경영퇴진,http://imnews.imbc.com/replay/2018/nwtoday/article/4788785_22669.html
3166,2018-08-28,대웅윤재승회장폭언논란두고오너리스크설왕설래,http://www.kpanews.co.kr/article/show.asp?idx=196390&table=article&category=D
3167,2018-08-28,검사출신윤재승대웅제약회장욕설파문에사의표명,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1191323
3168,2018-08-28,욕설갑질논란윤재승대웅제약회장경영퇴진,http://imnews.imbc.com/replay/2018/nwtoday/article/4788946_22669.html
3169,2018-08-28,윤재승대웅제약회장폭언욕설파문직전미국行,http://www.ajunews.com/view/20180828075429345
3170,2018-08-28,신문브리핑욕설막말윤재승대웅제약회장경영에서물러나겠다법원전두환알츠하이머라며회고록어떻게나외주요기사2,http://www.mbn.co.kr/pages/vod/programView.mbn?bcastSeqNo=1191343
3171,2018-08-28,직원에욕설파문윤재승대웅제약회장경영손떼겠다,http://news.jtbc.joins.com/html/114/NB11687114.html
3172,2018-08-28,대웅제약윤재승회장갑질논란하루만에시총521억원날아가다,http://www.mdtoday.co.kr/mdtoday/index.html?no=330674
3173,2018-08-28,윤재승대웅제약회장갑질로사퇴,https://cnbc.sbs.co.kr/article_hub/10000913063?division=NAVER
3174,2018-08-28,상습폭언욕설대웅제약윤재승회장돌연출국도피성아니냐”지적,http://www.mydaily.co.kr/new_yk/html/read.php?newsid=201808280903563192&ext=na
3175,2018-08-28,신동욱욕설논란대웅제약윤재승저격정신병자가만든우루사꼴,http://www.sedaily.com/NewsView/1S3JAYY535
3176,2018-08-28,특징주회장님갑질파문대웅제약장초반하락세이틀연속↓,http://www.kukinews.com/news/article.html?no=579911
3177,2018-08-28,우루사먹으면간이붓는다하태경대웅제약회장갑질에직격탄,http://kpenews.com/Board.aspx?BoardNo=18206
3178,2018-08-28,대웅제약주가추가하락윤재승회장기습출국경영퇴진물거품되나,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20180828.99099012801
3179,2018-08-28,폭언욕설파문윤재승대웅제약회장사퇴,https://cnbc.sbs.co.kr/article_hub/10000913074?division=NAVER
3180,2018-08-28,증시현황28일대웅제약주가오전10시40분193000원,http://www.anewsa.com/detail.php?number=1361985&thread=10r04
3181,2018-08-28,한국당김병준대웅제약회장갑질비판하며SNS에올린무지의장막,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201808281049001&code=910100
3182,2018-08-28,종목이슈갑질대웅제약버티는주가에도우려는있다,http://www.newspim.com/news/view/20180828000180
3183,2018-08-28,갑질의혹대웅제약윤재승회장경영사퇴”,http://www.ichannela.com/news/main/news_detailPage.do?publishId=000000109647
3184,2018-08-28,욕설파문사퇴밝힌윤재승대웅회장공시해야확정,http://www.intn.co.kr/news/articleView.html?idxno=2001653
3185,2018-08-28,오너갑질대웅제약尹회장취임후직원근속연수계속줄었다,http://news.heraldcorp.com/view.php?ud=20180828000491
3186,2018-08-28,대웅윤재춘단독대표이사체제로변경,http://news.mt.co.kr/mtview.php?no=2018082813133144277
3187,2018-08-28,윤재승대웅제약회장모든직위물러나회사떠난다,http://www.edaily.co.kr/news/newspath.asp?newsid=02945446619311912
3188,2018-08-28,윤재승대웅제약회장회사떠난다,http://www.kukinews.com/news/article.html?no=580009
3189,2018-08-28,속보욕설논란대웅제약윤재승회장사임,http://www.ytn.co.kr/_ln/0103_201808281328148869
3190,2018-08-28,대웅윤재춘대표체제로변경,http://view.asiae.co.kr/news/view.htm?idxno=2018082813290756172
3191,2018-08-28,대웅윤재승대표이사사임윤재춘단독대표로변경,http://biz.chosun.com/site/data/html_dir/2018/08/28/2018082801570.html
3192,2018-08-28,윤재승회장대웅제약대웅대표이사등기이사사임,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221542
3193,2018-08-28,윤재승대웅회장사임공식화회사떠나자숙하겠다,http://www.dailian.co.kr/news/view/735488/?sc=naver
3194,2018-08-28,대웅윤재춘대표단독체제로변경,http://www.newspim.com/news/view/20180828000270
3195,2018-08-28,대웅윤재춘단독대표이사체제로변경,http://www.etoday.co.kr/news/section/newsview.php?idxno=1656974
3196,2018-08-28,윤재승대웅회장모든직위내려놓는다,http://www.dailymedi.com/detail.php?number=834110&thread=22r05
3197,2018-08-28,윤재승대웅제약회장모든직위사임회사떠난다,http://www.dailypharm.com/News/243170
3198,2018-08-28,대웅제약윤재승회장모든직위내려놓는다,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059734
3199,2018-08-28,욕설파문윤재승회장대웅대웅제약대표및등기임원사임,http://news.hankyung.com/article/2018082851826
3200,2018-08-28,대웅윤재춘단독대표체제로변경,http://www.sedaily.com/NewsView/1S3JB0ZCHP
3201,2018-08-28,욕설갑질윤재승대웅제약회장모든직위사임,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003314040
3202,2018-08-28,욕설논란윤재승회장대웅모든직위사퇴,http://www.biospectator.com/view/news_view.php?varAtcId=6105
3203,2018-08-28,대웅윤재승사임윤재춘단독대표이사체제로변경,http://www.newsis.com/view/?id=NISX20180828_0000402378&cID=10401&pID=10400
3204,2018-08-28,대웅윤재춘단독대표이사체제로변경,http://news.hankyung.com/article/2018082852036
3205,2018-08-28,윤재승회장대웅제약떠나다,http://www.whosaeng.com/sub_read.html?uid=103947§ion=sc5
3206,2018-08-28,대웅윤재춘대표이사단독체제로변경,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221544
3207,2018-08-28,대웅윤재춘단독대표로변경,http://www.edaily.co.kr/news/newspath.asp?newsid=02984806619311912
3208,2018-08-28,윤재승대웅제약회장모든등기이사직에서사임하겠다”,http://news.heraldcorp.com/view.php?ud=20180828000537
3209,2018-08-28,공시대웅윤재승대표이사사임윤재춘단독대표체제,http://www.newsway.co.kr/news/view?tp=1&ud=2018082813433752958
3210,2018-08-28,대웅윤재승대표이사사임,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180828092700008&did=1195m
3211,2018-08-28,갑질공분윤재승대웅회장모든직위서물러날것,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180828092100017&did=1195m
3212,2018-08-28,폭언논란윤재승대웅제약회장등기이사사퇴,http://news1.kr/articles/?3410419
3213,2018-08-28,대웅윤재춘단독대표이사체제로변경,http://www.mdtoday.co.kr/mdtoday/index.html?no=330723
3214,2018-08-28,윤재승대웅제약회장모든직위물러나회사떠난다,http://www.anewsa.com/detail.php?number=1362228&thread=09r02
3215,2018-08-28,욕설파문윤재승회장대웅제약지주사의모든직위사임,http://news.mk.co.kr/newsRead.php?year=2018&no=540266
3216,2018-08-28,대웅제약윤재승회장모든직위물러나회사떠나겠다,http://www.kpanews.co.kr/article/show.asp?idx=196417&table=article&category=D
3217,2018-08-28,윤재승대웅제약회장모든직위물러나회사떠난다”,http://www.econovill.com/news/articleView.html?idxno=344806
3218,2018-08-28,폭언논란윤재승대웅제약회장사임전문경영인체제로운영,http://www.newsis.com/view/?id=NISX20180828_0000402405&cID=13001&pID=13000
3219,2018-08-28,윤재승대웅제약회장모든직위물러나회사떠나겠다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018082813510925194
3220,2018-08-28,폭언논란윤재승회장대웅제약대웅모든직위사임,http://www.newspim.com/news/view/20180828000284
3221,2018-08-28,이사회의장도내려놔윤재승대웅제약회장사임공식화상보,http://www.edaily.co.kr/news/newspath.asp?newsid=03020886619311912
3222,2018-08-28,대웅제약윤재승회장등기임원도사임회사떠나겠다,http://www.medisobizanews.com/news/articleView.html?idxno=54992
3223,2018-08-28,윤재승대웅제약회장공식사임모든직위물러나회사떠난다”,http://www.etoday.co.kr/news/section/newsview.php?idxno=1656984
3224,2018-08-28,윤재승대웅제약회장회사떠나겠다”,http://it.chosun.com/site/data/html_dir/2018/08/28/2018082801659.html
3225,2018-08-28,욕설논란윤재승대웅제약회장사임,http://news.mt.co.kr/mtview.php?no=2018082813552947801
3226,2018-08-28,윤재승대웅제약회장대웅모든직위사임,http://www.newsprime.co.kr/news/article.html?no=427853
3227,2018-08-28,막말갑질대웅제약윤재승모든직위내놓고자숙하겠다미국서이메일,http://www.segye.com/content/html/2018/08/28/20180828003473.html?OutUrl=naver
3228,2018-08-28,갑질논란윤재승대웅제약회장모든직위서물러날것,http://www.sedaily.com/NewsView/1S3JC1HU4Q
3229,2018-08-28,폭언논란윤재승대웅회장모든직위서물러나겠다,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808280289&t=NN
3230,2018-08-28,대웅제약윤재승회장거취관련최종입장발표죄송하다회사떠나겠다,http://www.g-enews.com/ko-kr/news/article/news_all/201808281310446603f6d02acec0_1/article.html
3231,2018-08-28,갑질공분윤재승대웅회장이메일입장문진정성있나”지적,http://sports.khan.co.kr/news/sk_index.html?art_id=201808281415003&sec_id=560901&pt=nv
3232,2018-08-28,윤재승대웅제약회장사임공식화,http://www.wikileaks-kr.org/news/articleView.html?idxno=33040
3233,2018-08-28,폭언논란윤재승대웅제약회장28일사임,http://www.fntimes.com/html/view.php?ud=20180828140842694902857eb1a_18
3234,2018-08-28,상습폭언윤재승회장대웅대웅제약모든직위서물러나,http://view.asiae.co.kr/news/view.htm?idxno=2018082814230951091
3235,2018-08-28,대웅제약윤재승회장사임전문경영인체제로운영,http://www.weeklytoday.com/news/articleView.html?idxno=67391
3236,2018-08-28,윤재승대웅제약회장지주사대웅대표이사등에서물러나,http://news.khan.co.kr/kh_news/khan_art_view.html?artid=201808281423001&code=920100
3237,2018-08-28,욕설논란윤재승회장대웅제약지주사모든직위서물러나,http://www.sisajournal-e.com/biz/article/188356
3238,2018-08-28,물러난폭언대웅제약윤재승회장돌아올수있는발판은많다,http://www.news2day.co.kr/109797
3239,2018-08-28,욕설논란대웅제약윤재승회장사임모든지위에서물러나자숙,http://www.ytn.co.kr/_ln/0103_201808281432181054
3240,2018-08-28,美체류윤재승대웅제약회장욕설논란또사과회사떠나겠다”,http://news.donga.com/3/all/20180828/91714635/2
3241,2018-08-28,상습폭언논란윤재승대웅제약회장모든직위서물러나자숙의시간가질것,http://www.mdtoday.co.kr/mdtoday/index.html?no=330738
3242,2018-08-28,윤재승대웅제약회장모든직위에서물러나,http://www.sedaily.com/NewsView/1S3JCC7X4K
3243,2018-08-28,윤재승대웅제약회장모든직위사임자숙시간가지고자신바꿔나갈것,http://www.enewstoday.co.kr/news/articleView.html?idxno=1225702
3244,2018-08-28,대웅제약윤재승회장대표이사등모두사임상처받은임직원들게진심으로사과,http://www.sisafocus.co.kr/news/articleView.html?idxno=191045
3245,2018-08-28,윤재승회장대웅대웅제약모든직위서물러나,http://www.newsway.co.kr/news/view?tp=1&ud=2018082814392194582
3246,2018-08-28,NW포토욕설논란윤재승대웅제약회장사임,http://www.newsway.co.kr/news/view?tp=1&ud=2018082814461039874
3247,2018-08-28,NW포토갑질공분산윤재승대웅제약회장사임,http://www.newsway.co.kr/news/view?tp=1&ud=2018082814482249861
3248,2018-08-28,NW포토대웅제약폭언논란윤재승회장사임,http://www.newsway.co.kr/news/view?tp=1&ud=2018082814471928907
3249,2018-08-28,폭언파문대웅제약윤재승모든직위서사임하겠다,http://www.sisaon.co.kr/news/articleView.html?idxno=76751
3250,2018-08-28,갑질논란윤재승대웅제약회장모든직위에서사임,http://www.mediapen.com/news/view/378987
3251,2018-08-28,대웅욕설파문윤재승대표이사사임윤재춘단독대표로변경,http://www.greened.kr/news/articleView.html?idxno=73267
3252,2018-08-28,NW포토오너갑질윤재승대웅제약회장사임,http://www.newsway.co.kr/news/view?tp=1&ud=2018082814494009665
3253,2018-08-28,폭언논란윤재승대웅제약회장모든직위서물러나겠다사과,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00009&news_seq_no=3620445
3254,2018-08-28,꼼수인가결단인가윤재승대웅회장즉각퇴진에쏟아지는눈총,http://www.sisajournal-e.com/biz/article/188360
3255,2018-08-28,욕설논란윤재승대웅제약회장모든지위사임,http://www.ytn.co.kr/_ln/0103_201808281458458874
3256,2018-08-28,욕설논란윤재승대웅제약회장모든지위사임,http://www.ytn.co.kr/_ln/0103_201808281458458874
3257,2018-08-28,폭언갑질윤재승회장대웅대웅제약모든직위사임,http://www.news2day.co.kr/109823
3258,2018-08-28,대웅윤재승대표이사사임,http://www.cstimes.com/?mod=news&act=articleView&idxno=284239
3259,2018-08-28,윤재승대웅제약회장씁쓸한퇴진법조인출신또누가있나,http://www.ekn.kr/news/article.html?no=382882
3260,2018-08-28,공시대웅윤재춘단독대표체제로변경,http://www.fnnews.com/news/201808281518220987
3261,2018-08-28,1조클럽눈앞대웅제약윤재승회장욕설논란어디까지번질까,http://www.ekn.kr/news/article.html?no=382829
3262,2018-08-28,욕설논란윤재승대웅제약회장모든자리에서물러나겠다,http://www.newsworks.co.kr/news/articleView.html?idxno=211003
3263,2018-08-28,대웅윤재승사임윤재춘단독대표이사체제로변경,http://www.econonews.co.kr/news/articleView.html?idxno=34198
3264,2018-08-28,폭언논란윤재승대웅제약회장모든직위서사임,http://www.m-i.kr/news/articleView.html?idxno=447503
3265,2018-08-28,대웅제약윤재승회장갑질에퇴사100여명공식회의에서도욕설,http://www.inews24.com/php/news_view.php?g_serial=1121055&g_menu=050300&rrf=nv
3266,2018-08-28,대웅제약윤재승회장씁쓸한사임자숙의시간부디자신을바꿔나가기를,http://www.econonews.co.kr/news/articleView.html?idxno=34205
3267,2018-08-28,마감증시보고대웅제약28일8월28일192500원장마쳐,http://www.anewsa.com/detail.php?number=1362385&thread=10r04
3268,2018-08-28,폭언논란대웅제약윤재승회장사임자숙의시간갖겠다,http://www.topstarnews.net/news/articleView.html?idxno=472306
3269,2018-08-28,욕설등갑질논란대웅제약윤재승회장모든직위서물러날것,http://www.kyeongin.com/main/view.php?key=20180828010009005
3270,2018-08-28,폭언논란윤재승대웅제약회장모든지위에서물러날것,http://sports.chosun.com/news/ntype.htm?id=201808290100262150019988&servicedate=20180828
3271,2018-08-28,대웅제약윤재승회장자숙의시간을가지고제자신을바꿔나가도록노력하겠다”,http://www.hkbs.co.kr/news/articleView.html?idxno=481516
3272,2018-08-28,윤재승대웅제약회장폭언논란에사임,http://news1.kr/photos/view/?3273989
3273,2018-08-28,윤재승대웅제약회장모든직위에서물러나회사떠난다갑질논란책임,http://www.asiatoday.co.kr/view.php?key=20180828010014788
3274,2018-08-28,윤재승회장사임적막감흐르는대웅제약,http://news1.kr/photos/view/?3273987
3275,2018-08-28,윤재승대웅제약회장폭언논란에사임,http://news1.kr/photos/view/?3273988
3276,2018-08-28,욕설논란대웅제약윤재승회장사임앞날은,http://news1.kr/photos/view/?3273984
3277,2018-08-28,먹구름드리운대웅제약,http://news1.kr/photos/view/?3273983
3278,2018-08-28,윤재승회장욕설논란에사임대웅제약의앞날은,http://news1.kr/photos/view/?3273996
3279,2018-08-28,대웅제약윤재승회장선수수준의말바꾸기조롱,http://www.sisunnews.co.kr/news/articleView.html?idxno=89122
3280,2018-08-28,대웅제약윤재승회장에여론말바꾸기지적,http://www.ecomedia.co.kr/news/newsview.php?ncode=1065596119100596
3281,2018-08-28,대웅제약의앞날은,http://news1.kr/photos/view/?3273991
3282,2018-08-28,갑질논란윤재승대웅제약회장모든직위서사임,http://www.rapportian.com/news/articleView.html?idxno=112506
3283,2018-08-28,직원욕설윤재승대웅회장모든직위사임”,http://news.kbs.co.kr/news/view.do?ncd=4030579&ref=A
3284,2018-08-28,폭언파문윤재승대웅제약회장모든직위서사임,http://www.wolyo.co.kr/news/articleView.html?idxno=66864
3285,2018-08-28,욕설파문윤재승대웅제약회장사임전승호윤재춘전문경영인체제,http://www.ezyeconomy.com/news/articleView.html?idxno=85184
3286,2018-08-28,갑질대웅제약윤재승회장모든직위에서물러나회사떠난다,http://news20.busan.com/controller/newsController.jsp?newsId=20180828000148
3287,2018-08-28,윤재승대웅제약회장대웅대표이사대웅제약사내이사사임,http://www.ceoscoredaily.com/news/article.html?no=45198
3288,2018-08-28,대웅제약윤재승회장1조원날린물의재계이단아의추락,http://www.betanews.net:8080/article/900650.html
3289,2018-08-28,이단아대웅제약윤재승회장의추락물의탓1조원꿈멀어져,http://www.dailian.co.kr/news/view/735567/?sc=naver
3290,2018-08-28,대웅제약윤재승회장직원향한막말정신병자미친X지징하며다리부러뜨릴것,http://www.tfnews.co.kr/news/article.html?no=52295
3291,2018-08-28,갑질논란윤재승대웅회장모든직위서물러날것,http://www.tbs.seoul.kr/news/bunya.do?method=daum_html2&typ_800=6&seq_800=10298207
3292,2018-08-28,욕설갑질논란윤재승대웅제약회장공식사임,http://www.breaknews.com/sub_read.html?uid=597701§ion=sc3
3293,2018-08-28,갑질물의윤재승대웅제약회장모든지위사임,http://www.fetv.co.kr/news/article.html?no=11606
3294,2018-08-28,욕설논란윤재승대웅회장사임회사떠나자숙,http://www.yonhapnewstv.co.kr/MYH20180828010900038/?did=1825m
3295,2018-08-28,대웅제약윤재승회장부메랑된인격모독언사,http://www.youngnong.co.kr/news/articleView.html?idxno=15027
3296,2018-08-28,대웅제약윤재승회장결국회사떠난다,http://biz.heraldcorp.com/culture/view.php?ud=201808281707062757272_1
3297,2018-08-28,대웅제약윤재승꼼수사퇴논란,http://www.kntimes.co.kr/news/articleView.html?idxno=27237
3298,2018-08-28,폭언논란대웅제약윤재승회장모든직위서물러나,http://www.k-health.com/news/articleView.html?idxno=37564
3299,2018-08-28,욕설파문윤재승회장대웅대웅제약등기임원사임,http://news.hankyung.com/article/2018082864781
3300,2018-08-28,유가증권시장공시두산중공업한라대웅,http://news.mk.co.kr/newsRead.php?year=2018&no=541250
3301,2018-08-28,폭언논란윤재승대웅제약회장사임전문경영인체제로운영,http://moneys.mt.co.kr/news/mwView.php?no=2018082817138032057
3302,2018-08-28,더벨대웅제약전문경영인체제전환오너십이사회변화는,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201808280100047260002976
3303,2018-08-28,윤재승대웅회장모든직위서물러날것,http://www.seoulfn.com/news/articleView.html?idxno=317981
3304,2018-08-28,대웅제약오너리스크최소화에안간힘,http://www.dt.co.kr/contents.html?article_no=2018082902101731102001&ref=naver
3305,2018-08-28,대웅제약윤재승회장직원향한막말논란정신병자미친X같다다리부러뜨리겠다,http://www.thegolftimes.co.kr/news/articleView.html?idxno=36039
3306,2018-08-28,오늘이슈정부복지예산345로확대박해미남편음주사망사고아우디A3할인판매무산6금리장병적금출시윤재승회장대웅대웅제약등기임원사임,http://www.econovill.com/news/articleView.html?idxno=344846
3307,2018-08-28,갑질논란대웅제약윤재승회장모든직위서물러나겠다이메일사과에진정성지적도,http://www.topstarnews.net/news/articleView.html?idxno=472513
3308,2018-08-28,윤재승대웅제약회장모든직위사임네이버이사장직은,http://daily.hankooki.com/lpage/economy/201808/dh20180828183156138060.htm
3309,2018-08-28,윤재승대웅제약지주사대표사임폭언파문진화에안간힘,http://www.businesspost.co.kr/BP?command=article_view&num=94134
3310,2018-08-28,대웅제약윤재승그의참을수없게만드는거친말들에회사나갔다업무내용보다는,http://www.ujnews.co.kr/news/articleView.html?idxno=421856
3311,2018-08-28,욕설논란윤재승대웅제약회장사임파문은계속,http://www.ytn.co.kr/_ln/0102_201808281916438643
3312,2018-08-28,폭언및욕설논란대웅제약윤재승회장모든직위물러나자숙전승호윤재춘공동대표중심전문경영인체제운영,http://www.topstarnews.net/news/articleView.html?idxno=472596
3313,2018-08-28,취재수첩윤재승대웅제약회장도피출장과오만한사과,http://biz.newdaily.co.kr/site/data/html/2018/08/28/2018082800164.html
3314,2018-08-28,병XXX욕설대웅제약윤재승사임에도들끓는여론네티즌우르사불매,http://www.asiatime.co.kr/news/articleView.html?idxno=196342
3315,2018-08-28,욕설논란윤재승대웅제약회장사임파문은계속,http://www.ytn.co.kr/_ln/0102_201808282238021814
3316,2018-08-29,직원폭언윤재승대웅제약회장모든직위사임전문경영인체제돌입,http://www.lawissue.co.kr/view.php?ud=201808282338111300d7f4c63cc6_12
3317,2018-08-29,우르사대웅제약윤재승모든직위서물러날것”기습미국행,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0300&key=20180829.99099013114
3318,2018-08-29,LGCJ대웅유한양행등당뇨복합제경쟁치열,http://www.dailymedi.com/detail.php?number=834129&thread=22r05
3319,2018-08-29,윤재승대웅회장6년만에퇴임후계구도는견고,http://www.dailypharm.com/News/243183
3320,2018-08-29,의사만아니면”대웅제약협력다국적사들불매운동걱정無,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059753
3321,2018-08-29,증시현황29일대웅제약주가오전9시31분197000원,http://www.anewsa.com/detail.php?number=1362676&thread=10r04
3322,2018-08-29,대웅윤재승사퇴를바라보는회의적인시선들,http://www.mediasr.co.kr/news/articleView.html?idxno=49323
3323,2018-08-29,대웅윤재승회장모든직위물러난다더니,http://www.newsway.co.kr/news/view?tp=1&ud=2018082917071121343
3324,2018-08-29,빅데이터주식투자코스피대웅제약,http://www.leaders.kr/news/articleView.html?idxno=73368
3325,2018-08-30,윤재승대웅제약회장갑질논란직전개인회사아이스콘지분전량처분왜,http://www.ceoscoredaily.com/news/article.html?no=45274
3326,2018-08-30,대웅제약나보타FDA심사재개내년2월최종결과,http://www.dailian.co.kr/news/view/736000/?sc=naver
3327,2018-08-30,대웅제약나보타미국FDA허가심사재개내년2월심사마무리,http://moneys.mt.co.kr/news/mwView.php?no=2018083009178065627
3328,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.newsway.co.kr/news/view?tp=1&ud=2018083009260868796
3329,2018-08-30,특징주대웅제약나보타FDA재신청접수완료강세,http://view.asiae.co.kr/news/view.htm?idxno=2018083009293847258
3330,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018083009262693271
3331,2018-08-30,특징주대웅제약美품목허가신청소식에상승,http://www.fnnews.com/news/201808300912050367
3332,2018-08-30,뉴스투데이E대웅제약나보타美FDA허가심사본격재개,http://www.news2day.co.kr/109959
3333,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.newsis.com/view/?id=NISX20180830_0000404411&cID=13001&pID=13000
3334,2018-08-30,대웅제약나보타美FDA심사재개,http://www.newsprime.co.kr/news/article.html?no=428097
3335,2018-08-30,대웅제약톡신나보타내년2월미국진출결정,http://medipana.com/news/news_viewer.asp?NewsNum=224573&MainKind=A&NewsKind=5&vCount=12&vKind=1
3336,2018-08-30,대웅제약나보타美FDA허가심사재개내년2월결정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1657779
3337,2018-08-30,대웅제약나보타내년2월미국시장진출하나,http://www.koreaittimes.com/news/articleView.html?idxno=85576
3338,2018-08-30,특징주대웅제약나보타FDA재신청소식에오름세,http://www.seoulfn.com/news/articleView.html?idxno=318157
3339,2018-08-30,대웅제약나보타美FDA허가심사본격재개,http://news.mt.co.kr/mtview.php?no=2018083009274372519
3340,2018-08-30,대웅제약보톡스미국진출내년2월결정,http://www.dailypharm.com/News/243238
3341,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.g-enews.com/ko-kr/news/article/news_all/201808300945028635f6d02acec0_1/article.html
3342,2018-08-30,특징주대웅제약美품목허가신청소식에강세,http://www.fetv.co.kr/news/article.html?no=11710
3343,2018-08-30,특징주대웅제약나보타FDA심사재개강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1657802
3344,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221622
3345,2018-08-30,대웅제약나보타로내년2월미국시장진출FDA허가심사재개,http://kpenews.com/Board.aspx?BoardNo=18313
3346,2018-08-30,대웅제약FDA나보타허가심사재개내년2월결과발표,http://view.asiae.co.kr/news/view.htm?idxno=2018083010012089678
3347,2018-08-30,대웅제약나보타내년봄미국시장진출가시화,http://www.bosa.co.kr/news/articleView.html?idxno=2089236
3348,2018-08-30,대웅제약나보타美FDA허가심사재개,http://www.dailymedi.com/detail.php?number=834181&thread=22r05
3349,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.wsobi.com/news/articleView.html?idxno=64252
3350,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.metroseoul.co.kr/news/newsview?newscd=2018083000016
3351,2018-08-30,대웅제약나보타FDA허가심사본격재개내년2월심사완료,http://www.ceoscoredaily.com/news/article.html?no=45305
3352,2018-08-30,특징주대웅제약美FDA품목허가재신청완료소식에상승세,http://moneys.mt.co.kr/news/mwView.php?no=2018083010288017489
3353,2018-08-30,대웅제약나보타FDA허가심사재개내년2월결과,http://www.newspim.com/news/view/20180830000133
3354,2018-08-30,대웅제약나보타FDA허가심사재개내년2월결과발표,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201808300174&t=NN
3355,2018-08-30,대웅제약나보타美진출2월결정,http://www.sedaily.com/NewsView/1S3K83WY26
3356,2018-08-30,대웅제약美FDA나보타품목허가재신청접수,http://news1.kr/articles/?3412473
3357,2018-08-30,대웅제약보톡스나보타美FDA허가심사본격재개,http://www.breaknews.com/sub_read.html?uid=598095§ion=sc3
3358,2018-08-30,대웅제약나보타FDA허가심사재개내년2월결과발표,http://news.hankyung.com/article/2018083029136
3359,2018-08-30,대웅제약나보타FDA허가심사재개,http://www.monews.co.kr/news/articleView.html?idxno=118379
3360,2018-08-30,대웅제약나보타내년상반기미국시장진출가시권,http://www.rapportian.com/news/articleView.html?idxno=112545
3361,2018-08-30,대웅제약나보타FDA허가심사재개내년2월판가름,http://www.medicaltimes.com/News/1120788
3362,2018-08-30,대웅제약나보타FDA허가심사본격재개내년2월결정될전망,http://www.viva100.com/main/view.php?key=20180830010009470
3363,2018-08-30,美FDA대웅제약나보타허가재신청접수내년2월까지결론,http://news.mk.co.kr/newsRead.php?year=2018&no=545851
3364,2018-08-30,대웅제약나보타美진출내년2월결정강세,http://www.mdtoday.co.kr/mdtoday/index.html?no=330957
3365,2018-08-30,보톡스앙숙대웅제약메디톡스美中진출내년초판가름,http://www.finomy.com/news/articleView.html?idxno=57662
3366,2018-08-30,대웅제약나보타美FDA허가심사본격재개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1226376
3367,2018-08-30,대웅제약내년봄나보타미국진출가시권,http://www.newstomato.com/ReadNews.aspx?no=844102
3368,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.mdtoday.co.kr/mdtoday/index.html?no=330963
3369,2018-08-30,대웅제약미국식품의약국에나보타품목허가재신청절차마쳐,http://www.businesspost.co.kr/BP?command=article_view&num=94321
3370,2018-08-30,대웅제약나보타미국진출내년2월판가름난다FDA허가심사본격재개,http://www.businesskorea.co.kr/news/articleView.html?idxno=24703
3371,2018-08-30,대웅제약나보타미국진출내년2월결정,http://news.mk.co.kr/newsRead.php?year=2018&no=546226
3372,2018-08-30,대웅제약나보타FDA허가심사재개내년2월허가목표,http://www.etnews.com/20180830000224
3373,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.kpanews.co.kr/article/show.asp?idx=196482&table=article&category=D
3374,2018-08-30,대웅제약나보타FDA허가심사본격재개내년2월초최종심사결과발표,http://www.segye.com/content/html/2018/08/30/20180830003850.html?OutUrl=naver
3375,2018-08-30,대웅제약나보타2019년2월미국진출하나,http://www.econovill.com/news/articleView.html?idxno=345026
3376,2018-08-30,힐리언스선마을대웅제약이지듀와스킨케어체험존오픈,http://www.betanews.net:8080/article/901807.html
3377,2018-08-30,폭언갑질윤재승대웅제약회장지분율믿고복귀노릴까,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003317090
3378,2018-08-30,대웅제약나보타美FDA허가심사본격적으로재개,http://www.k-health.com/news/articleView.html?idxno=37593
3379,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.m-i.kr/news/articleView.html?idxno=448148
3380,2018-08-30,엎치락뒤치락종근당과대웅제약올해승자는,http://www.sisajournal-e.com/biz/article/188477
3381,2018-08-30,대웅제약나보타FDA허가심사본격재개미국진출청신호,http://www.100ssd.co.kr/news/articleView.html?idxno=55967
3382,2018-08-30,대웅제약나보타FDA심사재개내년2월허가목표,http://www.wolyo.co.kr/news/articleView.html?idxno=67036
3383,2018-08-30,욕설갑질윤재승대웅제약회장모든직위에서물러난것맞나,http://www.insightkorea.co.kr//news/articleView.html?idxno=30233
3384,2018-08-30,美FDA대웅제약나보타허가심사재개,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059848
3385,2018-08-30,대웅제약나보타FDA허가심사재개,http://www.sporbiz.co.kr/news/articleView.html?idxno=267778
3386,2018-08-30,대웅제약나보타美진출내년2월초결판,http://www.kormedi.com/news/news/drug_dist/1229018_2906.html
3387,2018-08-30,대웅제약나보타FDA허가심사본격재개내년2월결정,http://www.wikileaks-kr.org/news/articleView.html?idxno=33403
3388,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.bokuennews.com/news/article.html?no=164345
3389,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.newscj.com/news/articleView.html?idxno=550737
3390,2018-08-30,대웅제약나보타FDA허가심사본격재개,http://www.lawissue.co.kr/view.php?ud=201808302325121731d7f4c63cc6_12
3391,2018-08-31,윤재승대웅제약회장개인회사로일감몰렸다,http://www.sisajournal.com/article/177226
3392,2018-08-31,오너갑질논란대웅제약혁신형제약기업지위는,http://www.rapportian.com/news/articleView.html?idxno=112563
3393,2018-08-31,대웅제약다음달4일기업설명회IR개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1658527
3394,2018-08-31,증시현황31일대웅제약주가오전11시30분206500원,http://www.anewsa.com/detail.php?number=1364204&thread=10r04
3395,2018-08-31,공시대웅제약9월4일해외기관투자자대상기업설명회개최,http://www.newsway.co.kr/news/view?tp=1&ud=2018083112062639897
3396,2018-08-31,마감증시보고대웅제약31일8월31일205000원,http://www.anewsa.com/detail.php?number=1364403&thread=10r04
3397,2018-08-31,대웅제약윤재승사회공헌재단이사장직고수왜,http://www.kntimes.co.kr/news/articleView.html?idxno=27303
3398,2018-09-03,Invest막말논란대웅제약4700억해외제약사MA도고배,http://www.investchosun.com/?p=3229915
3399,2018-09-03,주간한국폭언갑질윤재승대웅제약회장향후행보는,http://daily.hankooki.com/lpage/economy/201809/dh20180903091301138080.htm
3400,2018-09-03,윤재승대웅제약회장대웅바이오대웅재단이사사퇴안했다,http://www.bizhankook.com/article/16160
3401,2018-09-03,윤재승회장폭언갑질논란대웅제약4747억짜리해외계약무산,http://www.insight.co.kr/news/176159
3402,2018-09-03,증시현황3일대웅제약주가오전11시30분200000원,http://www.anewsa.com/detail.php?number=1365273&thread=10r04
3403,2018-09-03,욕설파문겪은대웅제약조직문화수술돌입하나,http://www.kpanews.co.kr/article/show.asp?idx=196526&table=article&category=D
3404,2018-09-04,서울바이로메드오너알리코대웅제약전문경영인,http://www.dailymedi.com/detail.php?number=834336&thread=22r05
3405,2018-09-04,더벨대웅제약신약개발속도항궤양치료제3상준비,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201809030100001340000084
3406,2018-09-04,대웅제약직원주인회사위한기업문화체질개선착수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221749
3407,2018-09-04,대웅기업문화개선5년근무12개월유급휴가제공,http://www.dailypharm.com/News/243379
3408,2018-09-04,대웅제약체질개선직원130명에15억스톡옵션,http://medipana.com/news/news_viewer.asp?NewsNum=224761&MainKind=A&NewsKind=5&vCount=12&vKind=1
3409,2018-09-04,회장갑질대웅제약기업문화체질개선나선다,http://view.asiae.co.kr/news/view.htm?idxno=2018090410001255205
3410,2018-09-04,대웅제약기업문화개선한다임직원복지제도확대,http://www.ceoscoredaily.com/news/article.html?no=45559
3411,2018-09-04,오너갑질대웅제약조직문화환골탈태합니다,http://www.edaily.co.kr/news/newspath.asp?newsid=02355046619336840
3412,2018-09-04,윤재승갑질대웅제약기업문화체질개선,http://www.sisajournal-e.com/biz/article/188644
3413,2018-09-04,대웅제약기업문화체질개선직원이주인인회사,http://www.asiatime.co.kr/news/articleView.html?idxno=197563
3414,2018-09-04,전승호대웅제약사장임직원신뢰회복새로운성장동력찾을것,http://www.newsis.com/view/?id=NISX20180904_0000408637&cID=13001&pID=13000
3415,2018-09-04,욕설파문대웅제약일하고싶은직장으로체질개선나서,http://www.kukinews.com/news/article.html?no=582383
3416,2018-09-04,대웅제약외부컨설팅도입기업문화혁신나서,http://www.newsprime.co.kr/news/article.html?no=428661
3417,2018-09-04,오너갑질대웅제약기업문화체질개선나선다,http://www.metroseoul.co.kr/news/newsview?newscd=2018090400040
3418,2018-09-04,대웅제약복지제도강화우수직원에15억스톡옵션,http://news1.kr/articles/?3416656
3419,2018-09-04,오너갑질논란대웅제약기업문화바꾼다복지제도강화,http://www.newspim.com/news/view/20180904000132
3420,2018-09-04,대웅제약직원들이주인되는회사로탈바꿈한다,http://www.seoulwire.com/news/articleView.html?idxno=25038
3421,2018-09-04,장기휴가주식보상사내대출등직원복지눈길대웅제약기업문화혁신,http://kpenews.com/Board.aspx?BoardNo=18487
3422,2018-09-04,대웅제약시프트체질개선모색,http://www.mhj21.com/sub_read.html?uid=116064§ion=sc243
3423,2018-09-04,대웅제약기업문화개선나서외부컨설팅도입,http://www.g-enews.com/ko-kr/news/article/news_all/20180904104541455f6d02acec0_1/article.html
3424,2018-09-04,오너막말대웅제약기업문화체질개선시도,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180904060800017&did=1195m
3425,2018-09-04,대웅제약기업문화체질개선직원이주인되는회사위해외부컨설팅착수,http://www.segye.com/content/html/2018/09/04/20180904001711.html?OutUrl=naver
3426,2018-09-04,오너갑질대웅제약복지제도강화우수임직원에스톡옵션15억,http://www.etoday.co.kr/news/section/newsview.php?idxno=1659731
3427,2018-09-04,대웅제약직원들이주인되는회사만들기나서,http://www.bosa.co.kr/news/articleView.html?idxno=2089509
3428,2018-09-04,대웅제약기업문화체질개선에나서다양한복지제도공개,http://www.viva100.com/main/view.php?key=20180904010000994
3429,2018-09-04,유통오늘롯데홈쇼핑증강현실체험ARView업계첫도입대웅제약기업문화체질개선에나서,http://www.sisaon.co.kr/news/articleView.html?idxno=76980
3430,2018-09-04,직원들이주인되는회사로대웅제약기업문화체질개선한다,http://www.businesskorea.co.kr/news/articleView.html?idxno=24805
3431,2018-09-04,회장욕설파문대웅제약체질개선나서,http://www.monews.co.kr/news/articleView.html?idxno=118574
3432,2018-09-04,갑질논란대웅제약기업문화체질개선시도,http://www.fetv.co.kr/news/article.html?no=11973
3433,2018-09-04,대웅제약기업문화체질개선나서외부컨설팅도입,http://www.bokuennews.com/news/article.html?no=164498
3434,2018-09-04,대웅제약위기를기회로만든다,http://www.whosaeng.com/sub_read.html?uid=104124§ion=sc5
3435,2018-09-04,스톡옵션부터유급휴가까지대웅직원우선주의눈길,http://www.medicaltimes.com/News/1120870
3436,2018-09-04,폭언논란대웅제약기업문화체질개선시동,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1059972
3437,2018-09-04,엎친데덮친대웅제약해외법인적자눈덩이,http://www.newsway.co.kr/news/view?tp=1&ud=2018090316372546697
3438,2018-09-04,조직문화수술들어간대웅제약,http://news.mk.co.kr/newsRead.php?year=2018&no=556759
3439,2018-09-04,오너이슈에놀란대웅제약기업문화대대적혁신,http://www.koreaittimes.com/news/articleView.html?idxno=85696
3440,2018-09-04,대웅제약기업문화체질개선에나서,http://www.wsobi.com/news/articleView.html?idxno=64495
3441,2018-09-04,대웅제약기업문화바꿔줄외부컨설팅업체선정돌입,http://news.mk.co.kr/newsRead.php?year=2018&no=556886
3442,2018-09-04,회사보다직원우선대웅제약기업문화바꾼다,http://www.kormedi.com/news/news/drug_dist/1229082_2906.html
3443,2018-09-04,대웅제약글로벌도전14년지난해수출액1000억돌파세계50위진입포부,http://www.segye.com/content/html/2018/09/04/20180904003507.html?OutUrl=naver
3444,2018-09-04,대웅제약직원주인되는회사위한기업문화외부컨설팅도입,http://www.getnews.co.kr/news/articleView.html?idxno=93602
3445,2018-09-04,오너갑질논란대웅제약대대적기업문화혁신추진,http://www.rapportian.com/news/articleView.html?idxno=112650
3446,2018-09-04,대웅장기근속자유급휴가주식보상제등도입파격,http://www.dailymedi.com/detail.php?number=834361&thread=22r05
3447,2018-09-04,오너갑질대웅제약기업문화체질개선다짐,http://www.seoulfn.com/news/articleView.html?idxno=318662
3448,2018-09-04,갑질파문대웅제약기업체질개선추진”,http://www.etnews.com/20180904000279
3449,2018-09-04,대웅제약기업문화체질개선나선다,http://www.kntimes.co.kr/news/articleView.html?idxno=27360
3450,2018-09-04,막말논란대웅제약기업문화체질개선나선다,http://www.ajunews.com/view/20180904154306086
3451,2018-09-04,오너갑질논란대웅제약기업문화체질개선시동”,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809040387&t=NN
3452,2018-09-04,기업문화혁신으로임직원신뢰회복”대웅제약변화나서,http://www.mdtoday.co.kr/mdtoday/index.html?no=331401
3453,2018-09-04,대웅제약기업문화혁신임직원신뢰회복할것,http://www.dailian.co.kr/news/view/737253/?sc=naver
3454,2018-09-04,대웅제약기업문화체질개선에나서,http://www.kpanews.co.kr/article/show.asp?idx=196596&table=article&category=D
3455,2018-09-04,대웅제약기업문화혁신임직원신뢰회복,http://www.finomy.com/news/articleView.html?idxno=57846
3456,2018-09-04,OBS비즈투데이대웅제약윤재승전회장욕설이후기업혁신外,http://www.obsnews.co.kr/news/articleView.html?idxno=1114217
3457,2018-09-04,대웅제약기업문화체질개선에나선다,http://www.ekn.kr/news/article.html?no=384361
3458,2018-09-04,논란대웅제약기업문화체질개선에나선다,http://www.doctorsnews.co.kr/news/articleView.html?idxno=125131
3459,2018-09-04,갑질논란대웅제약기업문화체질개선에나선다,http://www.econovill.com/news/articleView.html?idxno=345480
3460,2018-09-04,대웅제약기업문화체질개선에나서,http://www.newscj.com/news/articleView.html?idxno=552144
3461,2018-09-05,제약톡톡오너갑질대웅기업문화개선한다지만소잃고외양간고치나,http://news.heraldcorp.com/view.php?ud=20180905000040
3462,2018-09-05,두번째옷벗은윤재승대웅회장얼마나자숙할까,http://news.bizwatch.co.kr/article/consumer/2018/09/04/0024/naver
3463,2018-09-05,대웅제약혁신안내놨지만조직문화개선한계,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003323133
3464,2018-09-05,대웅제약기업문화체질개선한다,http://www.sisaweek.com/news/articleView.html?idxno=113054
3465,2018-09-05,오너갑질대웅제약기업문화개선위해팔걷어붙여,http://www.nextdaily.co.kr/news/article.html?id=20180905800025
3466,2018-09-05,증시현황5일대웅제약주가오후2시23분197000원,http://www.anewsa.com/detail.php?number=1366965&thread=10r04
3467,2018-09-05,갑질논란대웅제약기업문화혁신나선다,http://www.m-i.kr/news/articleView.html?idxno=449821
3468,2018-09-05,폭언갑질윤재승대웅전회장경영일선퇴진은소나기피하자는식,http://www.newsfc.co.kr/news/articleView.html?idxno=33546
3469,2018-09-06,퀵리포트대웅제약매수유지목표가9↑23만원케이프證,http://www.itooza.com/common/iview.php?no=2018090607322614638
3470,2018-09-06,대웅제약나보타미국품목허가기대목표가↑케이프투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1660508
3471,2018-09-06,I리포트대웅제약나보타경쟁제품대비가격우위케이프證,http://www.inews24.com/php/news_view.php?g_serial=1123561&g_menu=022300&rrf=nv
3472,2018-09-06,대웅제약목표가9↑23만원제시케이프證,http://www.newspim.com/news/view/20180906000046
3473,2018-09-06,대웅제약나보타캐나다를시작으로미국으로확대예상케이프證,http://news.mt.co.kr/mtview.php?no=2018090608081711105
3474,2018-09-06,대웅제약목표주가높아져나보타의북미진출기대커져,http://www.businesspost.co.kr/BP?command=article_view&num=95086
3475,2018-09-06,케이프투자증권대웅제약나보타캐나다시작으로미국까지확대예상”,http://www.newsway.co.kr/news/view?tp=1&ud=2018090608453551995
3476,2018-09-06,대웅제약나보타美진출가능성고조목표가↑케이프,http://www.edaily.co.kr/news/newspath.asp?newsid=01777766619337496
3477,2018-09-06,대웅제약나보타의미국진출가능성목표가상향케이프,http://www.newstomato.com/ReadNews.aspx?no=845350
3478,2018-09-06,증시현황6일대웅제약주가오전10시14분194500원,http://www.anewsa.com/detail.php?number=1367649&thread=10r04
3479,2018-09-06,대웅제약나보타는캐나다를시작으로미국으로확대예상,http://www.newsworks.co.kr/news/articleView.html?idxno=213307
3480,2018-09-06,대웅7월원외처방액성장률급등전월대비37억상승,http://www.medicaltimes.com/News/1120948
3481,2018-09-06,제약사생산실적셀트리온한미종근당대웅순,http://www.medicaltimes.com/News/1120942
3482,2018-09-06,대웅코프로모션호실적7월원외처방11성장,http://www.dailypharm.com/News/243479
3483,2018-09-06,레이더M오너막말파동에대웅제약MA급제동,http://news.mk.co.kr/newsRead.php?year=2018&no=562407
3484,2018-09-06,제약사별생산실적셀트리온한미약품종근당대웅제약순,http://medicalworldnews.co.kr/news/view.php?idx=1510927311
3485,2018-09-07,증시현황7일대웅제약주가오전9시40분195000원,http://www.anewsa.com/detail.php?number=1368523&thread=10r04
3486,2018-09-07,MJ포토채용박람회서구직자취업상담진행하는대웅제약,http://www.mhj21.com/sub_read.html?uid=116152§ion=section21
3487,2018-09-09,WeeklyCEO전승호대웅제약사장뻔한제스처인가진짜혁신인가,http://www.thescoop.co.kr/news/articleView.html?idxno=31842
3488,2018-09-10,더벨㈜대웅나보타상업화로열티수익기대,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201809070100011600000721
3489,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.newsway.co.kr/news/view?tp=1&ud=2018091009065500232
3490,2018-09-10,대웅제약새CF로우루사간기능개선효과재조명,http://medipana.com/news/news_viewer.asp?NewsNum=225025&MainKind=A&NewsKind=5&vCount=12&vKind=1
3491,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.dailypharm.com/News/243571
3492,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.bokuennews.com/news/article.html?no=164768
3493,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221957
3494,2018-09-10,대웅제약신규CF팩트를보면우루사편공개,http://www.seoulwire.com/news/articleView.html?idxno=25807
3495,2018-09-10,대웅제약신규광고캠페인팩트를보면우루사공개,http://www.k-health.com/news/articleView.html?idxno=37713
3496,2018-09-10,증시현황10일대웅제약주가오전9시37분196000원,http://www.anewsa.com/detail.php?number=1369785&thread=10r04
3497,2018-09-10,대웅제약임상서입증된효과재조명팩트를보면우루사CF공개,http://kpenews.com/Board.aspx?BoardNo=18689
3498,2018-09-10,대웅제약윤종신모델로우루사새광고시작,http://www.rapportian.com/news/articleView.html?idxno=112762
3499,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.dailymedi.com/detail.php?number=834559&thread=22r05
3500,2018-09-10,대웅제약윤종신모델로한우루사신규광고캠페인온에어,http://www.enewstoday.co.kr/news/articleView.html?idxno=1229738
3501,2018-09-10,대웅제약우루사팩트를보면편새TV광고시작,http://www.medisobizanews.com/news/articleView.html?idxno=55198
3502,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.bosa.co.kr/news/articleView.html?idxno=2089877
3503,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.getnews.co.kr/news/articleView.html?idxno=94502
3504,2018-09-10,대웅제약팩트를보면우루사신규CF,http://www.g-enews.com/ko-kr/news/article/news_all/201809101049386341f6d02acec0_1/article.html
3505,2018-09-10,대웅제약우루사신규광고캠페인선봬,http://www.newsprime.co.kr/news/article.html?no=429349
3506,2018-09-10,대웅제약신규CF팩트를보면우루사공개,http://www.businesskorea.co.kr/news/articleView.html?idxno=24930
3507,2018-09-10,대웅제약우루사신규CF공개간기능개선재조명,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1060205
3508,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.ftoday.co.kr/news/articleView.html?idxno=102641
3509,2018-09-10,대웅제약우루사신규CF선봬,http://www.100ssd.co.kr/news/articleView.html?idxno=56245
3510,2018-09-10,대웅제약가수윤종신모델로팩트를보면우루사새CF온에어,http://www.insightkorea.co.kr//news/articleView.html?idxno=30977
3511,2018-09-10,씨엔알리서치대웅제약DIAPV워크숍개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=221992
3512,2018-09-10,대웅제약팩트를보면우루사新CF눈길,http://www.whosaeng.com/sub_read.html?uid=104298§ion=sc5
3513,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.dailian.co.kr/news/view/738410/?sc=naver
3514,2018-09-10,대웅제약혁신형제약기업지정서탈락하나,http://www.insightkorea.co.kr//news/articleView.html?idxno=31041
3515,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.newscj.com/news/articleView.html?idxno=553691
3516,2018-09-10,대웅제약팩트를보면우루사신규CF선봬,http://www.kpanews.co.kr/article/show.asp?idx=196776&table=article&category=D
3517,2018-09-10,대웅제약팩트를보면우루사신규CF공개,http://www.lawissue.co.kr/view.php?ud=201809102154508161d7f4c63cc6_12
3518,2018-09-11,윤재승대웅제약회장5년천하풀스토리,http://www.ilyosisa.co.kr/news/articleView.html?idxno=151607
3519,2018-09-11,기자수첩윤재승전대웅제약회장30년전초심으로돌아가라,http://www.sisajournal-e.com/biz/article/188912
3520,2018-09-11,유한대웅종근당SGLT2억제제시장재편,http://www.monews.co.kr/news/articleView.html?idxno=118864
3521,2018-09-11,증시현황11일대웅제약주가오전10시12분196000원,http://www.anewsa.com/detail.php?number=1370884&thread=10r04
3522,2018-09-11,한경로보뉴스대웅5이상상승외국인기관각각4일연속순매수4일연속순매도,http://news.hankyung.com/article/201809112469L
3523,2018-09-11,대웅제약팩트를보면우루사신규CF공개,http://www.wsobi.com/news/articleView.html?idxno=64854
3524,2018-09-12,오늘의추천종목유안타증권대웅제약NH투자증권등,http://www.asiatoday.co.kr/view.php?key=20180912010006645
3525,2018-09-12,증시현황12일대웅제약주가오전10시10분198500원,http://www.anewsa.com/detail.php?number=1372025&thread=10r04
3526,2018-09-12,문재인정부공정경제에찬물광동제약대웅제약등제약업계왜이러나,http://www.choicenews.co.kr/news/articleView.html?idxno=44479
3527,2018-09-12,국세청대웅제약세무조사착수,http://www.g-enews.com/ko-kr/news/article/news_all/201809121526225789f6d02acec0_1/article.html
3528,2018-09-12,국세청대웅제약세무조사착수,http://www.newsway.co.kr/news/view?tp=1&ud=2018091217534029053
3529,2018-09-13,추석선물대웅제약간해독작용강화에효과장기간복용해도내성없어,http://news.mk.co.kr/newsRead.php?year=2018&no=576933
3530,2018-09-13,증시현황13일대웅제약주가오전10시10분196000원,http://www.anewsa.com/detail.php?number=1373216&thread=10r04
3531,2018-09-13,증시현황13일대웅제약주가오후1시10분195000원,http://www.anewsa.com/detail.php?number=1373625&thread=10r04
3532,2018-09-13,단독막말윤재승대웅회장개인회사서울대병원독점계약논란,http://www.bizhankook.com/article/16228
3533,2018-09-13,국세청대웅제약세무조사착수불법리베이트오너일감몰기의혹관련수사추정,http://www.newsworker.co.kr/news/articleView.html?idxno=21804
3534,2018-09-13,안보공단서부지사주대웅페이퍼무재해1배달성인증서전달,http://www.kbsm.net/default/index_view_page.php?idx=217946&part_idx=320
3535,2018-09-14,대웅제약이지듀DWEGF크림프레좀출시,http://www.bosa.co.kr/news/articleView.html?idxno=2090233
3536,2018-09-14,증시현황14일대웅제약주가오전10시21분195000원,http://www.anewsa.com/detail.php?number=1374348&thread=10r04
3537,2018-09-14,제약업계훈풍기대감에광동대웅제약찬물,http://www.kpinews.co.kr/news/articleView.html?idxno=81120
3538,2018-09-14,고성읍대웅웨딩홀신숙순대표이웃돕기성금기탁,http://www.upkorea.net/news/articleView.html?idxno=392209
3539,2018-09-14,마감증시보고대웅제약9월14일194000원으로종료,http://www.anewsa.com/detail.php?number=1375012&thread=10r04
3540,2018-09-14,5년연속세무조사받는대웅제약그룹중부국세청과질긴악연,http://www.sisajournal-e.com/biz/article/189088
3541,2018-09-14,역대급스펙장착한대웅제약이지듀EGF크림시즌3출시,http://www.kjdaily.com/read.php3?aid=1536908400448312203
3542,2018-09-14,대웅제약이지듀시즌3핑크크림DWEGF크림프레좀출시,http://www.mdtoday.co.kr/mdtoday/index.html?no=332565
3543,2018-09-14,대웅제약이지듀DWEGF크림프레좀출시,http://kdfnews.com/news/view.php?idx=32222
3544,2018-09-14,고성대웅웨딩홀신숙순대표성금기탁,http://www.anewsa.com/detail.php?number=1375346&thread=01r01
3545,2018-09-17,2018올해의브랜드대상대웅제약이지덤피부자극최소화한프리미엄습윤드레싱,http://www.ajunews.com/view/20180916154322381
3546,2018-09-17,증시현황17일대웅제약주가오전11시08분190500원,http://www.anewsa.com/detail.php?number=1375905&thread=10r04
3547,2018-09-17,마감증시보고대웅제약오후4시16분191000원으로장마감,http://www.anewsa.com/detail.php?number=1376335&thread=10r04
3548,2018-09-17,한가위부모님건강챙기세요대웅제약임팩타민면역력에신진대사까지구내염개선도,http://www.sedaily.com/NewsView/1S4O8SWYU0
3549,2018-09-18,고성대웅웨딩홀신숙순대표성금기탁,http://www.idomin.com/?mod=news&act=articleView&idxno=576602
3550,2018-09-18,18일대웅제약주가오전10시27분191500원,http://www.anewsa.com/detail.php?number=1376865&thread=10r04
3551,2018-09-18,대웅오픈콜라보신약개발AtoZ핵심은,http://www.dailypharm.com/News/243890
3552,2018-09-19,대웅공모전전용홈페이지로오픈콜라보2기시작,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222297
3553,2018-09-19,19일대웅제약주가오전11시19분192500원,http://www.anewsa.com/detail.php?number=1377989&thread=10r04
3554,2018-09-19,대웅제약9월19일191500원마감해,http://www.anewsa.com/detail.php?number=1378570&thread=10r04
3555,2018-09-19,대웅구강용품개발사에스티에이치이솔루션자회사로편입,http://www.edaily.co.kr/news/newspath.asp?newsid=04578886619341760
3556,2018-09-19,대웅에스티에이치이솔루션자회사편입,http://www.sedaily.com/NewsView/1S4P5G61RD
3557,2018-09-19,대웅에스티에이치이솔루션자회사로편입,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20180919151800008&did=1195m
3558,2018-09-19,㈜대웅구강관리벤처기업투자사업포트폴리오강화,http://www.koreaittimes.com/news/articleView.html?idxno=86104
3559,2018-09-19,대웅구강용품업체에스티에이치이솔루션자회사편입,http://news.mt.co.kr/mtview.php?no=2018091916300258327
3560,2018-09-19,공시대웅에스티에이치이솔루션자회사로편입”,http://www.newsway.co.kr/news/view?tp=1&ud=2018091916285919381
3561,2018-09-19,윤재춘㈜대웅사장구강관리전문기업에스티에이치이솔루션인수,http://www.businesskorea.co.kr/news/articleView.html?idxno=25197
3562,2018-09-19,대웅서울대서설립된구강관련제품솔루션벤처기업인수,http://news.mk.co.kr/newsRead.php?year=2018&no=592317
3563,2018-09-19,대웅에스티에이치이솔루션자회사로편입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018091916330089536
3564,2018-09-19,대웅구강관리벤처에스티에이치솔루션인수,http://www.biospectator.com/view/news_view.php?varAtcId=6241
3565,2018-09-19,대웅구강관리제품벤처기업자회사로편입,http://www.newspim.com/news/view/20180919000514
3566,2018-09-19,대웅구강관리벤처기업인수자회사편입,http://www.newsis.com/view/?id=NISX20180919_0000423930&cID=13001&pID=13000
3567,2018-09-19,대웅5억원에구강관리업체지분60인수자회사편입,http://biz.chosun.com/site/data/html_dir/2018/09/19/2018091902578.html
3568,2018-09-19,대웅에스티에이치이솔루션지분인수자회사편입,http://www.seoulwire.com/news/articleView.html?idxno=27178
3569,2018-09-19,대웅구강관리벤처기업투자로포트폴리오강화,http://medipana.com/news/news_viewer.asp?NewsNum=225554&MainKind=A&NewsKind=5&vCount=12&vKind=1
3570,2018-09-19,대웅구강관리벤처기업투자로포트폴리오강화,http://www.ekn.kr/news/article.html?no=387488
3571,2018-09-19,대웅에스티에이치이솔루션지분60인수자회사편입,http://www.newsprime.co.kr/news/article.html?no=430635
3572,2018-09-19,대웅구강관리벤처기업에스티에이치이솔루션지분60인수,http://www.ceoscoredaily.com/news/article.html?no=46205
3573,2018-09-19,대웅구강위생용품기업에스티에이치이솔루션자회사로편입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1665803
3574,2018-09-19,대웅주에스티에이치이솔루션인수자회사편입,http://www.dailymedi.com/detail.php?number=834906&thread=22r05
3575,2018-09-19,대웅구강관리벤처기업투자로포트폴리오강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222345
3576,2018-09-19,대웅구강건강벤처에스티에이치이5억에인수,http://www.dailypharm.com/News/243950
3577,2018-09-19,대웅구강관리벤처기업투자로포트폴리오강화,http://www.100ssd.co.kr/news/articleView.html?idxno=56445
3578,2018-09-19,대웅구강관련솔루션개발업체인수라인업강화,http://www.medisobizanews.com/news/articleView.html?idxno=55405
3579,2018-09-19,대웅자회사로에스티에이치이솔루션편입,http://www.newsis.com/view/?id=NISX20180919_0000424036&cID=10401&pID=10400
3580,2018-09-19,대웅구강관리벤처기업에스티에이치이솔루션자회사편입,http://www.newstomato.com/ReadNews.aspx?no=847892
3581,2018-09-19,유가증권시장공시한국유리공업CJCGV대웅,http://news.mk.co.kr/newsRead.php?year=2018&no=592567
3582,2018-09-19,대웅구강건강업체에스티에이치이솔루션자회사편입,http://www.sporbiz.co.kr/news/articleView.html?idxno=273674
3583,2018-09-19,대웅구강관리벤처에스티에이치이솔루션자회사편입,http://www.dailian.co.kr/news/view/740655/?sc=naver
3584,2018-09-19,대웅구강관리벤처자회사로편입제품포트폴리오강화,http://www.wolyo.co.kr/news/articleView.html?idxno=68325
3585,2018-09-19,대웅구강관리벤처기업투자포트폴리오강화,http://www.ftoday.co.kr/news/articleView.html?idxno=102916
3586,2018-09-19,대웅구강관리벤처기업인수,http://news.mk.co.kr/newsRead.php?year=2018&no=592776
3587,2018-09-19,㈜대웅구강관리벤처기업자회사편입,http://www.seoulfn.com/news/articleView.html?idxno=320179
3588,2018-09-19,대웅구강관리벤처에스티에이치이솔루션자회사로편입,http://www.mdtoday.co.kr/mdtoday/index.html?no=333034
3589,2018-09-19,대웅지주회사에스티에이치이솔루션자회사편입,http://www.nspna.com/news/?mode=view&newsid=307523
3590,2018-09-19,대웅구강관리벤처기업자회사편입,http://www.m-i.kr/news/articleView.html?idxno=454877
3591,2018-09-19,대웅구강관리벤처기업STH이솔루션자회사편입,http://www.kpanews.co.kr/article/show.asp?idx=197061&table=article&category=D
3592,2018-09-19,대웅구강관리벤처기업투자로포트폴리오강화,http://www.lawissue.co.kr/view.php?ud=201809192240001772d7f4c63cc6_12
3593,2018-09-19,대웅구강위생용품개발에스티에이치이솔루션자회사로편입,http://www.econonews.co.kr/news/articleView.html?idxno=36817
3594,2018-09-20,고성대웅웨딩홀대표성금기탁,http://www.gnmaeil.com/news/articleView.html?idxno=382875
3595,2018-09-20,대웅상생펀드는스타트업의미더운친구죠,http://www.dailypharm.com/News/243940
3596,2018-09-20,대웅제약글로벌헬스케어그룹도약꿈무르익다,http://www.bosa.co.kr/news/articleView.html?idxno=2090593
3597,2018-09-20,대웅벤처기업에스티에이치솔루션지분인수,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1060626
3598,2018-09-20,대웅구강관리스타트업에스티에이치이솔루션인수,http://www.sedaily.com/NewsView/1S4PKYQK4J
3599,2018-09-20,대웅제약목표가23만원신규제시전일종가원삼성證,http://www.newspim.com/news/view/20180920000123
3600,2018-09-20,퀵리포트대웅제약매수목표가23만원신규제시삼성證,http://www.itooza.com/common/iview.php?no=2018092009061916846
3601,2018-09-20,ET투자뉴스대웅제약돋보일이익증가와BUY삼성증권,http://www.etnews.com/20180920000021
3602,2018-09-20,대웅제약주식사도된다나보타수출확대로내년수익급증,http://www.businesspost.co.kr/BP?command=article_view&num=96686
3603,2018-09-20,20일대웅제약주가오전10시27분195500원,http://www.anewsa.com/detail.php?number=1379163&thread=10r04
3604,2018-09-20,대웅전일대비약3상승한18500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201809200284&t=NN
3605,2018-09-20,팩트를보면대웅제약본사서우루사이벤트,http://www.mhj21.com/sub_read.html?uid=116401§ion=sc243
3606,2018-09-20,대웅제약임직원대상우루사홍보이벤트진행,http://www.dailypharm.com/News/243990
3607,2018-09-20,대웅제약우루사사내이벤트진행,http://www.edaily.co.kr/news/newspath.asp?newsid=03837606619342088
3608,2018-09-20,대웅제약임직원대상우루사홍보이벤트진행,http://www.g-enews.com/ko-kr/news/article/news_all/201809201415037534f6d02acec0_1/article.html
3609,2018-09-20,대웅제약우루사올해400억매출달성기원,http://medipana.com/news/news_viewer.asp?NewsNum=225627&MainKind=A&NewsKind=5&vCount=12&vKind=1
3610,2018-09-20,대웅제약우루사매출400억달성염원사내이벤트진행,http://www.koreaittimes.com/news/articleView.html?idxno=86143
3611,2018-09-20,대웅제약임직원대상우루사홍보이벤트진행,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018092014414930624
3612,2018-09-20,대웅제약우루사사내홍보이벤트실시,http://www.seoulwire.com/news/articleView.html?idxno=27302
3613,2018-09-20,대웅제약임직원대상우루사홍보행사열어연매출400억기원,http://www.ceoscoredaily.com/news/article.html?no=46306
3614,2018-09-20,대웅제약우루사400억원매출앞두고사내홍보이벤트,http://www.medisobizanews.com/news/articleView.html?idxno=55432
3615,2018-09-20,대웅제약글로벌헬스케어그룹도약박차,http://www.iminju.net/news/articleView.html?idxno=38664
3616,2018-09-20,벤처투자나선대웅구강관리벤처자회사편입,http://www.monews.co.kr/news/articleView.html?idxno=119264
3617,2018-09-20,대웅임직원대상사내우루사홍보이벤트진행,http://www.dailymedi.com/detail.php?number=834950&thread=22r05
3618,2018-09-20,대웅제약우루사임직원대상사내홍보이벤트진행,http://www.getnews.co.kr/news/articleView.html?idxno=96553
3619,2018-09-20,대웅제약우루사올해매출400억달성목표,http://www.rapportian.com/news/articleView.html?idxno=113045
3620,2018-09-20,대웅제약우루사임직원대상사내홍보이벤트진행,http://www.bokuennews.com/news/article.html?no=165397
3621,2018-09-20,대웅제약우루사임직원대상사내홍보이벤트,http://www.bosa.co.kr/news/articleView.html?idxno=2090686
3622,2018-09-20,대웅제약9월20일192500원마감해,http://www.anewsa.com/detail.php?number=1379809&thread=10r04
3623,2018-09-20,대웅제약우루사임직원대상사내이벤트진행,http://www.whosaeng.com/sub_read.html?uid=104587§ion=sc5
3624,2018-09-20,대웅제약우루사임직원대상사내홍보이벤트진행,http://www.sisa-news.com/news/article.html?no=114901
3625,2018-09-20,대웅제약현지화전략앞세워글로벌헬스케어그룹기반다져,http://www.businesspost.co.kr/BP?command=article_view&num=96743
3626,2018-09-20,대웅제약우루사임직원대상으로홍보이벤트진행,http://www.k-health.com/news/articleView.html?idxno=37946
3627,2018-09-20,대웅제약글로벌도전성과2020년세계50위진입,http://www.dailian.co.kr/news/view/740939/?sc=naver
3628,2018-09-20,대웅제약임직원대상우루사홍보이벤트진행,http://www.100ssd.co.kr/news/articleView.html?idxno=56468
3629,2018-09-20,대웅제약임직원대상으로우루사사내홍보,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1060676
3630,2018-09-20,대웅제약글로벌도전14년세계50위진입할것”,http://www.sisa-news.com/news/article.html?no=114920
3631,2018-09-20,뉴스투데이E대웅서울치대구강관리벤처에스티에이치이솔루션인수,http://www.news2day.co.kr/111432
3632,2018-09-20,우루사400억매출목표대웅임직원의기투합,http://www.medicaltimes.com/News/1121257
3633,2018-09-20,대웅구강관리벤처기업5억원에인수,http://www.kormedi.com/news/article/1229355_2892.html
3634,2018-09-20,대웅구강관리벤처기업자회사로편입포트폴리오강화,http://www.insight.co.kr/news/179780
3635,2018-09-20,대웅제약우루사임직원대상사내홍보이벤트진행,http://www.lawissue.co.kr/view.php?ud=201809202329155637d7f4c63cc6_12
3636,2018-09-21,빅데이터MSI시장심리톱5삼성전자대한항공네이버영원무역대웅제약,http://www.newsis.com/view/?id=NISX20180921_0000425693&cID=10401&pID=10400
3637,2018-09-21,대웅제약나보타신흥시장본격진출,http://www.koreaittimes.com/news/articleView.html?idxno=86169
3638,2018-09-21,21일대웅제약주가오전10시27분193500원,http://www.anewsa.com/detail.php?number=1380449&thread=10r04
3639,2018-09-21,대웅제약현지화∙기업문화혁신으로글로벌헬스케어그룹일군다,http://www.seoulfn.com/news/articleView.html?idxno=320369
3640,2018-09-21,대웅제약아사콜좌약공급재개,http://www.bosa.co.kr/news/articleView.html?idxno=2090737
3641,2018-09-21,대웅제약활발한해외진출통해세계50위제약사진입목표,http://www.sisafocus.co.kr/news/articleView.html?idxno=192519
3642,2018-09-21,대웅궤양성대장염치료아사콜좌약공급재개,http://www.dailypharm.com/News/244023
3643,2018-09-21,대웅제약보툴리눔톡신나보타파머징시장공략박차,http://www.mhj21.com/sub_read.html?uid=116420§ion=sc243
3644,2018-09-21,대웅vs메디톡스이번엔미국서맞붙는다,http://www.newsway.co.kr/news/view?tp=1&ud=2018092114170209186
3645,2018-09-21,대웅제약주가195500원마감해,http://www.anewsa.com/detail.php?number=1380987&thread=10r04
3646,2018-09-21,대웅제약임직원과우루사연매출400억달성기원,http://www.seoulfn.com/news/articleView.html?idxno=320444
3647,2018-09-21,공시대웅제약임직원101명에1만752주주식매수선택권부여,http://www.newsway.co.kr/news/view?tp=1&ud=2018092117362977862
3648,2018-09-21,공시대웅임직원25명에2만5337주주식매수선택권부여,http://www.newsway.co.kr/news/view?tp=1&ud=2018092117410505337
3649,2018-09-21,전세계동시품절아사콜좌약대웅제약공급재개,http://www.medicaltimes.com/News/1121284
3650,2018-09-21,대웅제약우루사400억매출앞두고임직원대상사내홍보이벤트진행,http://www.insight.co.kr/news/180011
3651,2018-09-21,대웅제약임직원대상우루사사내홍보이벤트진행,http://www.newscj.com/news/articleView.html?idxno=557083
3652,2018-09-21,대웅구강관리벤처기업인수자회사로편입,http://www.wsobi.com/news/articleView.html?idxno=65382
3653,2018-09-22,한미종근당대웅유한양행원외처방Top품목,http://www.dailymedi.com/detail.php?number=835014&thread=22r05
3654,2018-09-26,대웅제약이지덤저소득환아위한사회공헌실시,http://www.metroseoul.co.kr/news/newsview?newscd=2018092600050
3655,2018-09-27,지속가능경영대웅제약우루사신화바탕글로벌시장사업확대,http://www.ceoscoredaily.com/news/article.html?no=46367
3656,2018-09-27,더벨대웅제약3D프린터HR솔루션전방위이종사업,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201809200100035810002212
3657,2018-09-27,27일대웅제약주가오전10시29분194000원,http://www.anewsa.com/detail.php?number=1382082&thread=10r04
3658,2018-09-27,기업특집대웅제약보툴리눔톡신나보타신흥시장공략선봉,http://www.viva100.com/main/view.php?key=20180927010009249
3659,2018-09-27,메가히트상품탄생스토리대웅제약우루사,http://www.metroseoul.co.kr/news/newsview?newscd=2018092700043
3660,2018-09-28,대웅제약2018KOTRA외국인유학생채용박람회참가,http://www.newsway.co.kr/news/view?tp=1&ud=2018092809164376780
3661,2018-09-28,대웅제약해외현지법인근무외국인우수인재찾기적극나섰다,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222493
3662,2018-09-28,대웅제약해외현지법인에서일할외국인우수인재찾기적극나서,http://www.newspim.com/news/view/20180928000114
3663,2018-09-28,대웅제약해외현지법인에서근무할외국인인재찾는다,http://www.ceoscoredaily.com/news/article.html?no=46451
3664,2018-09-28,대웅제약코트라외국인유학생채용박람회참가,http://www.dailypharm.com/News/244137
3665,2018-09-28,대웅제약해외현지법인에서일할외국인우수인재찾기나선다,http://www.viva100.com/main/view.php?key=20180928010009512
3666,2018-09-28,대웅제약외국인인재찾아채용박람회참가,http://medipana.com/news/news_viewer.asp?NewsNum=225807&MainKind=A&NewsKind=5&vCount=12&vKind=1
3667,2018-09-28,대웅제약해외현지법인에서일할외국인우수인재찾기적극나서,http://www.g-enews.com/ko-kr/news/article/news_all/20180928100509936f6d02acec0_1/article.html
3668,2018-09-28,대웅제약해외현지법인서일할외국인인재찾는다,http://www.vop.co.kr/A00001336562.html
3669,2018-09-28,대웅제약2018코트라외국인유학생채용박람회참가,http://www.fnnews.com/news/201809281015279546
3670,2018-09-28,대웅제약해외현지법인서일할외국인우수인재찾기적극나서,http://www.mdtoday.co.kr/mdtoday/index.html?no=333557
3671,2018-09-28,28일대웅제약주가오전10시26분195500원,http://www.anewsa.com/detail.php?number=1383148&thread=10r04
3672,2018-09-28,대웅제약해외현지법인직원외국인우수인재채용나서,http://www.getnews.co.kr/news/articleView.html?idxno=97544
3673,2018-09-28,대웅제약2018코트라외국인유학생채용박람회참가글로벌인재채용목적,http://www.enewstoday.co.kr/news/articleView.html?idxno=1234887
3674,2018-09-28,대웅제약해외현지법인외국인인재채용,http://www.newsis.com/view/?id=NISX20180928_0000429238&cID=13001&pID=13000
3675,2018-09-28,대웅제약KOTRA외국인유학생채용박람회참가우수인재확보총력,http://www.wikileaks-kr.org/news/articleView.html?idxno=36629
3676,2018-09-28,대웅제약해외현지법인외국인우수인재찾기나서,http://www.bokuennews.com/news/article.html?no=165615
3677,2018-09-28,대웅해외법인근무외국인인재발굴,http://www.dailymedi.com/detail.php?number=835105&thread=22r05
3678,2018-09-28,대웅제약외국인우수인재찾기적극나서,http://www.bosa.co.kr/news/articleView.html?idxno=2090919
3679,2018-09-28,제약산업대웅제약해외현지법인근무할외국인우수인재찾기外,http://www.kukinews.com/news/article.html?no=589180
3680,2018-09-28,대웅제약해외현지법인서근무할외국인인재채용나서,http://www.mhj21.com/sub_read.html?uid=116457§ion=sc243
3681,2018-09-28,대웅제약해외현지법인서일할외국인우수인재찾는다KOTRA외국인유학생채용박람회참가,http://www.businesskorea.co.kr/news/articleView.html?idxno=25331
3682,2018-09-28,대웅제약해외법인근무할글로벌인재선발,http://www.edaily.co.kr/news/newspath.asp?newsid=02492806619344712
3683,2018-09-28,대웅제약해외현지법인외국인우수인재찾기나서,http://www.kpanews.co.kr/article/show.asp?idx=197211&table=article&category=D
3684,2018-09-28,대웅제약해외법인서일할글로벌인재채용,http://www.koreaittimes.com/news/articleView.html?idxno=86273
3685,2018-09-28,대웅제약해외법인근무할글로벌인재선발,http://www.sisa-news.com/news/article.html?no=115083
3686,2018-09-28,유통오늘대웅제약외국인우수인재찾기적극나서GC녹십자4가독감백신전연령접종가능,http://www.sisaon.co.kr/news/articleView.html?idxno=77773
3687,2018-09-28,대웅제약해외현지법인서근무할글로벌인재채용추진,http://www.rapportian.com/news/articleView.html?idxno=113141
3688,2018-09-28,대웅제약글로벌인재채용나선다,http://www.kormedi.com/news/article/1229450_2892.html
3689,2018-09-28,대웅제약해외현지법인서일할외국인우수인재를찾습니다,http://www.segye.com/content/html/2018/09/28/20180928003407.html?OutUrl=naver
3690,2018-09-28,대웅제약2018유학생채용박람회참가,http://www.kpinews.co.kr/news/articleView.html?idxno=81747
3691,2018-09-28,대웅제약주가194000원으로장마감,http://www.anewsa.com/detail.php?number=1383645&thread=10r04
3692,2018-09-28,대웅제약미국중국등현지법인서일할외국인인재찾아요,http://www.sporbiz.co.kr/news/articleView.html?idxno=275399
3693,2018-09-28,대웅제약해외현지법인서근무할외국인유학생채용,http://www.newspost.kr/news/articleView.html?idxno=65800
3694,2018-09-28,대웅제약KOTRA채용박람회참가,http://www.fnnews.com/news/201809281646371824
3695,2018-09-28,대웅제약해외현지법인근무외국인유학생채용,http://view.asiae.co.kr/news/view.htm?idxno=2018092817004019697
3696,2018-09-28,대웅제약해외현지법인서일할외국인우수인재찾기적극나서,http://www.ekn.kr/news/article.html?no=388653
3697,2018-09-28,대웅제약해외현지법인에서함께일할글로벌인재찾습니다,http://www.insight.co.kr/news/180988
3698,2018-09-28,대웅제약해외현지법인에서일할외국인우수인재찾기적극나서,http://www.newscj.com/news/articleView.html?idxno=558410
3699,2018-09-29,뉴스투데이J대웅제약KOTRA유학생채용박람회참가글로벌인재채용나서,http://www.news2day.co.kr/111640
3700,2018-09-29,대웅제약글로벌시장성과앞당겨지며우수인재확보에역량집중,http://www.lawissue.co.kr/view.php?ud=20180929121709820d7f4c63cc6_12
3701,2018-09-30,대웅제약2018KOTRA외국인유학생채용박람회참가,http://www.ftoday.co.kr/news/articleView.html?idxno=103090
3702,2018-09-30,메디톡스휴온스대웅제약휴젤보톡스해외진출발걸음재촉,http://www.businesspost.co.kr/BP?command=article_view&num=97392
3703,2018-09-30,대웅제약상생펀드로헬스케어생태계성장지원,http://view.asiae.co.kr/news/view.htm?idxno=2018093011254283095
3704,2018-09-30,콧대높은美제약시장셀트리온대웅녹십자진땀,http://www.finomy.com/news/articleView.html?idxno=58571
3705,2018-10-01,더벨대웅첫스톡옵션지급주식보상제도실행,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201809280100042490002603
3706,2018-10-01,대웅제약해외진출위해외국인인재찾기적극나서,http://www.metroseoul.co.kr/news/newsview?newscd=2018093000049
3707,2018-10-01,1일대웅제약주가오전10시28분189000원,http://www.anewsa.com/detail.php?number=1384400&thread=10r04
3708,2018-10-01,대웅제약2018하반기공개채용실시,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222552
3709,2018-10-01,대웅제약2018하반기공개채용진행110명규모,http://medipana.com/news/news_viewer.asp?NewsNum=225891&MainKind=A&NewsKind=5&vCount=12&vKind=1
3710,2018-10-01,대웅제약2018하반기공개채용실시,http://www.dailypharm.com/News/244196
3711,2018-10-01,대웅제약2018하반기공개채용실시총110명규모,http://www.wikileaks-kr.org/news/articleView.html?idxno=36889
3712,2018-10-01,대웅제약하반기신입경력사원공채,http://www.seoulfn.com/news/articleView.html?idxno=320882
3713,2018-10-01,대웅제약2018하반기공개채용실시,http://www.ekn.kr/news/article.html?no=388950
3714,2018-10-01,대웅제약전일대비약3하락한188000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810010232&t=NN
3715,2018-10-01,대웅제약하반기공개채용,http://www.koreaittimes.com/news/articleView.html?idxno=86296
3716,2018-10-01,대웅제약2018하반기공개채용실시,http://www.bokuennews.com/news/article.html?no=165701
3717,2018-10-01,적합인재는모두채용대웅제약정원없앤공채실시,http://www.medicaltimes.com/News/1121364
3718,2018-10-01,대웅제약2018하반기공개채용,http://www.medical-tribune.co.kr/news/articleView.html?idxno=81502
3719,2018-10-01,대웅제약하반기110명공개채용실시17일까지,http://www.seoulwire.com/news/articleView.html?idxno=28190
3720,2018-10-01,대웅제약2018하반기공개채용실시,http://www.bosa.co.kr/news/articleView.html?idxno=2091015
3721,2018-10-01,대웅제약법무마케팅등100여명신입공채실시,http://www.rapportian.com/news/articleView.html?idxno=113170
3722,2018-10-01,대웅제약2018하반기공개채용실시110명뽑아,http://www.ajunews.com/view/20181001113434665
3723,2018-10-01,대웅제약하반기신입및경력사원공채,http://www.edaily.co.kr/news/newspath.asp?newsid=03083206619368656
3724,2018-10-01,대웅제약하반기공채실시연구영업등110여명규모,http://www.100ssd.co.kr/news/articleView.html?idxno=56586
3725,2018-10-01,대웅제약하반기공채실시,http://www.monews.co.kr/news/articleView.html?idxno=119453
3726,2018-10-01,대웅제약하반기신입경력공채실시,http://www.etoday.co.kr/news/section/newsview.php?idxno=1668511
3727,2018-10-01,대웅제약2018하반기공개채용실시,http://www.newsway.co.kr/news/view?tp=1&ud=2018100112345261198
3728,2018-10-01,대웅제약2018하반기공개채용실시,http://www.sedaily.com/NewsView/1S5QS7ADLV
3729,2018-10-01,대웅제약17일까지하반기신입경력공개채용,http://www.newspim.com/news/view/20181001000365
3730,2018-10-01,대웅제약이번달17일까지하반기신입경력사원공개채용,http://www.enewstoday.co.kr/news/articleView.html?idxno=1235479
3731,2018-10-01,대웅제약2018하반기신입경력공개채용실시,http://moneys.mt.co.kr/news/mwView.php?no=2018100113568042878
3732,2018-10-01,유통오늘대웅제약하반기공개채용실시하이트진로강다니엘스페셜캔출시,http://www.sisaon.co.kr/news/articleView.html?idxno=77841
3733,2018-10-01,대웅제약하반기신입경력공개채용나서,http://news.mk.co.kr/newsRead.php?year=2018&no=612033
3734,2018-10-01,대웅제약2018하반기공개채용실시,http://www.g-enews.com/ko-kr/news/article/news_all/20181001141914254f6d02acec0_1/article.html
3735,2018-10-01,대웅제약2018하반기공개채용실시,http://www.g-enews.com/ko-kr/news/article/news_all/20181001141914254f6d02acec0_1/article.html
3736,2018-10-01,대웅제약2018하반기공개채용실시,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018100113580545967
3737,2018-10-01,대웅제약17일까지하반기신입및경력사원공개채용실시,http://www.fnnews.com/news/201810011457580077
3738,2018-10-01,대웅제약2018하반기공개채용실시,http://www.getnews.co.kr/news/articleView.html?idxno=98094
3739,2018-10-01,JOB속보대웅제약하반기공채시작적합인재라면정원규모넘어채용할것”,http://www.news2day.co.kr/111765
3740,2018-10-01,대웅제약2018하반기공개채용실시,http://www.economytalk.kr/news/articleView.html?idxno=170186
3741,2018-10-01,대웅제약2018하반기공개채용실시,http://www.mdtoday.co.kr/mdtoday/index.html?no=333785
3742,2018-10-01,대웅제약외국인우수인재모십니다”,http://www.whosaeng.com/sub_read.html?uid=104746§ion=sc5
3743,2018-10-01,대웅제약주가188500원으로마감,http://www.anewsa.com/detail.php?number=1384983&thread=10r04
3744,2018-10-01,대웅제약2018하반기공개채용실시,http://www.viva100.com/main/view.php?key=20181001010000406
3745,2018-10-01,대웅제약오는17일까지하반기공채실시연구생산등110명규모채용,http://www.businesskorea.co.kr/news/articleView.html?idxno=25380
3746,2018-10-01,대웅제약하반기신입경력사원110명공채,http://www.medisobizanews.com/news/articleView.html?idxno=55555
3747,2018-10-01,대웅제약2018하반기공개채용실시,http://www.dt.co.kr/contents.html?article_no=2018100102109931102007&ref=naver
3748,2018-10-01,대웅제약하반기공개채용110명규모,http://www.kpinews.co.kr/news/articleView.html?idxno=81868
3749,2018-10-01,대웅제약2018하반기공개채용실시,http://www.newscj.com/news/articleView.html?idxno=559063
3750,2018-10-02,대웅제약2018하반기공개채용실시,http://www.lawissue.co.kr/view.php?ud=20181001235548483d7f4c63cc6_12
3751,2018-10-02,대웅제약나보타캐나다출시임박북미교두보확보,http://www.medisobizanews.com/news/articleView.html?idxno=55565
3752,2018-10-02,2일대웅제약주가오전10시29분185500원,http://www.anewsa.com/detail.php?number=1385490&thread=10r04
3753,2018-10-02,대웅제약2018하반기110명공개채용돌입,http://www.kpanews.co.kr/article/show.asp?idx=197298&table=article&category=D
3754,2018-10-02,대웅제약17일까지2018하반기공개채용진행,http://www.k-health.com/news/articleView.html?idxno=38068
3755,2018-10-02,함께일할인재를찾습니다대웅제약하반기공개채용실시,https://www.insight.co.kr/news/181753
3756,2018-10-03,대웅제약2018하반기공채실시,http://www.segye.com/content/html/2018/10/02/20181002002621.html?OutUrl=naver
3757,2018-10-04,대웅제약나보타중국임상시험승인자진회수,http://medipana.com/news/news_viewer.asp?NewsNum=226050&MainKind=A&NewsKind=5&vCount=12&vKind=1
3758,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222653
3759,2018-10-04,대웅제약中임상시험계획자진회수2공장생산으로계획변경,http://view.asiae.co.kr/news/view.htm?idxno=2018100410451344951
3760,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수생산공장변경,http://moneys.mt.co.kr/news/mwView.php?no=2018100410448039263
3761,2018-10-04,대웅제약나보타중국임상시험계획서재제출예정,http://www.medicaltimes.com/News/1121441
3762,2018-10-04,대웅제약나보타中임상시험계획청구자진회수재제출위한대승적인결단,http://www.segye.com/content/html/2018/10/04/20181004001229.html?OutUrl=naver
3763,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수연내재신청,http://www.medigatenews.com/news/1219552618
3764,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수,http://www.bosa.co.kr/news/articleView.html?idxno=2091246
3765,2018-10-04,대웅제약나보타中임상시험계획승인자진회수2공장으로재신청,http://www.newsis.com/view/?id=NISX20181004_0000433642&cID=13001&pID=13000
3766,2018-10-04,대웅제약나보타중국임상계획자진철회,http://biz.chosun.com/site/data/html_dir/2018/10/04/2018100401223.html
3767,2018-10-04,대웅제약나보타중국임상신청자진회수한이유는,http://news.hankyung.com/article/201810040797f
3768,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수,http://www.g-enews.com/ko-kr/news/article/news_all/201810041049216847f6d02acec0_1/article.html
3769,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수2공장으로변경,http://www.mediapen.com/news/view/386706
3770,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수,http://www.kukinews.com/news/article.html?no=590753
3771,2018-10-04,대웅제약나보타中임상시험계획승인자진회수,http://biz.newdaily.co.kr/site/data/html/2018/10/04/2018100400062.html
3772,2018-10-04,대웅나보타中임상계획신청자진철회,http://www.dailymedi.com/detail.php?number=835289&thread=22r05
3773,2018-10-04,대웅제약나보타중국임상계획자진회수2공장생산으로변경,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810040229&t=NN
3774,2018-10-04,대웅제약나보타중국임상시험승인자진회수,http://www.dailian.co.kr/news/view/742880/?sc=naver
3775,2018-10-04,대웅제약나보타中CTA자진회수결정,http://www.whosaeng.com/sub_read.html?uid=104838§ion=sc5
3776,2018-10-04,대웅제약나보타中임상승인자진회수생산량늘려재제출할것,http://www.metroseoul.co.kr/news/newsview?newscd=2018100400083
3777,2018-10-04,대웅제약나보타中임상승인자진회수안정적진출위한선택,http://www.rapportian.com/news/articleView.html?idxno=113231
3778,2018-10-04,대웅제약나보타中임상계획자진회수올해재제출,http://www.biospectator.com/view/news_view.php?varAtcId=6310
3779,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수∙재제출이유는,http://www.getnews.co.kr/news/articleView.html?idxno=98558
3780,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수,http://www.newsprime.co.kr/news/article.html?no=431630
3781,2018-10-04,대웅제약나보타中임상시험계획자진회수연내재제출예정,http://www.etoday.co.kr/news/section/newsview.php?idxno=1669668
3782,2018-10-04,대웅제약보툴리눔톡신나보타中임상계획자진회수,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181004086600017&did=1195m
3783,2018-10-04,대웅나보타중국임상계획자진회수재제출,http://www.kpanews.co.kr/article/show.asp?idx=197353&table=article&category=D
3784,2018-10-04,대웅제약나보타中임상계획서자진회수연내다시제출,http://news1.kr/articles/?3441512
3785,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수재제출,http://www.seoulwire.com/news/articleView.html?idxno=28610
3786,2018-10-04,대웅제약중국나보타임상계획자진회수,http://kormedi.com/1250511
3787,2018-10-04,대웅나보타중국물량위해CTA자진회수,http://www.monews.co.kr/news/articleView.html?idxno=119682
3788,2018-10-04,대웅제약나보타중국임상승인자진회수,http://www.sporbiz.co.kr/news/articleView.html?idxno=276589
3789,2018-10-04,대웅나보타中임상시험계획자진회수다시제출할것,http://www.medical-tribune.co.kr/news/articleView.html?idxno=81576
3790,2018-10-04,대웅제약나보타中임상계획자진회수,http://www.fetv.co.kr/news/article.html?no=13314
3791,2018-10-04,대웅제약나보타中임상계획서자진회수,http://www.ebn.co.kr/news/view/957042
3792,2018-10-04,대웅제약나보타中임상계획승인자진회수올중재제출,http://www.medisobizanews.com/news/articleView.html?idxno=55617
3793,2018-10-04,대웅제약보툴리눔톡신나보타中임상시험계획자진회수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018100413442363033
3794,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수결정생산효율고려,http://www.wikileaks-kr.org/news/articleView.html?idxno=37198
3795,2018-10-04,더벨대웅제약나보타새중국임상기존프로토콜과동일,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201810040100005250000318
3796,2018-10-04,대웅제약나보타중국임상시험계획자진회수재제출하기로,http://www.sedaily.com/NewsView/1S5S6SLSSE
3797,2018-10-04,대웅제약보툴리눔톡신나보타중국임상계획자진회수,http://www.seoulfn.com/news/articleView.html?idxno=321164
3798,2018-10-04,대웅제약나보타中임상시험계획승인자진회수,http://www.bokuennews.com/news/article.html?no=165857
3799,2018-10-04,대웅제약나보타中임상시험계획승인자진회수올해안으로재신청,http://www.enewstoday.co.kr/news/articleView.html?idxno=1236465
3800,2018-10-04,대웅제약나보타中임상시험계획승인자진회수재제출결단,http://www.mdtoday.co.kr/mdtoday/index.html?no=334088
3801,2018-10-04,대웅제약나보타중국임상시험계획자진회수뒤재제출,http://www.100ssd.co.kr/news/articleView.html?idxno=56623
3802,2018-10-04,대웅제약생산공장변경위해나보타中임상승인자진회수,http://news.mt.co.kr/mtview.php?no=2018100411015188510
3803,2018-10-04,대웅제약나보타中임상시험계획자진회수재제출결단내려,http://www.ekn.kr/news/article.html?no=389680
3804,2018-10-04,대웅제약주가186000원장마쳐,http://www.anewsa.com/detail.php?number=1387314&thread=10r04
3805,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수,http://www.economytalk.kr/news/articleView.html?idxno=170398
3806,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수및재제출결단내려,http://www.lawissue.co.kr/view.php?ud=201810041629278880d7f4c63cc6_12
3807,2018-10-04,대웅제약생산공장변경으로나보타중국임상시험계획승인자진회수,http://www.fnnews.com/news/201810041700574483
3808,2018-10-04,대웅제약나보타중국임상시험계획승인자진회수및재제출결단내려,http://www.wsobi.com/news/articleView.html?idxno=65796
3809,2018-10-04,대웅제약하반기공채정원안따지고인재발굴,http://www.mhj21.com/sub_read.html?uid=116539§ion=sc243
3810,2018-10-04,뉴스투데이L대웅제약나보타중국임상시험계획재제출한다,http://www.news2day.co.kr/111949
3811,2018-10-04,대웅제약생산공장변경위해나보타中임상시험자진회수,http://www.inthenews.co.kr/news/article.html?no=11694
3812,2018-10-04,대웅제약나보타中임상승인자진회수연내다시제출,https://www.insight.co.kr/news/182205
3813,2018-10-04,대웅제약나보타中임상시험계획승인자진회수,http://www.ajunews.com/view/20181004135303717
3814,2018-10-05,CTA자진회수대웅제약중국진출승부수던져,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1060987
3815,2018-10-05,대웅제약보툴리눔톡신나보타중국임상계획자진회수,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3650871
3816,2018-10-05,특징주대웅제약보툴리눔톡신나보타출시지연리스크부각외인매도나서,http://www.g-enews.com/ko-kr/news/article/news_all/201810050923072188c16aa2f016_1/article.html
3817,2018-10-05,나보타파트너사주요경영진대웅제약향남공장방문파트너십강화,http://www.enewstoday.co.kr/news/articleView.html?idxno=1236705
3818,2018-10-05,대웅제약에볼루스나보타발매준비협력강화,http://www.medicaltimes.com/News/1121466
3819,2018-10-05,대웅제약나보타출시앞두고美에볼루스와파트너십강화,http://www.newspim.com/news/view/20181005000155
3820,2018-10-05,대웅제약에볼루스나보타발매준비협력관계강화,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222693
3821,2018-10-05,대웅제약에볼루스나보타미국성공적진입위해맞손,http://www.ebn.co.kr/news/view/957173
3822,2018-10-05,대웅제약나보타美출시앞두고에볼루스와파트너십강화,http://www.medisobizanews.com/news/articleView.html?idxno=55631
3823,2018-10-05,미국에볼루스신임사장대웅제약본사방문,http://medipana.com/news/news_viewer.asp?NewsNum=226116&MainKind=A&NewsKind=5&vCount=12&vKind=1
3824,2018-10-05,나보타발매앞두고美에볼루스주요경영진대웅본사및나보타공장방문,http://www.medigatenews.com/news/2796518758
3825,2018-10-05,나보타파트너사에볼루스경영진대웅제약방문,http://www.dailypharm.com/News/244353
3826,2018-10-05,대웅제약에볼루스나보타협력관계다져,http://www.monews.co.kr/news/articleView.html?idxno=119747
3827,2018-10-05,대웅제약에볼루스나보타美발매위해파트너십강화,http://www.k-health.com/news/articleView.html?idxno=38105
3828,2018-10-05,美에볼루스경영진대웅제약전격방문,http://kormedi.com/1250676
3829,2018-10-05,대웅제약美에볼루스사장나보타공장방문,http://view.asiae.co.kr/news/view.htm?idxno=2018100511065306518
3830,2018-10-05,대웅제약에볼루스나보타발매파트너십강화,http://www.100ssd.co.kr/news/articleView.html?idxno=56634
3831,2018-10-05,대웅제약나보타미파트너에볼루스파트너십강화,http://www.bosa.co.kr/news/articleView.html?idxno=2091335
3832,2018-10-05,대웅제약美에볼루스와나보타발매준비협력다져,http://www.wolyo.co.kr/news/articleView.html?idxno=68910
3833,2018-10-05,나보타파트너사에볼루스경영진대웅제약방문,http://www.g-enews.com/ko-kr/news/article/news_all/201810051126595667f6d02acec0_1/article.html
3834,2018-10-05,대웅제약과에볼루스나보타미국진출협력관계다져,http://www.bokuennews.com/news/article.html?no=165929
3835,2018-10-05,대웅제약나보타발매앞두고에볼루스와협력관계다져,http://www.economytalk.kr/news/articleView.html?idxno=170444
3836,2018-10-05,대웅제약∙에볼루스나보타발매준비협력관계다져,http://www.getnews.co.kr/news/articleView.html?idxno=98724
3837,2018-10-05,대웅제약나보타파트너사에볼루스신임사장대웅본사및나보타공장방문,http://www.fnnews.com/news/201810051221276459
3838,2018-10-05,대웅제약전일대비약6하락한174500원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810050348&t=NN
3839,2018-10-05,전승호대웅제약사장나보타미국등해외시장진입역량집중,http://www.rapportian.com/news/articleView.html?idxno=113262
3840,2018-10-05,대웅제약나보타파트너사에볼루스사장대웅본사방문,http://www.etnews.com/20181005000089
3841,2018-10-05,대웅제약에볼루스나보타발매준비위한파트너십강화,http://www.dt.co.kr/contents.html?article_no=2018100502109931102003&ref=naver
3842,2018-10-05,대웅제약나보타성공위해에볼루스와전략회의진행,http://www.edaily.co.kr/news/newspath.asp?newsid=02935606619369968
3843,2018-10-05,대웅제약인도네시아에2000만원상당의약품지원,http://www.etoday.co.kr/news/section/newsview.php?idxno=1670295
3844,2018-10-05,대웅제약지진피해인도네시아에의약품지원,http://moneys.mt.co.kr/news/mwView.php?no=2018100514158076502
3845,2018-10-05,대웅제약지진피해인도네시아에2000만원상당의약품지원,http://www.ekn.kr/news/article.html?no=389827
3846,2018-10-05,대웅제약지진피해인도네시아2천만원상당의약품지원,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222705
3847,2018-10-05,대웅제약지진피해인니에의약품지원,http://www.bosa.co.kr/news/articleView.html?idxno=2091367
3848,2018-10-05,5일대웅제약주가오후2시25분176500원,http://www.anewsa.com/detail.php?number=1388061&thread=10r04
3849,2018-10-05,대웅제약지진피해인도네시아에2천만원상당의약품지원,http://www.wsobi.com/news/articleView.html?idxno=65837
3850,2018-10-05,대웅제약지진피해입은인도네시아에2000만원의약품지원,http://www.metroseoul.co.kr/news/newsview?newscd=2018100500061
3851,2018-10-05,대웅제약과에볼루스나보타美진출위한협력관계다져,http://www.metroseoul.co.kr/news/newsview?newscd=2018100500059
3852,2018-10-05,대웅제약지진피해인도네시아에의약품지원,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018100514275840149
3853,2018-10-05,대웅제약인도네시아에2천만원의약품지원,http://medipana.com/news/news_viewer.asp?NewsNum=226139&MainKind=A&NewsKind=5&vCount=12&vKind=1
3854,2018-10-05,대웅제약지진피해인도네시아에의약품지원,http://www.sisa-news.com/news/article.html?no=115324
3855,2018-10-05,대웅제약인도네시아지진피해지역에2천만원상당의약품지원,http://www.sporbiz.co.kr/news/articleView.html?idxno=277021
3856,2018-10-05,대웅제약지진피해印尼에2000만원상당의약품지원,http://www.medisobizanews.com/news/articleView.html?idxno=55642
3857,2018-10-05,대웅제약에볼루스나보타발매준비위해긴밀히협력,http://www.segye.com/content/html/2018/10/05/20181005002498.html?OutUrl=naver
3858,2018-10-05,대웅제약에볼루스나보타발매준비위해양사간협력관계다져,http://www.ekn.kr/news/article.html?no=389841
3859,2018-10-05,대웅제약지진피해인니에의약품지원,http://www.rapportian.com/news/articleView.html?idxno=113268
3860,2018-10-05,대웅제약지진피해인도네시아에의약품지원,http://www.dailian.co.kr/news/view/743226/?sc=naver
3861,2018-10-05,대웅제약지진피해인도네시아에의약품지원,http://www.newsprime.co.kr/news/article.html?no=431850
3862,2018-10-05,대웅제약지진피해인도네시아2천만원의약품지원,http://www.getnews.co.kr/news/articleView.html?idxno=98743
3863,2018-10-05,대웅제약인도네시아에2000만원의약품지원,http://www.fnnews.com/news/201810051529496007
3864,2018-10-05,대웅제약인도네시아재난지역에의약품지원,http://www.kpinews.co.kr/news/articleView.html?idxno=82112
3865,2018-10-05,대웅인도네시아2000만원상당의약품지원,http://www.dailymedi.com/detail.php?number=835352&thread=22r05
3866,2018-10-05,대웅제약주가175500원으로마감,http://www.anewsa.com/detail.php?number=1388178&thread=10r04
3867,2018-10-05,대웅제약지진피해인니에2000만원상당의약품지원,http://www.mdtoday.co.kr/mdtoday/index.html?no=334228
3868,2018-10-05,대웅제약지진피해인도네시아에2천만원상당의약품지원,http://www.g-enews.com/ko-kr/news/article/news_all/201810051603157705f6d02acec0_1/article.html
3869,2018-10-05,대웅제약인도네시아지진피해지역에의약품지원,http://www.seoulwire.com/news/articleView.html?idxno=28847
3870,2018-10-05,대웅제약인도네시아지진피해의약품지원,http://www.ajunews.com/view/20181005160831650
3871,2018-10-05,대웅제약에볼루스나보타발매준비위해협력관계다져,http://www.mdtoday.co.kr/mdtoday/index.html?no=334232
3872,2018-10-05,대웅제약나보타美출시앞두고성공위해에볼루스와전략회의진행,https://www.insight.co.kr/news/182445
3873,2018-10-05,대웅제약나보타파트너사와美진출전협력,http://www.fnnews.com/news/201810051649404295
3874,2018-10-05,대웅제약인도네시아에2천만원상당의약품지원,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061015
3875,2018-10-05,대웅제약에볼루스나보타미국시장진출협력강화,http://www.wikileaks-kr.org/news/articleView.html?idxno=37360
3876,2018-10-05,대웅제약과에볼루스나보타발매준비를위해양사간파트너십강화,http://www.lawissue.co.kr/view.php?ud=201810051820332125d7f4c63cc6_12
3877,2018-10-05,대웅제약지진피해인도네시아에2천만원상당의약품지원,http://www.lawissue.co.kr/view.php?ud=201810051900446317d7f4c63cc6_12
3878,2018-10-05,대웅제약미에볼루스주요경영진본사및나보타공장방문,http://www.kpanews.co.kr/article/show.asp?idx=197413&table=article&category=D
3879,2018-10-05,대웅제약지진피해인도네시아2천만원상당의약품지원,http://www.kpanews.co.kr/article/show.asp?idx=197418&table=article&category=D
3880,2018-10-05,대웅제약과에볼루스나보타발매준비를위해양사간협력관계다져,http://www.newscj.com/news/articleView.html?idxno=560210
3881,2018-10-06,대웅제약美에볼루스나보타진출위한파트너쉽다져,http://www.seoulwire.com/news/articleView.html?idxno=28911
3882,2018-10-06,대웅제약미국에볼루스와파트너십강화,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3652181
3883,2018-10-07,대웅제약지진피해인도네시아에2000만원어치의약품지원,http://www.edaily.co.kr/news/newspath.asp?newsid=01285766619370624
3884,2018-10-07,대웅제약지진피해인도네시아에2000만원상당의약품지원,http://www.ftoday.co.kr/news/articleView.html?idxno=103289
3885,2018-10-07,대웅제약에볼루스나보타발매준비위한파트너십강화,http://www.dt.co.kr/contents.html?article_no=2018100702109931102005&ref=naver
3886,2018-10-08,대웅제약지진피해인도네시아에의약품지원,http://www.bokuennews.com/news/article.html?no=165981
3887,2018-10-08,8일대웅제약주가오전10시28분178500원,http://www.anewsa.com/detail.php?number=1389097&thread=10r04
3888,2018-10-08,재계34세시즌2③대웅제약묘수냐꼼수냐,http://news.bizwatch.co.kr/article/policy/2018/10/05/0002/naver
3889,2018-10-08,ET투자뉴스대웅제약_주요매물구간인194000원선이저항대로작용,http://www.etnews.com/20181008000159
3890,2018-10-08,대웅제약주가175500원으로장마감,http://www.anewsa.com/detail.php?number=1389660&thread=10r04
3891,2018-10-10,10일대웅제약주가오전10시29분174000원,http://www.anewsa.com/detail.php?number=1390375&thread=10r04
3892,2018-10-11,대웅제약직원성장회사발전새문화정착주력,http://www.dailymedi.com/detail.php?number=835513&thread=22r05
3893,2018-10-11,DataScore대웅제약상반기순익261감소,http://www.ceoscoredaily.com/news/article.html?no=46295
3894,2018-10-11,단독대웅제약비타민제간질환치료제UDCA포함논란,http://www.getnews.co.kr/news/articleView.html?idxno=99376
3895,2018-10-11,11일대웅제약주가오전10시30분161500원,http://www.anewsa.com/detail.php?number=1391417&thread=10r04
3896,2018-10-11,대웅제약15일기업설명회개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1672398
3897,2018-10-11,대웅제약전일대비약5하락한160000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810110712&t=NN
3898,2018-10-11,대웅제약주가159500원마감해,http://www.anewsa.com/detail.php?number=1392052&thread=10r04
3899,2018-10-12,12일대웅제약주가오전10시28분161500원,http://www.anewsa.com/detail.php?number=1392582&thread=10r04
3900,2018-10-12,ET투자뉴스대웅제약_거래비중기관277외국인2465,http://www.etnews.com/20181012000070
3901,2018-10-12,대웅제약주가164500원장마쳐,http://www.anewsa.com/detail.php?number=1393145&thread=10r04
3902,2018-10-15,더벨대웅제약나보타美출시앞두고해외투자유치박차,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201810120100017680001064
3903,2018-10-15,15일대웅제약주가오전10시29분161000원,http://www.anewsa.com/detail.php?number=1394049&thread=10r04
3904,2018-10-15,대웅제약취업준비생본사초청해채용설명회개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=222997
3905,2018-10-15,대웅제약취업준비생본사초청채용설명회개최,http://medipana.com/news/news_viewer.asp?NewsNum=226598&MainKind=A&NewsKind=5&vCount=12&vKind=1
3906,2018-10-15,대웅제약취업준비생본사초청채용설명회개최,http://www.ekn.kr/news/article.html?no=391457
3907,2018-10-15,대웅제약취업준비생본사초청채용설명회개최,http://www.getnews.co.kr/news/articleView.html?idxno=100109
3908,2018-10-15,대웅제약취업준비생본사초청채용설명회개최,http://www.economytalk.kr/news/articleView.html?idxno=171000
3909,2018-10-15,대웅제약취업준비생본사초청채용설명회개최,http://www.ebn.co.kr/news/view/958137
3910,2018-10-15,대웅제약취업준비생본사초청해채용설명회개최,http://www.medicaltimes.com/News/1121664
3911,2018-10-15,대웅제약취업준비생본사초청해채용설명회개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1239161
3912,2018-10-15,대웅제약취업준비생150명초청채용설명회전개,http://www.wikileaks-kr.org/news/articleView.html?idxno=38213
3913,2018-10-15,대웅제약취준생대상채용설명회개최,http://www.sisa-news.com/news/article.html?no=115572
3914,2018-10-15,대웅제약취업준비생150명본사초청해채용설명회개최,http://www.ceoscoredaily.com/news/article.html?no=46967
3915,2018-10-15,대웅제약상승하루만에5대낙폭오후2시부터대거매도세,http://www.econonews.co.kr/news/articleView.html?idxno=38972
3916,2018-10-15,대웅제약의초청채용설명회에취준생들배려받은느낌,http://www.medisobizanews.com/news/articleView.html?idxno=55760
3917,2018-10-15,대웅제약회사에서취업준비생초청채용설명회개최,http://news.mk.co.kr/newsRead.php?year=2018&no=641519
3918,2018-10-15,대웅제약전일대비약5하락한156000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810150442&t=NN
3919,2018-10-15,대웅전일대비약4하락한15300원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810150447&t=NN
3920,2018-10-15,화촉대웅제약이정석과장,http://www.whosaeng.com/sub_read.html?uid=105133§ion=sc5
3921,2018-10-15,대웅제약취업준비생150명초청해채용설명회개최,http://www.insightkorea.co.kr//news/articleView.html?idxno=31660
3922,2018-10-15,대웅제약하반기공개채용설명회진행,http://www.newsprime.co.kr/news/article.html?no=432682
3923,2018-10-15,대웅제약주가156000원장마쳐,http://www.anewsa.com/detail.php?number=1394639&thread=10r04
3924,2018-10-15,대웅제약홍보팀이정석과장결혼1110일,http://medipana.com/news/news_viewer.asp?NewsNum=226613&MainKind=A&NewsKind=5&vCount=12&vKind=1
3925,2018-10-15,대웅제약취업준비생본사초청채용설명회,http://www.bosa.co.kr/news/articleView.html?idxno=2091923
3926,2018-10-15,대웅제약취업준비생본사초청해채용설명회개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018101515265788150
3927,2018-10-15,취업준비생본사로초청대웅제약채용설명회개최,http://www.segye.com/content/html/2018/10/15/20181015003607.html?OutUrl=naver
3928,2018-10-15,대웅제약취업준비생본사초청해채용설명회개최,http://www.lawissue.co.kr/view.php?ud=201810151644112172d7f4c63cc6_12
3929,2018-10-15,대웅제약취업준비생본사초청해채용설명회개최,http://www.g-enews.com/ko-kr/news/article/news_all/201810151653051039f6d02acec0_1/article.html
3930,2018-10-15,대웅제약취업준비생본사초청채용설명회개최,http://www.dailian.co.kr/news/view/745160/?sc=naver
3931,2018-10-15,대웅제약취업생초청채용설명회성료,http://www.kpinews.co.kr/news/articleView.html?idxno=82590
3932,2018-10-15,대웅제약취업준비생본사초청해설명회개최,http://www.mhj21.com/sub_read.html?uid=116767§ion=sc243
3933,2018-10-15,대웅제약취준생초청채용설명회개최,http://www.100ssd.co.kr/news/articleView.html?idxno=56868
3934,2018-10-15,뉴스투데이L대웅제약인재찾기위한취업설명회개최,http://www.news2day.co.kr/112521
3935,2018-10-15,대웅제약취업준비생삼성동본사초청해채용설명회개최,https://www.insight.co.kr/news/184445
3936,2018-10-15,대웅제약취업준비생본사초청채용설명회개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=335280
3937,2018-10-15,대웅제약취업준비생초청채용설명회개최,http://www.newscj.com/news/articleView.html?idxno=562999
3938,2018-10-16,이정석대웅제약홍보팀과장,http://www.doctorsnews.co.kr/news/articleView.html?idxno=125765
3939,2018-10-16,대웅제약취준생본사초청해채용설명회진행,http://www.sporbiz.co.kr/news/articleView.html?idxno=279741
3940,2018-10-16,대웅전일대비약3상승한15800원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810160176&t=NN
3941,2018-10-16,16일대웅제약주가오전10시25분157000원,http://www.anewsa.com/detail.php?number=1395214&thread=10r04
3942,2018-10-16,화촉대웅제약이정석과장,http://www.monews.co.kr/news/articleView.html?idxno=120212
3943,2018-10-16,대웅제약대웅바이오글로벌로CPhI참가,http://medipana.com/news/news_viewer.asp?NewsNum=226671&MainKind=A&NewsKind=5&vCount=12&vKind=1
3944,2018-10-16,대웅제약대웅바이오CPhI월드와이드서주력품목홍보,http://www.dailypharm.com/News/244757
3945,2018-10-16,대웅제약대웅바이오한국넘어글로벌로세계의약품전시회참가,http://www.upinews.kr/news/newsview.php?ncode=1065578039523518
3946,2018-10-16,대웅제약대웅바이오해외진출가능성타진,http://www.bokuennews.com/news/article.html?no=166423
3947,2018-10-16,대웅제약대웅바이오CPHI서혁신신약파이프라인소개,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223062
3948,2018-10-16,대웅제약대웅바이오세계의약품전시회적극참가,http://www.getnews.co.kr/news/articleView.html?idxno=100343
3949,2018-10-16,대웅제약세계의약품전시회서단독부스마련해홍보,http://www.edaily.co.kr/news/newspath.asp?newsid=02853606619373576
3950,2018-10-16,대웅제약대웅바이오세계의약품전시회참가,http://www.100ssd.co.kr/news/articleView.html?idxno=56879
3951,2018-10-16,대웅제약대웅바이오세계의약품전시회CPhI참가,http://www.sedaily.com/NewsView/1S5XP1N238
3952,2018-10-16,대웅제약대웅바이오글로벌시장공략강화,http://www.dailymedi.com/detail.php?number=835755&thread=22r05
3953,2018-10-16,대웅제약대웅바이오세계의약품전시회참가혁신신약파이프라인소개,http://www.wikileaks-kr.org/news/articleView.html?idxno=38309
3954,2018-10-16,대웅제약대웅바이오CPhI월드와이드2018참가글로벌시장도전,http://www.dt.co.kr/contents.html?article_no=2018101602109931102001&ref=naver
3955,2018-10-16,대웅제약대웅바이오한국넘어글로벌로,http://www.bosa.co.kr/news/articleView.html?idxno=2092007
3956,2018-10-16,대웅제약대웅바이오세계의약품전시회참가,http://www.etnews.com/20181016000231
3957,2018-10-16,대웅제약대웅바이오2018세계의약품전시회참가,http://moneys.mt.co.kr/news/mwView.php?no=2018101614118048189
3958,2018-10-16,대웅제약세계의약품전시회서글로벌기업홍보나서,http://www.mhj21.com/sub_read.html?uid=116784§ion=sc243
3959,2018-10-16,대웅제약대웅바이오CPhI월드와이드참가,http://www.ebn.co.kr/news/view/958327
3960,2018-10-16,대웅제약대웅바이오CPhI에별도부스내고제품파이프라인홍보,http://news.mk.co.kr/newsRead.php?year=2018&no=644364
3961,2018-10-16,대웅제약스페인서개최된CPhI월드와이드2018세계의약품전시회참가,http://www.fnnews.com/news/201810161501241181
3962,2018-10-16,대웅제약대웅바이오2018세계의약품전시회참가,http://www.kpanews.co.kr/article/show.asp?idx=197789&table=article&category=D
3963,2018-10-16,대웅제약대웅바이오세계의약품전시회참가,http://www.kpinews.co.kr/news/articleView.html?idxno=82652
3964,2018-10-16,대웅제약대웅바이오CPhlWorldwide2018참가다양한혁신신약파이프라인소개,http://www.enewstoday.co.kr/news/articleView.html?idxno=1239644
3965,2018-10-16,대웅제약대웅바이오2018세계의약품전시회참가한국넘어글로벌로,http://www.ekn.kr/news/article.html?no=391700
3966,2018-10-16,대웅제약대웅바이오세계의약품전시회참가,http://www.seoulwire.com/news/articleView.html?idxno=30013
3967,2018-10-16,대웅제약대웅바이오CPhI월드와이드서주력품목소개,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018101615444566957
3968,2018-10-16,대웅제약스페인CPhI2018참가신약소개,http://www.finomy.com/news/articleView.html?idxno=59104
3969,2018-10-16,대웅제약2018세계의약품전시회CPHI참가,http://www.economytalk.kr/news/articleView.html?idxno=171098
3970,2018-10-16,대웅제약홍보팀이정석과장,http://www.bosa.co.kr/news/articleView.html?idxno=2092021
3971,2018-10-16,대웅제약2018세계의약품전시회CPhI참가,http://www.inthenews.co.kr/news/article.html?no=11784
3972,2018-10-16,대웅제약CPhI서눈도장한국넘어글로벌로,http://www.monews.co.kr/news/articleView.html?idxno=120233
3973,2018-10-16,대웅제약대웅바이오세계의약품전시회서제품파이프라인전시세계의약품관계자에눈도장,http://www.businesskorea.co.kr/news/articleView.html?idxno=25727
3974,2018-10-16,대웅제약홍보팀이정석과장결혼1110,http://www.bokuennews.com/news/article.html?no=166455
3975,2018-10-16,​​대웅제약대웅바이오세계의약품전시회CPhI참가글로벌눈도장,http://www.etoday.co.kr/news/section/newsview.php?idxno=1674616
3976,2018-10-16,​​대웅제약대웅바이오2018세계의약품전시회CPHI참가,http://www.babytimes.co.kr/news/articleView.html?idxno=22499
3977,2018-10-16,대웅제약대웅바이오세계의약품전시회CPHI서적극적인홍보활동,http://www.k-health.com/news/articleView.html?idxno=40148
3978,2018-10-16,대웅제약대웅바이오세계의약품전시회CPHI참가혁신신약파이프라인소개,http://www.lawissue.co.kr/view.php?ud=201810162036226363d7f4c63cc6_12
3979,2018-10-17,대웅제약대웅바이오세계의약품전시회참가,http://www.mdtoday.co.kr/mdtoday/index.html?no=335497
3980,2018-10-17,대웅제약치밀한현지화전략글로벌헬스케어그룹도전장,http://news.mk.co.kr/newsRead.php?year=2018&no=645824
3981,2018-10-17,17일대웅제약주가오전10시27분161000원,http://www.anewsa.com/detail.php?number=1396047&thread=10r04
3982,2018-10-17,대웅전일대비약4상승한16250원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810170218&t=NN
3983,2018-10-17,대웅제약주가159000원으로장마감,http://www.anewsa.com/detail.php?number=1396759&thread=10r04
3984,2018-10-18,18일대웅제약주가오전10시27분159500원,http://www.anewsa.com/detail.php?number=1397273&thread=10r04
3985,2018-10-18,매일유업대웅제약합자사엠디웰새로운케톤포뮬라케토웰이달출시,http://www.segye.com/content/html/2018/10/18/20181018001563.html?OutUrl=naver
3986,2018-10-18,대웅제약대웅바이오2018세계의약품전시회참가글로벌진출본격화,https://www.insight.co.kr/news/184920
3987,2018-10-18,화촉이정석대웅제약홍보과장,http://www.medisobizanews.com/news/articleView.html?idxno=55820
3988,2018-10-18,매일유업대웅제약암환자용케톤생성포뮬라개발,http://www.inthenews.co.kr/news/article.html?no=11810
3989,2018-10-18,상장제약올상반기장사잘했다유한녹십자대웅순,http://www.kpanews.co.kr/article/show.asp?idx=197868&table=article&category=C
3990,2018-10-18,대웅제약주가157500원으로종료,http://www.anewsa.com/detail.php?number=1397841&thread=10r04
3991,2018-10-18,SR경제라이프매일유업대웅제약합작사엠디웰신규케톤생성포뮬라케토웰실험결과발표,http://www.srtimes.kr/news/articleView.html?idxno=25987
3992,2018-10-18,매일유업대웅제약합자사엠디웰신규케톤포뮬라케토웰개발,http://www.straightnews.co.kr/news/articleView.html?idxno=37153
3993,2018-10-18,대웅바이오한국넘어글로벌로2018세계의약품전시회참가로,http://www.wsobi.com/news/articleView.html?idxno=66354
3994,2018-10-19,제약사상반기매출유한녹십자종근당대웅順,http://www.dailymedi.com/detail.php?number=835866&thread=22r05
3995,2018-10-19,서울제약황우성대표복귀2달대웅제약출신들역할주목,http://www.sisajournal-e.com/biz/article/190402
3996,2018-10-19,19일대웅제약주가159500원,http://www.anewsa.com/detail.php?number=1398509&thread=10r04
3997,2018-10-19,윤재승전대웅제약회장모든직위내려놓은것맞나,http://www.insightkorea.co.kr//news/articleView.html?idxno=31746
3998,2018-10-22,오명씻고글로벌무대로”전승호대웅제약사장구슬땀,http://www.etoday.co.kr/news/section/newsview.php?idxno=1676626
3999,2018-10-22,대웅제약나보타해외의사교육프로그램NMCFALL2018INKOREA개최,http://www.vop.co.kr/A00001344067.html
4000,2018-10-22,대웅제약해외의사교육나보타마스터클래스개최,http://www.edaily.co.kr/news/newspath.asp?newsid=01889286619375544
4001,2018-10-22,대웅제약해외의사대상보툴리눔톡신제제나보타사용법교육개최,http://news.mk.co.kr/newsRead.php?year=2018&no=656668
4002,2018-10-22,대웅제약나보타관련NMCFALL2018INKOREA개최,http://www.ebn.co.kr/news/view/958990
4003,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://www.newsway.co.kr/news/view?tp=1&ud=2018102209320339173
4004,2018-10-22,대웅제약나보타해외의사교육프로그램실시,http://www.dailypharm.com/News/245030
4005,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://www.sisa-news.com/news/article.html?no=115726
4006,2018-10-22,대웅제약해외현지화전략박차글로벌헬스케어그룹으로거듭난다,http://www.ekn.kr/news/article.html?no=392572
4007,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://www.medigatenews.com/news/2357455031
4008,2018-10-22,백문이불여일체험대웅제약해외의사나보타시술교육,http://www.medicaltimes.com/News/1121837
4009,2018-10-22,대웅제약나보타마스터클래스성료,http://www.dailymedi.com/detail.php?number=835964&thread=22r05
4010,2018-10-22,대웅제약해외6개국의사대상나보타마스터클래스개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1676775
4011,2018-10-22,대웅제약해외의사초청나보타소개,http://www.whosaeng.com/sub_read.html?uid=105336§ion=sc5
4012,2018-10-22,22일대웅제약주가155500원,http://www.anewsa.com/detail.php?number=1399819&thread=10r04
4013,2018-10-22,대웅제약나보타해외의사대상NMCFALL2018INKOREA개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223284
4014,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018102210164714089
4015,2018-10-22,대웅제약나보타해외의사교육프로그램NMCFALL2018INKOREA개최,http://www.g-enews.com/ko-kr/news/article/news_all/201810221034575901f6d02acec0_1/article.html
4016,2018-10-22,대웅제약나보타마스터클래스성료,http://www.enewstoday.co.kr/news/articleView.html?idxno=1241142
4017,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://www.dailian.co.kr/news/view/746523/?sc=naver
4018,2018-10-22,대웅제약나보타해외의사교육프로그램성료,http://www.bosa.co.kr/news/articleView.html?idxno=2092369
4019,2018-10-22,대웅제약나보타해외의사교육프로그램NMCFALL2018INKOREA개최,http://www.getnews.co.kr/news/articleView.html?idxno=101462
4020,2018-10-22,대웅제약1718일나보타마스터클래스성료,http://www.kpinews.co.kr/news/articleView.html?idxno=82914
4021,2018-10-22,대웅제약나보타해외의사대상NMCFALL2018INKOREA개최​,http://www.100ssd.co.kr/news/articleView.html?idxno=56968
4022,2018-10-22,대웅제약나보타해외의사교육프로그램NMCFALL2018INKOREA성황,http://www.insightkorea.co.kr//news/articleView.html?idxno=31758
4023,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://www.monews.co.kr/news/articleView.html?idxno=120481
4024,2018-10-22,대웅제약나보타마스터클래스2018개최,http://www.sedaily.com/NewsView/1S60FIRCKR
4025,2018-10-22,대웅제약해외의사대상나보타마스터클래스진행,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061500
4026,2018-10-22,대웅제약목표가4↓22만원제시삼성證,http://www.newspim.com/news/view/20181022000300
4027,2018-10-22,퀵리포트대웅제약매수유지목표가4↓22만원삼성證,http://www.itooza.com/common/iview.php?no=2018102212445619623
4028,2018-10-22,대웅제약해외의사교육프로그램나보타마스터클래스개최,http://www.k-health.com/news/articleView.html?idxno=40220
4029,2018-10-22,대웅제약나보타해외의사교육프로그램NMCFALL2018INKOREA개최,http://www.ekn.kr/news/article.html?no=392706
4030,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://www.economytalk.kr/news/articleView.html?idxno=171534
4031,2018-10-22,대웅제약NMCFALL2018INKOREA개최나보타시술법등최신지견공유,http://www.segye.com/content/html/2018/10/22/20181022002961.html?OutUrl=naver
4032,2018-10-22,대웅제약해외의사초청해나보타홍보,http://www.finomy.com/news/articleView.html?idxno=59325
4033,2018-10-22,대웅제약나보타마스터클래스개최해외의사60명초청,http://news.donga.com/3/all/20181022/92530519/2
4034,2018-10-22,대웅제약나보타해외의사교육프로그램NMCFALL2018INKOREA개최​,http://www.newscj.com/news/articleView.html?idxno=565107
4035,2018-10-22,대웅제약해외의사교육프로그램나보타마스터클래스개최,https://www.insight.co.kr/news/185793
4036,2018-10-22,대웅제약나보타해외의사교육프로그램열어,http://www.inthenews.co.kr/news/article.html?no=11853
4037,2018-10-22,대웅제약나보타해외의사교육프로그램성료,http://www.wikileaks-kr.org/news/articleView.html?idxno=38878
4038,2018-10-22,대웅제약나보타해외의사교육프로그램개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=336254
4039,2018-10-22,대웅제약외국인직원채용확대글로벌진출탄력,http://news1.kr/articles/?3457088
4040,2018-10-22,대웅제약나보타해외의사교육프로그램성료​,http://www.seoulwire.com/news/articleView.html?idxno=30793
4041,2018-10-23,대웅제약나보타해외의사교육프로그램NMCFALL2018INKOREA개최,http://www.lawissue.co.kr/view.php?ud=201810222316491404d7f4c63cc6_12
4042,2018-10-23,I리포트대웅제약신공장관련비용증가목표가↓삼성證,http://www.inews24.com/php/news_view.php?g_serial=1134842&g_menu=022300&rrf=nv
4043,2018-10-23,23일대웅제약주가152000원,http://www.anewsa.com/detail.php?number=1400915&thread=10r04
4044,2018-10-23,ET투자뉴스대웅제약주가하락이가져온BUY삼성증권,http://www.etnews.com/20181023000189
4045,2018-10-23,대웅제약NMCFALL2018INKOREA열어,http://www.kpanews.co.kr/article/show.asp?idx=198074&table=article&category=D
4046,2018-10-23,환절기건강관리대웅제약임팩타민눈피로풀어주고구내염개선효과도,http://www.sedaily.com/NewsView/1S60X0ERVN
4047,2018-10-23,대웅제약나보타에대한시장의관심증가전망,http://www.newsworks.co.kr/news/articleView.html?idxno=305062
4048,2018-10-23,기업문화혁신나선대웅제약신약개발속도낸다,http://www.dt.co.kr/contents.html?article_no=2018102402101731102001&ref=naver
4049,2018-10-24,대웅CJ케이캡에도전장5000억시장후끈,http://www.dailymedi.com/detail.php?number=836062&thread=22r05
4050,2018-10-24,대웅제약차세대항궤양제3상승인,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061580
4051,2018-10-24,최동락교수대웅의료상간이식임상연구상수상,http://medipana.com/news/news_viewer.asp?NewsNum=227154&MainKind=A&NewsKind=5&vCount=12&vKind=1
4052,2018-10-24,24일대웅제약주가149500원,http://www.anewsa.com/detail.php?number=1402039&thread=10r04
4053,2018-10-24,대구가톨릭대최동락교수대웅의료상이승규간이식임상연구상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=81968
4054,2018-10-24,대구가톨릭대병원최동락교수대웅의료상이승규간이식임상연구상첫수상자로선정,http://www.nspna.com/news/?mode=view&newsid=313627
4055,2018-10-24,간이식대가대가대최동락교수대웅의료상,http://www.idaegu.co.kr/news/articleView.html?idxno=261265
4056,2018-10-25,대가대병원최동락교수대웅의료상李承奎간이식임상연구상,http://www.ksmnews.co.kr/default/index_view_page.php?idx=223835&part_idx=289
4057,2018-10-25,대구가톨릭대병원외과최동락교수대웅의료상李承奎이승규간이식임상연구상수상,http://www.ajunews.com/view/20181025011752729
4058,2018-10-25,대웅제약PCAB계열항궤양제신약임상3상허가,http://www.mdtoday.co.kr/mdtoday/index.html?no=336492
4059,2018-10-25,대구가톨릭대병원최동락교수대웅의료상수상,http://www.newsway.co.kr/news/view?tp=1&ud=2018102509095381129
4060,2018-10-25,25일대웅제약주가146000원,http://www.anewsa.com/detail.php?number=1403186&thread=10r04
4061,2018-10-25,대웅제약ACR서신약파이프라인2종포스터발표,http://medipana.com/news/news_viewer.asp?NewsNum=227240&MainKind=A&NewsKind=5&vCount=12&vKind=1
4062,2018-10-25,대웅제약섬유증자가면역질환치료제연구성과발표,http://www.medicaltimes.com/News/1121979
4063,2018-10-25,대웅제약美류마티스학회서신약후보물질2종연구결과발표,http://www.newspim.com/news/view/20181025000289
4064,2018-10-25,대웅제약자가면역치료제DWP213388BTK저해제보다효과5배,http://www.ceoscoredaily.com/news/article.html?no=47421
4065,2018-10-25,대웅제약美학회서신약파이프라인2종연구성과발표,http://news.mt.co.kr/mtview.php?no=2018102510551829359
4066,2018-10-25,대웅제약美류마티스학회서신약후보물질2개연구발표,http://www.medigatenews.com/news/2957888645
4067,2018-10-25,대웅제약美류마티스학회ACR서섬유증치료제자가면역질환치료제연구성과발표,http://www.ekn.kr/news/article.html?no=393516
4068,2018-10-25,대웅美섬유증자가면역질환신약연구발표,http://www.bosa.co.kr/news/articleView.html?idxno=2092658
4069,2018-10-25,대웅제약미류마티스학회서섬유증치료제자가면역질환치료제연구성과발표,http://www.asiatoday.co.kr/view.php?key=20181025010014514
4070,2018-10-25,대웅美류마티스학회서자가면역질환섬유증치료제발표,http://www.newsis.com/view/?id=NISX20181025_0000453265&cID=13001&pID=13000
4071,2018-10-25,대웅제약美류마티스학회서신약2종전임상결과공개,http://www.mhj21.com/sub_read.html?uid=117007§ion=sc243
4072,2018-10-25,대웅제약섬유증자가면역질환치료제연구성과발표,http://www.upinews.kr/news/newsview.php?ncode=1065579321925423
4073,2018-10-25,대웅ACR서2개신약파이프라인소개,http://www.whosaeng.com/sub_read.html?uid=105470§ion=sc5
4074,2018-10-25,대웅제약현재개발중인신약가능성예고,http://www.dailymedi.com/detail.php?number=836133&thread=22r05
4075,2018-10-25,유나이티드대웅과모사프리드특허분쟁승기잡아,http://www.dailypharm.com/News/245219
4076,2018-10-25,직업이야기5030대해외지사장배출한대웅제약의4가지인재중용방식,http://www.news2day.co.kr/113227
4077,2018-10-25,대웅제약美류마티스학회서신약파이프라인2종연구성과발표,http://www.ftoday.co.kr/news/articleView.html?idxno=103740
4078,2018-10-25,대웅제약미국류마티스학회서섬유증치료제자가면역질환치료제연구성과발표,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018102513281428337
4079,2018-10-25,대구가톨릭최동락교수대웅이승규간이식임상연구상수상,http://www.whosaeng.com/sub_read.html?uid=105474§ion=sc7
4080,2018-10-25,대웅제약美서섬유증자가면역질환치료제연구성과발표,http://www.seoulwire.com/news/articleView.html?idxno=31191
4081,2018-10-25,대웅제약美류마티스학회ACR서섬유증치료제자가면역질환치료제연구성과발표,http://www.g-enews.com/ko-kr/news/article/news_all/20181025135855424f6d02acec0_1/article.html
4082,2018-10-25,대웅제약美류마티스학회서섬유증자가면역질환치료제연구성과발표,http://www.wolyo.co.kr/news/articleView.html?idxno=70242
4083,2018-10-25,대웅제약美류마티스학회서신약2종전임상결과공개,http://www.medisobizanews.com/news/articleView.html?idxno=55948
4084,2018-10-25,대웅제약美류마티스학회서섬유증치료제연구성과발표,http://www.ebn.co.kr/news/view/959531
4085,2018-10-25,대웅제약미국류마티스학회서신약파이프라인2종연구성과발표,http://www.etnews.com/20181025000304
4086,2018-10-25,대웅제약주가147000원으로종료,http://www.anewsa.com/detail.php?number=1403789&thread=10r04
4087,2018-10-25,대웅제약ACR서신약파이프라인연구성과발표,http://www.monews.co.kr/news/articleView.html?idxno=120743
4088,2018-10-25,대웅제약ACR2018서섬유증자가면역질환치료제연구성과발표,http://www.dt.co.kr/contents.html?article_no=2018102502109931102004&ref=naver
4089,2018-10-25,대웅제약자가면역치료제BTK저해제보다효능우수,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810250603&t=NN
4090,2018-10-25,대웅제약美류머티스학회서신약2종연구성과공개,http://kormedi.com/?p=1253100
4091,2018-10-25,대웅제약미국류마티스학회서섬유증치료제연구성과발표,http://news.mk.co.kr/newsRead.php?year=2018&no=667099
4092,2018-10-25,​​대웅제약섬유증치료제자가면역질환치료제연구성과美학회서발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1678978
4093,2018-10-25,대웅제약美류마티스학회서신약파이프라인2종발표,http://www.m-i.kr/news/articleView.html?idxno=463996
4094,2018-10-25,대웅제약美류마티스학회서신약파이프라인2종발표,http://www.100ssd.co.kr/news/articleView.html?idxno=57077
4095,2018-10-25,대웅제약美류마티스학회ACR서신약파이프라인연구성과발표,http://www.economytalk.kr/news/articleView.html?idxno=171798
4096,2018-10-25,대웅제일CJ케이캡에도전장항궤양제신약3파전,http://www.newsway.co.kr/news/view?tp=1&ud=2018102516585793526
4097,2018-10-25,대웅제약미류마티스학회서섬유증치료제등연구발표,http://www.kpanews.co.kr/article/show.asp?idx=198179&table=article&category=D
4098,2018-10-25,대웅제약美류마티스학회서연구성과발표내년해외임상1상진행예정,http://www.segye.com/content/html/2018/10/25/20181025004827.html?OutUrl=naver
4099,2018-10-25,대웅제약美류마티스학회자가면역질환치료제연구성과발표,http://www.getnews.co.kr/news/articleView.html?idxno=102161
4100,2018-10-25,대웅제약미류마티스학회서신약2종포스터발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=336698
4101,2018-10-25,대웅제약美류마티스학회서신약파이프라인2종연구성과발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223445
4102,2018-10-25,대웅제약美류마티스학회서신약연구성과발표,http://www.edaily.co.kr/news/newspath.asp?newsid=04952806619376528
4103,2018-10-25,대웅제약美류마티스학회ACR서섬유증치료제자가면역질환치료제연구성과발표,http://www.lawissue.co.kr/view.php?ud=201810252253433640d7f4c63cc6_12
4104,2018-10-26,대구가톨릭대병원최동락교수대웅의료상李承奎이승규간이식임상연구상수상,http://medicalworldnews.co.kr/news/view.php?idx=1510927942
4105,2018-10-26,유나이티드제약대웅제약에또다시승소가스티인CR꽃길,http://www.mdtoday.co.kr/mdtoday/index.html?no=336724
4106,2018-10-26,대웅제약美류마티스학회서섬유증치료제연구발표,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061689
4107,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.dailian.co.kr/news/view/747676/?sc=naver
4108,2018-10-26,대웅제약건강한삶기술창업벤처PEF상생펀드데모데이개최,http://www.fnnews.com/news/201810260908536617
4109,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.newsway.co.kr/news/view?tp=1&ud=2018102609144456505
4110,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.edaily.co.kr/news/newspath.asp?newsid=02223846619376856
4111,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018102609124525524
4112,2018-10-26,대웅제약헬스케어기술상생펀드데모데이개최,http://www.econovill.com/news/articleView.html?idxno=349161
4113,2018-10-26,대웅제약상생펀드데모데이개최스타트업적극지원,http://www.etoday.co.kr/news/section/newsview.php?idxno=1679220
4114,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.koreaittimes.com/news/articleView.html?idxno=86861
4115,2018-10-26,대웅제약건강한삶․기술상생펀드데모데이개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223457
4116,2018-10-26,대웅제약스타트업지원펀드행사개최사업현황공유,http://www.newspim.com/news/view/20181026000191
4117,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.enewstoday.co.kr/news/articleView.html?idxno=1242533
4118,2018-10-26,대웅제약건강한삶․기술상생펀드데모데이개최,http://www.getnews.co.kr/news/articleView.html?idxno=102251
4119,2018-10-26,대웅제약상생펀드지원스타트업체와정보공유,http://www.dailypharm.com/News/245261
4120,2018-10-26,26일대웅제약주가144500원,http://www.anewsa.com/detail.php?number=1404277&thread=10r04
4121,2018-10-26,대웅제약스타트업대상상생펀드데모데이열어,http://www.rapportian.com/news/articleView.html?idxno=113680
4122,2018-10-26,대웅제약건강한삶․기술상생펀드데모데이개최,http://www.g-enews.com/ko-kr/news/article/news_all/201810261035545740f6d02acec0_1/article.html
4123,2018-10-26,대웅제약헬스케어바이오분야스타트업지원지속,http://www.bokuennews.com/news/article.html?no=166967
4124,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.ftoday.co.kr/news/articleView.html?idxno=103756
4125,2018-10-26,대웅제약건기펀스타트업선정사와현황공유,http://www.whosaeng.com/sub_read.html?uid=105507§ion=sc5
4126,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.wolyo.co.kr/news/articleView.html?idxno=70345
4127,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.bosa.co.kr/news/articleView.html?idxno=2092749
4128,2018-10-26,대웅제약스타트업지원펀드데모데이개최,http://www.kpinews.co.kr/news/articleView.html?idxno=83246
4129,2018-10-26,대웅제약상생펀드지원스타트업과사업현황공유,http://www.100ssd.co.kr/news/articleView.html?idxno=57102
4130,2018-10-26,대웅제약스타트업과상생행보,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1061718
4131,2018-10-26,대웅유나이티드특허분쟁양사모두무효치명타,http://www.dailypharm.com/News/245270
4132,2018-10-26,유대웅장중신저가기록14150→13850▼300,http://www.sedaily.com/NewsView/1S629MY3UQ
4133,2018-10-26,대웅건강한삶기술상생펀드데모데이개최,http://www.dailymedi.com/detail.php?number=836200&thread=22r05
4134,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.viva100.com/main/view.php?key=20181026010009576
4135,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=336802
4136,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.ekn.kr/news/article.html?no=393708
4137,2018-10-26,대웅제약주가140000원마감,http://www.anewsa.com/detail.php?number=1404845&thread=10r04
4138,2018-10-26,비즈피플전승호대웅제약사장바이오분야의연구자스타트업지원지속”외2건,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018102615481155573
4139,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.seoulwire.com/news/articleView.html?idxno=31380
4140,2018-10-26,대웅제약벤처PEF상생펀드데모데이개최,http://www.fnnews.com/news/201810261644111688
4141,2018-10-26,대웅제약스타트업지원건강한삶기술상생펀드데모데이개최,http://www.medisobizanews.com/news/articleView.html?idxno=55973
4142,2018-10-26,대웅제약글로벌인재모시기에집중,http://www.news2day.co.kr/113383
4143,2018-10-26,대웅제약글로벌인재모시기에집중,http://www.news2day.co.kr/113361
4144,2018-10-26,대웅제약건강한삶․기술상생펀드데모데이개최,http://www.economytalk.kr/news/articleView.html?idxno=171910
4145,2018-10-26,대웅제약스타트업상생펀드데모데이개최3개업체참여,http://news.donga.com/3/all/20181026/92605303/2
4146,2018-10-26,대웅제약건강한삶․기술상생펀드데모데이개최,http://medipana.com/news/news_viewer.asp?NewsNum=227350&MainKind=A&NewsKind=5&vCount=12&vKind=1
4147,2018-10-26,대웅제약스타트업지원하는건강한삶기술상생펀드데모데이개최,https://www.insight.co.kr/news/186890
4148,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.newscj.com/news/articleView.html?idxno=566669
4149,2018-10-26,대웅제약건강한삶기술상생펀드데모데이개최,http://www.kpanews.co.kr/article/show.asp?idx=198222&table=article&category=D
4150,2018-10-27,대웅제약건강한삶․기술상생펀드데모데이개최,http://www.lawissue.co.kr/view.php?ud=201810271206005490d7f4c63cc6_12
4151,2018-10-27,대웅제약건강한삶․기술상생펀드데모데이개최,http://www.medicaltimes.com/News/1122003
4152,2018-10-28,대웅동아종근당한미등타깃특허도전증가전망,http://www.dailymedi.com/detail.php?number=836246&thread=22r05
4153,2018-10-29,대웅바이오제일명문돌풍아리셉트제네릭시장요동,http://www.dailypharm.com/News/245315
4154,2018-10-29,대웅과유나이티드모사프리드특허분쟁결국둘다피해,http://www.mdtoday.co.kr/mdtoday/index.html?no=336846
4155,2018-10-29,대웅제약글로벌제약사도약외국인인재확보잰걸음,http://www.asiatoday.co.kr/view.php?key=20181029010016258
4156,2018-10-29,대웅바이오제약협동조합이사장배축구대회우승,http://medipana.com/news/news_viewer.asp?NewsNum=227408&MainKind=A&NewsKind=5&vCount=12&vKind=1
4157,2018-10-29,ET투자뉴스대웅제약_상장주식수대비거래량은041로적정수준,http://www.etnews.com/20181029000066
4158,2018-10-29,29일대웅제약주가143000원,http://www.anewsa.com/detail.php?number=1405800&thread=10r04
4159,2018-10-29,제약협동조합이사장배축구대회대웅바이오우승,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223501
4160,2018-10-29,대웅제약美류마티스학회ACR서섬유증치료제자가면역질환치료제연구성과발표,http://www.wsobi.com/news/articleView.html?idxno=66625
4161,2018-10-29,대웅제약주가138000원으로장마감,http://www.anewsa.com/detail.php?number=1406430&thread=10r04
4162,2018-10-29,대웅제약여범동이사모친상,http://medipana.com/news/news_viewer.asp?NewsNum=227473&MainKind=A&NewsKind=5&vCount=12&vKind=1
4163,2018-10-30,대웅줄기세포치료제독성시험시작내년상반기임상진입,http://www.ceoscoredaily.com/news/article.html?no=47531
4164,2018-10-30,부음여범동대웅제약이사모친,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=3&ID=15978
4165,2018-10-30,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.mhj21.com/sub_read.html?uid=117109§ion=sc243
4166,2018-10-30,대웅제약이종욱고문재미한인제약인協공로상받아,http://medipana.com/news/news_viewer.asp?NewsNum=227521&MainKind=A&NewsKind=5&vCount=12&vKind=1
4167,2018-10-30,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.etoday.co.kr/news/section/newsview.php?idxno=1680733
4168,2018-10-30,대웅제약이종욱고문재미한인제약인협회공로상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223576
4169,2018-10-30,대웅제약재미한인제약인협회KASBP추계심포지엄참여,http://www.wolyo.co.kr/news/articleView.html?idxno=70575
4170,2018-10-30,여범동대웅제약이사모친상,http://www.bosa.co.kr/news/articleView.html?idxno=2092955
4171,2018-10-30,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.newsway.co.kr/news/view?tp=1&ud=2018103010101422241
4172,2018-10-30,대웅재미한인제약인협회추계심포지엄참석,http://www.ebn.co.kr/news/view/959975
4173,2018-10-30,30일대웅제약주가140000원,http://www.anewsa.com/detail.php?number=1407029&thread=10r04
4174,2018-10-30,대웅제약KASBP심포지엄참석해글로벌네트워크강화,http://www.econovill.com/news/articleView.html?idxno=349366
4175,2018-10-30,대웅제약KASBP추계심포지엄참석,http://www.monews.co.kr/news/articleView.html?idxno=120930
4176,2018-10-30,대웅제약재미한인제약인협회심포지엄서글로벌네트워크강화,http://www.medisobizanews.com/news/articleView.html?idxno=56020
4177,2018-10-30,이종욱대웅제약고문재미한인제약인협회서공로상,http://www.rapportian.com/news/articleView.html?idxno=113751
4178,2018-10-30,대웅제약재미한인제약인협회추계심포지엄참석,http://www.dailymedi.com/detail.php?number=836322&thread=22r05
4179,2018-10-30,대웅제약후원KASBP심포지엄메사추세츠서진행,http://www.bosa.co.kr/news/articleView.html?idxno=2092986
4180,2018-10-30,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.getnews.co.kr/view.php?ud=2018103011481735041d0c69529_16
4181,2018-10-30,아리셉트제네릭시장서대웅바이오제일약품명문제약등거센추격,http://www.mdtoday.co.kr/mdtoday/index.html?no=337038
4182,2018-10-30,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.metroseoul.co.kr/news/newsview?newscd=2018103000126
4183,2018-10-30,대웅제약재미한인제약인협회추계심포지엄참석,http://www.100ssd.co.kr/news/articleView.html?idxno=57201
4184,2018-10-30,대웅제약2018KASBP추계심포지엄참석최신글로벌RD동향파악,http://www.enewstoday.co.kr/news/articleView.html?idxno=1243485
4185,2018-10-30,대웅제약이종욱고문KASBP공로상수상,http://kormedi.com/?p=1253516
4186,2018-10-30,여범동대웅제약이사모친상,http://www.rapportian.com/news/articleView.html?idxno=113766
4187,2018-10-30,대웅제약KASBP심포지엄참석RD동향파악,http://www.finomy.com/news/articleView.html?idxno=59615
4188,2018-10-30,대웅제약주가144000원마감,http://www.anewsa.com/detail.php?number=1407653&thread=10r04
4189,2018-10-30,대웅제약재미한인제약인협회추계심포지엄참가,http://www.seoulwire.com/news/articleView.html?idxno=31825
4190,2018-10-30,대웅제약2018KASBP추계심포지엄참석,http://www.mdtoday.co.kr/mdtoday/index.html?no=337194
4191,2018-10-30,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.economytalk.kr/news/articleView.html?idxno=172132
4192,2018-10-30,대웅제약재미한인제약인협회추계심포지엄참석,http://www.vop.co.kr/A00001347194.html
4193,2018-10-30,대웅제약재미한인제약인협회추계심포지엄참석,http://www.ftoday.co.kr/news/articleView.html?idxno=103848
4194,2018-10-30,대웅제약재미한인제약인협회추계심포지엄참석,http://www.newscj.com/news/articleView.html?idxno=567841
4195,2018-10-30,대웅제약재미한인제약인협회추계심포지엄후원,http://news.donga.com/3/all/20181030/92658629/2
4196,2018-10-31,31일대웅제약주가141000원,http://www.anewsa.com/detail.php?number=1408231&thread=10r04
4197,2018-10-31,대웅제약재미한국제약전문가와다양한교류韓제약산업발전에기여,http://www.segye.com/content/html/2018/10/31/20181031001551.html?OutUrl=naver
4198,2018-10-31,대웅전일대비약4하락한13950원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201810310492&t=NN
4199,2018-10-31,대웅제약주가141000원마감해,http://www.anewsa.com/detail.php?number=1408842&thread=10r04
4200,2018-11-01,대웅제약재미한인제약인협회KASBP추계심포지엄참석,http://www.lawissue.co.kr/view.php?ud=201810312320373050d7f4c63cc6_12
4201,2018-11-01,DPP4정체SLGT2급성장대웅판매당뇨약강세,http://www.dailypharm.com/News/245509
4202,2018-11-01,1일대웅제약주가142500원,http://www.anewsa.com/detail.php?number=1409468&thread=10r04
4203,2018-11-01,한경로보뉴스대웅5이상상승주가5일이평선상회단기중기이평선역배열,http://news.hankyung.com/article/201811018661L
4204,2018-11-01,대웅전일대비약5상승한14650원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811010459&t=NN
4205,2018-11-01,대웅제약올해3Q영업익80억전년비447↓,http://www.newspim.com/news/view/20181101000694
4206,2018-11-01,실적속보대웅제약별도20183Q영업이익80억원전년비447감소,http://www.fntimes.com/html/view.php?ud=2018110116525825985dfa830f48_18
4207,2018-11-01,컨센미달대웅제약올해3Q영업익80억컨센비145↓,http://www.itooza.com/common/iview.php?no=2018110116534818350
4208,2018-11-01,대웅제약3분기영업익30억원전년比447↓,http://www.etoday.co.kr/news/section/newsview.php?idxno=1682343
4209,2018-11-01,대웅제약3분기영업이익80억원45감소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181101158500008&did=1195m
4210,2018-11-01,대웅제약3분기영업이익80억원45감소,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181101158500008&did=1195m
4211,2018-11-01,대웅제약3분기영업익80억전년비447↓,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110117031667891
4212,2018-11-01,대웅제약3분기누계매출액6861억원,http://www.dailypharm.com/News/245576
4213,2018-11-01,대웅제약3Q영업익80억전년比45↓,http://news.mt.co.kr/mtview.php?no=2018110117105691728
4214,2018-11-01,대웅제약3Q영업이익80억전년比45↓,http://www.sedaily.com/NewsView/1S70RK3GXT
4215,2018-11-01,대웅제약3Q누계매출6860억원‥수익부문하락,http://medipana.com/news/news_viewer.asp?NewsNum=227718&MainKind=A&NewsKind=5&vCount=12&vKind=1
4216,2018-11-01,대웅제약3분기영업익80억전년比447감소,http://biz.newdaily.co.kr/site/data/html/2018/11/01/2018110100258.html
4217,2018-11-01,대웅제약3분기영업이익80억원전년동기대비447↓,http://news.mk.co.kr/newsRead.php?year=2018&no=684756
4218,2018-11-01,대웅제약3분기영업익80억원전년대비44감소,http://www.ceoscoredaily.com/news/article.html?no=47753
4219,2018-11-01,대웅제약3분기영업익80억원전년비447↓,http://www.dailian.co.kr/news/view/749096/?sc=naver
4220,2018-11-01,대웅제약3분기영업이익80억전년동기比447↓,http://www.nspna.com/news/?mode=view&newsid=315647
4221,2018-11-01,대웅제약3분기영업익80억원전년比447↓,http://www.newsis.com/view/?id=NISX20181101_0000461117&cID=10401&pID=10400
4222,2018-11-01,실적발표대웅제약하나투어대림씨엔에스,http://www.businesspost.co.kr/BP?command=article_view&num=100993
4223,2018-11-01,대웅제약올3분기영업이익80억원45↓,http://view.asiae.co.kr/news/view.htm?idxno=2018110119182949051
4224,2018-11-01,대웅제약3분기매출2320억영업익전년비44감소,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223726
4225,2018-11-02,수익성악화했지만대웅창립첫매출9천억유력,http://www.dailypharm.com/News/245578
4226,2018-11-02,클릭e종목대웅제약시장기대치30하회목표주가↓,http://view.asiae.co.kr/news/view.htm?idxno=2018110207182909599
4227,2018-11-02,대웅제약실적우려선반영매수NH투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1682470
4228,2018-11-02,퀵리포트대웅제약TradingBUY유지목표가8↓15만5000원신한금투,http://www.itooza.com/common/iview.php?no=2018110207565819297
4229,2018-11-02,대웅제약나보타미국진출까지기다려야목표가↓신한,http://news.hankyung.com/article/2018110222906
4230,2018-11-02,대웅제약목표가4↓24만원제시KTB證,http://www.newspim.com/news/view/20181102000128
4231,2018-11-02,대웅제약목표가12↓22만원제시유안타證,http://www.newspim.com/news/view/20181102000162
4232,2018-11-02,대웅제약목표가8↓15만5000원제시신한금투,http://www.newspim.com/news/view/20181102000084
4233,2018-11-02,아주종목분석대웅제약고정비증가로수익성감소,http://www.ajunews.com/view/20181102080831407
4234,2018-11-02,대웅제약3분기실적예상치하회목표가↓KTB,http://www.edaily.co.kr/news/newspath.asp?newsid=01702326619401784
4235,2018-11-02,대웅제약3분기실적추정치밑돌아목표가하향신한금투,http://www.dailian.co.kr/news/view/749132/?sc=naver
4236,2018-11-02,I리포트대웅제약나보타미국진출기다려야목표가↓신금투,http://www.inews24.com/php/news_view.php?g_serial=1137422&g_menu=022300&rrf=nv
4237,2018-11-02,퀵리포트대웅제약매수유지목표가4↓24만원KTB證,http://www.itooza.com/common/iview.php?no=2018110207342889583
4238,2018-11-02,STOCK대웅제약바이오업종투자심리하락영향목표가↓,http://moneys.mt.co.kr/news/mwView.php?no=2018110208568067937
4239,2018-11-02,대웅제약바이오업종투심악화목표가↓유안타증권,http://www.fntimes.com/html/view.php?ud=2018110208474555981d6f57e61a_18
4240,2018-11-02,대웅제약3분기실적부진목표가↓신한금융투자,http://www.etoday.co.kr/news/section/newsview.php?idxno=1682503
4241,2018-11-02,대웅제약3분기영업이익80억원기록,http://www.nspna.com/news/?mode=view&newsid=315722
4242,2018-11-02,퀵리포트대웅제약매수유지목표가12↓22만원유안타證,http://www.itooza.com/common/iview.php?no=2018110207430112161
4243,2018-11-02,퀵리포트대웅제약매수유지목표가27만원유지NH證,http://www.itooza.com/common/iview.php?no=2018110207534911527
4244,2018-11-02,대웅제약목표가18만원유지전일종가14만4000원DB금투,http://www.newspim.com/news/view/20181102000169
4245,2018-11-02,퀵리포트대웅제약매수로상향목표가18만원DB금투,http://www.itooza.com/common/iview.php?no=2018110209162416908
4246,2018-11-02,대웅제약목표주가하향보톡스미국진출기대는여전히유효,http://www.businesspost.co.kr/BP?command=article_view&num=101033
4247,2018-11-02,대웅제약3Q영업이익80억3800만원전년동기대비447↓,http://www.mdtoday.co.kr/mdtoday/index.html?no=337567
4248,2018-11-02,대웅제약은우수인재발굴약대생은실무경험,http://medipana.com/news/news_viewer.asp?NewsNum=227741&MainKind=A&NewsKind=5&vCount=12&vKind=1
4249,2018-11-02,한경로보뉴스대웅제약5이상상승20182Q매출액2616억67영업이익86억227,http://news.hankyung.com/article/201811022892L
4250,2018-11-02,특징주대웅제약3분기실적시장기대치하회,http://www.sisaon.co.kr/news/articleView.html?idxno=78881
4251,2018-11-02,ET투자뉴스대웅제약나보타에다시관심BUY삼성증권,http://www.etnews.com/20181102000054
4252,2018-11-02,대웅제약약학대학생실습프로그램PharmDW참가자모집,http://news.heraldcorp.com/view.php?ud=20181102000165
4253,2018-11-02,​대웅제약약학대학생대상PharmDW참가자모집,http://www.g-enews.com/ko-kr/news/article/news_all/201811020946358501f6d02acec0_1/article.html
4254,2018-11-02,대웅제약약대생심화실습프로그램PharmDW의참가자를모집합니다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110209484827038
4255,2018-11-02,대웅제약약학대학생대상심화실습프로그램참가자모집,http://www.newsway.co.kr/news/view?tp=1&ud=2018110209474791582
4256,2018-11-02,대웅제약약대생대상PharmDW참가자모집,http://www.ebn.co.kr/news/view/960497
4257,2018-11-02,ET투자뉴스대웅제약4분기는개선기대TRADINGBUY유지신한금융투,http://www.etnews.com/20181102000067
4258,2018-11-02,ET투자뉴스대웅제약나보타PDUFABUYM유안타증권,http://www.etnews.com/20181102000074
4259,2018-11-02,2일대웅제약주가151000원,http://www.anewsa.com/detail.php?number=1410642&thread=10r04
4260,2018-11-02,대웅제약약학대학생대상팜DW참가자모집,http://www.newsprime.co.kr/news/article.html?no=434866
4261,2018-11-02,대웅제약약학대학생심화실습프로그램참가자모집,http://news.donga.com/3/all/20181102/92699130/2
4262,2018-11-02,대웅제약약대생대상PharmDW참가자모집,http://www.bosa.co.kr/news/articleView.html?idxno=2093256
4263,2018-11-02,약학대학생진로고민대웅제약실무체험코스활짝,http://www.medicaltimes.com/News/1122163
4264,2018-11-02,대웅제약약학대생인턴십팜DW참가자모집,http://www.kpinews.co.kr/news/articleView.html?idxno=83646
4265,2018-11-02,대웅제약약대생심화실습프로그램팜DW참가자모집,http://www.etoday.co.kr/news/section/newsview.php?idxno=1682603
4266,2018-11-02,ET투자뉴스대웅제약보툴리눔톡신기업BUYKTB투자증권,http://www.etnews.com/20181102000126
4267,2018-11-02,대웅제약약학대학생심화실습프로그램팜DW참가자모집,http://www.wikileaks-kr.org/news/articleView.html?idxno=39827
4268,2018-11-02,ET투자뉴스대웅제약실적우려는선반영BUY유지NH투자증권,http://www.etnews.com/20181102000136
4269,2018-11-02,대웅제약약대생심화실습프로그램PharmDW참가자모집,http://www.medisobizanews.com/news/articleView.html?idxno=56098
4270,2018-11-02,대웅제약약학대학생대상심화실습프로그램참가자모집,http://www.ftoday.co.kr/news/articleView.html?idxno=103934
4271,2018-11-02,ET투자뉴스대웅제약19년2월의나보BUY상향DB금융투자,http://www.etnews.com/20181102000152
4272,2018-11-02,​대웅제약약학대학생대상PharmDW참가자모집,http://www.100ssd.co.kr/news/articleView.html?idxno=57233
4273,2018-11-02,대웅제약실습프로그램참가할약학대학생모집,http://www.ajunews.com/view/20181102114452652
4274,2018-11-02,대웅제약전일대비약6상승한153000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811020396&t=NN
4275,2018-11-02,골드만삭스대웅제약나보타美유럽성장살펴야,http://www.choicenews.co.kr/news/articleView.html?idxno=45693
4276,2018-11-02,대웅제약국제품질경진대회금상,http://www.medical-tribune.co.kr/news/articleView.html?idxno=82193
4277,2018-11-02,대웅제약국제품질경진대회금상수상업계최초,http://www.seoulwire.com/news/articleView.html?idxno=32366
4278,2018-11-02,대웅약대생심화실습팜DW참가자모집,http://www.dailymedi.com/detail.php?number=836476&thread=22r05
4279,2018-11-02,대웅제약나보타출시에따라발생할실적기대삼성증권,http://www.economytalk.kr/news/articleView.html?idxno=172329
4280,2018-11-02,대웅제약품질분임조제약업계최초로국제품질경진대회에서금상수상,http://www.g-enews.com/ko-kr/news/article/news_all/201811021324404341f6d02acec0_1/article.html
4281,2018-11-02,한경로보뉴스대웅5이상상승20182Q매출액3084억78영업이익252억32,http://news.hankyung.com/article/201811024455L
4282,2018-11-02,대웅제약품질분임조제약업계최초국제품질경진대회금상,http://www.newspim.com/news/view/20181102000390
4283,2018-11-02,대웅제약약학대학생대상심화실습프로그램PharmDW참가자모집,http://www.getnews.co.kr/view.php?ud=20181102115116593041d0c69529_16
4284,2018-11-02,대웅제약품질분임조2018국제품질경진대회금상제약계최초,http://www.medisobizanews.com/news/articleView.html?idxno=56104
4285,2018-11-02,대웅제약품질분임조제약업계최초국제품질경진대회서금상쾌거,http://www.economytalk.kr/news/articleView.html?idxno=172348
4286,2018-11-02,대웅제약PharmDW약학대학생심화실습참가자모집,http://www.inthenews.co.kr/news/article.html?no=11970
4287,2018-11-02,대웅제약품질분임조제약업계최초2018국제품질경진대회금상,http://www.fnnews.com/news/201811021439043259
4288,2018-11-02,3분기매출성장은한미대웅종근당영업이익은부광약품눈길,http://www.sisajournal-e.com/biz/article/191001
4289,2018-11-02,대웅제약제약업계최초국제품질경진대회금상수상,http://medipana.com/news/news_viewer.asp?NewsNum=227772&MainKind=A&NewsKind=5&vCount=12&vKind=1
4290,2018-11-02,대웅제약품질분임조업계최초국제품질경진대회금상,http://www.mhj21.com/sub_read.html?uid=117236§ion=sc243
4291,2018-11-02,대웅제약국제품질경진대회금상수상국내제약업체첫수상,http://news.donga.com/3/all/20181102/92703199/2
4292,2018-11-02,대웅제약업계최초국제품질경진대회금상수상,http://www.newstomato.com/ReadNews.aspx?no=855621
4293,2018-11-02,대웅제약품질분임조업계최초2018국제품질경진대회금상수상,http://moneys.mt.co.kr/news/mwView.php?no=2018110216058073238
4294,2018-11-02,대웅제약약학대학생인턴십팜DW참가자모집,http://news.mk.co.kr/newsRead.php?year=2018&no=687290
4295,2018-11-02,대웅제약국내제약업계최초국제품질경진대회금상,http://www.viva100.com/main/view.php?key=20181102010000819
4296,2018-11-02,대웅제약품질분임조제약업계최초국제품질경진대회금상쾌거,http://www.mdtoday.co.kr/mdtoday/index.html?no=337626
4297,2018-11-02,대웅제약약대생대상심화실습프로그램참가자모집,http://www.bokuennews.com/news/article.html?no=167335
4298,2018-11-02,​대웅제약약대생대상프로그램PharmDW참가자모집,http://www.k-health.com/news/articleView.html?idxno=40541
4299,2018-11-02,대웅제약품질분임조2018국제품질경진대회금상수상쾌거,http://www.wikileaks-kr.org/news/articleView.html?idxno=39869
4300,2018-11-02,대웅제약품질분임조국제품질경진대회서금상수상,http://news.mk.co.kr/newsRead.php?year=2018&no=687583
4301,2018-11-02,대웅제약품질분임조제약업계최초2018국제품질경진대회서금상수상쾌거,http://www.segye.com/content/html/2018/11/02/20181102003549.html?OutUrl=naver
4302,2018-11-02,뉴스투데이L대웅제약성장맞춤형인턴십팜DW참가자모집,http://www.news2day.co.kr/113916
4303,2018-11-02,대웅제약2018국제품질경진대회서금상수상제약업계최초,http://www.vop.co.kr/A00001348761.html
4304,2018-11-02,대웅제약3분기영업이익80억원전년동기대비447감소,http://www.econonews.co.kr/news/articleView.html?idxno=41032
4305,2018-11-02,대웅제약국제품질경진대회ICQCC2018첫금상쾌거,http://www.bokuennews.com/news/article.html?no=167350
4306,2018-11-02,대웅제약품질분임조국제품질경진대회금상수상,http://www.dt.co.kr/contents.html?article_no=2018110202109931102006&ref=naver
4307,2018-11-02,대웅제약제약업계최초로2018국제품질경진대회ICQCC2018금상수상,http://www.businesskorea.co.kr/news/articleView.html?idxno=26259
4308,2018-11-02,대웅제약품질분임조제약업계최초2018국제품질경진대회서금상쾌거,http://www.newscj.com/news/articleView.html?idxno=569037
4309,2018-11-02,대웅제약품질분임조싱가포르국제품질경진대회서금상영예,http://www.g-enews.com/ko-kr/news/article/news_all/201811022151353379fd4d2b07dc_1/article.html
4310,2018-11-03,대웅제약품질분임조제약업계최초로2018국제품질경진대회ICQCC2018에서금상쾌거,http://www.lawissue.co.kr/view.php?ud=201811030035567827d7f4c63cc6_12
4311,2018-11-03,대웅제약종근당3분기매출↑영업이익↓,http://www.dailymedi.com/detail.php?number=836493&thread=22r05
4312,2018-11-03,대웅제약품질분임조제약업계최초로2018국제품질경진대회서금상쾌거,http://www.ekn.kr/news/article.html?no=395364
4313,2018-11-04,내일사볼까대웅제약내년초나보타허가기대감↑,http://news.heraldcorp.com/view.php?ud=20181102000539
4314,2018-11-04,대웅제약품질분임조제약사최초국제품질경진대회금상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223784
4315,2018-11-04,대웅제약제약업계최초2018국제품질경진대회금상수상,http://www.babytimes.co.kr/news/articleView.html?idxno=22867
4316,2018-11-05,대웅제약목표가25만원유지KTB證,http://www.newspim.com/news/view/20181105000251
4317,2018-11-05,퀵리포트대웅제약매수유지목표가25만원유지KTB證,http://www.itooza.com/common/iview.php?no=2018110509382013369
4318,2018-11-05,대웅제약품질분임조ICQCC2018금상수상,http://www.monews.co.kr/news/articleView.html?idxno=121245
4319,2018-11-05,대웅70억규모SAPERP재구축통합프로세스구현,http://www.dailypharm.com/News/245686
4320,2018-11-05,대웅그룹글로벌제약사도약SAPERP고도화S4프로젝트돌입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=223810
4321,2018-11-05,대웅그룹글로벌표준프로세스도입글로벌제약사도약할것,http://www.segye.com/content/html/2018/11/05/20181105000904.html?OutUrl=naver
4322,2018-11-05,대웅제약내년9월까지최신SAPERP도입해그룹업무통합키로,http://news.mk.co.kr/newsRead.php?year=2018&no=691023
4323,2018-11-05,대웅글로벌도약위한S4프로젝트돌입,http://www.doctorsnews.co.kr/news/articleView.html?idxno=126163
4324,2018-11-05,대웅그룹S4프로젝트글로벌제약사드라이브,http://www.mhj21.com/sub_read.html?uid=117265§ion=sc243
4325,2018-11-05,글로벌제약사도약대웅제약SAPERP고도화작업착수,http://www.medisobizanews.com/news/articleView.html?idxno=56129
4326,2018-11-05,대웅제약경영인프라S4프로젝트구축,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811050293&t=NN
4327,2018-11-05,대웅글로벌제약사도약위한S4프로젝트돌입,http://www.wolyo.co.kr/news/articleView.html?idxno=70957
4328,2018-11-05,대웅그룹SAPERP고도화S4프로젝트돌입,http://www.bosa.co.kr/news/articleView.html?idxno=2093372
4329,2018-11-05,대웅글로벌제약사도약위한S4프로젝트돌입,http://www.newsway.co.kr/news/view?tp=1&ud=2018110511192481232
4330,2018-11-05,​대웅그룹내년9월까지그룹업무통합SAPERP고도화S4프로젝트돌입,http://www.businesskorea.co.kr/news/articleView.html?idxno=26275
4331,2018-11-05,대웅그룹글로벌제약사도약위해S4프로젝트돌입,http://medipana.com/news/news_viewer.asp?NewsNum=227874&MainKind=A&NewsKind=5&vCount=12&vKind=1
4332,2018-11-05,대웅그룹글로벌제약사로도약S4프로젝트돌입,http://www.medicaltimes.com/News/1122207
4333,2018-11-05,대웅제약70억원규모최신IT환경구축,http://kormedi.com/?p=1254133
4334,2018-11-05,대웅제약계열사통합관리S4프로젝트내년9월도입,http://www.g-enews.com/ko-kr/news/article/news_all/20181105130331751325b4ac5ede_1/article.html
4335,2018-11-05,대웅제약70억들여ERP재구축그룹통합관리,http://view.asiae.co.kr/news/view.htm?idxno=2018110513175489737
4336,2018-11-05,대웅그룹70억투자해그룹통합관리체계구축,http://www.newspim.com/news/view/20181105000459
4337,2018-11-05,대웅SAPERP고도화프로젝트도입글로벌제약사도약,http://www.monews.co.kr/news/articleView.html?idxno=121351
4338,2018-11-05,대웅제약내년9월까지독일SAP사ERP도입그룹업무통합,http://www.etnews.com/20181105000303
4339,2018-11-05,대웅그룹글로벌제약사도약위한S4프로젝트돌입,http://www.economytalk.kr/news/articleView.html?idxno=172447
4340,2018-11-05,대웅그룹SAPERP고도화S4프로젝트돌입,http://www.seoulwire.com/news/articleView.html?idxno=32679
4341,2018-11-05,5일대웅제약주가160500원,http://www.anewsa.com/detail.php?number=1412394&thread=10r04
4342,2018-11-05,대웅제약SAPERP고도화S4프로젝트돌입,http://www.100ssd.co.kr/news/articleView.html?idxno=57330
4343,2018-11-05,대웅그룹SAPERP고도화S4프로젝트돌입,http://www.ebn.co.kr/news/view/960714
4344,2018-11-05,대웅그룹SAPERP고도화S4프로젝트돌입,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110514332514016
4345,2018-11-05,대웅제약주가159500원으로마감,http://www.anewsa.com/detail.php?number=1412514&thread=10r04
4346,2018-11-05,대웅SAPERP고도화S4프로젝트돌입,http://www.newscj.com/news/articleView.html?idxno=569591
4347,2018-11-05,대웅SAPERP고도화S4프로젝트돌입,http://www.bokuennews.com/news/article.html?no=167439
4348,2018-11-05,대웅글로벌제약사도약위한S4프로젝트실시,http://www.dailymedi.com/detail.php?number=836552&thread=22r05
4349,2018-11-05,대웅그룹글로벌제약사도약S4프로젝트돌입,http://www.getnews.co.kr/view.php?ud=20181105164305878841d0c69529_16
4350,2018-11-05,대웅제약글로벌제약사도약위한S4프로젝트실시,https://www.insight.co.kr/news/189084
4351,2018-11-05,대웅제약글로벌수준경영인프라구축S4프로젝트돌입,http://www.dailian.co.kr/news/view/749715/?sc=naver
4352,2018-11-05,대웅제약최신자원관리시스템도입해그룹업무통합,http://www.econovill.com/news/articleView.html?idxno=349835
4353,2018-11-05,대웅제약최예다운씨가회사아닌리틀베어에출근한이유는,http://www.m-i.kr/news/articleView.html?idxno=467117
4354,2018-11-05,대웅그룹SAPERP고도화S4프로젝트돌입,http://www.kpanews.co.kr/article/show.asp?idx=198516&table=article&category=D
4355,2018-11-05,대웅제약제약업계첫ICQCC2018금상영예,http://www.kpanews.co.kr/article/show.asp?idx=198526&table=article&category=D
4356,2018-11-05,대웅제약품질분임조제약업계최초국제품질경진대회서금상쾌거,https://www.insight.co.kr/news/188997
4357,2018-11-05,대웅그룹SAPERP고도화S4프로젝트돌입,http://www.mdtoday.co.kr/mdtoday/index.html?no=337815
4358,2018-11-05,대웅그룹글로벌제약사위해SAPERP고도화S4프로젝트돌입,http://www.lawissue.co.kr/view.php?ud=201811052136341927d7f4c63cc6_12
4359,2018-11-06,대웅제약목표가11↓24만원제시NH證,http://www.newspim.com/news/view/20181106000172
4360,2018-11-06,퀵리포트대웅제약매수유지목표가11↓24만원NH證,http://www.itooza.com/common/iview.php?no=2018110609174520184
4361,2018-11-06,보톡스라이벌대웅제약메디톡스美中시장서진검승부,http://www.ekn.kr/news/article.html?no=395689
4362,2018-11-06,한경로보뉴스대웅제약5이상상승최근3일간기관대량순매수,http://news.hankyung.com/article/201811064298L
4363,2018-11-06,fnRASSI대웅제약069620현재1003↑,http://www.fnnews.com/news/201811060958292353
4364,2018-11-06,대웅제약전일대비약8상승한172000원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811060168&t=NN
4365,2018-11-06,한경로보뉴스대웅5이상상승주가20일이평선상회단기중기이평선역배열,http://news.hankyung.com/article/201811064578L
4366,2018-11-06,대웅제약목표가6↑23만원제시하이투자證,http://www.newspim.com/news/view/20181106000246
4367,2018-11-06,퀵리포트대웅제약매수유지목표가6↑23만원하이투자證,http://www.itooza.com/common/iview.php?no=2018110610055111544
4368,2018-11-06,6일대웅제약주가169500원,http://www.anewsa.com/detail.php?number=1413031&thread=10r04
4369,2018-11-06,대웅제약6일오전급등세신약기대감때문,http://www.choicenews.co.kr/news/articleView.html?idxno=45755
4370,2018-11-06,ET투자뉴스대웅제약내년2월2일나BUY유지NH투자증권,http://www.etnews.com/20181106000178
4371,2018-11-06,유대웅전일대비749상승일일회전율은017기록,http://www.sedaily.com/NewsView/1S731FQSFJ
4372,2018-11-06,한미대웅신라젠등RD과제핵심임상발표초읽기,http://www.dailypharm.com/News/245778
4373,2018-11-06,ET투자뉴스대웅제약실적과RD모멘BUYINITIATE하이투자증권,http://www.etnews.com/20181106000232
4374,2018-11-06,더벨대웅제약석천나눔재단첫부동산투자,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201811050100005420000321
4375,2018-11-06,대웅그룹글로벌제약사로도약하기위해SAPERP고도화S4프로젝트돌입,http://www.wsobi.com/news/articleView.html?idxno=66944
4376,2018-11-06,대웅제약주가170000원장마쳐,http://www.anewsa.com/detail.php?number=1413572&thread=10r04
4377,2018-11-06,내외TV마감증시11월6일대웅16450원으로장마감,http://www.nbntv.co.kr/news/articleView.html?idxno=126730
4378,2018-11-06,단독대웅제약당뇨병치료제리피메트서방정긴급회수조치,http://www.inthenews.co.kr/news/article.html?no=12004
4379,2018-11-07,제약조합이사장배축구대회대웅바이오제약우승영예,http://news.kbiz.or.kr/news/articleView.html?idxno=48234
4380,2018-11-07,7일대웅제약주가176000원,http://www.anewsa.com/detail.php?number=1414084&thread=10r04
4381,2018-11-07,한경로보뉴스대웅제약5이상상승20182Q매출액2616억67영업이익86억227,http://news.hankyung.com/article/201811079508L
4382,2018-11-07,대웅글로벌인재육성프로젝트로NO1빅파마도전,http://www.dailypharm.com/News/245845
4383,2018-11-07,ET투자뉴스대웅제약_거래비중기관2614외국인2885,http://www.etnews.com/20181107000159
4384,2018-11-07,대웅제약주가166500원으로장마감,http://www.anewsa.com/detail.php?number=1414708&thread=10r04
4385,2018-11-07,남북전염병정보교환대웅체계구축등보건의료협력합의,http://www.mdtoday.co.kr/mdtoday/index.html?no=338071
4386,2018-11-08,대웅제약목표가25만원유지전일종가16만6500원골든브릿지證,http://www.newspim.com/news/view/20181108000207
4387,2018-11-08,퀵리포트대웅제약매수유지목표가25만원유지골든브릿지證,http://www.itooza.com/common/iview.php?no=2018110807310851290
4388,2018-11-08,8일대웅제약주가173500원,http://www.anewsa.com/detail.php?number=1415249&thread=10r04
4389,2018-11-08,한경로보뉴스대웅제약5이상상승최근3일간기관대량순매수,http://news.hankyung.com/article/201811084014L
4390,2018-11-08,대웅전일대비약4상승한16650원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811080445&t=NN
4391,2018-11-08,대웅제약주가173500원으로마감,http://www.anewsa.com/detail.php?number=1415842&thread=10r04
4392,2018-11-09,연구조직파격개편5개월대웅RD성과잰걸음,http://www.dailypharm.com/News/245866
4393,2018-11-09,대웅제약식약처나보타주50단위눈가주름개선적응증획득,http://www.fnnews.com/news/201811090859299639
4394,2018-11-09,대웅제약보톡스나보타눈가주름개선적응증추가획득,http://www.g-enews.com/ko-kr/news/article/news_all/20181109090132791025b4ac5ede_1/article.html
4395,2018-11-09,대웅제약나보타국내보톡스최초눈가주름적응증획득,http://www.ceoscoredaily.com/news/article.html?no=48048
4396,2018-11-09,대웅제약나보타​눈가주름적응증추가획득,http://www.biospectator.com/view/news_view.php?varAtcId=6545
4397,2018-11-09,대웅제약나보타눈가주름적응증획득,http://www.ebn.co.kr/news/view/961269
4398,2018-11-09,대웅제약나보타국산보툴리눔톡신최초로눈가주름개선적응증획득,http://news.mk.co.kr/newsRead.php?year=2018&no=702627
4399,2018-11-09,대웅제약톡신나보타눈가주름개선적응증획득,http://www.dailypharm.com/News/245944
4400,2018-11-09,대웅제약나보타눈가주름적응증획득,http://www.viva100.com/main/view.php?key=20181109010003323
4401,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://moneys.mt.co.kr/news/mwView.php?no=2018110909148040851
4402,2018-11-09,대웅제약나보타국내보툴리눔톡신최초로눈가주름적응증획득,http://www.newsway.co.kr/news/view?tp=1&ud=2018110909255740646
4403,2018-11-09,대웅나보타눈가주름적응증획득,http://www.medical-tribune.co.kr/news/articleView.html?idxno=82366
4404,2018-11-09,대웅제약나보타눈가주름적응증획득총3개적응증확보,http://www.medigatenews.com/news/3871428255
4405,2018-11-09,대웅제약나보타눈가주름적응증획득국내보톡스로는처음,http://biz.newdaily.co.kr/site/data/html/2018/11/09/2018110900016.html
4406,2018-11-09,대웅제약나보타눈가주름적응증추가획득,http://www.dailian.co.kr/news/view/750579/?sc=naver
4407,2018-11-09,대웅제약나보타눈가주름적응증획득보톨리눔톡신최초,http://www.upinews.kr/news/newsview.php?ncode=1065573986689073
4408,2018-11-09,대웅제약나보타눈가주름개선적응증추가획득,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811090117&t=NN
4409,2018-11-09,대웅제약나보타눈가주름적응증획득국내보툴리눔톡신최초,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018110909035434658
4410,2018-11-09,대웅제약나보타눈가주름적응증획득해,http://www.wolyo.co.kr/news/articleView.html?idxno=71346
4411,2018-11-09,대웅제약보툴리눔톡신나보타눈가주름개선허가획득,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181109046600017&did=1195m
4412,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://news.mk.co.kr/newsRead.php?year=2018&no=702891
4413,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://www.polinews.co.kr/news/article.html?no=371869
4414,2018-11-09,대웅제약나보타눈가주름적응증획득,http://www.monews.co.kr/news/articleView.html?idxno=121637
4415,2018-11-09,9일대웅제약주가171000원,http://www.anewsa.com/detail.php?number=1416359&thread=10r04
4416,2018-11-09,대웅제약나보타눈가주름개선용도승인,http://www.newsis.com/view/?id=NISX20181109_0000468399&cID=13001&pID=13000
4417,2018-11-09,대웅제약나보타눈가주름개선용도로식약처추가승인,http://view.asiae.co.kr/news/view.htm?idxno=2018110908232151819
4418,2018-11-09,대웅제약보툴리눔톡신나보타눈가주름개선허가획득,http://www.asiatoday.co.kr/view.php?key=20181109010005355
4419,2018-11-09,대웅제약나보타눈가주름개선사용허가획득,http://biz.chosun.com/site/data/html_dir/2018/11/09/2018110901055.html
4420,2018-11-09,대웅제약나보타국내보툴리눔톡신최초로눈가주름적응증획득,http://www.ekn.kr/news/article.html?no=396670
4421,2018-11-09,대웅제약나보타눈가주름적응증획득,http://www.bosa.co.kr/news/articleView.html?idxno=2093735
4422,2018-11-09,대웅제약나보타눈가주름적응증획득,http://www.newsprime.co.kr/news/article.html?no=435690
4423,2018-11-09,대웅제약나보타국내보톡스최초눈가주름적응증획득,http://www.edaily.co.kr/news/newspath.asp?newsid=02915926619404080
4424,2018-11-09,대웅제약나보타국내최초눈가주름개선사용허가획득,http://www.insightkorea.co.kr//news/articleView.html?idxno=32142
4425,2018-11-09,대웅제약나보타눈가주름적응증획득국내보톡스최초,http://www.sporbiz.co.kr/news/articleView.html?idxno=286817
4426,2018-11-09,대웅제약나보타눈가주름개선적응증획득국산보툴리눔최초,http://www.medisobizanews.com/news/articleView.html?idxno=56223
4427,2018-11-09,대웅제약나보타보툴리눔톡신최초눈가주름적응증획득,http://www.k-health.com/news/articleView.html?idxno=40661
4428,2018-11-09,대웅제약국산톡신최초눈가주름적응증획득,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062245
4429,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://www.inthenews.co.kr/news/article.html?no=12039
4430,2018-11-09,대웅제약나보타눈가주름개선적응증추가획득,http://www.rapportian.com/news/articleView.html?idxno=113986
4431,2018-11-09,대웅제약나보타韓보툴리눔톡신최초로눈가주름적응증획득,http://www.segye.com/content/html/2018/11/09/20181109001725.html?OutUrl=naver
4432,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://www.getnews.co.kr/view.php?ud=20181109122048147841d0c69529_16
4433,2018-11-09,주식그래프대웅제약주가9일현재168000원,http://www.nbntv.co.kr/news/articleView.html?idxno=127758
4434,2018-11-09,대웅제약보톨리눔톡신나보타국내최초눈가주름적응증획득,http://www.sedaily.com/NewsView/1S74E61MUN
4435,2018-11-09,대웅제약나보타눈가주름적응증획득보톡스대비비열등성입증,http://www.wikileaks-kr.org/news/articleView.html?idxno=40367
4436,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://www.newspim.com/news/view/20181109000445
4437,2018-11-09,대웅제약보툴리눔톡신나보타눈가주름적응증추가,http://news1.kr/articles/?3473005
4438,2018-11-09,대웅제약나보타국내보툴리눔톡신첫눈가주름적응증획득,http://www.enewstoday.co.kr/news/articleView.html?idxno=1246208
4439,2018-11-09,대웅제약보툴리눔톡신나보타국내최초눈가주름적응증획득,http://news.hankyung.com/article/201811099390f
4440,2018-11-09,대웅제약보툴리눔톡신나보타눈가주름개선허가획득”,http://www.dt.co.kr/contents.html?article_no=2018110902109931102002&ref=naver
4441,2018-11-09,대웅제약주가171500원으로마감,http://www.anewsa.com/detail.php?number=1416783&thread=10r04
4442,2018-11-09,대웅제약보툴리눔톡신나보타눈가주름적응증획득,http://www.seoulfn.com/news/articleView.html?idxno=324530
4443,2018-11-09,대웅제약나보타눈가주름적응증획득보톡스넘어선효능입증”,http://news.donga.com/3/all/20181109/92806588/2
4444,2018-11-09,대웅제약나보타국내보툴리눔톡신최초로눈가주름적응증획득,http://www.economytalk.kr/news/articleView.html?idxno=172791
4445,2018-11-09,화촉대웅제약이정석과장,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062265
4446,2018-11-09,대웅제약보툴리눔톡신나보타눈가주름적응증획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=338330
4447,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://www.ftoday.co.kr/news/articleView.html?idxno=104136
4448,2018-11-09,대웅제약인재가우선국내외인재잡기위해올인,http://www.news2day.co.kr/114411
4449,2018-11-09,대웅제약나보타눈가주름개선적응증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=84057
4450,2018-11-09,대웅나보타적응증추가로시장확대,http://www.sisa-news.com/news/article.html?no=115960
4451,2018-11-09,대웅제약나보타국내보툴리눔톡신최초눈가주름적응증획득,http://www.babytimes.co.kr/news/articleView.html?idxno=23036
4452,2018-11-09,대웅제약나보타국내최초로눈가주름적응증획득,https://www.insight.co.kr/news/190084
4453,2018-11-09,11월9일대웅16300원으로장마감,http://www.nbntv.co.kr/news/articleView.html?idxno=127932
4454,2018-11-09,대웅제약나보타국내보툴리눔톡신최초로눈가주름적응증획득,http://www.newscj.com/news/articleView.html?idxno=571029
4455,2018-11-10,㈜대웅생명과학주름개선을위한프리미엄제비집골드젤리마스크팩추천,http://www.kjdaily.com/read.php3?aid=1541808000452297203
4456,2018-11-10,대웅제약나보타국내보툴리눔톡신최초로눈가주름적응증획득,http://www.wsobi.com/news/articleView.html?idxno=67070
4457,2018-11-11,2020년글로벌톱50진입”대웅제약총력전,http://news.kmib.co.kr/article/view.asp?arcid=0924030583&code=14130000&cp=nv
4458,2018-11-12,대웅제약내년상반기중나보타미국출시자신감,http://www.rapportian.com/news/articleView.html?idxno=114012
4459,2018-11-12,더벨대웅제약수익성악화불구ETCOTC쌍끌이개선,http://www.thebell.co.kr/front/free/contents/news/article_view.asp?key=201811080100014910000924
4460,2018-11-12,대웅제약이지듀완판크림랄라블라파워팩프로모션최초공개,http://www.newsworks.co.kr/news/articleView.html?idxno=309917
4461,2018-11-12,12일대웅제약주가171500원,http://www.anewsa.com/detail.php?number=1417583&thread=10r04
4462,2018-11-12,주식주가대웅제약주가12일현재171500원,http://www.nbntv.co.kr/news/articleView.html?idxno=128364
4463,2018-11-12,대웅제약주가171000원으로마감,http://www.anewsa.com/detail.php?number=1418156&thread=10r04
4464,2018-11-12,대웅제약이지듀랄라블라와파워팩프로모션실시,http://www.bokuennews.com/news/article.html?no=167805
4465,2018-11-13,제약바이오株실적기반접근필요최선호대웅제약삼성바이오”,http://www.edaily.co.kr/news/newspath.asp?newsid=01892566619405392
4466,2018-11-13,대웅제약목표가24만원유지전일종가17만1000원NH證,http://www.newspim.com/news/view/20181113000198
4467,2018-11-13,바이오株지금이투자할때대웅제약삼바추천NH,http://www.fnnews.com/news/201811130922015661
4468,2018-11-13,13일대웅제약주가170000원,http://www.anewsa.com/detail.php?number=1418617&thread=10r04
4469,2018-11-13,대웅제약증권투자13일현재175000원,http://www.nbntv.co.kr/news/articleView.html?idxno=128917
4470,2018-11-13,대웅제약주가177500원으로마감,http://www.anewsa.com/detail.php?number=1419111&thread=10r04
4471,2018-11-14,그룹사로진화한제약기업대웅동아자회사최다,http://www.dailypharm.com/Users/News/NewsView.html?ID=246143&REFERER=NP
4472,2018-11-14,제약톡톡대웅나보타국내보톡스최초눈가주름도편다,http://news.heraldcorp.com/view.php?ud=20181114000054
4473,2018-11-14,대웅제약목표가23만원유지전일종가17만7500원한투證,http://www.newspim.com/news/view/20181114000264
4474,2018-11-14,퀵리포트대웅제약매수유지목표가23만원유지한투證,http://www.itooza.com/common/iview.php?no=2018111409175215040
4475,2018-11-14,14일대웅제약주가180000원,http://www.anewsa.com/detail.php?number=1419670&thread=10r04
4476,2018-11-14,동아유한종근당대웅블라인드채용,http://www.dailymedi.com/detail.php?number=836893&thread=22r05
4477,2018-11-14,대웅S4프로젝트로신개념경영솔루션구축,http://www.dailypharm.com/News/246173
4478,2018-11-14,11월14일대웅제약주식현황394184500원,http://www.nbntv.co.kr/news/articleView.html?idxno=129607
4479,2018-11-14,대웅주가종목그래프14일현재16550원,http://www.gokorea.kr/news/articleView.html?idxno=56524
4480,2018-11-14,대웅제약혁신통합시스템S4HANA경영인프라구축,http://www.etnews.com/20181114000509
4481,2018-11-14,한경로보뉴스대웅제약5이상상승전일기관대량순매수,http://news.hankyung.com/article/201811144983L
4482,2018-11-14,실적속보대웅제약3Q영업이익71억전년비46↓,http://www.itooza.com/common/iview.php?no=2018111414340718714
4483,2018-11-14,대웅제약3분기연결영업이익71억전년비46↓,http://www.newspim.com/news/view/20181114000886
4484,2018-11-14,코스피대웅제약분기보고서201809,http://news.kmib.co.kr/article/view.asp?arcid=0012841308&code=61141211&cp=nv
4485,2018-11-14,대웅3분기연결영업이익238억전년비9↓,http://www.newspim.com/news/view/20181114000910
4486,2018-11-14,코스피대웅분기보고서201809,http://news.kmib.co.kr/article/view.asp?arcid=0012841336&code=61141211&cp=nv
4487,2018-11-14,실적속보대웅3Q영업이익238억전년비9↓,http://www.itooza.com/common/iview.php?no=2018111414422715579
4488,2018-11-14,ET투자뉴스대웅제약_거래비중기관2913외국인289,http://www.etnews.com/20181114000591
4489,2018-11-14,ET투자뉴스대웅제약18년3분기실적매출액영업이익하락,http://www.etnews.com/20181114000638
4490,2018-11-14,대웅제약주가184000원으로종료,http://www.anewsa.com/detail.php?number=1420197&thread=10r04
4491,2018-11-14,ET투자뉴스대웅18년3분기실적발표당기순이익1745억원전년동기대비1704감,http://www.etnews.com/20181114000655
4492,2018-11-15,15일대웅제약주가180500원,http://www.anewsa.com/detail.php?number=1420768&thread=10r04
4493,2018-11-15,대웅제약주식추천주15일현재182000원,http://www.nbntv.co.kr/news/articleView.html?idxno=130478
4494,2018-11-15,양진호갑질에대웅제약윤재승전회장극악무도갑질재조명,http://www.todaykorea.co.kr/news/view.php?no=258018
4495,2018-11-16,16일대웅제약주가180000원,http://www.anewsa.com/detail.php?number=1421828&thread=10r04
4496,2018-11-16,UNIST대웅제약인공지능이용한신약개발나선다,http://www.newsworks.co.kr/news/articleView.html?idxno=311434
4497,2018-11-16,UNIST대웅제약빅데이터와인공지능활용공동신약개발,http://biz.chosun.com/site/data/html_dir/2018/11/16/2018111601409.html
4498,2018-11-16,UNIST대웅제약산학협력MOU바이오메디컬공동연구,http://news1.kr/articles/?3478685
4499,2018-11-16,대웅제약인공지능이용신약개발나선다,http://www.monews.co.kr/news/articleView.html?idxno=121936
4500,2018-11-16,대웅제약UNIST업무협약인공지능활용신약개발나서,http://www.fnnews.com/news/201811160913302151
4501,2018-11-16,대웅제약UNIST와손잡고AI이용한신약개발추진,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1062525
4502,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU,http://www.medigatenews.com/news/2293151196
4503,2018-11-16,UNIST대웅제약인공지능이용한신약개발나서,http://www.dhnews.co.kr/news/articleView.html?idxno=88356
4504,2018-11-16,UNIST대웅제약인공지능이용신약개발힘모은다,http://www.nocutnews.co.kr/news/5062123
4505,2018-11-16,대웅주가종목그래프16일현재16300원,http://www.gokorea.kr/news/articleView.html?idxno=56898
4506,2018-11-16,인공지능이용해신약개발한다UNIST대웅제약MOU,http://www.newsis.com/view/?id=NISX20181116_0000475270&cID=10814&pID=10800
4507,2018-11-16,UNIST대웅제약신약개발협약체결,http://www.newsis.com/view/?id=NISI20181116_0000230682
4508,2018-11-16,대웅제약UNIST와인공지능활용한신약개발공동연구,http://news1.kr/articles/?3478709
4509,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.sedaily.com/NewsView/1S77MFPGPT
4510,2018-11-16,대웅제약울산과기원UNIST과AI활용신약개발나서,http://www.ceoscoredaily.com/news/article.html?no=48334
4511,2018-11-16,대웅제약UNIST인공지능이용신약개발공동연구돌입,http://www.newsprime.co.kr/news/article.html?no=436545
4512,2018-11-16,대웅제약UNIST인공지능활용신약개발공동연구MOU,http://www.medisobizanews.com/news/articleView.html?idxno=56362
4513,2018-11-16,대웅제약UNIST인공지능이용신약개발공동연구,http://www.biospectator.com/view/news_view.php?varAtcId=6604
4514,2018-11-16,대웅제약UNIST와산학협력MOU바이오메디컬공동연구,http://www.g-enews.com/ko-kr/news/article/news_all/20181116133631641125b4ac5ede_1/article.html
4515,2018-11-16,대웅제약UNIST인공지능신약개발공동연구MOU체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1688409
4516,2018-11-16,UNIST대웅제약인공지능이용한신약개발나선다,http://www.ujnews.co.kr/news/articleView.html?idxno=431539
4517,2018-11-16,대웅제약인공지능활용해신약개발추진”산학협력협약체결,http://news.donga.com/3/all/20181116/92903086/2
4518,2018-11-16,대웅제약울산과학기술원과인공지능신약개발공동연구체결,http://www.rapportian.com/news/articleView.html?idxno=114174
4519,2018-11-16,대웅제약인공지능빅데이터이용신약개발추진,http://medipana.com/news/news_viewer.asp?NewsNum=228660&MainKind=A&NewsKind=5&vCount=12&vKind=1
4520,2018-11-16,대웅제약UNIST인공지능신약개발공동연구협약체결,http://www.seoulwire.com/news/articleView.html?idxno=34622
4521,2018-11-16,대웅제약UNISTAI신약개발공동연구,http://kormedi.com/?p=1255771
4522,2018-11-16,대웅제약UNIST인공지능이용신약개발공동연구,http://news.mt.co.kr/mtview.php?no=2018111613343054726
4523,2018-11-16,대웅제약UNIST인공지능이용신약개발공동연구협약,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811160388&t=NN
4524,2018-11-16,대웅제약UNIST인공지능활용해신약개발,http://www.100ssd.co.kr/news/articleView.html?idxno=57510
4525,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.newspim.com/news/view/20181116000342
4526,2018-11-16,UNIST대웅제약AI인공지능이용한신약개발추진,http://news.heraldcorp.com/view.php?ud=20181116000442
4527,2018-11-16,대웅제약UNIST와손잡고AI이용신약개발공동연구,http://moneys.mt.co.kr/news/mwView.php?no=2018111614038078390
4528,2018-11-16,대웅제약UNIST와인공지능신약개발및바이오메디컬분야공동연구,http://www.fnnews.com/news/201811161408081313
4529,2018-11-16,신약개발에도인공지능접목대웅제약UNIST도전,http://www.etnews.com/20181116000219
4530,2018-11-16,UNIST대웅제약빅데이터와인공지능활용공동신약개발,http://www.etnews.com/20181116000232
4531,2018-11-16,UNIST대웅제약인공지능이용한신약개발나선다,http://www.mdtoday.co.kr/mdtoday/index.html?no=338880
4532,2018-11-16,UNIST대웅제약인공지능이용한신약개발나선다,http://edu.donga.com/?p=article&ps=view&at_no=20181116143802916588
4533,2018-11-16,대웅제약UNIST인공지능이용신약개발공동연구,http://www.newsis.com/view/?id=NISX20181116_0000475604&cID=13001&pID=13000
4534,2018-11-16,대웅AI신약개발공동연구MOU,http://www.bosa.co.kr/news/articleView.html?idxno=2094259
4535,2018-11-16,대웅제약UNIST와인공지능활용공동신약개발나선다,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111614382475873
4536,2018-11-16,UNIST대웅제약인공지능이용한신약개발나선다,http://www.edaily.co.kr/news/newspath.asp?newsid=03253766619406376
4537,2018-11-16,대웅제약UNIST와손잡고AI활용한RD나서기로,http://news.mk.co.kr/newsRead.php?year=2018&no=720010
4538,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구,http://news.hankyung.com/article/2018111637766
4539,2018-11-16,울산과기원대웅제약인공지능활용한신약개발협약,http://app.yonhapnews.co.kr/YNA/Basic/SNS/r.aspx?c=AKR20181116104700057&did=1195m
4540,2018-11-16,대웅제약중국헬스케어컨퍼런스서파이프라인소개,http://medipana.com/news/news_viewer.asp?NewsNum=228669&MainKind=A&NewsKind=5&vCount=12&vKind=1
4541,2018-11-16,대웅제약中헬스케어회담서RD역량발표,http://www.g-enews.com/ko-kr/news/article/news_all/20181116153231828325b4ac5ede_1/article.html
4542,2018-11-16,대웅제약UNIST인공지능이용한신약개발MOU체결,http://www.medicaltimes.com/News/1122550
4543,2018-11-16,대웅제약울산과학기술원인공지능이용신약개발공동연구MOU,http://www.wikileaks-kr.org/news/articleView.html?idxno=40944
4544,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=224257
4545,2018-11-16,대웅제약UNIST인공지능활용신약공동연구나선다,http://www.sporbiz.co.kr/news/articleView.html?idxno=289171
4546,2018-11-16,대웅제약차이나헬스케어서밋참가파이프라인사업현황소개,http://news.mk.co.kr/newsRead.php?year=2018&no=720116
4547,2018-11-16,대웅제약울산과기원AI활용한신약개발협력,http://view.asiae.co.kr/news/view.htm?idxno=2018111615455455110
4548,2018-11-16,대웅제약차이나헬스케어서밋서기업비전발표,http://www.dt.co.kr/contents.html?article_no=2018111602109931102004&ref=naver
4549,2018-11-16,대웅제약ChinaHealthcareSummit서기업비전및RD역량발표,http://newsbrite.net/sub_read.html?uid=19983§ion=sc8
4550,2018-11-16,대웅제약기업비전및RD역량발표,http://www.medicaltimes.com/News/1122551
4551,2018-11-16,대웅울산과기원인공지능활용신약개발MOU,http://www.dailymedi.com/detail.php?number=837007&thread=22r05
4552,2018-11-16,대웅제약주가179000원장마쳐,http://www.anewsa.com/detail.php?number=1422319&thread=10r04
4553,2018-11-16,대웅제약ChinaHealthcareSummit서RD역량발표,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=224261
4554,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.viva100.com/main/view.php?key=20181116010006241
4555,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.ekn.kr/news/article.html?no=398045
4556,2018-11-16,대웅제약제5회차이나헬스케어서밋기업비전및RD역량발표,http://www.ekn.kr/news/article.html?no=398048
4557,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.inthenews.co.kr/news/article.html?no=12111
4558,2018-11-16,대웅제약차이나헬스케어서밋참가파이프라인소개,http://www.dailian.co.kr/news/view/752336/?sc=naver
4559,2018-11-16,대웅제약UNIST와손잡고인공지능활용한신약개발나서,http://www.newspost.kr/news/articleView.html?idxno=66811
4560,2018-11-16,대웅제약제5회차이나헬스케어섬밋서기업비전RD역량발표,http://www.mdtoday.co.kr/mdtoday/index.html?no=338931
4561,2018-11-16,대웅제약차이나헬스케어서밋서비전연구개발역량발표,http://www.wikileaks-kr.org/news/articleView.html?idxno=40953
4562,2018-11-16,대웅제약UNIST와신약개발공동연구MOU체결,http://www.economytalk.kr/news/articleView.html?idxno=173231
4563,2018-11-16,UNIST대웅제약인공지능활용한신약개발협약체결,http://www.seoul.co.kr/news/newsView.php?id=20181116500132&wlog_tag3=naver
4564,2018-11-16,대웅제약ChinaHealthcareSummit서비전RD역량발표,http://www.seoulwire.com/news/articleView.html?idxno=34662
4565,2018-11-16,대웅제약인공지능이용한신약개발나선다,http://www.bokuennews.com/news/article.html?no=168113
4566,2018-11-16,대웅제약中헬스케어박람회서기업비전RD발표,http://www.rapportian.com/news/articleView.html?idxno=114178
4567,2018-11-16,대웅제약UNISTAI이용신약개발공동연구MOU체결,http://www.getnews.co.kr/view.php?ud=20181116165942357941d0c69529_16
4568,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구,http://www.newsway.co.kr/news/view?tp=1&ud=2018111617245546633
4569,2018-11-16,대웅제약울산과학기술원과신약바이오메디컬연구,http://www.finomy.com/news/articleView.html?idxno=60239
4570,2018-11-16,비즈피플전승호대웅제약사장AI활용해신약개발추진,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018111615210183364
4571,2018-11-16,대웅제약유니스트인공지능이용한신약개발공동연구MOU체결,http://www.ftoday.co.kr/news/articleView.html?idxno=104369
4572,2018-11-16,대웅제약UNIST와손잡고인공지능이용한신약개발,https://www.insight.co.kr/news/191641
4573,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.lawissue.co.kr/view.php?ud=201811161806061982d7f4c63cc6_12
4574,2018-11-16,대웅제약UNISTAI이용신약개발MOU,http://www.upinews.kr/news/newsview.php?ncode=1065603677278692
4575,2018-11-16,대웅제약제5회ChinaHealthcareSummit에서기업비전∙RD역량발표,http://www.getnews.co.kr/view.php?ud=2018111618090280441d0c69529_16
4576,2018-11-16,대웅제약제5회ChinaHealthcareSummit에서기업비전및RD역량발표,http://www.lawissue.co.kr/view.php?ud=201811161902263633d7f4c63cc6_12
4577,2018-11-16,대웅제약UNIST인공지능이용한신약개발공동연구MOU체결,http://www.newscj.com/news/articleView.html?idxno=573584
4578,2018-11-17,UNIST대웅제약AI접목신약개발추진,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0300&key=20181117.22008007055
4579,2018-11-17,대웅中서기업비전전해다국적투자유치모색,http://www.doctorsnews.co.kr/news/articleView.html?idxno=126388
4580,2018-11-17,유니스트대웅제약인공지능이용한신약개발나선다,http://www.segye.com/content/html/2018/11/16/20181116002651.html?OutUrl=naver
4581,2018-11-17,대웅제약UNISTAI이용한신약개발MOU체결,http://www.ebn.co.kr/news/view/962172
4582,2018-11-17,UNIST대웅제약인공지능이용한신약개발나선다,http://www.boannews.com/media/view.asp?idx=74712&kind=2
4583,2018-11-18,전승호대웅제약사장中서기업비전및RD역량발표,https://www.insight.co.kr/news/191948
4584,2018-11-18,UNIST대웅제약AI이용해신약개발한다,http://hellodd.com/?md=news&mt=view&pid=66716
4585,2018-11-18,대웅기업비전신약포함RD역량공개,http://www.dailymedi.com/detail.php?number=837040&thread=22r05
4586,2018-11-18,UNIST대웅제약과인공지능활용신약개발,http://www.ksilbo.co.kr/news/articleView.html?idxno=669220
4587,2018-11-18,UNIST대웅제약인공지능활용신약개발,http://www.ujeil.com/news/articleView.html?idxno=220584
4588,2018-11-18,울산과기원대웅제약인공지능활용한신약개발나서,http://www.iusm.co.kr/news/articleView.html?idxno=825017
4589,2018-11-19,19일대웅제약주가180000원,http://www.anewsa.com/detail.php?number=1423212&thread=10r04
4590,2018-11-19,대웅제약울산과기원인공지능이용한신약개발공동연구MOU체결,http://www.babytimes.co.kr/news/articleView.html?idxno=23218
4591,2018-11-19,대웅제약기업비전RD역량발표,http://www.bosa.co.kr/news/articleView.html?idxno=2094324
4592,2018-11-19,대웅제약중국서기업비전RD역량발표,http://www.100ssd.co.kr/news/articleView.html?idxno=57604
4593,2018-11-19,증시현황19일대웅제약주가184000원,http://www.anewsa.com/detail.php?number=1423661&thread=10r02
4594,2018-11-19,대웅제약중국서기업비전발표,http://www.monews.co.kr/news/articleView.html?idxno=121974
4595,2018-11-19,대웅제약주가184500원으로마감,http://www.anewsa.com/detail.php?number=1423970&thread=10r04
4596,2018-11-19,11월16일대웅제약주식그래프084178000원,http://www.nbntv.co.kr/news/articleView.html?idxno=131010
4597,2018-11-19,건강한연말보내기대웅제약이지덤,http://www.sedaily.com/NewsView/1S79134FXZ
4598,2018-11-20,클릭e종목대웅제약내년美톡신출시로본격성장,http://view.asiae.co.kr/news/view.htm?idxno=2018112007375825655
4599,2018-11-20,퀵리포트대웅제약매수유지목표가23만원유지한투證,http://www.itooza.com/common/iview.php?no=2018112007370312718
4600,2018-11-20,대웅제약목표가23만원유지전일종가18만4500원한투證,http://www.newspim.com/news/view/20181120000056
4601,2018-11-20,대웅제약매년영업이익확대전망,http://www.nspna.com/news/?mode=view&newsid=319564
4602,2018-11-20,대웅제약美톡신상표명승인으로수익성개선기대,http://www.asiatoday.co.kr/view.php?key=20181120010011264
4603,2018-11-20,HotLine대웅제약나보타미국진출계획대로,http://news.mk.co.kr/newsRead.php?year=2018&no=725603
4604,2018-11-20,대웅제약내년상반기나보타모멘텀집중한국투자증권,http://www.etoday.co.kr/news/section/newsview.php?idxno=1689363
4605,2018-11-20,대웅제약주식사도된다미국에서보톡스나보타판매임박,http://www.businesspost.co.kr/BP?command=article_view&num=103117
4606,2018-11-20,STOCK대웅제약내년美시장나보타출시기대,http://moneys.mt.co.kr/news/mwView.php?no=2018112008458094744
4607,2018-11-20,대웅제약내년2월미국보톡스판매허가결정될것”,http://www.newspim.com/news/view/20181120000121
4608,2018-11-20,대웅제약美보툴리늄톡신상표승인매수한국투자증권,http://www.ekn.kr/news/article.html?no=398560
4609,2018-11-20,한국투자증권대웅제약내년상반기모멘텀집중장기수익성개선기대”,http://www.newsway.co.kr/news/view?tp=1&ud=2018112008515998163
4610,2018-11-20,대웅제약보툴리늄톡신미국판매기대목표가상향한투,http://www.newstomato.com/ReadNews.aspx?no=858957
4611,2018-11-20,대웅제약내년미국서본격성장한국,http://www.sedaily.com/NewsView/1S79FG4V8S
4612,2018-11-20,대웅제약나보타선진국허가기념NABOTA심포지엄진행,http://www.k-health.com/news/articleView.html?idxno=40848
4613,2018-11-20,대웅제약나보타선진국허가기념NABOTA심포지엄개최,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=224366
4614,2018-11-20,대웅제약나보타정보교류하는NABOTA심포지엄개최,http://www.ceoscoredaily.com/news/article.html?no=48434
4615,2018-11-20,대웅나보타캐나다허가선진국임상결과공유,http://www.dailypharm.com/News/246420
4616,2018-11-20,대웅제약나보타국산보툴리눔톡신최초선진국허가기념NABOTA심포지엄개최,http://www.ekn.kr/news/article.html?no=398567
4617,2018-11-20,대웅제약나보타의캐나다허가기념심포지엄개최,http://news.mk.co.kr/newsRead.php?year=2018&no=725774
4618,2018-11-20,제약계뒤안길에서대웅은위스키광동은막걸리,http://www.medisobizanews.com/news/articleView.html?idxno=56408
4619,2018-11-20,ET투자뉴스대웅제약OK대웅제약계매수유지한국투자증권,http://www.etnews.com/20181120000026
4620,2018-11-20,대웅제약나보타캐나다허가기념심포지엄열어,http://www.newsis.com/view/?id=NISX20181120_0000478032&cID=13001&pID=13000
4621,2018-11-20,대웅제약나보타심포지엄개최,http://www.g-enews.com/ko-kr/news/article/news_all/20181120093616102125b4ac5ede_1/article.html
4622,2018-11-20,특징주대웅제약보툴리늄톡신미국수출기대에강세,http://www.etoday.co.kr/news/section/newsview.php?idxno=1689410
4623,2018-11-20,대웅제약내년부터매출비중늘어,http://www.sisafocus.co.kr/news/articleView.html?idxno=196574
4624,2018-11-20,대웅제약NABOTA심포지엄,http://www.ebn.co.kr/news/view/962379
4625,2018-11-20,대웅제약나보타선진국허가기념NABOTA심포지엄개최,http://www.asiatoday.co.kr/view.php?key=20181120010011387
4626,2018-11-20,대웅제약보툴리눔톡신나보타캐나다허가기념심포지엄개최,http://www.etoday.co.kr/news/section/newsview.php?idxno=1689405
4627,2018-11-20,대웅제약선진국허가나보타정보공유장마련,http://medipana.com/news/news_viewer.asp?NewsNum=228805&MainKind=A&NewsKind=5&vCount=12&vKind=1
4628,2018-11-20,대웅제약나보타선진국허가기념심포지엄성료,http://www.wikileaks-kr.org/news/articleView.html?idxno=41172
4629,2018-11-20,대웅제약나보타캐나다허가기념심포지엄개최,http://www.newsway.co.kr/news/view?tp=1&ud=2018112009564094522
4630,2018-11-20,대웅제약나보타선진국서인정한프리미엄보툴리눔톡신,http://www.medisobizanews.com/news/articleView.html?idxno=56409
4631,2018-11-20,대웅제약내년미국톡신출시로성장목표주가23만원,https://www.insight.co.kr/news/192346
4632,2018-11-20,20일대웅제약주가189500원,http://www.anewsa.com/detail.php?number=1424466&thread=10r04
4633,2018-11-20,대웅제약나보타캐나다진출기념심포지엄열어,http://www.rapportian.com/news/articleView.html?idxno=114227
4634,2018-11-20,대웅제약이제나보타가아닌Jeuveau로불러주세요,http://www.newsworks.co.kr/news/articleView.html?idxno=312142
4635,2018-11-20,대웅제약나보타1박2일심포지엄개최,http://www.monews.co.kr/news/articleView.html?idxno=122018
4636,2018-11-20,대웅제약나보타심포지엄개최캐나다이어미국유럽공략”,http://news.donga.com/3/all/20181120/92943093/2
4637,2018-11-20,대웅제약NABOTA심포지엄진행,http://www.inthenews.co.kr/news/article.html?no=12150
4638,2018-11-20,대웅제약나보타캐나다허가기념심포지엄성료,http://www.wolyo.co.kr/news/articleView.html?idxno=71993
4639,2018-11-20,대웅제약나보타선진국허가획득기념심포지엄진행,http://www.newsprime.co.kr/news/article.html?no=436877
4640,2018-11-20,대웅제약나보타심포지엄개최,http://news.hankyung.com/article/201811203038f
4641,2018-11-20,대웅제약나보타선진국허가기념심포지엄,http://www.bosa.co.kr/news/articleView.html?idxno=2094423
4642,2018-11-20,대웅나보타캐나다허가기념심포지엄개최,http://www.sisa-news.com/news/article.html?no=116075
4643,2018-11-20,대웅제약나보타심포지엄성황리개최임상결과공유,http://www.dt.co.kr/contents.html?article_no=2018112002109931102002&ref=naver
4644,2018-11-20,대웅제약나보타캐나다허가기념심포지엄개최,http://www.kpinews.co.kr/news/articleView.html?idxno=84577
4645,2018-11-20,대웅제약나보타NABOTA심포지엄개최,http://www.getnews.co.kr/view.php?ud=20181120113014379041d0c69529_16
4646,2018-11-20,주식장대웅제약주가20일현재188500원,http://www.nbntv.co.kr/news/articleView.html?idxno=131894
4647,2018-11-20,대웅주가증권투자정보20일현재16500원,http://www.gokorea.kr/news/articleView.html?idxno=57425
4648,2018-11-20,대웅제약선진국허가기념NABOTA심포지엄,http://www.whosaeng.com/sub_read.html?uid=106161§ion=sc5
4649,2018-11-20,대웅제약주가187500원마감,http://www.anewsa.com/detail.php?number=1424959&thread=10r04
4650,2018-11-20,대웅제약나보타美FDA허가심사절차순조롭게진행내년상반기나보타시판가능,http://sports.khan.co.kr/news/sk_index.html?art_id=201811201557003&sec_id=561801&pt=nv
4651,2018-11-20,대웅제약나보타심포지엄개최,http://www.babytimes.co.kr/news/articleView.html?idxno=23262
4652,2018-11-20,대웅제약2019년톡신수익성확대예상한국투증,http://www.economytalk.kr/news/articleView.html?idxno=173489
4653,2018-11-20,대웅제약나보타선진국허가기념NABOTA심포지엄개최,https://www.insight.co.kr/news/192389
4654,2018-11-20,대웅제약나보타캐나다허가기념심포지엄개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=339221
4655,2018-11-20,대웅제약나보타국산보툴리눔톡신최초NABOTA심포지엄개최,http://www.lawissue.co.kr/view.php?ud=201811202211294530d7f4c63cc6_12
4656,2018-11-21,퀵리포트대웅제약매수유지목표가22만원유지유안타證,http://www.itooza.com/common/iview.php?no=2018112107312487292
4657,2018-11-21,대웅제약목표가22만원유지전일종가18만7500원유안타證,http://www.newspim.com/news/view/20181121000057
4658,2018-11-21,대웅제약목표가24만원유지전일종가18만7500원키움證,http://www.newspim.com/news/view/20181121000165
4659,2018-11-21,퀵리포트대웅제약매수유지목표가24만원유지키움證,http://www.itooza.com/common/iview.php?no=2018112109003014312
4660,2018-11-21,클릭e종목대웅제약내년나보타글로벌판매기대,http://view.asiae.co.kr/news/view.htm?idxno=2018112109033500066
4661,2018-11-21,21일대웅제약주가182500원,http://www.anewsa.com/detail.php?number=1425478&thread=10r04
4662,2018-11-21,ET투자뉴스대웅제약19년봄나보타의BUYREINITIATE키움증권,http://www.etnews.com/20181121000092
4663,2018-11-21,제약바이오의료기기업계이모저모대웅제약UNIST인공지능이용신약개발MOU,http://news.heraldcorp.com/view.php?ud=20181121000334
4664,2018-11-21,대웅제약주식종목21일현재183500원,http://www.nbntv.co.kr/news/articleView.html?idxno=132441
4665,2018-11-21,대웅제약나보타의캐나다허가기념심포지엄개최,http://www.etnews.com/20181121000261
4666,2018-11-21,ET투자뉴스대웅제약글로벌톡신산업에BUYM유안타증권,http://www.etnews.com/20181121000268
4667,2018-11-21,대웅제약주가184500원장마쳐,http://www.anewsa.com/detail.php?number=1426012&thread=10r04
4668,2018-11-21,대웅제약내년나보타글로벌판매기대,http://www.newsworks.co.kr/news/articleView.html?idxno=312751
4669,2018-11-22,22일대웅제약주가183000원,http://www.anewsa.com/detail.php?number=1426551&thread=10r04
4670,2018-11-22,11월22일대웅제약증권투자183500원054,http://www.nbntv.co.kr/news/articleView.html?idxno=132983
4671,2018-11-22,대웅제약주가184500원마감,http://www.anewsa.com/detail.php?number=1427139&thread=10r04
4672,2018-11-23,23일대웅제약주가182500원,http://www.anewsa.com/detail.php?number=1427664&thread=10r04
4673,2018-11-23,11월23일대웅제약오늘증권시세182000원136,http://www.nbntv.co.kr/news/articleView.html?idxno=133541
4674,2018-11-23,대웅제약주가181500원으로마감,http://www.anewsa.com/detail.php?number=1428153&thread=10r04
4675,2018-11-25,폭언갑질윤재승대웅제약회장오송공장투자책임은누구몫,http://www.asiatime.co.kr/news/articleView.html?idxno=213156
4676,2018-11-25,류재학대웅제약CH본부장부친상,http://medipana.com/news/news_viewer.asp?NewsNum=229077&MainKind=A&NewsKind=5&vCount=12&vKind=1
4677,2018-11-25,반복되는오너갑질대웅제약윤재승전회장극악무도갑질재조명,http://www.newsfreezone.co.kr/news/articleView.html?idxno=89142
4678,2018-11-25,부음류재학대웅제약CH본부장부친상,http://www.medisobizanews.com/news/articleView.html?idxno=56488
4679,2018-11-25,부고류재학씨대웅제약CH본부장부친상조현균씨아이앤솔루션대표빙부상,http://www.g-enews.com/ko-kr/news/article/news_all/20181125131453747825b4ac5ede_1/article.html
4680,2018-11-25,부음류재학씨대웅제약CH본부장부친상조현균씨아이앤솔루션대표빙부상,http://www.seoulwire.com/news/articleView.html?idxno=36035
4681,2018-11-25,부고류재학대웅제약CH본부장씨부친상,http://www.edaily.co.kr/news/newspath.asp?newsid=01751526619409328
4682,2018-11-25,부고류재학대웅제약CH본부장씨부친상,http://biz.newdaily.co.kr/site/data/html/2018/11/25/2018112500046.html
4683,2018-11-25,부고류재학대웅제약CH본부장씨부친상,http://www.wikileaks-kr.org/news/articleView.html?idxno=41541
4684,2018-11-25,부고대웅제약CH본부장류재학씨부친상,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018112513554556803
4685,2018-11-25,부고류재학씨대웅제약CH본부장부친상,http://www.nextdaily.co.kr/news/article.html?id=20181125800006
4686,2018-11-25,부고류재학대웅제약CH본부장씨부친상,http://www.dailian.co.kr/news/view/754016/?sc=naver
4687,2018-11-25,부고류재학대웅제약CH본부장부친상조현균아이앤솔루션대표빙부상,http://www.fetv.co.kr/news/article.html?no=16062
4688,2018-11-25,부고류재학씨대웅제약CH본부장부친상,http://www.shinailbo.co.kr/news/articleView.html?idxno=1121348
4689,2018-11-25,부고류재학대웅제약CH본부장부친상,http://www.viva100.com/main/view.php?key=20181125010009420
4690,2018-11-25,부고류재학대웅제약CH본부장씨부친상,http://www.mediapen.com/news/view/397960
4691,2018-11-25,부고류재학대웅제약CH본부장부친상조현균아이앤솔루션대표빙부상,http://www.ftoday.co.kr/news/articleView.html?idxno=104618
4692,2018-11-25,부고류재학대웅제약CH본부장씨부친상,http://www.kpinews.co.kr/news/articleView.html?idxno=84886
4693,2018-11-25,부고류재학대웅제약CH본부장부친상조현균아이앤솔루션대표빙부상,http://www.k-health.com/news/articleView.html?idxno=40982
4694,2018-11-25,류재학대웅제약CH본부장부친상,http://www.doctorsnews.co.kr/news/articleView.html?idxno=126531
4695,2018-11-25,부고류재학대웅제약CH본부장부친상,http://news.donga.com/3/all/20181125/93025396/2
4696,2018-11-26,부고대웅제약류재학CH본부장부친상,http://www.babytimes.co.kr/news/articleView.html?idxno=23386
4697,2018-11-26,대웅제약류재학CH본부장부친상,http://www.bosa.co.kr/news/articleView.html?idxno=2094783
4698,2018-11-26,부음류재학대웅제약CH본부장부친,http://www.dailypharm.com/Users/News/TodayFocus.html?mode=View&nKind=3&ID=16039
4699,2018-11-26,부고류재학대웅제약CH본부장씨부친상,http://www.inthenews.co.kr/news/article.html?no=12242
4700,2018-11-26,류재학대웅제약CH본부장부친상,http://www.bokuennews.com/news/article.html?no=168490
4701,2018-11-26,부고류재학대웅제약CH본부장부친상,http://www.newsprime.co.kr/news/article.html?no=437483
4702,2018-11-26,부고류재학대웅제약CH본부장씨부친상,http://www.seoulfn.com/news/articleView.html?idxno=325875
4703,2018-11-26,부고류재학대웅제약CH본부장씨부친상,http://www.newsis.com/view/?id=NISX20181126_0000483678&cID=10904&pID=16000
4704,2018-11-26,부고류재학대웅제약CH본부장씨부친상조현균아이앤솔루션대표씨빙부상,http://www.ceoscoredaily.com/news/article.html?no=48660
4705,2018-11-26,부고류재학대웅제약CH본부장부친상,http://www.sporbiz.co.kr/news/articleView.html?idxno=291656
4706,2018-11-26,부고류재학대웅제약CH본부장부친상,http://www.wolyo.co.kr/news/articleView.html?idxno=72393
4707,2018-11-26,부고대웅제약류재학CH본부장부친상,http://www.whosaeng.com/sub_read.html?uid=106327§ion=sc7
4708,2018-11-26,26일대웅제약주가185500원,http://www.anewsa.com/detail.php?number=1428954&thread=10r04
4709,2018-11-26,대웅전일대비약3상승한16600원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201811260293&t=NN
4710,2018-11-26,부고류재학대웅제약CH본부장씨부친상,http://www.newscj.com/news/articleView.html?idxno=576553
4711,2018-11-26,주가그래프대웅제약주가26일현재187000원,http://www.nbntv.co.kr/news/articleView.html?idxno=134166
4712,2018-11-26,부고류재학대웅제약CH본부장씨부친상,http://www.dt.co.kr/contents.html?article_no=2018112602109931102003&ref=naver
4713,2018-11-26,대웅제약주가188500원으로마감,http://www.anewsa.com/detail.php?number=1429469&thread=10r04
4714,2018-11-26,부고류재학씨대웅제약CH본부장부친상조현균씨아이앤솔루션대표빙부상,http://www.lawissue.co.kr/view.php?ud=201811262004279688d7f4c63cc6_12
4715,2018-11-27,제약바이오밸류로가치이동대웅제약한미약품톱픽신영證,http://news.mt.co.kr/mtview.php?no=2018112708261384345
4716,2018-11-27,대웅제약목표가22만원신규제시전일종가18만8500원신영證,http://www.newspim.com/news/view/20181127000104
4717,2018-11-27,퀵리포트대웅제약매수목표가22만원신규제시신영證,http://www.itooza.com/common/iview.php?no=2018112708343317844
4718,2018-11-27,대웅제약28일기관투자자대상기업설명회IR,http://www.etoday.co.kr/news/section/newsview.php?idxno=1692056
4719,2018-11-27,대웅제약목표가4↓24만원제시KTB證,http://www.newspim.com/news/view/20181127000137
4720,2018-11-27,퀵리포트대웅제약매수유지목표가4↓24만원KTB證,http://www.itooza.com/common/iview.php?no=2018112708551513871
4721,2018-11-27,대웅제약2019년수출기반성장세지속신영,http://news.mt.co.kr/mtview.php?no=2018112709113313655
4722,2018-11-27,27일대웅제약주가185000원,http://www.anewsa.com/detail.php?number=1429974&thread=10r04
4723,2018-11-27,대웅제약국제미용성형학회서나보타우수성알려,http://www.metroseoul.co.kr/news/newsview?newscd=2018112700044
4724,2018-11-27,대웅제약태국국제미용학회서나보타임상결과발표,http://www.etoday.co.kr/news/section/newsview.php?idxno=1692158
4725,2018-11-27,대웅제약국제미용성형학회ICAD참가,http://www.ebn.co.kr/news/view/963239
4726,2018-11-27,대웅제약국제미용성형학회참가나보타우수성알려,http://www.bosa.co.kr/news/articleView.html?idxno=2094934
4727,2018-11-27,대웅제약ICAD서나보타임상결과발표,http://www.fetv.co.kr/news/article.html?no=16166
4728,2018-11-27,대웅제약국제미용성형학회서나보타최신시술법공개,http://www.econovill.com/news/articleView.html?idxno=351371
4729,2018-11-27,대웅제약ICAD2018서나보타임상결과공유,http://medipana.com/news/news_viewer.asp?NewsNum=229201&MainKind=A&NewsKind=5&vCount=12&vKind=1
4730,2018-11-27,나보타우수성알렸다대웅제약태국국제미용성형학회참가,http://www.g-enews.com/ko-kr/news/article/news_all/20181127110906792725b4ac5ede_1/article.html
4731,2018-11-27,대웅제약국제미용성형학회ICAD2018참가나보타우수성알려,http://www.viva100.com/main/view.php?key=20181127010010124
4732,2018-11-27,대웅제약국제미용성형학회2018참가해나보타우수성알려,http://www.medigatenews.com/news/2778441285
4733,2018-11-27,대웅제약국제미용성형학회서나보타우수성알려,http://www.newsway.co.kr/news/view?tp=1&ud=2018112711244421613
4734,2018-11-27,대웅제약국제미용성형학회ICAD2018참가나보타우수성알려,http://www.getnews.co.kr/view.php?ud=20181127113041237041d0c69529_16
4735,2018-11-27,대웅제약국제미용성형학회참가나보타우수성알려,http://www.koreaittimes.com/news/articleView.html?idxno=87562
4736,2018-11-27,대웅제약방콕국제미용성형학회서나보타우수성대대적홍보,http://www.medisobizanews.com/news/articleView.html?idxno=56525
4737,2018-11-27,대웅제약위식도역류차세대신약물질임상3상승인,http://news1.kr/articles/?3486766
4738,2018-11-27,대웅제약국제미용성형학회서나보타임상결과시술법전파,http://www.seoulwire.com/news/articleView.html?idxno=36369
4739,2018-11-27,대웅제약국제미용성형학회ICAD2018참가,http://www.economytalk.kr/news/articleView.html?idxno=174049
4740,2018-11-27,대웅제약국제미용성형학회ICAD2018참가나보타우수성알려,http://www.ekn.kr/news/article.html?no=399989
4741,2018-11-27,대웅제약나보타미국유럽캐나다임상결과발표,http://www.dailymedi.com/detail.php?number=837379&thread=22r05
4742,2018-11-27,증권주식대웅제약주가27일현재187500원,http://www.nbntv.co.kr/news/articleView.html?idxno=134690
4743,2018-11-27,대웅제약ICAD서보툴리눔톡신나보타임상결과발표,http://www.k-health.com/news/articleView.html?idxno=41015
4744,2018-11-27,대웅제약국제미용성형학회서보툴리눔톡신나보타알려,http://www.nextdaily.co.kr/news/article.html?id=20181127800030
4745,2018-11-27,대웅제약국제미용성형학회서나보타우수성알려,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=224687
4746,2018-11-27,대웅제약국제미용성형학회서나보타임상결과시술법홍보,http://news.mk.co.kr/newsRead.php?year=2018&no=741694
4747,2018-11-27,대웅제약국제미용성형학회ICAD2018참가,http://www.dailypharm.com/Users/News/NewsView.html?ID=246725&REFERER=NP
4748,2018-11-27,대웅제약보툴리눔톡신나보타국제미용성형학회에서아시아시장노크,http://www.newsworks.co.kr/news/articleView.html?idxno=314218
4749,2018-11-27,대웅제약주가187000원으로종료,http://www.anewsa.com/detail.php?number=1430554&thread=10r04
4750,2018-11-27,대웅제약국제미용성형학회서나보타우수성알려,http://www.100ssd.co.kr/news/articleView.html?idxno=57805
4751,2018-11-27,대웅제약나보타태국서대규모임상결과공개,http://kormedi.com/?p=1256849
4752,2018-11-27,대웅제약국제미용성형학회참가해나보타홍보,http://www.kpinews.co.kr/news/articleView.html?idxno=85037
4753,2018-11-27,대웅제약나보타효과안정성우수”,http://www.sporbiz.co.kr/news/articleView.html?idxno=292123
4754,2018-11-27,대웅국제미용성형학회참가나보타우수성알려,http://www.newsis.com/view/?id=NISX20181127_0000485756&cID=13001&pID=13000
4755,2018-11-27,대웅제약국제미용성형학회서나보타임상결과시술법알려,http://www.mdtoday.co.kr/mdtoday/index.html?no=339903
4756,2018-11-27,대웅제약국제미용성형학회서나보타임상발표,http://www.kpanews.co.kr/article/show.asp?idx=199349&table=article&category=D
4757,2018-11-27,제약바이오성장여력여전한미대웅등유망,http://www.sentv.co.kr/news/view/546189
4758,2018-11-27,대웅제약국제미용성형학회2018참가나보타우수성알려,https://www.insight.co.kr/news/194165
4759,2018-11-27,대웅제약국제학회서나보타최신정보공유해외공략박차,http://news.donga.com/3/all/20181127/93056690/2
4760,2018-11-27,대웅제약국제미용성형학회ICAD2018참가나보타우수성알려,http://www.newscj.com/news/articleView.html?idxno=577206
4761,2018-11-27,대웅제약국제미용성형학회ICAD2018참가나보타우수성알려,http://www.lawissue.co.kr/view.php?ud=201811272255172436d7f4c63cc6_12
4762,2018-11-28,내년바이오RD기대한미대웅SK바이오팜FDA허가주목”,http://www.newspim.com/news/view/20181128000059
4763,2018-11-28,대웅제약목표가26만원유지전일종가18만7000원SK證,http://www.newspim.com/news/view/20181128000081
4764,2018-11-28,퀵리포트대웅제약매수유지목표가26만원유지SK證,http://www.itooza.com/common/iview.php?no=2018112808254019239
4765,2018-11-28,I리포트대웅제약내년나보타美FDA승인기대SK證,http://www.inews24.com/php/news_view.php?g_serial=1142092&g_menu=022300&rrf=nv
4766,2018-11-28,28일대웅제약주가188500원,http://www.anewsa.com/detail.php?number=1431025&thread=10r04
4767,2018-11-28,ICAD2018참가한대웅제약나보타우수성알려,http://www.monews.co.kr/news/articleView.html?idxno=122423
4768,2018-11-28,11월28일대웅제약주가차트189500원134,http://www.nbntv.co.kr/news/articleView.html?idxno=135236
4769,2018-11-28,ET투자뉴스대웅제약보톡스와RD를매수유지SK증권,http://www.etnews.com/20181128000286
4770,2018-11-28,국산신약30호케이캡추격나선대웅제약,http://www.newstomato.com/ReadNews.aspx?no=860769
4771,2018-11-28,대웅제약주가189000원장마쳐,http://www.anewsa.com/detail.php?number=1431587&thread=10r04
4772,2018-11-29,29일대웅제약주가189500원,http://www.anewsa.com/detail.php?number=1432160&thread=10r04
4773,2018-11-29,대웅제약베트남제약사지분투자현지화속도,http://www.dailymedi.com/detail.php?number=837550&thread=22r05
4774,2018-11-29,11월29일대웅제약주식추천주189000원000,http://www.nbntv.co.kr/news/articleView.html?idxno=135854
4775,2018-11-29,제약계하반기에도일자리창출앞장한미종근당대웅등주도,http://www.medisobizanews.com/news/articleView.html?idxno=56578
4776,2018-11-29,대웅제약주가188500원으로종료,http://www.anewsa.com/detail.php?number=1432659&thread=10r04
4777,2018-11-29,대웅제약나보타눈가주름적응증획득국내보툴리눔톡신최초,http://www.seoulwire.com/news/articleView.html?idxno=36904
4778,2018-11-29,오너리스크터진대웅제약굳건히지킨전승호대표의리더십,https://www.insight.co.kr/news/194564
4779,2018-11-30,대웅제약전국품질분임조경진대회대통령상금은상영예,http://medipana.com/news/news_viewer.asp?NewsNum=230410&MainKind=A&NewsKind=5&vCount=12&vKind=1
4780,2018-11-30,대웅제약전국품질분임조경진대회대통령상금은상수상,http://www.g-enews.com/ko-kr/news/article/news_all/20181130095308733825b4ac5ede_1/article.html
4781,2018-11-30,대웅제약품질분임조경진대회서대통령상금은상수상,http://www.mhj21.com/sub_read.html?uid=117872§ion=sc243
4782,2018-11-30,대웅제약전국품질분임조경진대회서대통령상금상은상수상,http://www.fnnews.com/news/201811300955070822
4783,2018-11-30,대웅제약품질분임조전국품질분임조경진대회대통령상금은상수상,http://www.etoday.co.kr/news/section/newsview.php?idxno=1693881
4784,2018-11-30,대웅제약품질분임조지난해이어대통령상수상영예,http://www.wolyo.co.kr/news/articleView.html?idxno=72745
4785,2018-11-30,대웅제약전국품질분임조대통령상금상은상수상,http://www.edaily.co.kr/news/newspath.asp?newsid=02040166619410968
4786,2018-11-30,대웅제약품질업무혁신올림픽서금은상수상,http://www.newsis.com/view/?id=NISX20181130_0000488866&cID=13001&pID=13000
4787,2018-11-30,대웅제약품질분임조전국경진대회대통령상금•은상수상,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=224840
4788,2018-11-30,30일대웅제약주가189500원,http://www.anewsa.com/detail.php?number=1433206&thread=10r04
4789,2018-11-30,대웅제약전국품질분임조경진대회서대통령상금은상수상,http://www.asiatime.co.kr/news/articleView.html?idxno=214580
4790,2018-11-30,대웅제약전국품질분임조경진대회서대통령상금상은상수상,http://www.insightkorea.co.kr//news/articleView.html?idxno=32554
4791,2018-11-30,대웅제약품질분임조전국품질분임조경진대회서금상은상수상,http://news.mk.co.kr/newsRead.php?year=2018&no=749793
4792,2018-11-30,대웅제약전국품절분임조경진대회서대통령상수상,http://www.monews.co.kr/news/articleView.html?idxno=122540
4793,2018-11-30,대웅제약전국품질분임조경진대회서금은상수상,http://biz.chosun.com/site/data/html_dir/2018/11/30/2018113001174.html
4794,2018-11-30,대웅제약전국품질분임조경진대회서대통령상금은상수상,http://www.medisobizanews.com/news/articleView.html?idxno=56590
4795,2018-11-30,대웅전국품질분임조경진대회잇단수상,http://www.dailymedi.com/detail.php?number=837582&thread=22r05
4796,2018-11-30,대웅제약전국품질분임조경진대회대통령상금은상수상,http://www.newsway.co.kr/news/view?tp=1&ud=2018113011202445052
4797,2018-11-30,대웅제약전국품질분임조경진대회대통령상금은상수상,http://www.fetv.co.kr/news/article.html?no=16454
4798,2018-11-30,대웅제약전국품질분임조경진대회대통령상금은상수상,http://www.seoulwire.com/news/articleView.html?idxno=37026
4799,2018-11-30,대웅전국품질분임조경진대회대통령상수상,http://www.dailypharm.com/Users/News/NewsView.html?ID=246908&REFERER=NP
4800,2018-11-30,11월30일대웅제약증권주식027189000원,http://www.nbntv.co.kr/news/articleView.html?idxno=136430
4801,2018-11-30,대웅제약전국품질분임조경진대회금은상수상,http://www.docdocdoc.co.kr/news/articleView.html?idxno=1063069
4802,2018-11-30,대웅제약품질분임조대통령상금은상수상,http://www.bosa.co.kr/news/articleView.html?idxno=2095214
4803,2018-11-30,대웅제약전문경영인체제에서원외처방지속성장,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=224855
4804,2018-11-30,대웅제약품질관리능력전국대회서금은상수상,http://www.econovill.com/news/articleView.html?idxno=351664
4805,2018-11-30,대웅제약전국품질분임조경진대회서대통령상금은상수상영예,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018113014211183057
4806,2018-11-30,대웅제약품질분임조전국품질분임조경진대회2년연속금은상수상영예,http://www.segye.com/content/html/2018/11/30/20181130002355.html?OutUrl=naver
4807,2018-11-30,대웅제약전국품질분임조경진대회금은상수상,http://www.100ssd.co.kr/news/articleView.html?idxno=57872
4808,2018-11-30,대웅제약주가189500원으로장마감,http://www.anewsa.com/detail.php?number=1433670&thread=10r04
4809,2018-11-30,대웅제약품질분임조전국품질분임조경진대회대통령상금은상수상쾌거,http://www.wikileaks-kr.org/news/articleView.html?idxno=42037
4810,2018-11-30,대웅제약전국품질분임조경진대회대통령상금∙은상수상,http://www.getnews.co.kr/view.php?ud=20181130160332562641d0c69529_16
4811,2018-11-30,대웅제약전국품질분임조경진대회서금상은상수상쾌거,https://www.insight.co.kr/news/194896
4812,2018-11-30,대웅제약향남공장품질분임조대회금은상,http://www.fnnews.com/news/201811301653070462
4813,2018-11-30,대웅제약품질분임조대통령상금은상수상,http://www.dailian.co.kr/news/view/755509/?sc=naver
4814,2018-11-30,대웅제약품질분임조지난해이어대통령상금은상수상쾌거,http://www.economytalk.kr/news/articleView.html?idxno=174452
4815,2018-11-30,대웅제약품질분임조전국품질분임조경진대회서대통령상금은상,http://www.mdtoday.co.kr/mdtoday/index.html?no=340249
4816,2018-11-30,대웅품질분임조경진대회서대통령상금은상수상영예,http://www.bokuennews.com/news/article.html?no=168850
4817,2018-11-30,대웅제약전국품질분임조경진대회서대통령상금상은상수상,http://www.newscj.com/news/articleView.html?idxno=578522
4818,2018-12-01,대웅유나이티드특허소송1건취하화해모드전환,http://www.dailypharm.com/Users/News/NewsView.html?ID=246921&REFERER=NP
4819,2018-12-01,대웅제약품질분임조전국품질분임조경진대회지난해이어대통령상금•은상수상영예,http://www.lawissue.co.kr/view.php?ud=201812011238313013d7f4c63cc6_12
4820,2018-12-01,대웅제약품질분임조전국품질분임조경진대회대통령상금은상수상,http://www.wsobi.com/news/articleView.html?idxno=67631
4821,2018-12-03,3일대웅제약주가192500원,http://www.anewsa.com/detail.php?number=1434599&thread=10r04
4822,2018-12-03,종목검색대웅제약주가3일현재191000원,http://www.nbntv.co.kr/news/articleView.html?idxno=137048
4823,2018-12-03,임상허가이벤트풍부대웅메지온신라젠스탠바이,http://www.medicaltimes.com/Users/News/NewsView.html?mode=view&ID=1122981&REFERER=NP
4824,2018-12-04,대웅모사프리드서방제제유나이티드특허소송1건취하,http://www.mdtoday.co.kr/mdtoday/index.html?no=340423
4825,2018-12-04,국내제약사바이오시밀러열기뜨겁다동아대웅제약에이어종근당가세,http://sports.khan.co.kr/news/sk_index.html?art_id=201812041526023&sec_id=561801&pt=nv
4826,2018-12-04,4일공감마감정보대웅주가17100원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=59781
4827,2018-12-05,일반약꿈나무키우는대웅이름에도공들인다,http://www.kpanews.co.kr/article/show.asp?idx=199629&table=article&category=D
4828,2018-12-05,특징주바른전자에서대웅제약까지오너리스크株줄줄이약세,http://www.sporbiz.co.kr/news/articleView.html?idxno=294217
4829,2018-12-05,5일대웅제약주가191000원,http://www.anewsa.com/detail.php?number=1436426&thread=10r04
4830,2018-12-05,대웅제약증권주식5일현재191000원,http://www.nbntv.co.kr/news/articleView.html?idxno=137788
4831,2018-12-05,대웅제약주가191000원마감,http://www.anewsa.com/detail.php?number=1437006&thread=10r04
4832,2018-12-06,6일대웅제약주가195500원,http://www.anewsa.com/detail.php?number=1437564&thread=10r04
4833,2018-12-06,한경로보뉴스대웅5이상상승전형적인상승세단기중기이평선정배열,http://news.hankyung.com/article/201812069626L
4834,2018-12-06,대웅제약주식종목6일현재192000원,http://www.nbntv.co.kr/news/articleView.html?idxno=138366
4835,2018-12-06,풍림대웅동국등14개사스티렌투엑스우판권획득,http://www.dailypharm.com/Users/News/NewsView.html?ID=247194&REFERER=NP
4836,2018-12-06,대웅제약주가189500원마감,http://www.anewsa.com/detail.php?number=1438135&thread=10r04
4837,2018-12-07,국내제약업계4분기실적희비엇갈려종근당대웅제약선방,http://www.ekn.kr/news/article.html?no=402022
4838,2018-12-07,7일대웅제약주가189500원,http://www.anewsa.com/detail.php?number=1438673&thread=10r04
4839,2018-12-07,12월7일대웅제약주식종목184000원290,http://www.nbntv.co.kr/news/articleView.html?idxno=138985
4840,2018-12-07,SK증권대웅제약보톡스와RD를동시보유,http://www.betanews.net:8080/article/941393.html
4841,2018-12-07,펩트론대웅제약과거래중단계약만료,http://view.asiae.co.kr/news/view.htm?idxno=2018120716305124207
4842,2018-12-07,펩트론대웅제약과거래중단전립선암치료제계약만료,http://news.hankyung.com/article/2018120752776
4843,2018-12-07,펩트론대웅제약과기술이전거래종료,http://yna.kr/AKR20181207133600008?did=1195m
4844,2018-12-07,펩트론계약기간만료로대웅제약과거래중단,http://www.newsis.com/view/?id=NISX20181207_0000496279&cID=10401&pID=10400
4845,2018-12-07,펩트론대웅제약과기술이전계약및원료공급거래중단,http://www.etoday.co.kr/news/section/newsview.php?idxno=1697085
4846,2018-12-07,펩트론대웅제약과전립선암치료제기술이전및원료공급거래중단,http://www.sedaily.com/NewsView/1S8DG3MXYY
4847,2018-12-07,공시펩트론대웅제약과기술이전거래종료,http://www.newsway.co.kr/news/view?tp=1&ud=2018120717145546786
4848,2018-12-07,펩트론대웅제약과기술이전거래중단,http://www.edaily.co.kr/news/newspath.asp?newsid=03263606619436224
4849,2018-12-08,대웅제약동물의약품시장진출한다동물용의약품해외출시추진,http://news1.kr/articles/?3495910
4850,2018-12-08,펩트론전립선암치료제의기술이전계약등만료로대웅제약과거래중단,http://www.econonews.co.kr/news/articleView.html?idxno=45079
4851,2018-12-08,펩트론약정만료로대웅제약과거래중단,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018120717312478394
4852,2018-12-09,펩트론대웅제약에기술이전계약기간만료거래중단,http://www.mdtoday.co.kr/mdtoday/index.html?no=340984
4853,2018-12-10,공정위도손못대는중견기업일감몰아주기풍산오뚜기하림SPC대교대웅현대,http://www.betanews.net:8080/article/945810.html
4854,2018-12-10,특징주펩트론대웅제약과기술이전거래중단에약세,http://www.newsprime.co.kr/news/article.html?no=439239
4855,2018-12-10,특징주펩트론대웅제약과기술이전거래중단소식에하락,http://www.edaily.co.kr/news/newspath.asp?newsid=01715446619437208
4856,2018-12-10,특징주펩트론대웅제약과기술이전중단에하락,http://www.etoday.co.kr/news/section/newsview.php?idxno=1697423
4857,2018-12-10,특징주펩트론대웅제약과의거래중단소식에약세,http://moneys.mt.co.kr/news/mwView.php?no=2018121009458037845
4858,2018-12-10,펩트론대웅제약에기술이전거래중단소식에약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=341034
4859,2018-12-10,10일대웅제약주가190500원,http://www.anewsa.com/detail.php?number=1439905&thread=10r04
4860,2018-12-10,대웅제약제7회웅비회송년의밤‥전현직화합과소통,http://medipana.com/news/news_viewer.asp?NewsNum=230931&MainKind=A&NewsKind=5&vCount=12&vKind=1
4861,2018-12-10,대웅제약전현직임직원화합제7회웅비회송년의밤개최,http://www.g-enews.com/ko-kr/news/article/news_all/20181210112747677125b4ac5ede_1/article.html
4862,2018-12-10,대웅제약제7회웅비회송년의밤성료,http://www.dailymedi.com/detail.php?number=837893&thread=22r05
4863,2018-12-10,대웅제약제7회웅비회송년의밤개최,http://www.bosa.co.kr/news/articleView.html?idxno=2095826
4864,2018-12-10,대웅제약웅비회전현직임직원화합과소통,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225255
4865,2018-12-10,대웅제약제7회웅비회송년의밤,http://www.econovill.com/news/articleView.html?idxno=352328
4866,2018-12-10,대웅제약제7회웅비회송년의밤열어,http://www.seoulwire.com/news/articleView.html?idxno=38605
4867,2018-12-10,대웅제약퇴직사우모임송년의밤가져,http://www.rapportian.com/news/articleView.html?idxno=114789
4868,2018-12-10,대웅제약웅비회송년의밤개최,http://www.sisa-news.com/news/article.html?no=116342
4869,2018-12-10,대웅제약전∙현직임직원화합∙소통제7회웅비회송년의밤개최,http://www.getnews.co.kr/view.php?ud=201812101154215441d0c69529_16
4870,2018-12-10,대웅주가12월10일현재17650원,http://www.gokorea.kr/news/articleView.html?idxno=60675
4871,2018-12-10,대웅제약전현직임직원화합위한웅비회송년의밤개최,http://www.metroseoul.co.kr/news/newsview?newscd=2018121000131
4872,2018-12-10,대웅제약제7회웅비회송년의밤‥전현직화합과소통,http://www.marketnews.co.kr/view.php?ud=2018121013433659798818e98b_24
4873,2018-12-10,대웅제약웅비회송년의밤성료전현직임직원소통,http://www.100ssd.co.kr/news/articleView.html?idxno=58097
4874,2018-12-10,대웅제약전현직임직원모여웅비회송년의밤행사개최,http://news.mk.co.kr/newsRead.php?year=2018&no=769938
4875,2018-12-10,대웅제약전현직임직원함께웅비회송년의밤개최,http://www.mhj21.com/sub_read.html?uid=118071§ion=sc243
4876,2018-12-10,대웅제약전현직임직원들뭉쳤다제7회웅비회송년의밤성료,http://www.medisobizanews.com/news/articleView.html?idxno=56765
4877,2018-12-10,대웅제약임직원화합소통위한제7회웅비회송년의밤개최,http://www.wolyo.co.kr/news/articleView.html?idxno=73396
4878,2018-12-10,대웅제약전현직임직원화합위한7회웅비회송년의밤개최,http://www.newsway.co.kr/news/view?tp=1&ud=2018121015041042445
4879,2018-12-10,대웅제약전현직임직원참여웅비회송년의밤개최,http://www.bokuennews.com/news/article.html?no=169272
4880,2018-12-10,대웅제약웅비회송년의밤개최,http://www.ebn.co.kr/news/view/964741
4881,2018-12-10,장종리포트대웅제약주가190500원장마쳐,http://www.anewsa.com/detail.php?number=1440488&thread=10r04
4882,2018-12-10,대웅제약눈가주름개선나보타로글로벌보톡스시장에도전,http://kor.theasian.asia/archives/197537
4883,2018-12-10,대웅제약전현직임직원소통웅비회송년의밤개최,http://www.shinailbo.co.kr/news/articleView.html?idxno=1125204
4884,2018-12-10,대웅제약전현직임직원유대강화,http://www.seoulfn.com/news/articleView.html?idxno=327544
4885,2018-12-10,대웅제약퇴직사우행사웅비회송년의밤개최,http://news.donga.com/3/all/20181210/93228707/2
4886,2018-12-10,대웅제약전현직임직원소통위한웅비회송년의밤개최,http://www.mdtoday.co.kr/mdtoday/index.html?no=341112
4887,2018-12-10,대웅제약웅비회제7회송년의밤개최,http://www.wikileaks-kr.org/news/articleView.html?idxno=42737
4888,2018-12-10,대웅제약전현직임직원화합소통위한제7회웅비회송년의밤개최,http://www.ekn.kr/news/article.html?no=402705
4889,2018-12-10,대웅제약웅비회송년의밤전현직임직원소통,http://www.kpinews.co.kr/news/articleView.html?idxno=85777
4890,2018-12-10,대웅제약화합과소통을위한제7회웅비회송년의밤개최,http://www.wsobi.com/news/articleView.html?idxno=67807
4891,2018-12-10,대웅제약제7회웅비회송년의밤열어,http://www.kpanews.co.kr/article/show.asp?idx=199851&table=article&category=D
4892,2018-12-10,대웅제약전•현직임직원화합과소통을위한제7회웅비회송년의밤개최,http://www.lawissue.co.kr/view.php?ud=20181210222046135d7f4c63cc6_12
4893,2018-12-11,대웅펩트론과계약만료루피어공급문제없어,http://www.dailypharm.com/Users/News/NewsView.html?ID=247357&REFERER=NP
4894,2018-12-11,오너→전문경영인대웅제약전문약처방호조,http://www.dailymedi.com/detail.php?number=837916&thread=22r05
4895,2018-12-11,11일대웅제약주가187500원,http://www.anewsa.com/detail.php?number=1440927&thread=10r04
4896,2018-12-11,12월11일대웅제약실시간증시188000원131,http://www.nbntv.co.kr/news/articleView.html?idxno=140285
4897,2018-12-11,대웅제약퇴직사우모임제7회웅비회송년의밤개최,https://www.insight.co.kr/news/197198
4898,2018-12-11,대웅나보타미간주름적응증안전성확인,http://www.dailypharm.com/Users/News/NewsView.html?ID=247417&REFERER=NP
4899,2018-12-11,대웅전일대비약5하락한16800원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812110400&t=NN
4900,2018-12-11,대웅제약나보타미간주름PMS안전성재확인,http://www.kpanews.co.kr/article/show.asp?idx=199893&table=article&category=D
4901,2018-12-11,대웅제약나보타재심사에서도안전성이상무,http://www.medisobizanews.com/news/articleView.html?idxno=56792
4902,2018-12-11,대웅제약나보타국내시판후조사결과안전성재확인,http://news1.kr/articles/?3498785
4903,2018-12-12,연속기획회장님이사는집대웅윤재승,http://www.ilyosisa.co.kr/news/articleView.html?idxno=200149
4904,2018-12-12,12일대웅제약주가185000원,http://www.anewsa.com/detail.php?number=1441934&thread=10r04
4905,2018-12-12,대웅제약증권플러스12일현재186500원,http://www.nbntv.co.kr/news/articleView.html?idxno=140918
4906,2018-12-13,대웅제약나보타약물이상반응에눈주위부종두통추가,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225404
4907,2018-12-13,13일대웅제약주가186500원,http://www.anewsa.com/detail.php?number=1442986&thread=10r04
4908,2018-12-13,주식종목시세대웅제약주가13일현재186000원,http://www.nbntv.co.kr/news/articleView.html?idxno=141553
4909,2018-12-14,14일대웅제약주가183500원,http://www.anewsa.com/detail.php?number=1444180&thread=10r04
4910,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.newsway.co.kr/news/view?tp=1&ud=2018121411222156340
4911,2018-12-14,대웅제약부패방지경영시스템인증획득,http://www.g-enews.com/ko-kr/news/article/news_all/20181214112232295225b4ac5ede_1/article.html
4912,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.biospectator.com/view/news_view.php?varAtcId=6798
4913,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.bosa.co.kr/news/articleView.html?idxno=2096196
4914,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://medipana.com/news/news_viewer.asp?NewsNum=231206&MainKind=A&NewsKind=5&vCount=12&vKind=1
4915,2018-12-14,대웅제약부패방지경영시스템ISO37001인증획득,http://www.mhj21.com/sub_read.html?uid=118199§ion=sc243
4916,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.getnews.co.kr/view.php?ud=20181214114903737341d0c69529_16
4917,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.econovill.com/news/articleView.html?idxno=352700
4918,2018-12-14,대웅제약13번째ISO37001인증획득,http://www.whosaeng.com/sub_read.html?uid=106796§ion=sc5
4919,2018-12-14,대웅제약부패방지경영시스템국제표준ISO37001인증,http://www.medisobizanews.com/news/articleView.html?idxno=56857
4920,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.rapportian.com/news/articleView.html?idxno=114915
4921,2018-12-14,대웅제약부패방지경영시스템국제표준ISO37001획득,http://www.seoulwire.com/news/articleView.html?idxno=39527
4922,2018-12-14,대웅제약부패방지경영시스템국제표준인증 ,http://www.seoulfn.com/news/articleView.html?idxno=328051
4923,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.m-i.kr/news/articleView.html?idxno=479568
4924,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225484
4925,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://kormedi.com/?p=1258667
4926,2018-12-14,대웅제약부패방지경영시스템ISO37001획득 ,http://www.shinailbo.co.kr/news/articleView.html?idxno=1126497
4927,2018-12-14,대웅제약부패방지경영시스템국제표준ISO37001인증획득,http://news.mk.co.kr/newsRead.php?year=2018&no=780970
4928,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.fnnews.com/news/201812141410300106
4929,2018-12-14,대웅부패방지시스템ISO37001획득윤리경영강화,http://www.dailypharm.com/Users/News/NewsView.html?ID=247585&REFERER=NP
4930,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.insightkorea.co.kr//news/articleView.html?idxno=32870
4931,2018-12-14,뉴스투데이L대웅제약부패방지경영시스템국제기준인정받아,http://www.news2day.co.kr/116759
4932,2018-12-14,대웅제약부패방지경영시스템ISO37001인증획득,http://www.kpinews.co.kr/news/articleView.html?idxno=86031
4933,2018-12-14,대웅메디톡스휴젤토종보톡스아시아경쟁본격화,http://www.newsway.co.kr/news/view?tp=1&ud=2018121414392968316
4934,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.newspim.com/news/view/20181214000433
4935,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.inthenews.co.kr/news/article.html?no=12554
4936,2018-12-14,유통오늘롯데百면접장크리스마스분위기로변신대웅제약부패방지경영시스템ISO37001획득,http://www.sisaon.co.kr/news/articleView.html?idxno=80390
4937,2018-12-14,대웅제약국제표준부패방지경영시스템ISO37001획득,http://www.businesskorea.co.kr/news/articleView.html?idxno=27472
4938,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.newstomato.com/ReadNews.aspx?no=864277
4939,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018121414410753450
4940,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.dailymedi.com/detail.php?number=838086&thread=22r05
4941,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.metroseoul.co.kr/news/newsview?newscd=2018121400040
4942,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.asiatime.co.kr/news/articleView.html?idxno=217620
4943,2018-12-14,대웅제약항암제루피어데포동종제형시장서판매1위수성,http://www.g-enews.com/ko-kr/news/article/news_all/20181214153202345025b4ac5ede_1/article.html
4944,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.ekn.kr/news/article.html?no=403709
4945,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.medigatenews.com/news/1086930953
4946,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.k-health.com/news/articleView.html?idxno=41356
4947,2018-12-14,대웅제약루피어데포GnRHa1개월지속제형시장1위,http://medipana.com/news/news_viewer.asp?NewsNum=231214&MainKind=A&NewsKind=5&vCount=12&vKind=1
4948,2018-12-14,대웅제약루피어데포고속성장동종제형시장1위수성,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225491
4949,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.ceoscoredaily.com/news/article.html?no=49730
4950,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.wikileaks-kr.org/news/articleView.html?idxno=43121
4951,2018-12-14,대웅제약항암제루피어데포같은제형시장서1위,http://www.newspim.com/news/view/20181214000551
4952,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.mhj21.com/sub_read.html?uid=118211§ion=sc243
4953,2018-12-14,대웅루피어데포글로벌까지넘본다,http://www.whosaeng.com/sub_read.html?uid=106807§ion=sc5
4954,2018-12-14,대웅제약ISO37001획득윤리경영박차,http://www.monews.co.kr/news/articleView.html?idxno=123106
4955,2018-12-14,대웅제약루피어데포주올3분기누적매출174억원으로시장1위,http://www.medisobizanews.com/news/articleView.html?idxno=56863
4956,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.getnews.co.kr/view.php?ud=201812141712586741d0c69529_16
4957,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.mdtoday.co.kr/mdtoday/index.html?no=341621
4958,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.mdtoday.co.kr/mdtoday/index.html?no=341620
4959,2018-12-14,대웅제약루피어데포초고속성장매출238억원,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83085
4960,2018-12-14,동종제형시장1위대웅제약루피어데포고성장눈길,http://kormedi.com/?p=1258765
4961,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.economytalk.kr/news/articleView.html?idxno=175560
4962,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.medigatenews.com/news/3305045888
4963,2018-12-14,뉴스투데이L대웅제약항암치료제루피어데포사업박차,http://www.news2day.co.kr/116800
4964,2018-12-14,대웅제약부패방지경영시스템글로벌인증획득,http://www.segye.com/content/html/2018/12/14/20181214003849.html?OutUrl=naver
4965,2018-12-14,14일공감주가마감대웅주가16300원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=62023
4966,2018-12-14,대웅제약부패방지경영시스템ISO37001인증획득,https://www.insight.co.kr/news/198089
4967,2018-12-14,대웅제약루피어데포동종제형시장1위올라,http://www.viva100.com/main/view.php?key=20181214010005167
4968,2018-12-14,대웅제약부패방지국제표준ISO37001인증,http://www.edaily.co.kr/news/newspath.asp?newsid=03316086619438520
4969,2018-12-14,대웅제약항암제루피어데포동종제형시장장악연매출230억원전망”,http://news.donga.com/3/all/20181214/93296445/2
4970,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.newscj.com/news/articleView.html?idxno=582510
4971,2018-12-14,대웅제약루피어데포동종제형시장1위수성,http://www.kpanews.co.kr/article/show.asp?idx=200054&table=article&category=D
4972,2018-12-14,대웅제약부패방지경영시스템ISO37001획득,http://www.kpanews.co.kr/article/show.asp?idx=200055&table=article&category=D
4973,2018-12-16,대웅제약부패방지경영시스템ISO37001획득,http://www.finomy.com/news/articleView.html?idxno=61277
4974,2018-12-16,대웅제약루피어데포제형시장1위수성,http://www.seoulwire.com/news/articleView.html?idxno=39715
4975,2018-12-16,대웅제약루피어데포동종제형시장서호실적기록,http://www.wsobi.com/news/articleView.html?idxno=67945
4976,2018-12-16,대웅제약고도성장혁신기업으로우뚝,http://news.kmib.co.kr/article/view.asp?arcid=0924045953&code=14130000&cp=nv
4977,2018-12-17,대웅루피어삼페넷슈펙트항암제라인업강화,http://www.dailymedi.com/detail.php?number=838125&thread=22r05
4978,2018-12-17,대웅제약루피어데포동종제형시장1위수성,http://www.bokuennews.com/news/article.html?no=169553
4979,2018-12-17,대웅제약루피어데포시장1위수성,http://www.bosa.co.kr/news/articleView.html?idxno=2096254
4980,2018-12-17,17일대웅제약주가183000원,http://www.anewsa.com/detail.php?number=1445639&thread=10r04
4981,2018-12-17,대웅제약항암제루피어데포올해매출230억전망,http://www.rapportian.com/news/articleView.html?idxno=114938
4982,2018-12-17,대웅제약부패방지경영시스템ISO37001획득,http://www.wsobi.com/news/articleView.html?idxno=67978
4983,2018-12-17,12월17일대웅제약증권주식183500원194,http://www.nbntv.co.kr/news/articleView.html?idxno=142788
4984,2018-12-17,펩트론대웅제약기술이전거래중단소식이후약세,http://www.mdtoday.co.kr/mdtoday/index.html?no=341749
4985,2018-12-17,장마감보고서17일대웅제약주가183000원마감해,http://www.anewsa.com/detail.php?number=1446302&thread=10r04
4986,2018-12-17,17일공감주가마감대웅주가16700원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=62433
4987,2018-12-17,대웅제약루피어데포동종제형시장1위수성,http://www.monews.co.kr/news/articleView.html?idxno=123145
4988,2018-12-17,대웅제약항암치료제루피어데포동종제형시장1위수성,http://www.lawissue.co.kr/view.php?ud=201812172246038890d7f4c63cc6_12
4989,2018-12-18,18일대웅제약주가182000원,http://www.anewsa.com/detail.php?number=1446871&thread=10r04
4990,2018-12-18,대웅전일대비약4상승한17300원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812180309&t=NN
4991,2018-12-18,대웅제약주식실시간18일현재183000원,http://www.nbntv.co.kr/news/articleView.html?idxno=143429
4992,2018-12-18,대웅주가증권투자정보18일현재17100원,http://www.gokorea.kr/news/articleView.html?idxno=62609
4993,2018-12-18,대웅특별관계자지분변동,http://news.kmib.co.kr/article/view.asp?arcid=0012928725&code=61141211&cp=nv
4994,2018-12-18,공시대웅최대주주친인척박현령씨보유주식9만1375주전량매도,http://www.newsway.co.kr/news/view?tp=1&ud=2018121817551190151
4995,2018-12-18,ET투자뉴스대웅지분변동윤재승외8명016p감소3811보유,http://www.etnews.com/20181218000358
4996,2018-12-19,대웅특별관계자지분율변동,http://www.mdtoday.co.kr/mdtoday/index.html?no=341937
4997,2018-12-19,대웅제약브릿지바이오궤양성대장염후보물질공동개발오픈이노베이션가속화,http://www.g-enews.com/ko-kr/news/article/news_all/20181219091308254225b4ac5ede_1/article.html
4998,2018-12-19,대웅제약브릿지바이오신약공동개발및기술이전계약,http://www.newspim.com/news/view/20181219000119
4999,2018-12-19,대웅면역질환후보물질도입계열최초신약개발추진,http://medipana.com/news/news_viewer.asp?NewsNum=232371&MainKind=A&NewsKind=5&vCount=12&vKind=1
5000,2018-12-19,대웅제약브릿지바이오와궤양성대장염신약후보물질도입계약체결,http://www.etoday.co.kr/news/section/newsview.php?idxno=1701371
5001,2018-12-19,대웅브릿지바이오궤양성대장염신약기술이전계약,http://www.dailypharm.com/Users/News/NewsView.html?ID=247719&REFERER=NP
5002,2018-12-19,대웅제약브릿지바이오와신약후보물질공동개발기술이전계약,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225611
5003,2018-12-19,대웅제약4000만불투입브릿지바이오파이프라인흡수,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018121909155723199
5004,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401공동개발,http://www.ceoscoredaily.com/news/article.html?no=49884
5005,2018-12-19,대웅제약브릿지바이오신약후보물질공동개발기술이전계약,http://www.dailian.co.kr/news/view/759819/?sc=naver
5006,2018-12-19,대웅제약브릿지바이오와신약후보물질공동개발및기술이전계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2018121909335959548
5007,2018-12-19,대웅제약브릿지바이오와염증성장질환신약공동개발,http://www.edaily.co.kr/news/newspath.asp?newsid=01853206619440160
5008,2018-12-19,대웅제약브릿지바이오궤양성대장염후보물질BBT401공동개발및기술이전계약,http://www.wikileaks-kr.org/news/articleView.html?idxno=43458
5009,2018-12-19,대웅제약브릿지바이오궤양성대장염신약공동개발,http://yna.kr/AKR20181219046200017?did=1195m
5010,2018-12-19,대웅제약브릿지바이오궤양성대장염신약공동개발,http://www.metroseoul.co.kr/news/newsview?newscd=2018121900024
5011,2018-12-19,대웅제약브릿지바이오와펠리노1저해제최초신약개발,http://kormedi.com/?p=1259115
5012,2018-12-19,대웅제약브릿지바이오와염증성질환치료신약후보물질도입계약체결,http://www.fnnews.com/news/201812191011356228
5013,2018-12-19,대웅제약브릿지바이오염증성장질환신약공동개발,http://www.newsis.com/view/?id=NISX20181219_0000506832&cID=13001&pID=13000
5014,2018-12-19,대웅제약궤양성대장염혁신신약후보물질기술도입,http://www.medisobizanews.com/news/articleView.html?idxno=56936
5015,2018-12-19,대웅제약브릿지바이오신약공동개발기술이전계약,http://www.kpinews.co.kr/news/articleView.html?idxno=86229
5016,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401공동개발및기술이전계약체결,http://www.ekn.kr/news/article.html?no=404508
5017,2018-12-19,대웅제약궤양성대장염신약물질도입,http://www.whosaeng.com/sub_read.html?uid=106896§ion=sc5
5018,2018-12-19,19일대웅제약주가183500원,http://www.anewsa.com/detail.php?number=1448095&thread=10r04
5019,2018-12-19,대웅제약브릿지바이오와면역질환신약기술도입계약,http://news.mt.co.kr/mtview.php?no=2018121908542599850
5020,2018-12-19,대웅제약브릿지바이오궤양성대장염신약공동개발,http://view.asiae.co.kr/news/view.htm?idxno=2018121910404449565
5021,2018-12-19,대웅제약신약후보물질BBT401기술이전계약체결,http://www.100ssd.co.kr/news/articleView.html?idxno=58288
5022,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401공동개발기술이전계약,http://www.sisajournal-e.com/biz/article/193005
5023,2018-12-19,대웅제약브릿지바이오와450억원규모기술이전계약체결,http://news.hankyung.com/article/201812191946f
5024,2018-12-19,대웅제약궤양성대장염신약후보물질확보,http://www.sedaily.com/NewsView/1S8IX4E4NP
5025,2018-12-19,대웅제약바이오벤처면역질환후보물질기술도입,http://www.bosa.co.kr/news/articleView.html?idxno=2096440
5026,2018-12-19,대웅제약브릿지바이오로부터염증성질환신약후보물질기술이전,http://www.econovill.com/news/articleView.html?idxno=352993
5027,2018-12-19,대웅제약브릿지바이오와대장염신약공동개발추진,http://www.rapportian.com/news/articleView.html?idxno=115003
5028,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401공동개발및기술이전계약체결,http://www.asiatime.co.kr/news/articleView.html?idxno=218511
5029,2018-12-19,대웅제약브릿지바이오궤양성대장염신약공동개발,http://www.seoulfn.com/news/articleView.html?idxno=328499
5030,2018-12-19,대웅제약궤양성대장염신약후보물질개발속도,http://www.monews.co.kr/news/articleView.html?idxno=123303
5031,2018-12-19,대웅제약브릿지바이오궤양성대장염치료제공동개발,http://biz.chosun.com/site/data/html_dir/2018/12/19/2018121901044.html
5032,2018-12-19,대웅제약브릿지바이오서궤양성대장염신약후보물질도입,http://news.mk.co.kr/newsRead.php?year=2018&no=790129
5033,2018-12-19,대웅제약브릿지바이오와신약후보물질공동개발기술이전계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=341966
5034,2018-12-19,대웅제약브릿지바이오와신약공동개발및기술이전계약체결,http://www.economytalk.kr/news/articleView.html?idxno=175850
5035,2018-12-19,대웅제약신약후보물질공동개발기술이전가속도,http://www.dt.co.kr/contents.html?article_no=2018121902109931102001&ref=naver
5036,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401기술이전계약,http://www.enewstoday.co.kr/news/articleView.html?idxno=1256154
5037,2018-12-19,대웅브릿지바이오궤양성대장염신약기술도입,http://www.doctorsnews.co.kr/news/articleView.html?idxno=126905
5038,2018-12-19,대웅제약브릿지바이오신약후보물질기술이전체결,http://www.inthenews.co.kr/news/article.html?no=12612
5039,2018-12-19,대웅제약증권주식19일현재183500원,http://www.nbntv.co.kr/news/articleView.html?idxno=144125
5040,2018-12-19,대웅제약브릿지바이오신약후보물질공동개발및기술이전계약체결,http://www.medigatenews.com/news/884136872
5041,2018-12-19,브릿지바이오대웅제약에염증신약물질BBT401기술이전,http://news1.kr/articles/?3505133
5042,2018-12-19,대웅제약브릿지바이오와염증성장질환신약공동개발,http://www.etnews.com/20181219000239
5043,2018-12-19,대웅제약브릿지바이오신약후보물질공동개발기술이전계약체결,http://www.wolyo.co.kr/news/articleView.html?idxno=74137
5044,2018-12-19,대웅제약브릿지바이오와신약공동개발계약체결,http://www.news2day.co.kr/117104
5045,2018-12-19,대웅제약브릿지바이오손잡고궤양성대장염치료신약개발,http://www.businesspost.co.kr/BP?command=article_view&num=106936
5046,2018-12-19,대웅제약궤양성대장염치료신약후보물질기술도입계약,http://news.donga.com/3/all/20181219/93372149/2
5047,2018-12-19,대웅제약브릿지바이오궤양성대장염신약공동개발,http://www.asiatoday.co.kr/view.php?key=20181219010012322
5048,2018-12-19,대웅제약브릿지바이오신약후보물질공동개발기술이전계약,http://www.newstomato.com/ReadNews.aspx?no=865174
5049,2018-12-19,19일마감보고대웅제약주가182500원마감,http://www.anewsa.com/detail.php?number=1448776&thread=10r04
5050,2018-12-19,대웅제약브릿지바이오궤양성대장염치료제공동개발,http://www.ajunews.com/view/20181219155437186
5051,2018-12-19,대웅제약브릿지바이오궤양성대장염신약공동개발,http://www.sporbiz.co.kr/news/articleView.html?idxno=297789
5052,2018-12-19,대웅제약신약후보물질BBT401공동개발∙기술이전계약체결,http://www.getnews.co.kr/view.php?ud=20181219161254803841d0c69529_16
5053,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401계약체결,http://www.mhj21.com/118287
5054,2018-12-19,NOAC2위꿰찬릭시아나대웅제약의힘,http://www.doctorsnews.co.kr/news/articleView.html?idxno=126920
5055,2018-12-19,대웅브릿지바이오궤양성대장염후보물질공동개발기술이전계약체결,http://www.seoulwire.com/news/articleView.html?idxno=40408
5056,2018-12-19,19일공감마감증시대웅17000원마감,http://www.gokorea.kr/news/articleView.html?idxno=63113
5057,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401공동개발및기술이전계약체결,http://www.newscj.com/news/articleView.html?idxno=583748
5058,2018-12-19,대웅제약브릿지바이오와신약후보물질BBT401공동개발및기술이전계약체결,http://www.lawissue.co.kr/view.php?ud=201812192315437998d7f4c63cc6_12
5059,2018-12-20,대웅제약브릿지바이오와신약후보물질공동개발및기술이전계약체결,https://www.insight.co.kr/news/199141
5060,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나수출계약2020년발매,http://www.g-enews.com/ko-kr/news/article/news_all/20181220093544528225b4ac5ede_1/article.html
5061,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.dailian.co.kr/news/view/760109/?sc=naver
5062,2018-12-20,대웅보툴리눔톡신나보타뉴질랜드이스라엘수출,http://medipana.com/news/news_viewer.asp?NewsNum=232446&MainKind=A&NewsKind=5&vCount=12&vKind=1
5063,2018-12-20,대웅제약나보타뉴질랜드이스라엘및우크라이나수출계약완료,http://www.fnnews.com/news/201812200944421912
5064,2018-12-20,대웅제약1200만달러규모나보타수출계약,http://view.asiae.co.kr/news/view.htm?idxno=2018122009473503257
5065,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출계약,http://news.hankyung.com/article/201812205678f
5066,2018-12-20,대웅제약나보타뉴질랜드이스라엘등135억원규모수출계약,http://www.ceoscoredaily.com/news/article.html?no=49963
5067,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.ekn.kr/news/article.html?no=404796
5068,2018-12-20,대웅제약나보타뉴질랜드이스라엘1200만弗수출계약,http://www.biospectator.com/view/news_view.php?varAtcId=6836
5069,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나3개국수출,http://biz.chosun.com/site/data/html_dir/2018/12/20/2018122001038.html
5070,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225674
5071,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.newsway.co.kr/news/view?tp=1&ud=2018122010105201058
5072,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드이스라엘수출,http://yna.kr/AKR20181220055700017?did=1195m
5073,2018-12-20,20일대웅제약주가178500원,http://www.anewsa.com/detail.php?number=1449432&thread=10r04
5074,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.newspim.com/news/view/20181220000221
5075,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나3개국수출,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812200262&t=NN
5076,2018-12-20,대웅제약나보타120억규모수출계약체결,http://www.dailypharm.com/Users/News/NewsView.html?ID=247780&REFERER=NP
5077,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출계약체결,http://www.metroseoul.co.kr/news/newsview?newscd=2018122000053
5078,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출,http://www.edaily.co.kr/news/newspath.asp?newsid=02318966619440488
5079,2018-12-20,대웅제약나보타뉴질랜드로수출,http://www.enewstoday.co.kr/news/articleView.html?idxno=1256511
5080,2018-12-20,대웅제약나보타뉴질랜드이스라엘등진출,http://www.newsis.com/view/?id=NISX20181220_0000508362&cID=13001&pID=13000
5081,2018-12-20,대웅나보타뉴질랜드이스라엘에수출계약,http://news.mk.co.kr/newsRead.php?year=2018&no=792757
5082,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드이스라엘등에1200만달러수출계약체결,http://www.businesskorea.co.kr/news/articleView.html?idxno=27630
5083,2018-12-20,대웅제약나보타해외시장공략본격화,http://www.monews.co.kr/news/articleView.html?idxno=123377
5084,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약,http://www.m-i.kr/news/articleView.html?idxno=481365
5085,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나진출,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018122010353673697
5086,2018-12-20,대웅제약나보타뉴질랜드이스라엘에수출계약1200만불공급,http://www.kukinews.com/news/article.html?no=614841
5087,2018-12-20,대웅제약나보타뉴질랜드등135억원규모수출계약,http://www.sporbiz.co.kr/news/articleView.html?idxno=298141
5088,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나에수출,http://news1.kr/articles/?3505977
5089,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.sisajournal-e.com/biz/article/193056
5090,2018-12-20,대웅제약1200만달러규모나보타수출계약,http://kormedi.com/?p=1259260
5091,2018-12-20,대웅나보타뉴질랜드이스라엘등에수출5년간1200만달러,http://www.medical-tribune.co.kr/news/articleView.html?idxno=83187
5092,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드이스라엘수출,http://www.asiatoday.co.kr/view.php?key=20181220010013060
5093,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나수출계약,http://www.etoday.co.kr/news/section/newsview.php?idxno=1702053
5094,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.economytalk.kr/news/articleView.html?idxno=175938
5095,2018-12-20,대웅제약나보타뉴질랜드등3개국수출계약,http://www.rapportian.com/news/articleView.html?idxno=115028
5096,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나수출,http://www.medisobizanews.com/news/articleView.html?idxno=56968
5097,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나수출계약완료,http://www.newsprime.co.kr/news/article.html?no=440622
5098,2018-12-20,대웅제약나보타뉴질랜드이스라엘까지진출,http://www.news2day.co.kr/117204
5099,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출계약체결,http://www.newstomato.com/ReadNews.aspx?no=865365
5100,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드이스라엘수출,http://www.kyeongin.com/main/view.php?key=20181220010006925
5101,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드이스라엘수출,http://www.kjdaily.com/read.php3?aid=1545277307455971208
5102,2018-12-20,오늘증권시세대웅제약주가20일현재181500원,http://www.nbntv.co.kr/news/articleView.html?idxno=144811
5103,2018-12-20,대웅제약브릿지바이오와신약후보물질BBT401공동개발기술이전계약,http://www.viva100.com/main/view.php?key=20181219010006769
5104,2018-12-20,대웅제약대규모수출계약호재주가는1떨어져비실비실18만5000원기록,http://www.g-enews.com/ko-kr/news/article/news_all/2018122012574071364e4869c120_1/article.html
5105,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출계약완료,http://www.joongboo.com/news/articleView.html?idxno=1312956
5106,2018-12-20,대웅제약나보타1200만불규모뉴질랜드이스라엘수출,http://www.koreaittimes.com/news/articleView.html?idxno=88126
5107,2018-12-20,대웅제약나보타보톡스한류연다세계수출길올라,http://www.ggilbo.com/news/articleView.html?idxno=576189
5108,2018-12-20,대웅제약의자체개발약품나보타뉴질랜드이스라엘등수출계약체결,http://www.asiatime.co.kr/news/articleView.html?idxno=218799
5109,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나에수출,http://www.sedaily.com/NewsView/1S8JEMCKCI
5110,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.etnews.com/20181220000176
5111,2018-12-20,대웅제약나보타수출계약완료에주가관심미FDA유럽EMA심사진행중,http://www.anewsa.com/detail.php?number=1449834&thread=10r02
5112,2018-12-20,대웅제약나보타1200만달러규모로해외수출향후주가의향배는,http://www.kookje.co.kr/news2011/asp/newsbody.asp?code=0200&key=20181220.99099008896
5113,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출미간주름개선등미용성형시술쓰여,http://www.kwnews.co.kr/view.asp?aid=218121900158&s=801
5114,2018-12-20,대웅제약나보타수출계약호재에도주가하락하락폭줄어드나관심 ,http://www.gokorea.kr/news/articleView.html?idxno=63324
5115,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약,http://www.bosa.co.kr/news/articleView.html?idxno=2096565
5116,2018-12-20,대웅제약나보타1200만달러규모수출계약체결,http://news.mk.co.kr/newsRead.php?year=2018&no=793294
5117,2018-12-20,대웅제약텔콘RF제약모두하락세대웅제약2거래일연속↓,http://www.econonews.co.kr/news/articleView.html?idxno=46748
5118,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.ajunews.com/view/20181220133647874
5119,2018-12-20,대웅제약코스피시장서롤러코스터행보보툴리눔톡신제제나보타수출효과미미,http://www.topstarnews.net/news/articleView.html?idxno=550177
5120,2018-12-20,대웅제약나보타1200만달러규모수출계약체결,http://www.100ssd.co.kr/news/articleView.html?idxno=58310
5121,2018-12-20,대웅제약나보타136억원규모뉴질랜드등수출계약,http://news.mt.co.kr/mtview.php?no=2018122014095944494
5122,2018-12-20,보톡스나보타수출대웅제약주가는전일보다하락,http://news.donga.com/3/all/20181220/93387794/2
5123,2018-12-20,대웅제약나보타뉴질랜드이스라엘등에수출어떤약품이길래,http://sports.hankooki.com/lpage/economy/201812/sp20181220141651137020.htm
5124,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출,http://www.dailymedi.com/detail.php?number=838260&thread=22r05
5125,2018-12-20,우루사알비스유명대웅제약실검에왜지난해매출9600억원평균연봉은얼마,http://www.g-enews.com/ko-kr/news/article/news_all/2018122014173932624e4869c120_1/article.html
5126,2018-12-20,대웅제약약135억규모나보타뉴질랜드이스라엘로수출,http://sports.khan.co.kr/news/sk_index.html?art_id=201812201424003&sec_id=564001&pt=nv
5127,2018-12-20,대웅제약나보타뉴질랜드이스라엘등140억수출계약체결,http://www.upinews.kr/news/newsview.php?ncode=1065590743189730
5128,2018-12-20,대웅제약나보타해외로쭉쭉뻗어나간다,http://www.segye.com/content/html/2018/12/20/20181220002730.html?OutUrl=naver
5129,2018-12-20,대웅제약왜실검지난해매출9600억원미간주름개선미용성형보톡스수출소식,http://www.sedaily.com/NewsView/1S8JELWQUW
5130,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드이스라엘수출,http://www.ebn.co.kr/news/view/966161
5131,2018-12-20,대웅제약나보타수출보툴리눔톡신제제효능무엇주름만드는근육이완,http://www.fntoday.co.kr/news/articleView.html?idxno=175083
5132,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출,http://news.bizwatch.co.kr/article/consumer/2018/12/20/0019/naver
5133,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나수출계약,http://www.mhj21.com/118319
5134,2018-12-20,대웅제약이지듀5년연속대한민국퍼스트브랜드대상수상,http://www.mdtoday.co.kr/mdtoday/index.html?no=342096
5135,2018-12-20,주름만드는근육이완효능대웅제약나보타수출에보툴리눔톡신관심,http://www.greened.kr/news/articleView.html?idxno=87976
5136,2018-12-20,대웅제약나보타뉴질랜드이스라엘수출계약소식에도주가는약세,http://www.seoulwire.com/news/articleView.html?idxno=40695
5137,2018-12-20,대웅제약나보타136억원규모수출계약해외보톡스시장잡는다”,http://news.donga.com/3/all/20181220/93389241/2
5138,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.medigatenews.com/news/3313285183
5139,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약,http://www.kpinews.co.kr/news/articleView.html?idxno=86324
5140,2018-12-20,대웅제약자체개발제품나보타수출계획수출규모는5년동안약135억원,http://www.topstarnews.net/news/articleView.html?idxno=550239
5141,2018-12-20,대웅제약나보타뉴질랜드∙이스라엘등수출계약체결,http://www.getnews.co.kr/view.php?ud=20181220151207525841d0c69529_16
5142,2018-12-20,대웅제약나보타수출소식에도불구주가는지지부진내심기대했는데,http://www.econonews.co.kr/news/articleView.html?idxno=46778
5143,2018-12-20,대웅제약나보타뉴질랜드와이스라엘우크라이나와수출계약완료FDAEMA심사절차중,http://www.yeongnam.com/mnews/newsview.do?mode=newsView&newskey=20181220.990011529593626
5144,2018-12-20,대웅제약보톡스나보타뉴질랜드이스라엘우크라이나수출하기로,http://news20.busan.com/controller/newsController.jsp?newsId=20181220000155
5145,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.mdtoday.co.kr/mdtoday/index.html?no=342126
5146,2018-12-20,대웅제약나보타뉴질랜드이스라엘팔레스타인우크라이나1200만달러수출계약완료,http://www.greened.kr/news/articleView.html?idxno=87991
5147,2018-12-20,대웅제약나보타中임상계획발뺀이유들어보니세계진출에빠진사연,http://www.youngnong.co.kr/news/articleView.html?idxno=19703
5148,2018-12-20,中빠진세계진출대웅제약나보타현지임상계획발뺀이유들어보니,http://biz.heraldcorp.com/culture/view.php?ud=201812201539436250560_1
5149,2018-12-20,장종리포트대웅제약주가181500원으로마감,http://www.anewsa.com/detail.php?number=1450054&thread=10r04
5150,2018-12-20,대웅제약해외보톡스시장에자체개발나보타1천2백만불수출계약성사,http://www.whitepaper.co.kr/news/articleView.html?idxno=134320
5151,2018-12-20,대웅제약나보타뉴질랜드이스라엘우크라이나수출,http://www.seoulfn.com/news/articleView.html?idxno=328663
5152,2018-12-20,대웅제약나보타136억규모수출계약체결,http://www.inthenews.co.kr/news/article.html?no=12649
5153,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://mbnmoney.mbn.co.kr/news/view?news_no=MM1003435549
5154,2018-12-20,대웅제약나보타수출2020년까지100개국이상발매,http://star.mt.co.kr/stview.php?no=2018122015421424227
5155,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.wikileaks-kr.org/news/articleView.html?idxno=43579
5156,2018-12-20,대웅제약보톡스제품나보타135억규모수출계약맺어,http://www.businesspost.co.kr/BP?command=article_view&num=107152
5157,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드등수출,http://news.hankyung.com/article/2018122083401
5158,2018-12-20,대웅제약나보타뉴질랜드이스라엘등글로벌진출,http://www.econovill.com/news/articleView.html?idxno=353116
5159,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약완료,http://www.seoulwire.com/news/articleView.html?idxno=40733
5160,2018-12-20,보폭넓히는대웅보톡스나보타2020년100개국이상판매목표”,http://news.kmib.co.kr/article/view.asp?arcid=0012935224&code=61121911&cp=nv
5161,2018-12-20,대웅제약나보타글로벌보톡스시장공략2020년100개국발매,http://www.4th.kr/news/articleView.html?idxno=7526
5162,2018-12-20,20일공감마감정보대웅주가16650원으로장마감,http://www.gokorea.kr/news/articleView.html?idxno=63452
5163,2018-12-20,대웅제약나보타뉴질랜드이스라엘등수출계약체결,https://www.insight.co.kr/news/199359
5164,2018-12-20,대웅제약보툴리눔톡신나보타뉴질랜드이스라엘수출,http://mbn.mk.co.kr/pages/news/newsView.php?category=mbn00003&news_seq_no=3716251
5165,2018-12-20,대웅제약나보타미국출시는언제,http://www.sporbiz.co.kr/news/articleView.html?idxno=298410
5166,2018-12-21,영상뉴스대웅제약나보타뉴질랜드이스라엘우크라이나수출계약,http://www.g-enews.com/ko-kr/news/article/news_all/201812201834074842e8b8a793f7_1/article.html
5167,2018-12-21,제약톡톡대웅나보타미FDA허가앞두고잇따라해외수출,http://news.heraldcorp.com/view.php?ud=20181221000078
5168,2018-12-21,대웅제약1200만달러규모나보타수출계약체결,https://jhealthmedia.joins.com/news/articleView.html?idxno=19929
5169,2018-12-21,시장을이겨라글로벌안면미용시장영역넓히는제약株대웅제약메디톡스,http://news.mtn.co.kr/newscenter/news_viewer.mtn?gidx=2018122109505162167
5170,2018-12-21,21일대웅제약주가180500원,http://www.anewsa.com/detail.php?number=1450709&thread=10r04
5171,2018-12-21,대웅주가12월21일현재16900원,http://www.gokorea.kr/news/articleView.html?idxno=63569
5172,2018-12-21,대웅전일대비약3상승한17200원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812210429&t=NN
5173,2018-12-21,대웅제약나보타뉴질랜드이스라엘등수출계약체결,http://www.viva100.com/main/view.php?key=20181220010007373
5174,2018-12-21,21일공감마감정보대웅17000원마감,http://www.gokorea.kr/news/articleView.html?idxno=63758
5175,2018-12-21,오너리스크위기극복한전승호대표의대웅제약에올해벌어진이슈8,https://www.insight.co.kr/news/199605
5176,2018-12-22,대웅유망바이오벤처와잇단맞손임상자금지원,http://www.dailypharm.com/Users/News/NewsView.html?ID=247825&REFERER=NP
5177,2018-12-22,포토공불련조계사대웅전서오심스님초청법회,http://www.gukjenews.com/news/articleView.html?idxno=1043640
5178,2018-12-22,포토공불련조계사대웅전서오심스님초청법회후함께,http://www.gukjenews.com/news/articleView.html?idxno=1043638
5179,2018-12-24,식약처대웅제약금연보조제품니코프리패취니코틴회수조치,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225747
5180,2018-12-24,24일대웅제약주가180500원,http://www.anewsa.com/detail.php?number=1452357&thread=10r04
5181,2018-12-24,대웅제약4대낙폭으로18만원선밑으로시간지날수록매도세,http://www.econonews.co.kr/news/articleView.html?idxno=47253
5182,2018-12-24,24일마감보고대웅제약주가180500원으로종료,http://www.anewsa.com/detail.php?number=1452874&thread=10r04
5183,2018-12-24,24일공감마감정보대웅16650원마감,http://www.gokorea.kr/news/articleView.html?idxno=64243
5184,2018-12-25,바이오벤처와오픈콜라보레이션강화대웅신약물질본격확보,http://www.mdtoday.co.kr/mdtoday/index.html?no=342450
5185,2018-12-26,12월26일대웅주식창16300원210,http://www.nbntv.co.kr/news/articleView.html?idxno=146709
5186,2018-12-26,26일대웅제약주가175000원,http://www.anewsa.com/detail.php?number=1453808&thread=10r04
5187,2018-12-26,대웅주가주가정보26일현재16350원증권그래프분석및주식시황,http://www.cctvnews.co.kr/news/articleView.html?idxno=94195
5188,2018-12-26,대웅제약국내벤처와염증성장질환신약개발추진,http://news.heraldcorp.com/view.php?ud=20181226000307
5189,2018-12-26,종목추적26일대웅제약주가172500원,http://www.anewsa.com/detail.php?number=1454278&thread=10r02
5190,2018-12-26,대웅제약주식실시간26일현재173000원,http://www.nbntv.co.kr/news/articleView.html?idxno=147454
5191,2018-12-26,시세보기대웅제약주가26일현재172500원,http://www.nbntv.co.kr/news/articleView.html?idxno=147536
5192,2018-12-26,대웅제약시세보기26일현재172500원,http://www.nbntv.co.kr/news/articleView.html?idxno=147656
5193,2018-12-26,26일마감보고대웅제약주가176000원으로장마감,http://www.anewsa.com/detail.php?number=1454620&thread=10r04
5194,2018-12-27,한경로보뉴스대웅제약5이상상승기관3일연속순매수19만주,http://news.hankyung.com/article/201812275626L
5195,2018-12-27,건기식협회올해대웅제약등18개사신규가입,http://www.newsis.com/view/?id=NISX20181227_0000513964&cID=13001&pID=13000
5196,2018-12-27,대웅주가및증권차트분석27일현재17100원증권시세,http://www.cctvnews.co.kr/news/articleView.html?idxno=95267
5197,2018-12-27,27일대웅제약주가184500원,http://www.anewsa.com/detail.php?number=1455373&thread=10r04
5198,2018-12-27,대웅오늘주식시세27일현재17100원,http://www.nbntv.co.kr/news/articleView.html?idxno=148402
5199,2018-12-27,건기식협회대웅제약등18개사신규가입,http://medipana.com/news/news_viewer.asp?NewsNum=232698&MainKind=A&NewsKind=5&vCount=12&vKind=1
5200,2018-12-27,건기식협회올해대웅제약등18개사신규가입,http://www.bokuennews.com/news/article.html?no=169955
5201,2018-12-27,건기식협회올해대웅제약등18개사신규가입,http://www.yakup.com/news/index.html?mode=view&cat=12&nid=225837
5202,2018-12-27,건기식협회올해대웅제약등18개사신규가입,http://www.getnews.co.kr/view.php?ud=20181227104056699741d0c69529_16
5203,2018-12-27,대웅제약등18개사건기식협회신규가입,http://www.kpanews.co.kr/article/show.asp?idx=200328&table=article&category=B
5204,2018-12-27,대웅종근당바이로메드등18개사건기식협회가입,http://www.dailypharm.com/Users/News/NewsView.html?ID=247968&REFERER=NP
5205,2018-12-27,주식현황대웅제약주가27일현재186000원,http://www.nbntv.co.kr/news/articleView.html?idxno=148798
5206,2018-12-27,대웅제약주식현재가27일현재185000원,http://www.nbntv.co.kr/news/articleView.html?idxno=148865
5207,2018-12-27,주식창대웅제약주가27일현재184500원,http://www.nbntv.co.kr/news/articleView.html?idxno=148960
5208,2018-12-27,아통경제27일대웅제약주가185000원,http://www.anewsa.com/detail.php?number=1455777&thread=10r02
5209,2018-12-27,한경로보뉴스대웅5이상상승,http://news.hankyung.com/article/201812277022L
5210,2018-12-27,대웅전일대비약6상승한17850원,http://news.wowtv.co.kr/NewsCenter/News/Read?articleId=A201812270424&t=NN
5211,2018-12-27,27일마감보고대웅제약주가186500원으로종료,http://www.anewsa.com/detail.php?number=1456056&thread=10r04
5212,2018-12-27,건기식협회대웅제약등올해18개사신규가입,http://www.ajunews.com/view/20181227154130261
5213,2018-12-27,대웅제약바이오메드등18개사건기식협회신규가입,http://www.etoday.co.kr/news/section/newsview.php?idxno=1704695
5214,2018-12-27,27일공감마감증시대웅17700원마감,http://www.gokorea.kr/news/articleView.html?idxno=65327
5215,2018-12-28,종목검색대웅주가28일현재17750원,http://www.nbntv.co.kr/news/articleView.html?idxno=151225
5216,2018-12-28,12월28일대웅제약주식현황190000원188,http://www.nbntv.co.kr/news/articleView.html?idxno=151440
5217,2018-12-28,28일대웅제약주가189500원,http://www.anewsa.com/detail.php?number=1456734&thread=10r04
5218,2018-12-28,장중주가28일대웅제약주가187000원,http://www.anewsa.com/detail.php?number=1457166&thread=10r02
5219,2018-12-28,장종리포트28일마감대웅제약주가188500원으로종료,http://www.anewsa.com/detail.php?number=1457499&thread=10r04
5220,2018-12-29,대웅바이오글리아타민상표권소송최종승소,http://www.dailypharm.com/Users/News/NewsView.html?ID=248016&REFERER=NP
5221,2018-12-31,12월31일대웅배당주식05617800원,http://www.nbntv.co.kr/news/articleView.html?idxno=152613
5222,2018-12-31,31일대웅제약주가188500원,http://www.anewsa.com/detail.php?number=1458560&thread=10r04
5223,2018-12-31,12월31일대웅제약주식현재가107188500원,http://www.nbntv.co.kr/news/articleView.html?idxno=152907
5224,2018-12-31,아통증시31일대웅제약주가188500원,http://www.anewsa.com/detail.php?number=1459019&thread=10r02
5225,2018-12-31,대웅주가증권그래프분석31일현재17800원및오늘시세,http://www.cctvnews.co.kr/news/articleView.html?idxno=96790
5226,2018-12-31,장종리포트31일마감대웅제약주가188500원으로마감,http://www.anewsa.com/detail.php?number=1459331&thread=10r04
